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ABSTRACT			
Background		
	 Community-based	rehabilitation	(CBR)	is	a	promising	intervention	to	address	the	complex	needs	of	people	with	schizophrenia	in	low-income	countries,	in	particular	the	high	levels	of	disability,	problems	accessing	treatment	and	stigma	experienced	by	this	group.	There	have	been	few	randomised	controlled	trials	of	community-	based	psychosocial	interventions	for	schizophrenia	using	non-specialist	workers,	and	none	which	have	utilised	a	community	mobilisation	approach	or	that	are	set	in	low-income	countries.	This	thesis	presents	the	intervention	development,	piloting	and	evaluation	plans	of	a	CBR	intervention	for	people	with	schizophrenia	in	Ethiopia.				
Methods		
	 A	theory	of	change	approach	was	used.	Intervention	development	work,	including		a	situational	analysis,	qualitative	interviews	and	participatory	workshops,	was	conducted	to	design	the	CBR	intervention.	The	intervention	was	manualised	and	ten	non-specialists	were	trained	to	deliver	CBR.	Ten	people	with	schizophrenia			and	their	caregivers	received	CBR	in	a	12	month	pilot	study.	Qualitative,	process	and	quantitative	data	were	collected.	The	protocol	for	a	cluster	randomised	trial	to	evaluate	CBR,	refined	on	the	basis	of	the	pilot	findings,	was	produced.			
Results		
	 CBR	delivered	by	non-specialists	is	an	acceptable	approach	for	people	with	schizophrenia	in	rural	Ethiopia.	This	CBR	intervention	is	likely	to	be	feasible	but	this	requires	evaluation	on	a	larger	scale.	CBR	may	improve	functioning	in	people	with	schizophrenia	through	maximising	family	and	community	support,	supporting	income-generating	activities,	facilitating	access	to	medication,	and	increasing	hope.	However,	contextual	factors,	including	poverty	and	inaccessible	anti-psychotic	medication,	may	be	beyond	the	capacity	of	CBR	to	overcome.										 		
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Conclusion	
	 A	community-based	intervention	such	as	CBR	should	be	provided	for	people	with	schizophrenia	in	low-income	countries,	alongside	accessible	anti-psychotic	medication.	There	are	indications	that	CBR	can	impact	on	functioning	but	a	randomised	controlled	trial	remains	essential.	The	trial	analysis	will	help	to	determine	the	‘active	ingredients’	of	CBR	that	should	be	prioritised	in	scaling	up.	
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ICF	 International	Classification	of	Functioning,	Disability	and	Health	IDEAS	 Indian	Disability	Evaluation	Assessment	Scale	ID	 Identification		 IDI	 In-depth	interview		 IEQ	 Involvement	Evaluation	Questionnaire		 IQR	 Interquartile	range		 LMIC	 Low	and	middle	income	countries		 LSHTM	 London	School	of	Hygiene	and	Tropical	Medicine	mhGAP	 Mental	health	Gap	Action	Programme	MHIN	 Mental	Health	Innovations	Network		 MRC	 Medical	Research	Council		 NGO	 Non-governmental	organisation	OPCRIT	 Operational	Criteria	for	Research	PANSS	 Positive	and	Negative	Syndrome	Scale	PHQ-9	 Patient	Health	Questionnaire-	9	PORT	 Schizophrenia	Patient	Outcomes	Research	Team	PRIME	 PRogramme	for	Improving	Mental	healthcarE	RAPID	 Rehabilitation	And	Prevention	Initiative	against	Disabilities	RCT	 Randomised	controlled	trial	RISE	 Rehabilitation	Intervention	for	people	with	Schizophrenia	in	Ethiopia		 ROSCA	 Rotating	Savings	and	Credit	Association	SDSS	 Social	Disability	Screening	Schedule	SMD	 Standardised	mean	difference		 SMR	 Standardised	mortality	ratio		 SOFAS	 Social	and	Occupational	Functioning	Assessment	Scale	SOP	 Standard	operating	procedure	SPIRIT	 Standard	Protocol	Items:	Recommendations	for	Interventional	
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Trials		 UN	 United	Nations		 WHO	 World	Health	Organisation		 WHODAS	2.0	 World	Health	Organisation	Disability	Assessment	Schedule	Version	2.0				
Other	terms	used	in	the	thesis	
	
Edir:	a	traditional	burial	association	that	may	also	offer	financial	or	practical	support	to	vulnerable	people.	Most	Ethiopians	are	members	of	one	or	more	edir	groups.		
Holy	water:	Holy	water	(tsebel)	is	found	at	sites	associated	with	the	Orthodox	Christian	church.	People	with	a	wide	range	of	physical	and	mental	illnesses	attend	holy	water	sites	to	bathe	in	and	drink	the	water	and	in	some	cases	to	have	the	devil	or	spirits	driven	out	of	them	by	a	holy	water	priest.		
Ihadig:	alternative	name	for	the	Ethiopian	People’s	Revolutionary	Democratic	Front	(EPRDF),	which	is	the	ruling	political	coalition	in	Ethiopia.	
	
Kebele:	Smallest	administrative	unit;	indicated	as	‘sub-district’	in	most	sections	of	the	thesis.		
Khat:	a	flowering	plant	native	to	the	Horn	of	Africa	that	contains	an	amphetamine-	like	stimulant.		
Mahber:	social	religious	meetings	usually	linked	to	the	Orthodox	Christian	church.	
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1 OUTLINE	OF	THESIS	
	
	
1.1 THESIS	STRUCTURE	
	 This	thesis	is	comprised	of	a	collection	of	research	papers	and	chapters,	which	are	the	core	outputs	to	date	of	the	Rehabilitation	Intervention	for	people	with	Schizophrenia	in	Ethiopia	(RISE)	project.	The	main	body	of	the	thesis	is	found	in	Volume	One	and	is	structured	as	follows.		
Chapter	2	is	an	introduction	that	covers	three	areas.	Section	A	describes	the	problem	that	this	thesis	aims	to	address,	namely	disability	related	to	schizophrenia.	Section	B	introduces	the	possible	solutions	to	that	problem,	focusing	on	psychosocial	interventions	for	schizophrenia	and	in	particular	community-based	rehabilitation	(CBR).	Section	C	explores	aspects	of	the	Ethiopian	context	that	are	relevant	to	the	implementation	of	CBR	for	schizophrenia,	including	existing	mental	health	services,	explanatory	models,	stigma	and	human	rights.		
Chapter	3	describes	the	rationale	for	the	thesis	as	well	as	the	aims	and	objectives.	It	also	gives	an	overview	of	the	theory	of	change	framework,	which	guided	the	work	presented	in	the	thesis,	the	timeline	and	the	setting	for	the	research.		
Chapter	4	presents	a	systematic	review,	which	will	be	prepared	for	publication,	of	the	effectiveness	of	community-based	psychosocial	interventions	for	people	with	schizophrenia	in	low	and	middle-income	countries	(LMIC).		
Chapter	5	is	a	published	paper	describing	the	development	of	a	CBR	intervention	for	people	with	schizophrenia	in	Ethiopia,	whilst	Chapter	6	presents	the	manualised	materials	I	created	to	guide	intervention	delivery.	Chapter	7	describes	the	RISE	pilot	study,	which	was	conducted	to	determine	the	acceptability	and	feasibility	of	the	CBR	intervention	in	practice.	The	pilot	is	presented	as	one	chapter	for	clarity,	but	will	be	drafted	into	two	research	papers	for	publication.		
Chapter	8	is	a	published	paper	presenting	the	protocol	for	the	RISE	cluster	randomised	trial	of	CBR	for	schizophrenia,	which	was	finalised	on	the	basis	of	the	pilot	findings.	
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Chapter	9	concludes	the	thesis	with	a	summary	of	the	findings	and	their	contributions	to	the	field	of	global	mental	health,	the	implications	of	the	findings	for	policy,	programmes	and	future	research,	as	well	as	the	limitations	of	the	research.	A	summary	of	the	RISE	trial	progress	to	date	is	also	presented.		 The	appendices	are	found	in	Volume	Two.				
1.2 CONTRIBUTIONS	OF	THE	CANDIDATE	
	 I	lived	in	Ethiopia	from	April	2013	until	October	2015	in	order	to	carry	out	the	work	contained	in	this	thesis.	I	led	on	the	planning,	data	collection,	analysis	and	write	up	of	all	aspects	of	the	intervention	development	work	(Chapter	5).	This	work	was	supervised	by	Mary	De	Silva	(London	School	of	Hygiene	and	Tropical	Medicine	(LSHTM))	and	Abebaw	Fekadu	(Addis	Ababa	University	(AAU)).	I	created	the	entire	set	of	RISE	materials	for	intervention	delivery,	including	the	RISE	manual,	training	materials	(including	slides	and	handouts)	and	assessments	(Chapter	6).	The	RISE	manual	utilised	material	from	the	COmmunity-based	intervention	for	People	with	Schizophrenia	in	India	(COPSI)	manual	with	permission	of	the	author,	Sudipto	Chatterjee	(Sangath	and	Parivartan	Trust,	India) [1].	Several	colleagues	contributed	to	revisions	of	the	RISE	manual	including	Charlotte	Hanlon	(AAU	and	Kings	College	London),	Mary	De	Silva,	Abebaw	Fekadu,	Julian	Eaton	(CBM	and	LSHTM)	and	Atalay	Alem	(AAU).		 In	relation	to	the	RISE	pilot	study	(Chapter	7),	I	led	on	the	planning,	intervention	implementation,	qualitative	and	process	data	collection	and	analysis,	and	quantitative	analysis.	I	supported	the	supervision	of	CBR	workers	delivering	the	pilot	CBR	intervention.	I	am	a	UK	public	health	speciality	registrar	with	a	medical	background,	but	I	have	no	training	in	clinical	psychiatry.	The	PRogramme	for	Improving	Mental	healthcarE	(PRIME)	project	(PI	Abebaw	Fekadu)	had	overall	responsibility	for	quantitative	data	collection	for	the	pilot.	However	at	midline	and	endline	I	revised	the	questionnaires,	led	on	data	collector	training,	produced	the	EpiData	databases	and	oversaw	data	quality	assurance	procedures.	Abebaw	Fekadu,	Charlotte	Hanlon	and	Mary	De	Silva	supported	the	pilot	implementation	through	discussion	and	critical	feedback	on	early	findings.	Rahel	Birhane	
18
(intervention	coordinator,	AAU)	was	responsible	for	the	day	to	day	running	of	the	CBR	intervention.	Alehegn	Habtamu	(research	assistant,	AAU)	conducted	the	qualitative	interviews.	Charlotte	Hanlon	supervised	the	qualitative	analysis.		 Across	all	components	of	the	RISE	project	I	was	responsible	for	financial	management,	contracting,	collaborator	liaison,	and	the	hiring	and	training	of	RISE	project	staff	and	CBR	workers	and	supervisors.	Data	collectors	were	recruited	and	managed	by	the	PRIME	project.	I	am	the	principal	investigator	and	trial	manager	of	the	RISE	trial	and	I	led	on	the	preparation	of	all	aspects	of	the	trial	protocol	(Chapter	8)	with	the	exception	of	the	cost-effectiveness	analysis	section,	which	was	prepared	by	Dan	Chisholm	(World	Health	Organisation	(WHO)).	Abebaw	Fekadu,	Mary	De	Silva,	Charlotte	Hanlon	and	Vikram	Patel	supported	the	design	of	the	trial.	Helen	Weiss	(LSHTM)	gave	support	on	the	statistical	analysis	and	randomisation	sections.				
1.3 ADDITIONAL	STUDY	OUTPUTS	
	 In	addition	to	the	research	presented	in	this	thesis,	I	have	achieved	several	other	outputs	from	the	RISE	study.		 1. First	author	on	a	paper	prepared	for	publication	‘“I	cry	every	day	and	night.	I	
have	my	son	tied	in	chains”:	Physical	restraint	of	people	with	schizophrenia	in	
community	settings	in	Ethiopia”.	To	be	submitted	to	Globalization	and	Health.	This	paper	uses	qualitative	data	from	the	interviews	conducted	for	the	RISE	intervention	development.	2. First	author	on	a	paper	in	preparation	for	publication	‘Competence	of	non-	
specialists	delivering	community-based	rehabilitation	for	people	with	
schizophrenia	in	Ethiopia’.	To	be	submitted	to	BMC	Psychiatry.	This	paper	presents	process	and	qualitative	data	collected	as	part	of	the	RISE	pilot,	as	well	as	the	adaptation	and	piloting	of	the	ENACT	(Enhancing	Assessment	of	Common	Therapeutic	Factors)	scale	[2],	which	I	led	on.	
3. Co-author	on	a	published	paper	‘Theory	of	Change:	a	theory-driven	approach	
to	enhance	the	Medical	Research	Council's	framework	for	complex	
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interventions’.	Published	in	Trials,	July	2014	[3].	This	paper	features	the	RISE	theory	of	change.	4. Co-author	on	a	published	paper,	‘Systematic	review	of	the	feasibility	and	
acceptability	of	psychosocial	interventions	for	schizophrenia	in	low	and	
middle	income	countries’.	Published	in	BMC	Psychiatry,	April	2015	[4].	I	produced	the	search	strategy	and	conducted	the	database	searches	for	this	review.	5. Co-author	on	a	published	paper	‘Beyond	the	biomedical:	community	
resources	for	mental	health	care	in	rural	Ethiopia’.	Published	in	PLoS	One,	December	2015	[5].	I	contributed	to	the	data	analysis	and	led	on	the	discussion,	using	knowledge	gained	during	the	RISE	intervention	development.	6. Last	author	on	a	paper	in	preparation	for	publication	‘Involvement	of	people	
with	schizophrenia	in	decision-making	relating	to	their	care	in	Ethiopia’.	This	paper	presents	qualitative	data	collected	as	part	of	the	RISE	pilot.				
1.4 INTRODUCTION	TO	ETHIOPIA	
	 Ethiopia,	which	is	officially	named	the	Federal	Democratic	Republic	of	Ethiopia,	is	a	landlocked	country	in	the	horn	of	Africa	(see	Figures	1.1	and	1.2).	The	capital	city	is	Addis	Ababa	and	the	country	is	divided	into	nine	ethnically-based	and	politically	autonomous	regional	states.	There	is	a	total	population	of	97	million	people	and	the	official	language	is	Amharic.	34.4%	of	the	population	belong	to	the	Oromo	ethnic	group,	whilst	27%	are	Amhara,	6.2%	are	Tigray	and	the	remaining	population	belong	to	other	ethnic	groups	[6].	According	to	the	2007	national	census,	43.5%	of	the	population	are	Ethiopian	Orthodox	Christian,	33.9%	are	Muslim,	18.5%	are	Protestant	and	2.7%	of	the	population	follow	a	traditional	belief	system.	Ethiopia	is	classified	by	the	World	Bank	as	a	low-income	economy,	and	had	a	Gross	Domestic	Product	per	capita	of	US$	619.1	in	2015	[7].	Ethiopia	is	one	of	the	largest	recipients	of	donor	aid	in	Africa,	receiving	almost	US$	3	billion	in	2015,	and	has	also	received	substantial	investment	from	China	[8].	Whilst	the	country	has	experienced	strong	economic	growth	in	the	past	decade,	much	of	the	population	continues	to	live	in	poverty.	Approximately	81%	of	the	Ethiopian	population	live	in	
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rural	areas,	where	only	7.6%	of	people	have	access	to	electricity	[7].	Whilst	unemployment	rates	are	low	(4.5%	of	the	total	labour	workforce),	there	are	very	high	rates	of	vulnerable	employment	(88.8%;	defined	as	unpaid	family	workers	and	own-account	workers)	[7].	Of	those	employed,	72.7%	are	estimated	to	work	in	agriculture	[7].	The	ruling	political	party	is	the	Ethiopian	People’s	Revolutionary	Democratic	Front	(EPRDF),	which	gained	power	in	1991.	In	the	2015	election	the	EPRDF	won	all	546	of	the	parliamentary	seats.	Opposition	supporters	and	journalists	are	reportedly	routinely	jailed	to	silence	dissent	[8].	In	2015	and	2016	there	have	been	numerous	anti-government	protests	and	severe	droughts	in	Ethiopia	[9,	10].		
	
Figure	1.1	Location	of	Ethiopia	
21
	
	
Figure	1.2	Map	of	Ethiopia	
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2 BACKGROUND	TO	THESIS	
	
	
SECTION	A:	BACKGROUND	TO	SCHIZOPHRENIA	
	
2.1 CLINICAL	FEATURES	AND	COURSE	OF	SCHIZOPHRENIA	
	
2.1.1 Clinical	features	
	 Schizophrenia	is	a	severe	mental	illness	that	is	characterised	by	its	heterogeneous	presentation.	In	acute	schizophrenia	positive	symptoms	predominate,	including	those	relating	to	reality	distortion	(hallucinations	and	delusions)	and	disorganisation	of	thoughts	and	behaviours.	Many	people	with	schizophrenia	progress	to	the	chronic	syndrome,	in	which	negative	symptoms	are	prominent.	Negative	symptoms	comprise	lack	of	motivation,	poor	self-care	and	social	withdrawal	[1,	2].	Cognitive	deficits	are	another	feature	of	schizophrenia,	including	problems	with	learning,	memory	and	attention	[3].	Depressive	symptoms	such	as	low	mood	and	anhedonia	are	also	common.	Negative,	cognitive	and	depressive	symptoms	may	all	be	present	from	the	onset	of	the	acute	syndrome	[1,	2].		 It	is	widely	accepted	that	the	illness	experience	of	schizophrenia,	for	example	the	content	of	delusions,	differs	by	cultural	context.	There	is	on	going	debate	as	to	whether	the	structure	and	symptom	composition	of	schizophrenia,	for	example	the	prevalence	or	form	of	delusions,	is	unaffected	by	culture	and	ethnicity	[4]	or	whether	cross-cultural	variations	exist	[5].				
2.1.2 Diagnosis	and	classification	
	 The	diagnosis	of	schizophrenia	is	made	on	the	basis	of	psychiatric	assessment,	structured	using	diagnostic	criteria.	The	DSM-IV	(Diagnostic	and	Statistical	Manual	for	Mental	Disorders,	4th	Edition)	criteria	for	schizophrenia	were	used	for	this	research	[2].	The	DSM-IV	describes	a	number	of	disorders	that	have	substantial	symptomatic	overlap	with	schizophrenia,	including	schizoaffective	disorder	and	schizophreniform	disorder.	This	thesis	describes	the	design,	pilot	and	evaluation	plans	for	an	intervention	for	people	with	schizophrenia,	schizoaffective	disorder	or	
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schizophreniform	disorder.	However,	for	clarity	the	term	schizophrenia	will	be	used	to	encompass	these	broader	diagnoses	throughout	the	thesis.		 The	validity	of	diagnostic	criteria	across	cultures	has	been	challenged	[5-7].	Such	criteria	nevertheless	represent	a	useful	approach	for	categorising	the	experience	of	mental	distress	in	order	to	allow	comparison	of	research	findings	between	settings.				
2.1.3 Clinical	recovery	and	course	
	 Following	the	first	psychotic	episode,	the	course	of	schizophrenia	tends	to	comprise	of	relapses	of	severe	psychotic	symptoms,	with	periods	of	partial	remission	in	between.	However,	the	course	of	schizophrenia	is	highly	variable	between	individuals	[8].	Determinants	of	outcome	may	include	clinical,	social	and	cultural	factors,	though	the	precise	mechanisms	are	not	well	understood	[9].	International	cohort	studies	have	demonstrated	substantial	heterogeneity	in	schizophrenia	outcomes	between	countries	[10,	11].	Traditionally,	these	differences	have	been	described	along	the	lines	of	‘developed’	and	‘developing’	countries,	with	the	latter	supposedly	associated	with	more	favourable	outcomes	[11,	12].	The	variations	have	been	attributed	to	the	supposed	high	levels	of	family	and	community	support	and	tolerance	for	people	with	mental	illness	in	LMIC	[13].	Others	have	challenged	these	assertions,	pointing	to	the	high	mortality	rates	in	low-income	settings,	which	could	have	caused	differential	attrition	of	severe	cases	[13-15].	Results	from	the	Butajira	Severe	Mental	Disorder	Study	in	Ethiopia	(the	‘Butajira	cohort’)	demonstrated	that	nearly	57%	of	participants	experienced	either	an	episodic	course	or	continuous	psychotic	symptoms	over	a	10-year	period,	whilst	only	11.8%	of	participants	experienced	a	single	psychotic	episode	followed	by	complete	remission	[16].	Unlike	previous	reports	[10,	12],	these	findings	indicated	that	outcomes	in	low-income	settings	might	be	comparable	to,	or	even	less	favourable	than,	those	in	high-income	countries.	The	Butajira	cohort,	set	in	the	Butajira	area	of	Southern	Ethiopia,	followed	people	with	severe	mental	illness	(schizophrenia,	bipolar	disorder	and	severe	depression)	from	1998	to	2013.	In	total	919	participants	were	included,	359	of	whom	had	schizophrenia.	90%	of	participants	were	treatment	naïve	at	recruitment	to	the	cohort.	The	Butajira	
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cohort	has	given	us	a	remarkably	rich	understanding	of	schizophrenia	in	the	Ethiopian	setting,	as	compared	to	any	other	low-income	country,	producing	data	on	course	and	outcome,	mortality,	disability,	stigma,	violent	victimization	and	caregiver	burden	[15-24].	These	findings	are	relevant	to	this	thesis	as	the	Butajira	area	is	adjacent	to	Sodo	district,	the	setting	for	this	research.		 Different	definitions	of	clinical	recovery	have	been	proposed,	but	typically	relate	to	symptom	remission	and	an	achieved	level	of	functioning	[25-27],	in	some	cases	for	a	specified	time	period	e.g.	two	years	[25].	Several	large-scale	studies	across	high	and	middle-income	countries	have	indicated	that	around	50%	of	people	with	schizophrenia	will	experience	clinical	recovery	[10,	27].				
2.1.4 Aetiology	
	 The	principal	influence	on	the	aetiology	of	schizophrenia	is	genetic;	approximately	80%	of	the	risk	is	inherited	[28].	Several	environmental	and	social	factors	have	been	identified,	including	birth	complications,	migration,	urban	living	and	paternal	age,	which	interact	with	the	genetic	predisposition	to	produce	a	neuro-	developmental	disturbance.	This	disturbance	is	the	origin	of	symptoms	which	may	or	may	not	later	emerge	[2].	Ethiopian	explanatory	models	for	schizophrenia	will	be	considered	in	Section	2.8.				
2.2 EPIDEMIOLOGY	OF	SCHIZOPHRENIA	
	
2.2.1 Incidence	
	 A	2004	systematic	review	found	a	median	schizophrenia	incidence	rate	of	15.2	(10%–90%	quantile	7.7,	43.0)	per	100,000	[29].	Rates	were	significantly	higher	in	men	compared	to	women,	in	urban	areas	compared	to	rural	areas	and	in	migrant	compared	to	native	populations	[29].	With	a	few	exceptions	this	review	included	only	studies	from	high-income	countries.	A	more	recent	review	of	incidence	studies	outside,	geographically,	of	North	America,	Europe,	and	Australasia	[30],	found	rates	ranging	from	11.0/	100,000	in	China	to	58.5/	100,000	in	India.	Yet	of	the	14	included	studies,	this	review	also	did	not	identify	any	data	from	low-income	
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countries,	and	there	was	only	one	study	from	the	African	continent	[30].	No	convincing	patterns	between	geographical	areas	were	detected.	There	are	currently	no	schizophrenia	incidence	estimates	available	from	Ethiopia.				
2.2.2 Prevalence	
	 There	is	more	information	available	on	the	prevalence	of	schizophrenia	in	LMIC.	A	2005	systematic	review	included	188	studies	conducted	across	46	countries,	including	several	low-income	countries	and	five	African	nations	[31].	Median	lifetime	prevalence	was	4.0	per	1,000	persons	(10%–90%	quantiles	1.6,	12.1)	[31].	No	significant	differences	were	found	between	men	and	women	or	between	urban	and	rural	sites,	but	the	prevalence	was	higher	in	migrants	compared	to	native-	born	individuals.	The	authors	found	that	prevalence	estimates	from	‘‘least	developed’’	countries	were	borderline	significantly	lower	than	those	from	‘‘emerging’’	or	‘‘developed’’	sites	(p=	0.04)	[31].	However,	lifetime	prevalence	estimates	from	the	baseline	of	the	Butajira	cohort	(which	were	not	included	in	the	review)	are	4.7/1000	[20],	slightly	higher	than	the	median	estimates	from	the	review.				
2.2.3 Mortality	There	is	a	recognized	association	between	schizophrenia	and	premature	mortality	[32].	A	2007	systematic	review	of	37	articles	from	25	nations	found	the	median	standardised	mortality	ratio	(SMR)	for	persons	with	schizophrenia	for	all-cause	mortality	was	2.58	(10%-90%	quantile	1.18,	5.76)[33].	At	10	years,	data	from	the	Butajira	cohort	showed	that	in	rural	Ethiopia	the	SMR	in	people	with	schizophrenia	was	higher	at	3.03	(95%	confidence	interval	(CI)	2.34,	3.86)	compared	to	the	general	population	[17].	Across	all	diagnoses	the	commonest	cause	of	death	was	infectious	disease	(49.6%),	followed	by	injury,	including	suicide	(15.7%)	and	accidents	(9.1%)	[17].	Compared	to	a	mean	life	expectancy	of	55.7	years	(95%	CI	50.6,	60.8)	in	the	general	population,	people	with	schizophrenia	in	Butajira	have	a	life	expectancy	of	46.3	years	(95%	CI	41.9,	50.6)	[17].	Increased	mortality	was	predicted	by	a	longer	duration	in	a	symptomatic	state	[17].	Higher	mortality	rates	amongst	people	with	mental	illness	are	likely	to	be	due	to	a	range	
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of	factors	including	poorer	access	to,	and	quality	of	,healthcare	[34],	poverty	and	overburdened	family	support	networks	[17,	34]	and	a	direct	contribution	of	psychopathology	[17].	In	high-income	settings	where	there	is	greater	availability	of	atypical	anti-psychotic	medication,	cardiovascular	disease	associated	with	metabolic	syndrome	(a	known	adverse	effect	of	this	group	of	drugs)	is	also	implicated	[33].				
2.3 DISABILITY	RELATING	TO	SCHIZOPHRENIA	
	
2.3.1 Model	of	disability	and	application	to	schizophrenia	The	conceptualisation	of	disability	is	multi-faceted,	complex	and	evolving.	The	WHO	has	attempted	to	define	and	classify	disability	with	the	International	Classification	of	Functioning,	Disability	and	Health	(ICF)[35].	A	key	principle	of	the	ICF	is	parity	between	physical	and	mental	health;	hence	the	framework	uses	neutral	language	and	does	not	differentiate	between	types	and	causes	of	disability	on	this	basis	[35].	The	ICF	describes	three	types	of	problems	with	human	functioning:	impairments	(problems	with	body	function	and	structure),	activity	limitations	and	participation	restrictions.	Disability	signifies	difficulties	faced	in	any	or	all	three	areas	of	functioning.	Table	2.1	gives	examples	of	these	three	functioning	problems	for	physical	and	mental	illness.			
Table	2.1	Functioning	problems	associated	with	physical	and	mental	illness	
	
Functioning	problem	 Physical	illness	 Mental	illness	
Impairment	 Paralysis;	blindness	 Poor	cognition	e.g.	problems	with	learning	
Activity	limitation	 Problems	with	walking	or	eating	 Poor	self	care	
Participation	
restriction	
Problems	using	public	transport	 Problems	participating	in	community	activities	
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Underpinning	the	ICF	is	the	notion	that	disability	arises	from	a	combination	of	environmental	and	disease	factors,	echoing	the	principles	of	the	United	Nations	(UN)	Convention	on	the	Rights	of	Persons	with	Disabilities	[36].	Environmental	factors,	which	may	be	either	facilitators	or	barriers,	include	products	and	technology;	the	natural	and	built	environment;	support	and	relationships;	attitudes;	and	services,	systems,	and	policies	[35].	The	prominence	of	the	environment	in	this	model	represents	an	important	shift	from	the	traditional	medical	model	of	disability,	in	which	problems	with	functioning	were	understood	solely	in	terms	of	bodily	impairments	[35].	Personal	factors,	such	as	age,	gender	and	coping	style,	are	also	recognised	as	contributory.	Figure	2.1	shows	the	generic	conceptual	model	of	the	ICF.		
Figure	2.1	ICF	framework	for	disability	
	
	
	
	
	The	ICF	framework	can	be	readily	applied	to	understand	the	genesis	of	disability	related	to	schizophrenia	[37,	38].	This	is	demonstrated	by	a	qualitative	study	in	the	Butajira	district,	which	found	that	broader	environmental	factors	were	at	least	as	important	as	clinical	symptoms	in	shaping	functioning	in	people	with	severe	mental	illness.	These	environmental	factors	included	lack	of	support	and	low		
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expectations	from	family	members;	poverty;	and	stigma	and	discrimination	[39].	Medication	side	effects	and	personal	factors,	such	as	a	low	self-	expectation	of	capacity,	were	also	influential	[39].	Some	groups	have	promoted	the	notion	that	psychotic	symptoms,	in	particular	hearing	voices,	can	be	a	meaningful	or	even	positive	experience,	rather	than	necessarily	a	disabling	one	[40].	However	the	Butajira	qualitative	study	showed	that	in	rural	Ethiopia	neither	people	with	mental	illness,	nor	the	wider	community,	conceive	of	any	functional	benefit	of	psychotic	illness	[39].		Figure	2.2	gives	an	overview	of	the	potential	key	factors	contributing	towards	disability	in	people	with	schizophrenia,	using	the	ICF	framework.	These	factors	could	vary	greatly	between	individuals	and	settings.	Figure	2.2	was	adapted	from	a	diagram	presented	by	Vroman	et	al	[37]	and	modified	to	reflect	the	findings	of	the	background	literature	review.		
Figure	2.2	Model	of	disability	relating	to	schizophrenia		
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2.3.2 Nature	of	disability	relating	to	schizophrenia	People	with	schizophrenia	may	experience	a	wide	range	of	problems	with	functioning,	which	can	be	classified	according	to	the	ICF	definitions	(see	Figure	2.2).	Problems	with	mental	functions	may	include	difficulties	with	cognition,	such	as	attention	and	learning;	hallucinations	and	disordered	thought;	difficulties	expressing	emotions;	lack	of	motivation;	and	problems	with	sleep.	Problems	with	activities	may	include	difficulties	managing	a	daily	routine,	handling	stress,	having	a	conversation,	doing	household	tasks,	self-care	and	problems	with	inter-personal	relationships.	Problems	with	participation	may	include	difficulties	in	education,	work,	and	recreation	and	leisure	[37].		 There	are	several	studies	from	high-income	countries	demonstrating	high	levels	of	disability	in	people	with	schizophrenia	[41,	42].	In	a	six-country	cohort	study	of	schizophrenia	in	Europe,	85%	had	some	degree	of	disability;	the	prevalence	remained	high	over	several	years	of	illness	[42].	No	clear	relationship	was	found	between	disability	levels	and	gender,	age,	onset	or	duration	of	untreated	illness	[42].	There	are	less	data	available	on	functioning	in	people	with	schizophrenia	in	LMICs	[9].	Results	from	the	Butajira	cohort	show	70.2%	of	participants	had	severe	functional	impairment,	measured	with	the	Global	Assessment	of	Functioning	scale	[16].	Over	four	years	of	follow	up	and	treatment	there	was	a	significant	trend	in	functional	improvement,	although	these	changes	were	not	as	substantial	as	improvements	in	positive	symptoms	[19].	There	was	an	inverse	relationship	between	symptom	scores	and	improvements	in	physical	and	social	functioning	and	role	limitations	[19].				
2.3.3 Disability,	mental	health	and	poverty	There	is	a	general	consensus	that	poverty	and	mental	health	are	highly	correlated	in	both	high	and	low-income	countries	[43].	On	the	one	hand	people	with	disabilities,	including	those	arising	from	mental	illness,	are	prone	to	experiencing	financial	hardship	(the	‘social	drift’	hypothesis).	This	may	be	due	to	inability	to	work	in	the	person	with	disability	or	their	family	(due	to	caring	responsibilities)	and/or	increased	healthcare	expenditure	[44-46].	In	the	Butajira	cohort,	75%	of	caregivers	reported	financial	difficulties	and	53%	had	problems	working	as	a	
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result	of	their	relative’s	illness[47].	The	qualitative	study	in	Butajira	found	that	for	many	people	with	severe	mental	illness,	impaired	functioning	meant	an	inability	to	farm	effectively.	This	in	turn	led	to	poverty,	signifying	that	functioning	problems	had	a	powerful	immediate	impact	on	survival	[39].	On	the	other	hand	people	living	in	poverty	have	a	greater	risk	of	developing	mental	disorders	[43],	though	this	social	causation	pathway	may	apply	more	readily	to	common	mental	disorders	compared	to	schizophrenia	[48].	Sen's	capabilities	approach	states	that	lack	of	development	arises	from	social	exclusion	and	disempowerment	rather	than	simply	lack	of	money	[49].	These	broader	social	factors	are	highly	relevant	to	people	with	schizophrenia	in	low-income	settings,	and	help	to	explain	why	this	group	experiences	high	levels	of	both	poverty	and	disability.				
2.3.4 Measurement	of	disability	In	order	to	fully	capture	the	experience	of	disability,	it	is	important	that	measurement	goes	beyond	simply	considering	impairment	to	assessing	activities	and	participation	[35].	The	WHO	Disability	Assessment	Schedule	(WHODAS)	2.0	comprises	questions	about	bodily,	individual	and	societal	functioning,	and	may	be	applied	to	both	mental	and	physical	disorders	as	diverse	as	schizophrenia	and	back	pain	[50].	The	WHODAS	is	conceptually	compatible	with	the	ICF	[51].	The	36-	item	version	provides	a	profile	of	functioning	across	six	activity	domains	(understanding	and	communicating,	getting	around,	self-care,	getting	along	with	others,	household	and	work	activities,	and	participation	in	society)	and	a	general	disability	score	[51].		 The	strength	of	such	generic	methods	of	assessing	disability	is	that	they	allow	comparisons	between	conditions	and	settings.	However,	there	are	growing	calls	to	advance	our	understanding	of	local	concepts	of	functioning	relating	to	mental	illness,	to	take	into	account	the	cultural,	social	and	economic	context	[13,	39,	52].	The	qualitative	study	in	Butajira	found	that	the	components	of	functioning	most	likely	to	be	affected	by	severe	mental	illness	corresponded	to	the	WHODAS	domains,	as	well	as	being	broadly	consistent	with	similar	studies	from	other	LMIC	[39].	However	the	study	found	that	within	these	broad	categories	there	are	specific	tasks	that	may	be	less	generalizable.	For	example,	there	was	emphasis	on	particular	types	of	farm	work	and	a	gendered	patterning	of	functioning	and	
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impairment.	It	follows	that	meaningful	assessment	of	functioning	may	only	be	possible	with	instruments	designed	to	tap	into	those	aspects	of	functioning	most	important	in	that	setting	[52,	53].		 One	of	the	Grand	Challenges	for	global	mental	health	is	to	“Incorporate	functional	impairment	and	disability	into	assessment”[54].	There	are	several	reasons	why	disability	or	functional	status	is	of	central	importance	in	the	assessment	of	the	impact	of	schizophrenia	and	evaluations	of	interventions	for	this	group.		 1. Poor	 functioning	 is	 a	 core	 feature	 of	 schizophrenia,	 forming	 part	 of	 the	diagnostic	criteria	[1,	2].	2. Absence	of	symptoms	is	not	necessarily	associated	with	functional	recovery	[55].	 Though	 some	 studies	 have	 found	 clear	 correlations	 [50],	 functional	impairments	 may	 not	 be	 entirely	 correlated	 with	 positive	 or	 negative	symptoms	 [51,	 56,	 57].	 It	 is	 therefore	 important	 to	 measure	 functioning	separately.	3. Inability	 to	work	by	 the	 person	with	 schizophrenia	 or	 their	 caregiver	 has	important	 economic	 consequences.	 A	 stronger	 case	 for	 investment	 in	mental	 health	 services	 may	 be	 made	 if	 high	 levels	 of	 disability	 in	 the	population	are	demonstrated,	and	improvements	in	disability	can	be	shown	from	an	intervention	[48].	4. People	 with	 schizophrenia	 may	 place	 greater	 value	 on	 improvements	 in	social	functioning	compared	to	improvements	in	positive	symptoms	[58].			
2.4 CONCEPTUALISATION	OF	RECOVERY	In	recent	decades	there	has	been	a	shift	in	the	concept	of	recovery	relating	to	severe	mental	illnesses	such	as	schizophrenia	[27].	According	to	the	traditional	concept	(often	known	as	‘clinical	recovery’)	recovery	is	an	observable	outcome,	often	dichotomous,	which	is	usually	determined	by	a	clinician	and	whose	criteria	does	not	vary	between	individuals	(See	Section	2.1.3)	[59].		 More	recently	the	concept	of	‘personal	recovery’	has	emerged,	driven	by	the	mental	health	service	user	movement,	but	now	prominent	in	mental	health	policy	and	practice	in	many	high-income	countries	[59].	The	key	tenets	of	personal	recovery	are	that	it	is	a	process	and	a	continuum;	that	it	is	a	subjective	concept	
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which	differs	between	individuals;	and	that	it	can	only	be	determined	by	the	person	experiencing	the	mental	health	problem,	rather	than	a	clinician	or	other	outsider	[59].	According	to	one	of	the	most	influential	descriptions,	recovery	is,	“a	deeply	personal,	unique	process	of	changing	one’s	attitudes,	values,	feelings,	goals,	skills,	and/or	roles.	It	is	a	way	of	living	a	satisfying,	hopeful,	and	contributing	life	even	with	limitations	caused	by	illness.	Recovery	involves	the	development	of	new	meaning	and	purpose	in	one’s	life	as	one	grows	beyond	the	catastrophic	effects	of	mental	illness”	[60].	A	more	recent	conceptual	framework	describes	five	key	recovery	processes:	connectedness;	hope	and	optimism	about	the	future;	identity;	meaning	in	life;	and	empowerment	[61].	There	are	currently	few	data	on	rates	of	personal	recovery	[27,	59].		 Little	is	known	about	the	cross-cultural	applicability	of	the	recovery	concept,	or	whether	it	can	be	meaningfully	transferred	to	LMIC	settings	with	limited	resources	to	provide	even	basic	mental	health	care	(see	Section	2.9.1)	[62,	63].	The	potential	inability	of	the	recovery	approach	to	adequately	address	macro-level	factors	that	may	affect	wellbeing	(including	poverty,	stigma	and	discrimination)	has	also	been	highlighted	[64].	Concepts	of	recovery	may	be	influenced	by	ethnicity,	with	black	and	minority	ethnic	groups	in	high-income	settings	[61]	and	people	with	mental	illness	in	Asia	[65]	and	Africa	[66]	placing	particular	emphasis	on	the	role	of	spirituality.	Collective	notions	of	recovery	may	also	be	an	important	influence	[62].				
2.5 DISEASE	BURDEN	AND	GLOBAL	HEALTH	IMPORTANCE	OF	SCHIZOPHRENIA	
	
2.5.1 Disease	burden	The	2010	Global	Burden	of	Disease	study	estimated	that	mental	and	substance	use	disorders	contributed	to	183.9	million	disability-adjusted	life	years	(DALYs)	(95%	CI	153.5	million,	216.7	million)	worldwide,	which	equates	to	7.4%	(6.2,	8.6)	of	total	disease	burden	[67].	Mental	and	substance	use	disorders	were	the	fifth	leading	disorder	category	of	global	DALYs	[67].	The	burden	relating	to	mental	and	substance	use	disorders	had	risen	from	5.4%	(4.5,	6.2)	in	1990,	a	change	largely	driven	by	population	growth	and	ageing	[67,	68].	As	proportions	of	all	mental	and	substance	use	disorders,	schizophrenia	contributed	7.4%	(4.9,	9.9)	to	the	total	years	lived	with	disability,	7.1%	(4.8,	10.2)	to	years	of	life	lost	and	7.4%	(5.0,	9.9)	
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to	DALYs	[67].	The	burden	associated	with	schizophrenia	peaked	between	25	to	50	years	of	age	[67].				
2.5.2 Global	health	importance	Using	disease	burden	instead	of	mortality	in	setting	public	health	priorities	has	been	central	to	the	increased	recognition	of	mental	disorders	on	the	global	health	agenda	[67].	Researchers	have	also	successfully	drawn	attention	to	the	substantial	global	economic	burden	of	mental	illness	[69,	70].	There	is	now	a	global	movement	striving	to	improve	the	lives	of	people	with	mental	illness,	primarily	through	improving	access	to	treatment.	This	was	spearheaded	by	two	Lancet	series	on	global	mental	health	[71,	72],	as	well	as	a	global	initiative	to	identify	Grand	Challenges	in	mental	health	[54].	There	has	been	increased	funding	for	global	mental	health	research	and	considerable	international	commitment	has	been	shown	with	adoption	of	the	WHO’s	Comprehensive	Mental	Health	Action	Plan	2013–2020.	In	another	important	step	forward	there	is	specific	inclusion	of	mental	health	in	the	Sustainable	Development	Goals,	which	was	absent	from	the	Millennium	Development	Goals	[73,	74].	A	parallel	development	is	the	increasing	inclusion	of	mental	health	into	the	non-communicable	disease	agenda	[75].		 Yet	severe	mental	illness	has	arguably	not	benefitted	to	the	same	extent	as	common	mental	disorders,	let	alone	physical	health	conditions,	in	terms	of	increased	attention	and	investment	[76].	This	may	be	partly	due	to	the	limitations	of	using	the	Global	Burden	of	Disease	estimates	in	isolation	to	understand	the	burden	of	schizophrenia	[68].	First,	these	metrics	do	not	include	excess	mortality	associated	with	schizophrenia,	as	only	deaths	directly	attributable	to	the	mental	disorder	are	included	(for	example,	suicide	is	classified	as	injury).	Second,	severe	mental	illnesses	such	as	schizophrenia	have	lower	prevalence	than	common	mental	disorders;	this	means	that	high	levels	of	disability	in	individuals	do	not	translate	to	a	high	place	in	the	burden	rankings	of	mental	disorders.	Third,	the	significant	social	and	economic	effects	of	schizophrenia,	in	particular	the	loss	of	economic	productivity	amongst	both	those	affected	and	their	caregivers,	are	not	reflected	in	these	estimates.	Finally,	human	rights	violations	are	not	taken	into	account	[68]. 
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 The	need	to	increase	the	priority	of	severe	mental	illness	such	as	schizophrenia	has	been	strongly	argued	[76],	alongside	a	general	call	to	look	beyond	economic	concerns	in	priority	setting	for	mental	health	[77].	The	young	age	of	onset,	chronic	course,	high	levels	of	disability	and	mortality,	psychological	distress,	family	burden,	social	exclusion,	loss	of	productivity	and	human	rights	violations	associated	with	schizophrenia	renders	it	capable	of	exerting	a	catastrophic	impact	on	individuals	and	their	families	in	low-income	settings.	The	next	section	describes	the	potential	interventions	and	models	of	care	that	may	address	the	needs	of	people	with	schizophrenia	in	LMICs.	
36
SECTION	B:	INTERVENTIONS	AND	MODELS	OF	CARE	FOR	
SCHIZOPHRENIA	
2.6 INTERVENTIONS	FOR	THE	TREATMENT	OF	SCHIZOPHRENIA	
	
2.6.1 Overview	of	effective	interventions	There	is	some	evidence	that	accessing	treatment	for	schizophrenia	does	improve	functional	outcomes.	For	example	a	cohort	study	in	India	comparing	the	course	of	treated	and	untreated	schizophrenia	demonstrated	that	those	not	receiving	treatment	with	antipsychotic	medication	are	likely	to	have	enduring	disability	over	time	[78].	However,	it	has	also	been	demonstrated	that	outcomes,	including	functioning,	have	not	improved	substantially	over	the	last	100	years	despite	developments	in	anti-psychotic	medication	and	psychosocial	interventions	[79].	This	suggests	that	the	relationship	between	treatment	and	functioning	is	far	from	straightforward.		 The	third	edition	of	the	Disease	Control	Priorities	(DCP-3),	published	by	the	World	Bank,	includes	recommendations	for	the	most	effective	and	cost-effective	interventions	for	schizophrenia	in	LMICs	[68].	The	DCP-3,	along	with	the	WHO’s	mental	health	Gap	Action	Programme	(mhGAP)	guidelines	[80],	recommends	a	combination	of	anti-psychotic	medication	and	psychosocial	interventions	for	the	treatment	of	schizophrenia	[68,	76].	Anti-psychotic	medication	has	been	shown	to	be	cost-effective	in	treating	schizophrenia	[68],	as	well	as	effective	at	preventing	relapse	[81].	Drug	treatments	generally	have	most	effect	on	positive	symptoms,	with	typically	little	effect	on	negative	symptoms	[82].	With	the	exception	of	clozapine,	there	is	little	to	distinguish	different	anti-psychotic	medications	(including	typical	and	atypical	antipsychotics)	in	terms	of	effectiveness.	However	the	more	burdensome	side	effect	profile	of	typical	anti-psychotic	medication	is	a	significant	disadvantage	of	this	group	of	drugs	[76,	83,	84].		 There	are	several	rationales	for	the	routine	use	of	psychosocial	interventions,	a	position	first	formally	endorsed	by	the	WHO	with	its	1996	Psychosocial	Rehabilitation	Consensus	Statement	[85].	First,	the	chronic	and	disabling	course	of	schizophrenia,	and	the	relative	inefficacy	of	anti-psychotic	medication	in	improving	functioning	[82],	mean	a	broader	supportive	approach	focused	on	rehabilitation	is	also	required.	Second,	psychosocial	interventions	typically	align	
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with	the	principles	of	personal	recovery,	for	example	supported	employment	and	social	skills	training	help	individuals	to	achieve	their	personal	goals	[27].	Third	psychosocial	interventions	are	more	likely	to	address	problems	with	functioning,	which	may	be	a	greater	priority	for	people	with	mental	illness	compared	to	addressing	positive	symptoms	[53].		 The	Schizophrenia	Patient	Outcomes	Research	Team	(PORT)	evidence-based	recommendations,	developed	in	the	United	States,	include	eight	psychosocial	interventions,	all	of	which	are	recommended	as	an	adjunct	to	pharmacotherapy:	assertive	community	treatment,	supported	employment,	cognitive	behavioural	therapy,	family-based	services,	token	economy,	skills	training,	and	psychosocial	interventions	for	alcohol,	substance	use	disorders	and	weight	management	[86].	Table	2.2	contains	a	summary	of	the	evidence	for	each	of	these	interventions.	PORT	excluded	recommendations,	on	the	basis	of	lack	of	evidence	of	effectiveness,	for	cognitive	retraining/	remediation,	adherence	therapy	and	self-help	or	peer	support	groups	[86].	
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Table	2.2	Overview	of	evidence	for	psychosocial	interventions	for	schizophrenia	(continued	overleaf)		
	
Psychosocial	intervention		 Systematic	reviews	across	all	settings*			 Individual	studies	from	low	and	middle-income	countries**		
Evidence	source			 Evidence	of	
effectiveness		
Quality			 Evidence	source			 Evidence	of	effectiveness***		
Recommended	by	PORT		
Assertive	community		 2010	Cochrane	review	of	intensive		 Effective	at	reducing		 Moderate		 8	studies	(China	[88,	89],	Iran		 May	be	effective	at	reducing		
treatment		 case	management		(38	studies-	0		 hospitalisation,		 quality		 [90,	91],	Malaysia	[92],	South		 admissions	&	relapse	rates,			 LMIC)	[87]		 increasing	social		 	 Africa	[93-95],	Turkey	[96])		 and	improving	functioning.				 	 functioning,	increasing		 	 	 		 	 retention	in	care		 	 	 	
		 2015	Cochrane	review	of	crisis	intervention	(8	studies-	0	LMIC	[97]		 Effective	at	reducing	hospital	admissions			 Low	–	moderate	quality		
None	identified		 n/a		
Supported	employment		 2013	Cochrane	review	of	supported	employment	(14	studies	–	0	LMIC)	[98]		
Effective	at	improving	vocational	outcomes		 Low	quality		 1	study	(Brazil)	[99]		 May	be	effective	at	improving	cognitive	function,	negative	symptoms	and	quality	of	life		
Cognitive	behavioural	
therapy		
2012	Cochrane	review	of	cognitive	behaviour	therapy	(20	studies-	0	LMIC)	[100]		
No	advantage	over	other	therapies		 Low	–	moderate	quality		
4	studies	(Brazil	[101,	102],	China	[103],	Pakistan	[104])		 May	be	effective	at	improving	psychopathology,	 functioning	and	quality	of	life.		
Family-based	services			 2010	Cochrane	review	of	family	intervention	(53	studies-	28	LMIC)	[105]		2014	Cochrane	review	of	brief	family	intervention	(4	studies-	1	LMIC)	[106]		
May	be	effective	at	reducing	relapse	rates	and	hospitalisations	No	evidence	for	effectiveness		
Low	quality		 Family	intervention:	14	studies	(China	[107-114],	Mexico	[115],	Malaysia	[116],	Iran	[117-119],	India[120],	Uganda	[121])			
May	be	effective	at	reducing	caregiver	burden,	improving	functioning,	improving	treatment	adherence.		
2011	Cochrane	review	of		 Effective	at	reducing		 Low		 Psychosocial	skills	(social	skills		 May	be	effective	at	reducing		psychoeducation	(44	studies	–	33		 readmissions	and		 quality		 training,	psychoeducation):	10		 relapse,	improving		LMIC)	[122].	2015	Cochrane	review		 relapse	rates	&		 	 studies	(Turkey	[124,	125],	China		 functioning,	and	improving		of	brief	psychoeducation	(20	studies-		 improving	adherence		 	 [126-130],	Mexico	[131-133])		 quality	of	life	and	adherence		12	LMIC)	[123]		 	 	 	 	
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Table	2.2	continued		
Psychosocial	intervention		 Systematic	reviews	across	all	settings*			 Individual	studies	from	LMIC**		
Evidence	source			 Evidence	of	
effectiveness		
Quality			 Evidence	source			 Evidence	of	effectiveness***		
Recommended	by	PORT		
Token	economy		 2000	Cochrane	review	of	token	economy	(3	studies-	1	LMIC)	[134]		 May	be	effective	at	reducing	negative	symptoms		
Low	quality		 None	identified		 n/a		
Skills	training		
	
		
2012	Cochrane	review	of	life	skills	programme	(7	studies-3	LMIC)	[135]		 No	evidence	for	effectiveness		 Very	low	quality		 5	studies	(China	[136-139],	India	[140])		 May	be	effective	at	improving	social	functioning	and	psychopathology		2015	Cochrane	review	of	social	skills	programme	(13	studies-	5	LMIC)	[141]		
May	be	effective	at	improving	social	skills	&	reducing	relapse	rates		
Very	low	quality		
Psychosocial	
interventions	for	alcohol	
and	substance	use			
	2013	Cochrane	review	(32	studies-	0	LMIC)	[142]		 No	evidence			 Low	quality		 None	identified		 n/a		
Psychosocial	
interventions	for	weight	
management		
2007	Cochrane	review	(5	non-	pharmacological	interventions-	0	LMIC)	[143]		
Effective	at	weight	loss	outcomes		 Low	quality		 None	identified		 n/a		
Other	psychosocial	interventions		
Peer	support/	self-help	
groups		
2014	systematic	review	of	peer	support	(18	studies-	0	LMIC)	[144]		 No	evidence	of	effectiveness		 Low	quality		 None	identified			 n/a		
Adherence	support		 2006	Cochrane	review	of	compliance	therapy	(1	study-	0	LMIC)[145]		 No	evidence	of	effectiveness		 Low	quality		 4	studies	(Thailand	[146],	Indonesia	[147],	Turkey[148],	Pakistan	[149]		
May	be	effective	at	improving	medication	adherence		
Cognitive	remediation/	
retraining		
2000	Cochrane	review	of	cognitive	rehabilitation	(3	studies–0	LMIC)[150]			2011	systematic	review	of	cognitive	remediation	(40	studies-0	LMIC)	[151]		
No	evidence	of	effectiveness			Effective	at	improving		functioning	&	cognition		
Low-	Moderate	quality			
5	studies	(Egypt	[152],	India	[153],	Brazil	[154],	Turkey	[155],	China	[156])		
May	be	effective	at	improving	social	cognition		
*Systematic	reviews	typically	have	broad	inclusion	criteria	with	respect	to	setting	(inpatient/	outpatient)	**Studies	listed	in	the	table	include	only	outpatient	or	community-based	interventions	&	controlled	studies	&	English	full	text	available.	***No	formal	quality	assessment	was	undertaken.				
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The	strongest	evidence	is	for	intensive	case	management	(which	has	evolved	from	assertive	community	treatment),	family	interventions	and	psychoeducation,	with	possible	impacts	on	functioning,	hospitalisations	and	relapse	rates.	However,	the	quality	of	evidence	is	generally	low	across	all	types	of	psychosocial	interventions.	It	has	also	been	noted	that	few	of	the	recommended	interventions	have	been	implemented	at	scale,	even	in	high-income	countries	[76].	There	is	generally	a	smaller	evidence	base	from	LMIC	for	these	psychosocial	interventions,	though	this	is	growing	with	several	studies	published	in	the	last	five	years	[103,	104,	117,	157].	However,	much	of	the	evidence	comes	from	China	with	very	low	numbers	of	studies	from	sub-saharan	Africa	[93,	121,	158].				 The	DCP-3	recommends	a	narrower	group	of	psychosocial	interventions,	for	which	there	is	evidence	of	effectiveness,	but	not	cost-effectiveness,	and	which	it	is	generally	accepted	are	more	feasible	in	low-income	settings	[159,	160]:	Family	therapy	or	support;	CBR;	and	self-help	and	support	groups	[68].	There	is	a	growing	body	of	evidence	to	support	these	more	pragmatic	interventions	[86].	These	programmes	often	use	a	community-based	approach	and	in	some	cases	an	explicit	‘mental	health	and	development’	model	[161].	CBR	is	an	approach	growing	in	prominence,	that	also	receives	a	specific	recommendation	in	the	WHO’s	mhGAP	guidelines	[80].		CBR	can	also	be	considered	as	a	model	of	care,	rather	than	a		stand-alone	intervention.	Section	2.7	discusses	CBR	and	related	approaches	in	greater	depth.						
2.6.2 Delivery	of	interventions	for	schizophrenia		
	
2.6.2.1 Task	shifting		The	task	shifting	of	mental	health	care	to	non-specialist	workers	is	advocated	as	a	central	approach	for	addressing	the	shortage	of	mental	health	specialists,	and	ultimately	the	treatment	gap,	present	in	Ethiopia	and	other	LMICs	[162]	(see	Section	2.9.2).	The	importance	of	maintaining	quality	of	care	in	task	shifting	interventions	has	been	highlighted,	and	is	an	area	currently	lacking	in	evidence	[163].	Adequate	supervision	is	likely	to	be	essential,	but	potentially	costly,	to	ensure	high	standards	of	care	are	kept	[157].	A	2013	systematic	review	found	that	interventions	using	non-specialist	workers	might	improve	outcomes	in	people			 		
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with	general	and	perinatal	depression,	post-traumatic	stress	disorder,	alcohol-use	disorders,	and	dementia	in	LMICs.	However,	much	of	the	evidence	was	of	low	quality	and	the	review	was	unable	to	make	conclusions	about	task-shifting	interventions	for	schizophrenia	due	to	a	lack	of	studies	[162].	It	has	been	shown	that	task-shifting	interventions	for	people	with	mental	illness	have	the	potential	to	be	acceptable	and	feasible	but	several	issues	need	to	be	carefully	considered	in	the	development	of	such	programmes	[164].	These	issues	include	possible	distress	amongst	non-specialist	workers;	their	self-perceived	competence	levels	and	potential	pressure	to	work	beyond	their	level	of	training	[165];	what,	if	any,	incentives	should	be	provided	to	workers;	and	potential	difficulties	with	the	acceptance	of	non-specialist	workers	by	health	care	professionals	[164].		
2.6.2.2 Models	of	community-based	care	The	balanced	care	model	proposes	that	mental	health	systems	should	include	both	community	and	hospital-based	care	[166].	Community	mental	health	care	refers	to	care	which	is	readily	accessible	to	people	living	in	the	community	rather	than	as	a	hospital	inpatient.	One	of	five	priority	Grand	Challenges	for	global	mental	health	is	to	“Provide	effective	and	affordable	community-based	care	and	rehabilitation”,	giving	recognition	to	the	substantial	impact	on	disease-burden	reduction	and	equity	this	approach	is	likely	to	have,	as	well	as	the	likely	immediacy	of	impact,	and	feasibility	[54].	It	is	recommended	that	in	low-resource	settings	community-based	care	should	focus	on	the	detection	and	treatment	of	mental	illness	in	primary	care,	to	include	both	pharmacological	and	psychosocial	interventions.	The	role	of	specialist	mental	health	staff	is	expected	to	be	limited	to	the	training	of	primary	care	staff,	and	treatment	of	complex	cases	in	outpatient	or	inpatient	settings	[166].	The	WHO’S	mhGAP	guides	the	integration	of	mental	health	into	primary	care	[80],	a	process	which	is	now	underway	in	several	LMICs	[167-169].	In	medium	resource	settings,	the	role	of	specialist	mental	health	staff	is	recommended	to	extend	to	the	provision	of	community	mental	health	teams	[166].	Community	mental	health	teams	typically	visit	service	users	in	their	place	of	residence,	a	factor	seen	as	vital	for	the	continuity	of	care	of	people	with	severe	mental	illness,	particularly	amongst	those	who	are	not	able	or	willing	to	visit	outpatient	facilities	[166].		 A	range	of	home-based	care	models	for	people	with	schizophrenia,	using	different	combinations	of	human	resources,	have	been	implemented	in	LMIC	in	both	
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research	projects	and	on-going	programmes.	These	range	from	community-based	care	delivery	by	lay	health	workers,	supervised	by	psychiatrists,	in	a	controlled	study	and	randomised	controlled	trial	(RCT)	in	India	(COmmunity-based	intervention	for	People	with	Schizophrenia	in	India	(COPSI))	[170,	171];	to	clinical	psychiatry	officers	delivering	community	mental	healthcare	in	Ghana	as	part	of	a	government	programme	[165,	172];	to	assertive	community	treatment	delivered	by	a	multi-disciplinary	team	in	a	South	African	RCT	[93,	94].	Within	these	home-	based	care	models	various	interventions	(as	described	in	Section	2.6.1)	may	be	delivered.	The	affordability	and	feasibility	of	these	models	inevitably	decreases	with	increasing	levels	of	specialist	support.	For	example	assertive	community	treatment	is	unlikely	to	be	feasible	in	low-income	settings	like	Ethiopia.		 The	distinction	between	research	projects	and	ongoing	programmes	should	be	noted,	with	the	former	by	their	nature	having	limited	timelines	and	a	lack	of	integration	into	national	policy	(though	they	may	pave	the	way	for	such	initiatives).	Coverage	of	community	mental	health	programmes	is	often	very	low	in	LMICs	[173],	though	there	are	some	exceptions.	China’s	nationwide	‘686’	programme,	which	includes	active	community	case	finding,	community-based	care	(including	multi-disciplinary	team	input)	and	hospital	care,	had	achieved	30%	coverage	of	the	whole	population	by	2011.	Over	a	five	year	period	the	proportion	of	patients	with	severe	mental	illnesses	without	relapse	for	five	years	or	longer	had	reportedly	increased	from	67%	to	91%	[174].	Many	programmes	are	wholly	or	partly	funded	and	run	by	non-governmental	organisations	(NGOs).	Whilst	NGOs	often	enable	the	development	of	innovative	programmes	targeting	neglected	groups,	there	are	several	disadvantages	including	lack	of	sustainability	and	low	coverage	[173,	175].	Thara	et	al	followed	up	people	with	schizophrenia	six	years	after	the	NGO-run	community	clinic	they	had	attended	had	closed	due	to	lack	of	funding.	They	found	that	only	15%	of	former	clinic	attendees	were	still	accessing	medication	and	associated	endeavours	initiated	by	the	NGO,	including	a	Citizen’s	group	and	self-employment	schemes,	had	all	been	discontinued	within	six	months	to	three	years	of	the	NGO	withdrawing	[176].	
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2.6.2.3 Innovations	in	community-based	care	for	schizophrenia	There	are	several	innovations	in	the	delivery	of	community-based	care	for	schizophrenia	and	other	mental	disorders	in	LMICs,	many	of	which	are	at	the	early	stages	of	implementation	and	evaluation.	These	include	the	following:		
• Projects	aiming	 to	 formalise	 collaborations	between	health	care	providers	and	traditional	or	religious	healers	in	sub-Saharan	Africa	[177-179].	
• Initiatives	 using	 mobile	 and	 information	 technologies	 to	 facilitate	 mental	healthcare	delivery	and	collaboration	[178-181].	
• Mobile	clinics	of	mental	health	specialists	visiting	remote	areas	[182].	
• Peer	 support	 groups	 in	Ghana	 [183]	 and	peer	 support	workers	delivering	home-based	care	in	Chile	and	Uganda	[184-186].	
• Initiatives	focused	on	removing	physical	restraints	from	people	with	mental	illness	at	home	or	hospital	(see	Section	2.10.2),	for	example	the	Chain	Free	Initiative	 in	 Somalia	 [187],	 targeted	 programmes	 in	 Indonesia	 [188],	 and	the	 ‘unlocking	and	treatment’	 intervention	part	of	 the	 ‘686’	programme	in	China	[189].	
• Social	contact	interventions	in	which	the	general	public,	or	targeted	groups	such	 as	 students,	 are	 facilitated	 to	 have	 direct	 or	 indirect	 contact	 with	people	with	mental	 illness.	 There	 is	 evidence	 these	 are	 the	most	 effective	intervention	for	short-term	change	in	attitudes.	However	there	are	very	few	studies	 from	 LMIC	 and	 little	 evidence	 for	 the	 impact	 on	 behaviours	 or	outcomes	for	people	with	mental	illness	[190].	
2.6.2.4 Promotion	of	personal	recovery	In	high-income	countries,	efforts	are	now	being	made	to	ensure	that	mental	health	services	incorporate	the	recovery	model,	both	in	terms	of	what	treatments	are	given,	and	how	they	are	given	[27].	Several	empirically	–validated	interventions	have	been	promoted	as	supporting	recovery	principles,	including	peer	support	workers,	advance	directives,	supported	housing,	and	mental	health	trialogues	(community	meetings	to	discuss	mental	health	issues)	[62].	Core	approaches	proposed	to	foster	the	recovery	model	within	mental	health	services	include	developing	a	shared	team	understanding	of	recovery,	working	in	partnership	with	service	users	and	raising	patient	expectations	[191].	There	has	been	little	investigation	to	date	as	to	how	recovery	principles	can	be	incorporated	into	mental	
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health	services	in	low-income	settings.				
2.6.3			Cost-effectiveness	The	need	to	ensure	the	costs	of	interventions	are	met	by	financial	protection	measures,	such	as	health	insurance	schemes,	rather	than	borne	by	the	individuals	with	mental	illness	and	their	families,	has	been	repeatedly	raised	[68].	In	a	modelled	cost-effectiveness	analysis,	a	range	of	treatment	options	for	schizophrenia	were	compared	for	Ethiopia,	assuming	75%	coverage	[163].	Incremental	cost-effectiveness	ratios	(ICERs)	were	calculated	in	comparison	to	the	null	scenario,	which	was	perceived	to	be	close	to	the	current	situation	due	to	low	coverage	of	most	mental	health	interventions	(see	Section	2.9.2).	In	this	study	treatment	with	anti-psychotic	medication	alone	(either	typical	or	atypical)	was	not	found	to	be	cost-effective.	The	following	two	combinations	were	cost-effective:	atypical	antipsychotics	and	psychosocial	treatment;	and	case	management,	atypical	antipsychotics	and	psychosocial	treatment.	The	annual	cost	of	the	former	combination,	the	most	cost-effective	for	schizophrenia,	would	be	US$	18.8	million,	for	which	10,650	DALYS	would	be	adverted	annually	(with	an	ICER	of	$1769/DALY	adverted)	[163].	Seen	in	the	context	of	other	neuropsychiatric	disorders	scaling	up	services	for	schizophrenia	may	not	represent	the	best	value	for	money	[68,	163].	For	example,	the	Ethiopia	analysis	found	that	treatment	of	epilepsy	with	older	anti-epileptic	medication	would	cost	US$	321/	DALY	adverted,	and	treatment	of	depression	with	newer	antidepressants,	psychotherapy,	and	maintenance	treatment	would	cost	US$	457/	DALY	adverted	[163].	However,	the	need	to	incorporate	other	factors	into	priority	setting	in	scaling	up	services	has	been	highlighted	[77,	163]	(see	Section	2.5.2).		 There	exist	only	a	small	handful	of	cost-effectiveness	analyses	alongside	evaluations	for	mental	illness	in	LMICs	[157,	192].	The	COPSI	trial	found	an	ICER	of	2514	Indian	Rupees	(US$	37);	representing	the	additional	expenditure	needed	to	achieve	a	1-point	reduction	on	the	Positive	and	Negative	Syndrome	Scale.	Community-based	care	cost	on	average	9500	rupees	(US$143)	per	participant	more	than	provision	of	only	facility-based	care,	with	the	greatest	cost	burden	relating	to	supervision	of	lay	health	workers	[157].	
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2.7 COMMUNITY-BASED				REHABILITATION	
	
2.7.1 Background	to	CBR	CBR	is	the	approach	advocated	by	the	WHO	for	the	poverty	reduction,	rehabilitation	and	social	inclusion	of	people	with	disabilities	in	LMIC	[193].	The	WHO	has	promoted	CBR	since	the	1978	Alma-Ata	Declaration,	since	which	time	hundreds	of	programmes	globally	have	employed	this	multi-sectoral	strategy	[194].	CBR	projects	support	people	with	a	broad	range	of	disabilities	including	those	associated	with	long-term	musculoskeletal	and	neurological	conditions	such	as	cerebral	palsy,	epilepsy	and	arthritis;	visual	and	hearing	impairments;	and	intellectual	impairments,	for	example	developmental	disorders	[193].	The	rationale	for	CBR	is	to	address	the	widespread	exclusion	of	people	with	disabilities	from	education,	health,	employment	and	other	aspects	of	society.	The	principles	of	CBR	are	therefore	closely	aligned	with	the	UN	Convention	on	the	Rights	of	Persons	with	Disabilities	[36]	.		 The	WHO’s	2010	CBR	guidelines	present	a	CBR	matrix	consisting	of	five	pillars:	health,	education,	livelihood,	social	and	empowerment	(see	Figure	2.3)	[194].	There	is	an	emphasis	on	facilitating	access	to	appropriate	governmental	and	non-	governmental	services	from	health,	educational,	vocational,	and	social	sectors	[195].	However	CBR	programmes	are	diverse	and	may	address	any	or	all	of	the	five	pillars	depending	on	the	local	context,	needs	and	resources.	Activities	may	range	from	the	provision	of	assistive	devices	to	the	organisation	of	a	Rotating	Savings	and	Credit	Association	(ROSCA).	A	ROSCA	involves	people	with	disabilities	regularly	paying	small	amounts	into	a	common	“pot”,	from	which	a	lump	sum	is	given	as	a	loan	or	grant	to	one	member	at	a	time	[194].	According	to	the	WHO	guidelines,	the	community	should	play	a	key	role	in	any	CBR	programme,	along	with	people	with	disabilities	and	their	families.	Community	mobilisation	may	involve	finding	out	about	the	community,	raising	awareness	about	disability	issues,	encouraging	community	members	to	support	CBR	activities	(for	example,	by	reducing	barriers	to	social	participation)	and	potentially	the	community-led	implementation	of	CBR	programmes.	Community	mobilisation	is	seen	as	the	lynch-	pin	of	creating	sustainable	CBR	programmes	[194].	
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Figure	2.3	WHO	CBR	matrix	(from	WHO	CBR	guidelines)	
	
	
	
	
	
	 The	personnel	involved	in	CBR	delivery	vary	considerably	depending	on	the	project	and	may	include	paid	non-specialists,	trained	volunteers,	family	members,	physiotherapists,	occupational	therapists,	community	nurses,	and	teachers	[194,	195].	In	some	cases,	non-specialist	CBR	personnel	take	on	a	task-shifting	role,	for	example	involvement	in	HIV	treatment,	care	and	prevention	[196].	Many	local	CBR	projects	operate	under	the	umbrella	of	larger	organisations,	such	as	the	international	disability	charity	CBM	(www.cbm.org).	Whilst	many	CBR	programmes	are	run	by	NGOs,	others	are	delivered	in	collaboration	with	local	government	or	national	government	departments	such	as	Ministries	of	Health	or	Education	[194].		 Whilst	there	is	a	growing	pool	of	published	literature	on	CBR	[197],	most	studies	are	descriptive	or	only	cover	CBR	theory	with	fewer	studies	evaluating	its	effectiveness	[198].	A	systematic	review	conducted	in	2012	by	Iemmi	et	al	identified	15	controlled	studies	of	CBR	for	a	range	of	physical	and	mental	disabilities.	A	beneficial	effect	of	CBR	was	found	for	stroke,	chronic	obstructive	pulmonary	disease	and	arthritis.	Iemmi	et	al	reported	that	overall	CBR	had	a	
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modest	positive	impact	on	people	with	mental	disabilities	including	dementia,	schizophrenia	and	intellectual	impairment.	However	they	highlighted	the	poor	quality	and	non-randomised	design	of	many	of	the	included	studies	[193].	There	are	diverging	views	on	what	constitutes	a	CBR	programme,	with	some	CBR-like	programmes	more	readily	classified	as	community-based	care	and	having	limited	community	mobilisation	[193].	A	broad	definition	of	CBR	was	employed	for	the	Iemmi	et	al	review,	which	resulted	in	the	inclusion	of	a	wide	range	of	intervention	types,	from	puppet	shows	for	arthritis	to	assertive	community	treatment	for	schizophrenia.	Several	studies	did	not	incorporate	a	substantial	community	mobilisation	element.				
2.7.2 Mental	health	and	CBR	There	are	several	reasons	why	CBR	is	a	fitting	approach	to	support	people	with	severe	mental	illness	in	LMICs.		
1. People	with	schizophrenia	experience	high	 levels	of	disability	(see	Section	2.3.2).		
2. CBR	 targets	 the	 key	 environmental	 factors	 (access	 to	 health	 services,	stigma)	and	personal	factors	(poverty,	coping	styles,	health	literacy)	which	create	 these	 high	 levels	 of	 disability	 (see	 Section	 2.3.1),	 in	 particular	through	utilising	a	development	approach	and	operating	within	an	explicit	human	rights	framework.		
3. Family	 members	 are	 heavily	 implicated	 in	 the	 lives	 of	 people	 with	schizophrenia	in	these	settings,	both	in	terms	of	experiencing	the	negative	impacts	such	as	stigma	and	economic	insecurity,	but	also	through	taking	on	a	 prominent	 caregiving	 role	 (see	 Section	 2.9.4).	 CBR	 explicitly	 engages	family	members.		
4. CBR	 aligns	 with	 the	 personal	 recovery	 model,	 as	 there	 is	 a	 focus	 on	empowerment	and	participation	(see	Section	2.4).			
5. CBR	 is	 a	means	of	providing	on-going	 community-based	 care	yet	 requires	low	 levels	of	 technical	expertise	so	may	be	 implemented	by	non-specialist	workers	 (see	 Section	 2.6.2).	 This	 is	 of	 utmost	 value	 in	 settings	 with	 few	formal	health	resources	such	as	Ethiopia	(see	Section	2.9.2).		
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6. CBR	could	represent	one	component	of	what	 is	 likely	 to	be	 the	most	cost-	effective	model	of	care	for	Ethiopia,	comprising	anti-psychotic	drugs	and	a	psychosocial	intervention	(see	Section	2.6.3).	7. CBR	aims	to	be	a	sustainable	approach	to	improving	functioning	in	people	with	 disabilities,	 particularly	 through	 the	 emphasis	 on	 community	mobilisation.	8. There	 is	 an	 existing	 global	 network	 of	 CBR	 projects	 that	 can	 act	 as	important	 resource	 to	 learn	 from	 in	 the	 development	 of	mental	 health	 in	CBR.	This	network	 also	 represents	 an	 important	 route	 for	 scaling	up	new	developments	in	CBR	for	mental	health.	9. CBR	 aims	 to	 utilise	 local	 knowledge	 and	 resources,	 including	 traditional	healers	where	appropriate.	Tapping	into	existing	expertise	and	capabilities	may	reduce	the	possibility	of	cultural	imperialism,	which	some	have	argued	threatens	global	mental	health	initiatives	[199,	200].			 In	recent	years	there	has	been	an	expansion	of	CBR	projects	supporting	people	with	mental	illness	[201],	reflected	in	the	inclusion	of	a	mental	health	supplement	to	the	WHO	CBR	guidelines	[194].	Globally,	there	are	estimated	to	be	20	to	25	CBM-partnered	CBR	programmes	that	support	people	with	mental	illness	(including	but	not	limited	to	schizophrenia);	around	half	of	these	are	found	in	sub-	Saharan	Africa.	Across	these	projects	there	is	likely	to	be	substantial	variation	in	coverage	and	the	nature	of	support	provided;	little	evaluation	has	been	conducted	to	date	but	this	is	planned	(personal	communication,	Julian	Eaton).		 There	may	be	several	differences	in	CBR	for	people	with	mental	disabilities	compared	to	physical	disabilities:	differences	in	specific	treatments	(supporting	access	to	anti-psychotic	medication	and	providing	psychosocial	support	compared	to	physiotherapy	and	orthopaedic	devices);	different	potential	trajectories	of	recovery;	a	greater	emphasis	on	adults	compared	to	children,	with	physical	disability	more	likely	to	be	detected	at	a	younger	age;	and	possible	greater	tendency	towards	different	explanatory	models	for	mental	illness	(see	Section	2.8)	[202].	Other	challenges	of	incorporating	mental	health	into	CBR	programmes	have	been	identified,	including	the	potential	greater	stigma	within	CBR	workers	
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towards	people	with	mental	illness	and	concomitant	unwillingness	to	work	with	this	group	[202].		 To	date,	two	non-randomised	longitudinal	evaluations	by	Chatterjee	et	al	in	India	may	represent	the	most	comprehensive	attempts	to	implement	CBR	for	schizophrenia	in	a	research	or	programmatic	setting,	in	that	there	is	a	clear	community	mobilisation	element	to	both	[170,	171].	In	the	first	study,	127	people	with	schizophrenia	receiving	CBR	were	compared	to	80	participants	receiving	standard	outpatient	care.	In	addition	to	outpatient	care,	the	CBR	group	received	home-based	support	from	lay	health	workers,	focused	on	social	and	vocational	rehabilitation.	Family	groups	and	local	village	health	groups	were	also	set	up	to	facilitate	social	inclusion	and	enhance	rehabilitation	strategies.	Among	the	117	participants	fully	adherent	to	anti-psychotic	medication,	the	CBR	model	was	more	effective	in	reducing	disability	compared	to	the	outpatient	care	group	[170].	In	a	subsequent	cohort	study	of	256	people	with	psychotic	disorders,	participants	received	psychoeducation,	adherence	management	support	and	rehabilitation	focused	on	resuming	work	and	social	activities.	Awareness-raising	activities,	focusing	on	reducing	stigma	and	increasing	social	inclusion,	were	conducted	in	villages	and	at	community	gatherings.	Self-help	groups,	comprising	service	users	and	community	members,	aimed	to	provide	livelihood	support	through	microfinance	facilities	and	social	reintegration	[171].	Over	a	median	follow	up	of	46	months,	cohort	participants	showed	significant	reductions	in	disability	(p<0.05)	[171].	Whilst	these	studies	provide	a	useful	blueprint	of	CBR	for	schizophrenia	as	well	as	valuable	information	on	feasibility	and	acceptability,	they	provide	only	an	initial	indication	of	the	possible	effectiveness	of	such	interventions.		 The	COPSI	RCT	in	India	used	a	similar	model	to	these	earlier	studies	for	the	home-	based	care	element	but	incorporated	minimal	community	mobilisation	and	no	microfinance	[157,	203].	The	effectiveness	of	this	trial	is	presented	as	part	of	a	systematic	literature	review	of	community-based	psychosocial	interventions	for	schizophrenia	in	LMIC	(Chapter	4).	
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2.7.3 Other	models	related	to	CBR	The	‘mental	health	and	development	model’,	largely	employed	by	the	organisation	BasicNeeds,	shares	a	similar	philosophy	with	CBR,	focusing	on	community	development	and	service	user	empowerment.	However	this	model	also	encompasses	health	system	strengthening	and	influencing	policy	[161].	BasicNeeds	programmes,	typically	include	medication	provision,	follow	up,	self-	help	groups,	grants,	occupational	training	and	counselling	[204].	A	network	of	BasicNeeds	self-help	groups	in	Ghana	have	a	prominent	microfinance	component,	offering	loans	to	mental	health	service	users	and	their	caregivers	that	are	used	for	small	enterprises.	Whilst	this	system	is	reportedly	beneficial	for	some	participants,	others	have	had	difficulty	repaying	their	loans	[183].	Mental	health	advocacy	groups	may	also	have	an	important	role	in	improving	mental	health	policy	and	services	[205],	though	such	groups	are	currently	absent	from	many	LMICs.	Stand	alone	mental	health	awareness-raising	programmes	have	been	conducted	in	some	LMICs;	one	programme	in	Nigeria	may	have	increased	the	use	of	community-based	mental	health	services	[206].		 The	relevance	of	CBR	for	people	with	schizophrenia,	and	the	shape	such	programmes	should	take,	is	to	a	great	extent	influenced	by	the	context.	The	next	section	explores	services	for	mental	health,	explanatory	models,	human	rights	issues	and	stigma	in	the	Ethiopian	setting.	
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SECTION	C:	UNDERSTANDING	THE	ETHIOPIAN	CONTEXT	
	
2.8 EXPLANATORY	MODELS	
	 Explanatory	models	may	exert	a	powerful	influence	on	the	experience	of	psychotic	symptoms,	and	treatment	seeking	behaviour	and	expectations	[207].	The	integration	of	appropriate	explanatory	models	into	culturally	adapted	therapies	may	be	the	most	important	determinant	of	therapy	effectiveness	[208].	In	Ethiopia,	health	is	traditionally	understood	as,	a	“state	of	equilibrium	among	the	physiological,	spiritual,	cosmological,	ecological	and	social	forces	associated	with	a	person”	[209].	Whilst	this	holistic	framework	bears	some	resemblance	to	the	biopsychosocial	model,	increasingly	favoured	to	explain	health	and	disease	states	in	the	West	[210],	the	prominence	of	spiritual	explanations	gives	a	distinctive	flavour	to	Ethiopian	concepts	of	health.	Descriptions	of	explanatory	models	for	mental	illness	in	Ethiopia	have	traditionally	focused	on	supernatural	explanations	[211-214].	These	have	typically	been	grouped	into	the	following:	(1)	Possession	by	evil	spirits	including	Satan	or	other	demons.	Various	behaviours	are	believed	to	leave	one	vulnerable	to	possession	including	falling	asleep	in	a	meadow	and	walking	alongside	a	river	at	noon;	(2)	Punishment	by	normally	benevolent	guardian	spirits	(e.g.	Zar)	for	sins	(or	even	contemplation	of	sinful	behaviour),	broken	taboos,	or	forgotten	rituals	(for	example,	entering	a	long-closed	room	without	blessing	oneself)	and	(3)	Bewitchment	or	curses,	such	as	evil	eye,	cast	by	individuals	thought	to	possess	special	powers,	including	Kalicha	(Muslim	spirit	medium)	or	Debtera	(Christian	cleric	diviner).	These	persons	are	believed	to	have	the	capacity	to	make	a	person	mentally	ill,	or	to	protect	one	from	illness	[211,	212,	215-217].	Supernatural	explanatory	models	seem	to	be	shared	across	Christian,	Muslim	and	animistic	faiths	in	Ethiopia	[215,	216].		 More	recently,	accounts	of	Ethiopian	explanatory	models	have	expanded	to	include	a	broader	more	pluralistic	set	of	beliefs	encompassing	both	supernatural	and	psychosocial	causes;	along	with	recognition	that	these	apparently	conflicting	beliefs	often	exist	within	the	same	community	and	even	the	same	individual	[215,	216].	The	capacity	to	hold	several	beliefs	at	once,	which	may	be	contradictory,	has	been	described	as	‘cognitive	tolerance’	[218]	and	is	a	phenomenon	observed	in	both	LMIC	and	high-income	settings	[215].	In	a	community-based	survey	in	
52
Southern	Ethiopia,	stress	(53.9%),	poverty	(53.4%)	and	rumination	(42.1%)	were	more	frequently	endorsed	as	causes	of	mental	illness	than	supernatural	explanations	including	God’s	punishment	(21%),	evil	spirits	(19.9%)	and	sinful	acts	(18.7%)	[219].	Other	commonly	cited	explanations	include	substance	abuse	(alcohol	and	khat),	childbirth,	grief	and	infections	such	as	malaria	[215,	216].	This	shift	may	represent	the	changing	beliefs	of	a	rapidly	developing	society.	In	one	community-based	survey	in	North-Western	Ethiopia,	younger	and	better	educated	people	were	less	likely	to	endorse	supernatural	explanations	compared	to	their	older	less	educated	counterparts	[215].	But	this	change	may	also	be	due	in	part	to	moving	on	from	a	reliance	on	small-scale	ethnographic	investigations	[211,	212,	214,	217]	towards	representative	community-based	quantitative	surveys	[215,	219].		 Alongside	aetiological	classifications,	a	system	of	phenomenological	classification	has	traditionally	existed	in	Ethiopia	[213].	Qualitative	work	has	shown	that	in	Christian,	Muslim	and	animistic	populations	there	is	a	notion	of	mental	illness	that	is	conceptually	equivalent	to	psychosis.	This	illness	is	usually	described	in	terms	of	overt	behavioural	features,	for	example,	talkativeness,	aggression,	or	disrobing,	rather	than	thought	disorders	[220,	221],	a	pattern	also	typical	in	other	African	countries	[222].	This	suggests	that	only	those	whose	behaviour	draws	outside	attention	are	recognised	as	having	a	mental	illness	in	need	of	treatment	[220].	It	has	been	noted	that	whilst	phenomenological	models	may	be	in	use	by	a	traditional	healer,	an	aetiological	classification	(for	example,	spirit	possession)	is	almost	always	provided	for	the	patient,	as	a	way	to	give	the	illness	experience	meaning	[222]. 
 
 
 
2.9 MENTAL	HEALTHCARE	IN	ETHIOPIA	
	
2.9.1 Healthcare	system	in	Ethiopia	
	 The	Ethiopian	Ministry	of	Health	operates	a	three-tier	health	care	system.	Level	one,	at	the	district	level,	is	a	primary	health	care	unit	comprising	of	a	hospital	(for	60	000–100	000	people),	health	centres	(for	15	000–25	000	people)	and	their	satellite	health	posts	(for	3000–5000	people).	Level	two	is	a	general	hospital	for	1–	
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1.5	million	people	and	level	three	is	a	specialized	hospital	for	3.5–5	million	people.	In	addition	there	exists	a	rapidly	expanding	private	sector	[223].	Health	centres	are	staffed	by	health	officers	(four	years	of	training)	and	general	nurses	(of	degree	or	diploma	level).	Each	health	post	covers	a	sub-district	(kebele)	and	is	staffed	by	two	health	extension	workers.	Health	extension	workers	are	high-school	graduates	with	one	year’s	training	in	health	promotion	and	illness	prevention.	They	are	all	women	residing	in	the	sub-district	where	they	deliver	health	education	and	basic	interventions	to	households.		 A	recent	expansion	of	primary	care	facilities	has	reportedly	improved	geographical	access	to	health	services,	resulting	in	an	estimated	92.2%	potential	health	service	coverage.	However,	health	care	utilization	remains	low	as	a	result	of	economic,	sociocultural	and	geographical	factors	[224].	Health	care	costs	are	largely	out-of-	pocket	and	there	are	no	health	insurance	schemes.	A	fee	waiver	is	available	for	the	poorest,	with	certificates	given	at	the	discretion	of	sub-district	officials.		 The	WHO	categorises	Ethiopia	as	having	a	critical	shortage	of	health	care	workers,	with	uneven	distribution	of	resources,	poor	skill	mix	and	high	attrition	of	trained	health	professionals	being	particular	concerns	[224].	There	is	generally	low	availability	of	medicines	due	to	an	unreliable	supply	system	and	long	procurement	procedures.	Availability	of	essential	medicines	is	52%	in	the	public	sector	and	88%	in	the	private	sector	[224].				
2.9.2 Biomedical	services	for	mental	health	
	 In	Ethiopia	formal	mental	health	care	is	very	limited	and	is	almost	entirely	based	in	Addis	Ababa	and	other	major	cities	[225].	For	a	population	of	97	million	people,	the	main	sources	of	care	are	Ammanuel	Psychiatric	Hospital	in	Addis	Ababa	(268	beds),	two	small	inpatient	units,	four	outpatients	clinics	and	57	nurse-led	psychiatric	units	in	other	cities	[226].	There	is	also	one	long	stay	‘psychiatric	rehabilitation	hospital’	with	190	beds,	though	in	reality	this	institution	offers	limited	rehabilitation	opportunities	and	no	community-based	support.	There	are	currently	60	psychiatrists	in	Ethiopia	(approximately	0.6/	1,000,000	population)	(personal	communication,	Dr	Charlotte	Hanlon).	As	of	2012	there	were	461	psychiatric	nurses	(though	there	is	no	accurate	estimate	of	the	number	still	
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working	in	mental	health),	14	psychologists	(of	whom	none	have	training	in	clinical	psychology),	three	social	workers	and	no	occupational	therapists	working	in	mental	healthcare	in	Ethiopia	[226].	In	the	last	five	years	several	Ethiopian	universities	have	begun	training	programmes	in	community	mental	health	and	psychiatric	nursing.	However	it	is	unclear	whether	these	developments	have	translated	into	increased	provision	of	mental	health	care.	Currently,	mental	health	care	is	generally	not	available	at	the	primary	care	or	community	level.	Access	to	psychological	therapies	is	only	available	to	the	tiniest	minority	in	Addis	Ababa.	There	are	also	no	disability	payments	available	or	other	formal	social	security	structures	in	place	in	Ethiopia.	This	serious	shortage	of	mental	health	specialists	and	facilities	is	common	to	many	LMICs	[159,	227].		 The	2012	National	Mental	Health	Strategy	of	Ethiopia	represented	an	important	development	in	mental	healthcare	provision.	The	Ministry	of	Health	has	committed	to	move	towards	integrating	mental	health	into	primary	care,	guided	by	the	WHO’s	mhGAP,	and	is	currently	piloting	this	model	in	several	sites	across	the	country	[168,	226,	228].	Of	central	importance	is	that	prescribing	privileges	for	anti-	psychotic	medication	are	to	be	extended	to	general	nurses	and	health	officers.		 The	following	anti-psychotic	medications	are	included	on	the	Essential	Drugs	List	for	Ethiopia:	chlorpromazine,	clozapine,	fluphenazine,	haloperidol,	olanzapine,	risperidone	and	trifluoperazine	[229].	In	practice	only	chlorpromazine	and	haloperidol	are	routinely	available	at	the	primary	health	centre	level,	with	fluphenazine	and	risperidone	sporadically	available	at	the	psychiatric	outpatient	clinics.		 Many	LMICs	currently	devote	less	than	2%	of	their	health	budget	towards	mental	health,	with	the	majority	of	funds	allocated	to	running	psychiatric	inpatient	services	[77].	Mental	health	expenditure	for	Ethiopia	is	not	available	[230].	However,	the	2012	Strategy	reported	a	recent	increase	in	annual	expenditure	from	300,000	birr	(£9,500)	to	10,000,000	birr	(£316,000)	on	psychotropic	medications	at	Ammanuel	Psychiatric	Hospital	[226].	The	2011	WHO	Mental	Health	Atlas	profile	for	Ethiopia	reported	that	mental	hospital	expenditures	formed	more	than	85%	of	the	total	mental	health	budget	[231].	The	2012	Mental	Health	Strategy	promised	to	allocate	specific	funding	for	the	implementation	of	mental	health	in	primary	care	[226].	
55
	
2.9.3 Traditional	and	religious	care	providers	There	are	several	types	of	traditional	healer	in	Ethiopia.	Tanqway	are	a	type	of	sorcerer	known	to	treat	evil	eye	or	spirit	possession	through	exorcism	and	various	rituals	including	preparation	of	tinctures	and	animal	sacrifice	[212,	232].	The	Zar	doctor	(balazar)	is	also	consulted	for	spirit	possession,	and	may	put	his	client	into	a	trance	to	relieve	them	of	the	possession	and/	or	use	beatings	or	burning	[212].	There	are	also	herbalists,	who	tend	to	be	consulted	for	physical	ailments	[212].		 Religious	healers	include	debtera,	kalicha	and	holy	water	priests.	Debtera,	associated	with	the	Orthodox	Christian	faith,	often	deal	with	prevention	rather	than	diagnosis	or	cure	[212].	They	inscribe	tailored	prayers	on	scrolls	or	amulets	
(kitab),	sometimes	written	in	a	secret	talismanic	language	(asmat),	to	be	used	by	the	bearer	to	ward	off	problems	[217].	Kalicha	have	a	similar	role	to	debtera	but	are	typically	associated	with	the	Muslim	faith	[233]	or	animistic	traditions.	Holy	water	(tsebel)	is	found	at	sites	associated	with	the	Orthodox	Christian	church.	People	with	a	wide	range	of	physical	and	mental	illnesses	attend	holy	water	sites	to	bathe	in	and	drink	the	water	and	in	some	cases	to	have	the	devil	or	spirits	driven	out	of	them	by	the	holy	water	priest	[211,	217].	Holy	water	attenders	often	live	around	the	church,	sometimes	in	group	houses	of	up	to	15	people,	whilst	others	visit	for	the	day.				
2.9.4 Family	support	
	 Arguably	the	family	is	the	main	source	of	care	for	most	people	with	mental	illness	in	Ethiopia	[47].	This	is	a	pattern	increasingly	reflected	in	high-income	countries,	though	to	a	much	lesser	extent	than	LMIC,	since	the	advent	of	deinstitutionalisation	[234].	Women	are	more	likely	to	take	on	a	caring	role	in	all	settings	[234].	Informal	caregivers	for	people	with	mental	illness	experience	physical,	social,	psychological	and	financial	burden	in	low,	middle	and	high-income	countries	and	across	cultures	[234-236].	In	Ethiopia	there	is	particular	emphasis	on	the	financial	burden	[47].	The	high	burden	is	likely	to	be	a	reflection	of	the	lack	of	formal	social	and	financial	support	available	in	this	setting.	Caregivers	are	often	
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forced	to	neglect	their	own	income-generating	activities	in	order	to	support	or	supervise	their	relative,	in	addition	to	losing	the	income	of	the	individual	with	mental	illness.	Remission	has	been	shown	to	be	associated	with	reduced	caregiver	burden	in	this	context	[21].	There	is	currently	no	self-advocacy	movement	in	Ethiopia.	However,	the	Mental	Health	Society,	led	largely	by	caregivers,	organises	awareness-raising	activities.				
2.9.5 Access	to	mental	healthcare	
	 Healthcare	access	is	an	issue	of	critical	importance,	as	even	the	most	effective	treatment	is	rendered	useless	if	it	is	not	utilised.	Five	dimensions	of	access	to	health	care	have	been	described:	availability,	geographical	accessibility,	affordability,	adequacy	and	acceptability	[237].	User	fees	mean	that	even	where	it	is	available,	mental	health	care	is	economically	inaccessible	to	many	people	with	mental	illness	in	Ethiopia	[238].	This	is	despite	a	one-month	course	of	chlorpromazine	typically	costing	only	30	birr	(£1)	and	a	monthly	fluphenazine	injection	costing	48	birr	(£1.50).	On	top	of	medication	expenses	the	cost	of	travel	to	services	is	prohibitive	for	many	people.	These	factors,	combined	with	the	lack	of	mental	health	services	in	large	parts	of	the	country,	mean	that	the	proportion	of	people	with	severe	mental	illness	in	rural	Ethiopia	who	do	not	receive	treatment	is	approximately	90%	[239].	This	is	even	greater	than	treatment	gap	estimates	from	other	LMICS	of	76–85%	[77].	There	is	little	accurate	information	available	on	either	the	contact	or	effective	coverage	of	mental	health	services.	A	recent	systematic	review	found	only	seven	studies	globally,	none	of	which	related	to	severe	mental	illness	in	LMIC	[240].				
2.9.6 Pathways	to	mental	healthcare	
	 Recent	systematic	reviews	have	shown	that	approximately	half	of	individuals	who	seek	biomedical	care	for	mental	disorders	in	Africa	have	previously	chosen	traditional	and	religious	healers	as	their	first	care	provider	[241,	242].	An	Ethiopian	study	found	that	of	1044	patients	that	attended	Ammanuel	Psychiatric	Hospital	over	a	two	month	period,	only	41%	came	without	having	previously	
57
sought	help	elsewhere.	Among	the	remaining	patients,	40%	initially	sought	help	from	holy	water	priests	or	a	church,	21.5%	consulted	doctors	other	than	psychiatrists	in	private	or	government	hospitals,	4.5%	contacted	herbalists,	and	2%	saw	general	nurses	or	psychiatric	nurses	[243].	A	study	in	South	Western	Ethiopia	found	similar	results,	with	over	half	having	attended	a	religious	healer	(30.2%)	or	a	herbalist	(20.1%)	prior	to	attending	a	psychiatric	inpatient	unit[244].	There	is	little	data	on	time	trends	in	use	of	traditional	forms	of	care	in	Ethiopia	or	other	LMIC	[242].		 Interventions	that	seek	to	engage	people	with	schizophrenia	in	biomedical	care	need	to	be	cognisant	of	the	other	treatment	options	available,	and	why	they	might	be	chosen	as	an	alternative.	The	decision	making	processes	around	choosing	a	care	provider	from	the	diverse	range	of	options	are	not	fully	understood	[245]	though	studies	in	Butajira	and	North	Western	Ethiopia	have	found	that	biomedical	care	is	more	likely	to	be	recommended	for	physical	conditions	compared	to	mental	health	problems	[215,	220].	It	has	been	suggested	that	for	psychosis	in	particular	a	wide	range	of	treatment	options	are	likely	to	be	sought,	including	both	traditional	and	biomedical	approaches,	due	to	the	severe	and	chronic	nature	of	the	illness	[215].	Furthermore,	it	is	proposed	that	many	families	have	a	pragmatic	attitude	towards	seeking	care	for	their	relative,	trying	different	options	until	they	strike	on	something	which	appears	to	be	effective	[216].		 People	in	LMICs	such	as	Ethiopia	may	be	more	inclined	to	use	traditional	or	religious	healing	for	mental	health	problems	not	just	because	this	provides	the	most	obvious	link	to	popular	explanatory	models.	Greater	accessibility	and	affordability	of	traditional	healers	and	holy	water	are	also	like	to	be	important	factors,	along	with	more	flexible	payment	options	(often	traditional	practitioners	only	receive	the	full	payment	on	cure)	[233,	242].	Attending	a	traditional	or	religious	healer	may	have	greater	cultural	and	social	acceptability;	the	average	rural	Ethiopian	may	be	more	likely	to	share	a	worldview	and	lifestyle	with	traditional	healers	compared	to	biomedical	providers	[215,	233].	There	may	also	be	less	stigma	associated	with	attending	a	traditional	healer	compared	to	receiving	a	psychiatric	diagnosis	[242].	
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2.10 STIGMA,	DISCRIMINATION	AND	HUMAN	RIGHTS	
	
2.10.1 Stigma	and	discrimination	It	has	been	shown	that	stigma	towards	people	with	mental	illness	is	a	universal	phenomenon,	transcending	economic	and	cultural	boundaries	[246,	247].	The	issue	of	stigma	includes	problems	of	knowledge	(misinformation),	attitudes	(prejudice)	and	behaviour	(discrimination)	[247].	Perceived	and	internalized	stigma	refer	to	the	experiences	of	people	with	mental	illness,	whereas	public	stigma	concerns	the	negative	attitudes	of	the	general	population	[248].	A	“backbone”	of	public	stigma	across	continents	seems	to	comprise	difficulty	accepting	that	people	with	mental	illness	can	take	authority	positions	and	discomfort	at	interactions	with	this	group,	underpinned	by	fear	of	possible	violence	[246].	However,	differences	in	the	extent	and	nature	of	stigma	have	been	identified	between	settings,	hence	the	phenomenon	is	also	understood	as	a	local	experience	[249].	In	all	settings,	a	low	level	of	mental	health	literacy	is	thought	to	be	one	of	the	factors	contributing	to	negative	attitudes	[219,	250].		 In	Ethiopia,	high	levels	of	internalised	stigma	have	been	found	in	people	with	schizophrenia.	In	one	survey	of	psychiatric	inpatients	nearly	all	participants	(97.4%)	reported	at	least	one	experience	of	internalised	stigma	and	46.7%	had	a	moderate	to	high	mean	stigma	score	[251].	In	Ethiopia	caregivers	of	people	with	mental	illness	are	also	stigmatised	[22,	252],	which	may	manifest	as	greater	burden	due	an	absence	of	community	support.	High	levels	of	public	stigma	have	been	demonstrated	in	Ethiopia	[219],	with	attitudes	generally	less	favourable	towards	people	with	psychotic	illness	compared	to	other	mental	disorders	[215].	Community-based	surveys	have	shown	greater	levels	of	public	stigma	in	rural	areas	and	amongst	those	with	lower	education	levels	[215,	219].		 Stigma	may	have	important	implications	for	the	experiences	of	people	with	mental	illness,	increasing	the	risk	of	self	harm	[253]	as	well	as	potentially	affecting	access	to	health	services,	and	adherence	to	treatment	[251].	Discrimination	may	lead	to	social	exclusion	of	people	with	schizophrenia	and	may	act	as	a	barrier	to	recovery	[247].	The	high	levels	of	violent	victimisation	identified	amongst	participants	in	the	Butajira	cohort	may	be	partly	attributable	to	stigma	[24].	
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2.10.2 Human	rights	Human	rights	violations	affecting	people	with	mental	illness	in	LMICs	span	basic	civil,	cultural,	economic,	political,	and	social	rights. Along	with	lack	of	access	to	mental	health	care,	and	denial	of	the	right	to	work	or	marry,	sits	the	issue	of	physical	restraint	[254].	These	problems,	operating	on	a	background	of	pervasive	stigma	and	discrimination,	may	disproportionately	affect	people	with	severe	mental	illness	compared	to	other	mental	disorders.		 The	restraint	and	confinement	of	people	with	mental	illness	by	their	family	members	is	described	in	several	accounts	from	sub-Saharan	Africa	and	Asia	[189,	255-260].	As	yet	the	extent	of	restraint	in	community	settings	in	Ethiopia	has	not	been	quantified.	However,	anecdotal	evidence	suggests	that	it	is	not	an	uncommon	experience	amongst	people	with	schizophrenia	in	this	context	[261].	A	relationship	between	lack	of	access	to	anti-psychotic	medication	and	subsequent	restraint	in	the	community	has	been	identified	[255,	256,	262].	Yet	there	is	a	propensity	towards	linking	restraint	with	misunderstandings	about	the	aetiology	of	mental	illness	(for	example	that	it	is	caused	by	spirit	possession)	and	associated	stigma	[258,	259,	263,	264].	Whilst	restraint	of	people	with	mental	illness	is	commonplace	in	LMICs,	its	extent	seems	to	vary	between	settings	and	the	drivers	behind	it	are	likely	to	be	contextual	[256].		 Since	it	was	adopted	by	the	UN	in	2006,	the	Convention	on	the	Rights	of	Persons	with	Disabilities	has	been	ratified	by	166	countries,	including	Ethiopia.	The	Convention	provides	a	legal	framework	for	protecting	and	promoting	the	human	rights	of	people	with	physical	and	mental	disabilities	[36].	There	is	currently	no	mental	health	legislation	in	Ethiopia	but	the	Ministry	of	Health	has	committed	to	developing	laws	which	aim	to	protect	the	rights	of	people	with	mental	illness	[226].		 This	background	chapter	has	described	the	problem	of	disability	relating	to	schizophrenia,	introduced	CBR	as	a	potential	solution	to	this	issue,	and	explored	some	of	context	relevant	to	developing	a	CBR	programme	for	schizophrenia	in	Ethiopia.	The	next	chapter	will	draw	together	these	themes	to	describe	the	rationale,	aims	and	objectives	for	the	novel	research	conducted	for	this	thesis.	
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3 THESIS	RATIONALE,	AIMS	AND	OBJECTIVES	AND	
OVERVIEW	OF	METHODOLOGY	
	
3.1 RATIONALE	FOR	THESIS	
	 Like	many	low-income	countries,	Ethiopia	is	making	important	strides	towards	improving	care	for	people	with	mental	illness,	in	particular	through	the	integration	of	mental	health	into	primary	care.	However	provision	of	anti-psychotic	medication	alone	is	inadequate	to	address	the	complex	social,	economic	and	health	needs	of	those	affected	by	a	chronic	and	highly	disabling	illness	such	as	schizophrenia.	CBR	is	a	promising	intervention	to	support	people	with	schizophrenia	in	LMIC.	CBR	aims	to	reduce	disability,	arguably	the	most	important	outcome	for	individuals,	their	families	and	communities,	by	addressing	both	personal	and	family	level	issues	and	societal	factors	such	as	poverty,	stigma	and	access	to	care.	CBR	is	also	a	relatively	low	intensity	model	of	care	that	can	be	delivered	by	non-specialists;	a	crucial	advantage	in	settings	with	limited	or	absent	mental	health	specialists.		 Despite	being	widely	advocated,	to	date	there	have	been	few	formal	evaluations	of	CBR	for	mental	illness	using	non-specialist	workers	and	none	in	low-income	settings.	As	a	highly	contexualised	approach,	any	CBR	programme	must	fit	the	needs	and	resources	of	the	local	setting.	Moreover,	it	is	recognised	that	complex	interventions	should	be	subject	to	rigorous	intervention	development	and	piloting	prior	to	a	full	evaluation	in	order	to	ensure	their	acceptability	and	feasibility.	The	body	of	work	contained	in	this	thesis	is	needed	to	address	the	substantial	gaps	in	the	evidence	base	relating	to	the	provision	of	care	for	people	with	schizophrenia	in	low-income	settings.	This	represents	the	first	intervention	development,	piloting	and	planning	for	a	trial	of	CBR	for	schizophrenia	in	any	low-income	country.	
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3.2 AIM		AND	 OBJECTIVES	
	 The	overall	aim	of	the	PhD	thesis	is	to	design,	pilot	and	create	the	evaluation	plans	for	a	CBR	intervention	for	people	with	schizophrenia	in	Ethiopia.	The	specific	objectives	of	the	PhD	thesis	are:		
Objective	1	(Chapter	4)	
	 To	determine	the	current	evidence	for	the	effectiveness	of	community-based	psychosocial	interventions	for	schizophrenia	in	LMIC.		
Objective	2	(Chapters	5	and	6)	
	 To	develop	an	acceptable	and	feasible	CBR	intervention	for	people	with	schizophrenia	in	Ethiopia.		
Objective	3	(Chapter	7)	
	 To	pilot	the	CBR	intervention	for	people	with	schizophrenia	to	determine	its	acceptability	and	feasibility	in	practice	and	to	refine	the	intervention	in	preparation	for	a	formal	evaluation.		
Objective	4	(Chapter	8)	
	 To	prepare	the	protocol	for	a	cluster	randomised	controlled	trial	to	evaluate	the	CBR	intervention.				
3.3 SETTING	
	 The	study	was	conducted	in	Sodo	district	in	the	Gurage	administrative	zone	of	the	Southern	Nations,	Nationalities	and	Peoples’	Region	of	Ethiopia.	The	district	is	100km	from	Addis	Ababa	and	has	around	170,000	inhabitants.	The	main	town	in	the	district	is	Bui.	The	majority	of	the	population	of	Sodo	live	in	rural	areas,	often	in	households	spread	out	over	large	distances	rather	than	concentrated	in	villages.	The	topography	is	variable,	encompassing	both	cool	mountainous	areas	and	lowlands	with	higher	temperatures.	Difficult	terrain	covers	most	of	the	district;	the	only	form	of	transport	are	carts	and	minibuses,	which	have	no	fixed	departure	
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times	and	do	not	extent	to	the	most	remote	areas.	Most	of	the	population	live	in	one-room	mud	and	straw	houses.	Around	51%	of	the	Sodo	population	is	estimated	to	be	literate	[1].	The	majority	of	the	population	in	this	district	are	Orthodox	Christian.		 Sodo	district	is	the	setting	for	the	Ethiopian	arm	of	the	PRIME	project.	PRIME	is	a	five-country	research	consortium	that	aims	to	generate	evidence	on	the	integration	and	scale	up	of	mental	health	into	primary	and	maternal	care	settings	[2].	As	part	of	PRIME	a	scalable	mental	health	care	plan	was	developed	and	implemented	in	Sodo	district	across	community,	facility	and	district	healthcare	levels.	At	the	facility	level,	PRIME	trained	primary	care	staff	to	identify	schizophrenia	and	offer	a	package	of	care	including	psychotropic	medication	(oral	haloperidol	and	chlorpromazine)	and	basic	psychoeducation	[3];	training	followed	the	WHO’s	mhGAP	guidelines	[4].	Sodo	was	selected	as	the	site	for	the	RISE	study	as	this	gave	the	opportunity	to	develop	and	evaluate	an	adjuvant	psychosocial	intervention,	CBR,	in	a	setting	where	facility-based	care	was	in	place	at	the	primary	care	level.	The	PRIME	mental	health	care	plan	was	implemented	immediately	before	the	RISE	pilot	study	(Chapter	7)	commenced.	PRIME	identified	people	with	schizophrenia	in	Sodo	using	the	Butajira	key	informant	method	[5]	and,	from	December	2014,	began	following	up	those	invited	to	access	facility-based	care	in	a	12-month	treatment	cohort	[6].	The	RISE	pilot	study	(Chapter	7)	and	trial	(protocol	in	Chapter	8)	were	nested	in	the	PRIME	cohort	study.				
3.4 OVERVIEW	OF	THESIS	METHODOLOGY	
	
3.4.1 Development	and	evaluation	of	complex	interventions	
	 As	a	multi-component	intervention	addressing	a	range	of	difficult	issues	and	behaviours	targeted	at	the	individual,	family	and	community	level,	within	which	there	is	flexibility	to	tailor	to	an	individual’s	needs,	CBR	can	readily	be	described	as	a	complex	intervention	[7].	The	2008	Medical	Research	Council	(MRC)	guidance	on	developing	and	evaluating	complex	interventions	recommends	four	phases,	though	these	may	be	completed	in	a	non-linear	sequence:	development,	feasibility	and	piloting,	evaluation	and	implementation	(see	Figure	3.1)	[7].	
81
		
Figure	3.1	Key	elements	of	the	development	and	evaluation	process	(from	MRC	guidance)	
	
Development:	In	this	phase	the	existing	evidence	should	be	identified	and	reviewed	and	a	theoretical	model	for	the	likely	process	of	change	should	be	developed	[7].	Formative	work	to	determine	the	likely	acceptability	and	feasibility	of	the	intervention	can	also	be	conducted	[8,	9].		
Feasibility	and	piloting:	In	this	phase	the	intervention	is	tested	in	practice,	allowing	a	fuller	assessment	of	acceptability	and	feasibility	[7].	A	process	evaluation,	which	considers	intervention	fidelity,	mechanisms	of	impact	and	context,	should	ideally	be	conducted	as	part	of	the	feasibility	testing	[10].		
Evaluation:	A	range	of	experimental	and	non-experimental	designs	exist	for	the	evaluation	of	complex	interventions,	with	randomised	studies	being	the	most	robust	[7].	A	process	evaluation	should	also	be	conducted	alongside	the	full	trial	as	different	issues	may	arise	when	the	intervention	is	delivered	at	a	larger	scale	[10].		
Implementation:	This	phase	incorporates	the	dissemination	and	scale	up	of	interventions,	along	side	their	on	going	monitoring	and	long	term	follow	up	[7,	11,	12].				
3.4.2 Introduction	to	theory	of	change	
	 Theory	of	change	is	one	method	of	theory	driven	evaluation,	amongst	a	wider	group	including	logic	models,	logical	frameworks,	outcome	hierarchies	and	realist	evaluation	[13].	Theory	of	change	has	been	defined	as,	“an	approach	which	describes	how	a	programme	brings	about	specific	long-term	outcomes	through	a	
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logical	sequence	of	intermediate	outcomes”	[13]. In	another	definition	theory	of	change	is,	“a	theory	of	how	and	why	an	initiative	works.”	[14].	Theory	of	change	maps	are	often	developed	through	participatory	stakeholder	workshops,	though	in	some	cases	stakeholders	have	minimal	involvement.	The	map	is	used	as	a	framework	for	intervention	development	and	evaluation,	with	some	researchers	refining	the	map	to	reflect	on	going	research	findings	[13].	The	map	includes	the	following	components:	(i)	the	desired	final	outcome,	(ii)	intermediate	outcomes	that	are	needed	to	achieve	the	final	outcome,	(iii)	interventions	which	are	needed	to	move	from	one	outcome	to	the	next,	(iv)	assumptions	(the	contextual	factors	or	other	conditions	which	the	causal	pathway	needs	in	order	to	progress),	(v)	rationale	for	each	link	in	the	pathway	and	(vi)	indicators	(to	evaluate	whether	each	intermediate	outcome	and	the	final	outcome	are	achieved).		 Theory	of	change	strengthens	the	MRC	framework	[14],	and	addresses	calls	to	incorporate	a	realist	approach	into	evaluation	[15],	in	several	ways:		
• Development:	The	intervention	design	is	explicitly	embedded	within	local	context	in	terms	of	social	and	economic	setting,	and	human	and	material	resources.	The	theory	of	change	map	provides	a	structured	presentation	of	the	hypothesised	process	of	change.	
• Piloting:	Modification	of	the	theory	of	change	map	on	the	basis	of	testing	assumptions	allows	a	structured	approach	to	identifying	and	overcoming	barriers,	therefore	producing	a	more	acceptable,	feasible	and	effective	intervention	for	evaluation.	Furthermore,	specifying	causal	assumptions	about	how	the	intervention	will	function	permits	others	to	assess	its	credibility	[10].	
• Evaluation:	Trial	outcomes,	including	intermediate	outcomes,	are	explicitly	identified	on	the	basis	of	the	theory	of	change.	Process	and	effectiveness	evaluations	are	combined	in	one	approach.	
• Implementation:	Modelling	the	relationship	between	specific	intervention	components	and	outcomes	may	facilitate	the	identification	of	‘active	ingredients’.	This	is	of	great	value	in	refining	complex	interventions	for	scale	up	and	dissemination.	
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Theory	of	change	is	an	increasingly	favoured	approach	for	the	development	of	interventions,	including	in	global	mental	health	research	[14].	A	recent	systematic	review	identified	its	use	in	62	papers	describing	the	development	and	/or	evaluation	of	public	health	interventions	[13].	Whilst	traditionally	CBR	programmes	have	lacked	formal	monitoring	and	evaluation	processes	[16]	structured	approaches	to	evaluation	are	now	being	developed	[17].	However,	even	the	few	RCTs	of	CBR-like	interventions,	whilst	having	followed	the	MRC	steps,	have	not	been	guided	by	a	theoretical	model	for	the	process	of	change	[8,	18].				
3.4.3 Use	of	theory	of	change	in	this	thesis	
	 Theory	of	change	was	used	as	a	framework	to	guide	the	intervention	development,	piloting	and	trial	protocol	presented	in	this	thesis.	An	initial	theory	of	change	map	was	developed	and	refined	through	theory	of	change	workshops	as	part	of	the	intervention	development	phase	(Chapter	5).	This	map	presented	the	hypothesised	mechanism	of	change,	as	well	as	capturing	important	contextual	issues	and	key	assumptions.	These	assumptions	formed	the	basis	of	research	questions	that	I	then	answered	-using	qualitative	and	quantitative	methods	and	measures	of	intervention	fidelity-	in	the	remaining	intervention	development	phase	and	in	the	pilot.	On	the	basis	of	on	going	findings,	assumptions	that	were	confirmed	to	be	well	founded	were	converted	into	rationale,	or	changes	were	made	to	the	intervention	design	to	fulfil	assumptions	(Chapter	7).	Revised	versions	of	the	theory	of	change	map	were	made	as	a	visual	representation	of	these	findings.	The	evaluation	plans	outlined	in	the	trial	protocol,	including	primary	and	secondary	outcomes,	process	data	collection,	and	the	focus	of	a	parallel	qualitative	study,	were	shaped	by	the	theory	of	change	indicators	(see	Chapter	8).		 Reflecting	the	participatory	emphasis	of	the	theory	of	change	approach,	people	with	schizophrenia	and	their	caregivers	were	involved	at	several	stages	in	the	conduct	of	this	research.	This	type	of	involvement	is	seen	as	an	important	component	of	efforts	to	safeguard	the	dignity	and	human	rights	of	people	with	mental	illness	[19].	The	UN	Convention	on	the	Rights	of	Persons	with	Disabilities	((Article	4(3))	also	highlights	the	importance	of	involving	people	with	disabilities	and	their	caregivers	in	the	development	of	policy	and	programmes	[20].	
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3.5 THESIS	TIMESCALE	
	 Figure	3.2	gives	an	overview	of	the	thesis	timescale.	The	initiation	of	the	trial	prior	to	completion	of	the	pilot	was	an	intentional	design	to	address	the	overall	time	constraints	relating	to	the	project	and	its	funding.	An	initial	literature	review	was	carried	out	as	part	of	the	intervention	development	(Chapter	5).	However	a	full	systematic	review	and	meta-analysis	was	subsequently	carried	out	for	completeness	and	to	better	contexualise	the	pilot	findings	within	the	current	evidence	base	(Chapter	4).	The	next	chapter	presents	this	systematic	review	of	community-based	psychosocial	interventions	for	schizophrenia.	
85
													
		 2012		 2013		 2014		 2015		 2016		 2017		
		
O
ct
-	D
ec
		
Ja
n-
	M
ar
		
A
pr
-	J
un
e	
	
Ju
ly
-	S
ep
t		
O
ct
-	D
ec
		
Ja
n-
	M
ar
		
A
pr
-	J
un
e	
	
Ju
ly
-	S
ep
t		
O
ct
-	D
ec
		
Ja
n-
	M
ar
		
A
pr
-	J
un
e	
	
Ju
ly
-	S
ep
t		
O
ct
-	D
ec
		
Ja
n-
	M
ar
		
A
pr
-	J
un
e	
	
Ju
ly
-	S
ep
t		
O
ct
-	D
ec
		
Ja
n-
	M
ar
		
A
pr
-	J
un
e	
	
Intervention	development	work	
(Chapter	5)		
	 	 	 	 		 		 		 		 		 		 		 		 		 		 		 		 		 		 		
Preparation	of	intervention	
materials	(Chapter	6)		
		 		 		 		 		 		 	 	 		 		 		 		 		 		 		 		 		 		 		
RISE	CBR	worker	training	
(Chapter	6)		
		 		 		 		 		 		 		 		 	 		 		 		 		 		 		 		 		 		 		
RISE	pilot	
(Chapter	7)		
		 		 		 		 		 		 		 		 		 	 	 	 	 		 		 		 		 		 		
RISE	trial			
(protocol	in	Chapter	8)		
		 		 		 		 		 		 		 		 		 		 		 		 	 	 	 	 	 	 	
Systematic	review	
(Chapter	4)		
		 		 		 		 		 		 		 		 		 		 		 		 		 		 	 	 		 		 		
Figure	3.2	Thesis	timescale		
	 		
86
3.6			REFERENCES		
	 1.	 Fekadu,	A.,	G.	Medhin,	M.	Selamu,	T.	Shiferaw,	M.	Hailemariam,	S.D.	Rathod,	M.	Jordans,	S.	Teferra,	C.	Lund,	E.	Breuer,	M.	Prince,	T.W.	Giorgis,	A.	Alem,	and	C.	Hanlon,	Non-fatal	suicidal	behaviour	in	rural	Ethiopia:	a	cross-	
sectional	facility-	and	population-based	study.	BMC	Psychiatry,	2016.	16(1):	p.	75.		2.	 Lund,	C.,	M.	Tomlinson,	M.	De	Silva,	A.	Fekadu,	R.	Shidhaye,	M.	Jordans,	I.	Petersen,	A.	Bhana,	F.	Kigozi,	M.	Prince,	G.	Thornicroft,	C.	Hanlon,	R.	Kakuma,	D.	McDaid,	S.	Saxena,	D.	Chisholm,	S.	Raja,	S.	Kippen-Wood,	S.	Honikman,	L.	Fairall,	and	V.	Patel,	PRIME:	A	Programme	to	Reduce	the	
Treatment	Gap	for	Mental	Disorders	in	Five	Low-	and	Middle-Income	
Countries.	PLoS	Med,	2012.	9(12):	p.	e1001359.		3.	 Fekadu,	A.,	C.	Hanlon,	G.	Medhin,	A.	Alem,	M.	Selamu,	T.W.	Giorgis,	T.	Shibre,	S.	Teferra,	T.	Tegegn,	E.	Breuer,	V.	Patel,	M.	Tomlinson,	G.	Thornicroft,	M.	Prince,	and	C.	Lund,	Development	of	a	scalable	mental	healthcare	plan	for	a	
rural	district	in	Ethiopia.	Br	J	Psychiatry,	2015.	208(Suppl	56):	p.	s4-12.		4.	 WHO.	mhGAP	Intervention	Guide	for	mental,	neurological	and	substance		use	disorders	in	non-specialized	health	settings.	World	Health	Organization.	2011.		5.	 Shibre,	T.,	D.	Kebede,	A.	Alem,	A.	Negash,	S.	Kibreab,	A.	Fekadu,	D.	Fekadu,	L.	Jacobsson,	and	G.	Kullgren,	An	evaluation	of	two	screening	methods	to	
identify	cases	with	schizophrenia	and	affective	disorders	in	a	community	
survey	in	rural	Ethiopia.	International	Journal	of	Social	Psychiatry,	2002.	
48(3):	p.	200-8.		6.	 De	Silva,	M.J.,	S.D.	Rathod,	C.	Hanlon,	E.	Breuer,	D.	Chisholm,	A.	Fekadu,	M.	Jordans,	F.	Kigozi,	I.	Petersen,	R.	Shidhaye,	G.	Medhin,	J.	Ssebunnya,	M.	Prince,	G.	Thornicroft,	M.	Tomlinson,	C.	Lund,	and	V.	Patel,	Evaluation	of	
district	mental	healthcare	plans:	the	PRIME	consortium	methodology.	Br	J	Psychiatry,	2016.	208	Suppl	56:	p.	s63-70.		7.	 Craig,	P.,	P.	Dieppe,	S.	Macintyre,	S.	Michie,	I.	Nazareth,	and	M.	Petticrew.	Developing	and	evaluating	complex	interventions:	new	guidance.	Medical	Research	Council.	2008.		8.	 Balaji,	M.,	S.	Chatterjee,	M.	Koschorke,	T.	Rangaswamy,	A.	Chavan,	H.	Dabholkar,	L.	Dakshin,	P.	Kumar,	S.	John,	G.	Thornicroft,	and	V.	Patel,	The	
development	of	a	lay	health	worker	delivered	collaborative	community	based	
intervention	for	people	with	schizophrenia	in	India.	BMC	Health	Serv	Res,	2012.	12:	p.	42.		9.	 Mendenhall,	E.,	M.J.	De	Silva,	C.	Hanlon,	I.	Petersen,	R.	Shidhaye,	M.	Jordans,	N.	Luitel,	J.	Ssebunnya,	A.	Fekadu,	V.	Patel,	M.	Tomlinson,	and	C.	Lund,	
Acceptability	and	feasibility	of	using	non-specialist	health	workers	to	deliver	
mental	health	care:	Stakeholder	perceptions	from	the	PRIME	district	sites	in	
Ethiopia,	India,	Nepal,	South	Africa,	and	Uganda.	Soc	Sci	Med,	2014.	118C:	p.	33-42.		10.	 Moore,	G.F.,	S.	Audrey,	M.	Barker,	L.	Bond,	C.	Bonell,	W.	Hardeman,	L.	Moore,	A.	O'Cathain,	T.	Tinati,	D.	Wight,	and	J.	Baird,	Process	evaluation	of	complex	
interventions:	Medical	Research	Council	guidance.	BMJ,	2015.	350:	p.	h1258.		11.	 Betancourt,	T.S.	and	D.A.	Chambers,	Optimizing	an	Era	of	Global	Mental	
Health	Implementation	Science.	JAMA	Psychiatry,	2016.	73(2):	p.	99-100.					 		
87
12. Thornicroft,	G.,	Evidence-based	mental	health	care	and	implementation	
science	in	low-	and	middle-income	countries.	Epidemiol	Psychiatr	Sci,	2012.	
21(3):	p.	241-4.	13. Breuer,	E.,	L.	Lee,	M.	De	Silva,	and	C.	Lund,	Using	theory	of	change	to	design	
and	evaluate	public	health	interventions:	a	systematic	review.	Implement	Sci,	2016.	11(1):	p.	63.	14. De	Silva,	M.J.,	E.	Breuer,	L.	Lee,	L.	Asher,	N.	Chowdhary,	C.	Lund,	and	V.	Patel,	
Theory	of	Change:	a	theory-driven	approach	to	enhance	the	Medical	Research	
Council's	framework	for	complex	interventions.	Trials,	2014.	15(1):	p.	267.	15. Bonell,	C.,	A.	Fletcher,	M.	Morton,	T.	Lorenc,	and	L.	Moore,	Realist	
randomised	controlled	trials:	a	new	approach	to	evaluating	complex	public	
health	interventions.	Soc	Sci	Med,	2012.	75(12):	p.	2299-306.	16. Grandisson,	M.,	M.	Hebert,	and	R.	Thibeault,	A	systematic	review	on	how	to	
conduct	evaluations	in	community-based	rehabilitation.	Disabil	Rehabil,	2014.	36(4):	p.	265-75.	17. Wickenden,	M.,	K.	Andrae,	H.	Cornielje,	E.	Post,	M.	Schneider,	and	R.	Gondwe.	PIE	Participatory	Inclusion	Evaluation:	A	flexible	approach	to	evaluating	the	impact	of	CBR	and	inclusive	development	programmes.	Institute	for	Global	Health,	University	College	London.	2016.	18. Chatterjee,	S.,	S.	Naik,	S.	John,	H.	Dabholkar,	M.	Balaji,	M.	Koschorke,	M.	Varghese,	R.	Thara,	H.A.	Weiss,	P.	Williams,	P.	McCrone,	V.	Patel,	and	G.	Thornicroft,	Effectiveness	of	a	community-based	intervention	for	people	with	
schizophrenia	and	their	caregivers	in	India	(COPSI):	a	randomised	controlled	
trial.	Lancet,	2014.	383(9926):	p.	1385-94.	19. Wallcraft,	J.,	M.	Amering,	J.	Freidin,	B.	Davar,	D.	Froggatt,	H.	Jafri,	A.	Javed,	S.	Katontoka,	S.	Raja,	S.	Rataemane,	S.	Steffen,	S.	Tyano,	C.	Underhill,	H.	Wahlberg,	R.	Warner,	and	H.	Herrman,	Partnerships	for	better	mental	health	
worldwide:	WPA	recommendations	on	best	practices	in	working	with	service	
users	and	family	carers.	World	Psychiatry,	2011.	10(3):	p.	229-36.	20. UN.	International	Convention	on	the	Rights	of	Persons	with	Disabilities.	Adopted	by	the	United	Nations	General	Assesmbly	in	December	2006.	
88
		
RESEARCH PAPER COVER SHEET 
 
 
PLEASE NOTE THAT A COVER SHEET MUST BE COMPLETED FOR EACH RESEARCH PAPER INCLUDED 
IN A THESIS. 
 
SECTION A – Student Details 
 
Student Laura Asher 
Principal Supervisor Vikram Patel 
Thesis Title The development and evaluation of a community-based rehabilitation intervention for people with schizophrenia in Ethiopia 
 
If the Research Paper has previously been published please complete Section B, if not please move to 
Section C 
 
SECTION B – Paper already published 
 
Where was the work published? 	
When was the work published? 	
If the work was published prior to 
registration for your research degree, 
give a brief rationale for its inclusion 
	
Have you retained the copyright for the 
work?* Choose an item. 
Was the work subject to 
academic peer review? 
Choose an 
item. 
 
*If yes, please attach evidence of retention. If no, or if the work is being included in its published format, please 
attach evidence of permission from the copyright holder (publisher or other author) to include this work. 
 
SECTION C – Prepared for publication, but not yet published 
 
Where is the work intended to be 
published? BMC Psychiatry 
Please list the paper’s authors in the 
intended authorship order: Laura Asher, Vikram Patel, Mary De Silva 
Stage of publication Not yet submitted 
 
SECTION D – Multi-authored work 
 
 
For multi-authored work, give full details of your role in 
the research included in the paper and in the preparation 
of the paper. (Attach a further sheet if necessary) 
I conceived the review, wrote the protocol and 
search strategy, ran the searches, extracted the 
data, assessed risk of bias, performed the meta- 
analysis and wrote the initial and final drafts 
Student Signature:    Date: 06.10.2016  
Supervisor Signature:    Date: 06.10.2016 
89
4 SYSTEMATIC	REVIEW	AND	META-ANALYSIS	
	
	
4.1 INTRODUCTION	
	 Community-based	psychosocial	interventions,	including	family	interventions	and	CBR,	are	advocated	as	appropriate	approaches	to	support	people	with	schizophrenia	in	LMICs	in	the	World	Bank	DCP-3	[1]	and	by	the	WHO’s	mhGAP	[2].	An	initial	scoping	search	undertaken	in	April	2016	indicated	that	additional	relevant	randomised	studies	had	been	published	since	the	Iemmi	et	al	review	of	CBR	was	conducted	in	2012	(see	Section	2.7.1).	This	suggested	that	an	updated	review	would	be	of	value.	Furthermore,	the	scope	of	the	review	was	broadened	to	all	community-based	psychosocial	interventions	for	schizophrenia	in	order	to	capture	all	potential	elements	of	a	CBR	programme	for	this	group.	This	was	deemed	appropriate	for	the	development	of	a	new	CBR	intervention,	due	to	the	broad	range	of	psychosocial	interventions	and	models	of	care	that	exist	for	people	with	schizophrenia	in	LMIC,	and	the	challenges	in	defining	what	constitutes	a	CBR	programme	[3].	The	aim	of	this	review	was	to	assess	the	effectiveness	of	community-based	psychosocial	interventions	for	people	with	schizophrenia	on	patient	outcomes	in	LMIC.			
4.2 METHODS	
	
4.2.1 Systematic	literature	search	
	
4.2.1.1 Eligibility	criteria		Eligible	interventions	were	any	community-based	psychosocial	intervention	delivered	to	people	with	schizophrenia	or	their	caregivers	with	the	aim	of	improving	patient	outcomes	(see	Table	4.1).	Psychosocial	interventions	were	defined	as	any	intervention	that	focused	on	psychological	and/	or	social	factors	rather	than	biological	factors	(for	example	a	pharmacological	intervention).	Interventions	could	have	one	or	multiple	components.	Community-based	interventions	were	defined	as	any	intervention	delivered	in	the	participant’s	home	or	another	community	setting.	Interventions	that	took	place	exclusively	in	health	or	other	institutional	facilities	(hospitals,	clinics,	outpatient	care	centres	or	
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specialised	care	centres)	were	excluded.	Papers	without	a	full	text	available	in	English	were	excluded	due	to	logistical	constraints.	Conference	abstracts,	Masters	dissertations	and	PhD	theses	were	also	excluded.		
Table	4.1	Inclusion	and	exclusion	criteria	(continued	overleaf)	
	 	 Included	 Excluded	
Publication	
type	
Any	date	
	 English	language	 No	full	text	available	in	English.	Conference	abstracts,	Masters	dissertations,	PhD	Theses	and	unpublished	studies.	
Study	design	 Individual	and	cluster	randomised	controlled	trials.	 Non-	randomised	controlled	intervention	studies,	case-control	or	cross-sectional	studies.	Retrospective/historical	controlled	cohorts.	
Study	
population	
General	adult	population	 Interventions	for	children	and	adolescents	(<18	years)	Study	conducted	in	a	LMIC	as	defined	by	the	World	Bank	 Study	conducted	in	high-income	country	or	territory	
Condition	of	
interest	
Schizophrenia	or	schizoaffective	disorder	as	defined	in	International	Classification	of	Diseases-10	(ICD-	10),	DSM-IV	or	Chinese	Classification	of	Mental	Disorders	(CCMD)	confirmed	by	a	clinical	diagnosis	or	a	validated	tool.	No	restriction	on	the	proportion	of	participants	with	schizophrenia	or	schizoaffective	disorder.	No	restriction	on	comorbid	mental	disorders.	
Other	mental	disorders	including	depression,	substance	abuse,	bipolar	disorder,	anxiety	disorder,	epilepsy,	other	types	of	disability,	brief	psychotic	disorders,	post-partum/	puerperal	psychosis,	populations	at	risk	of	psychosis.	
Intervention	 Community-based	psychosocial	interventions	delivered	to	people	with	schizophrenia	or	their	caregivers	with	the	aim	of	improving	patient	outcomes.	Psychosocial	interventions	were	defined	as	any	intervention	that	focused	on	psychological	and/	or	social	factors	rather	than	biological	factors	(for	example	a	pharmacological	intervention),	including	psychological	therapies,	rehabilitation,	psychoeducation,	adherence	support,	stigma	reduction	strategies,	social	skills	training,	life	skills	training,	self-help	groups,	group	support	sessions	and	livelihoods	interventions.	Community-based	interventions	were	defined	as	any	intervention	delivered	in	the	individual’s	home	or	another	community	setting.	
Studies	were	excluded	if	the	intervention	took	place	only	in	health	or	other	institutional	facilities	(defined	as	places	that	provide	health	care:	hospitals,	clinics,	outpatient	care	centres,	specialised	care	centres).	
	 The	following	interventions	were	also	excluded:	those	specifically	designed	for	humanitarian	crisis	settings;	those	employing	solely	physical	therapies	including	yoga;	interventions	solely	targeting	depression,	substance	use,	or	smoking;	interventions	focusing	exclusively	on	‘at	risk’	groups;	interventions	using	telephone	reminders	only	and	involving	no	face	to	face	contact;	and	interventions	which	were	entirely	computer-based	(e.g.	cognitive	training).	
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Table	4.1	continued	
Outcome	 Any	patient	outcomes	including	
	 -Clinical	outcomes	(e.g.	symptoms,	severity,	relapse,	mortality)	
	 -Health	service	use	including	hospitalisation	
	 -Adherence	to	antipsychotic	medication	
	 -Change	in	disability	and	functioning	(e.g.	improved	coping	skills,	quality	of	life,	social	functioning,	self-esteem)	
	 -Economic	status	outcomes,	for	e.g.	return	to	work,	employment	status	
	 -Understanding	of	mental	illness/	schizophrenia	
	 -Stigma/	discrimination	
Studies	were	excluded	if	outcomes	were	measured	in	caregivers	or	family	members	only	
Control	
Group	
Any	control	group	including	treatment	as	usual,	no	intervention,	treatment	delivered	in	a	health	care	setting	or	pharmacological	intervention	only	
n/a	
	
	
4.2.1.2 Information	sources	Database	searches	were	carried	out	on	the	18th	and	19th	April	2016.	The	following	databases	were	searched:	Medline,	EMBASE,	PsycINFO,	Global	Health,	CINAHL	and	Africa	Wide	information.	In	addition	the	Cochrane	Library	was	searched	for	relevant	systematic	reviews.	The	included	studies	list	of	each	relevant	Cochrane	review	was	searched	for	additional	references	not	already	identified	in	the	previous	database	searches.	The	Clinicaltrials.gov	database	was	searched	for	relevant	trials;	for	all	trials	identified,	a	search	was	carried	out	for	relevant	linked	publications	on	the	clinicaltrials.gov	database	and	on	PubMed.	The	websites	of	organisations	known	to	conduct	relevant	research	projects	and	progammes,	including	BasicNeeds,	CBM,	and	Sangath,	were	searched	for	relevant	reports	and	studies.	All	innovation	entries	on	the	Mental	Health	Innovations	Network	(MHIN)	database	were	reviewed	for	relevance	and	linked	publications	were	sought	on	PubMed.	MHIN	is	an	online	platform	and	database	for	sharing	knowledge,	experiences	and	resources	relating	to	global	mental	health	
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(www.mhinnovation.net).	Reports	and	guidelines	relating	to	mental	health	and	development	or	CBR	were	reviewed	for	relevant	programmes,	including	the	WHO	CBR	guidelines	[4],	WHO	report	on	Mental	Health	and	Development	[5]	and	the	UK	government	Mental	Health	for	Sustainable	Development	Report	[6].	Relevant	literature	reviews	relating	to	CBR	[3],	psychosocial	interventions	[7,	8],	task-	sharing	[9,	10]	and	packages	of	care	[1,	11,	12]	for	mental	illness	in	LMIC	were	also	reviewed	for	relevant	references.		
4.2.1.3 Search	strategy	The	search	identified	studies	covering	four	domains:	A:	Schizophrenia	or	schizoaffective	disorder	+	B:	community-based	psychosocial	intervention	+	C:	low	or	middle-income	country	+	D:	controlled	study.	Appendix	A	(i)	presents	the	search	strategy	that	was	designed	for	Medline;	minor	modifications	were	made	as	required	for	other	databases.	A	broad	range	of	search	terms	were	used	for	domain	B,	including	terms	relating	to	psychoeducation,	adherence	support,	family	support,	rehabilitation,	psychotherapy	and	counselling,	self	help	groups,	health	promotion	and	community-based	care.	For	domain	C,	separate	terms	were	included	for	each	LMIC,	along	with	generic	terms	such	as	‘developing	country’.		
4.2.1.4 Study	selection	The	results	of	all	database	searches	were	downloaded	to	Endnote	X7.	Duplicates	were	removed	and	the	titles	and	abstracts	of	the	remaining	records	were	screened	for	relevance.	The	full	texts	of	those	deemed	to	be	relevant	were	acquired	and	reviewed.	A	final	list	of	included	eligible	studies	was	compiled	after	reviewing	the	full	text.				
4.2.2			Data	extraction	and	quality	assessment	Key	features	and	findings	of	each	included	study	were	extracted	onto	a	specially	designed	database.	Data	were	extracted	on	study	characteristics	(setting,	design,	number	of	participants	randomised	and	duration	of	follow	up),	inclusion	criteria,	characteristics	of	the	interventions	(content,	frequency	and	duration)	and	outcomes.	The	Cochrane	Collaboration	risk	of	bias	tool	was	used	to	assess	each	included	study	[13].	A	rating	of	low,	high	or	unclear	risk	of	bias	was	given	for	the	following	domains:	sequence	generation;	allocation	concealment;	masking	of	
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assessors;	selective	outcome	reporting;	incomplete	data	and	other	source	of	bias.	Blinding	of	participants	and	personnel	was	not	possible	due	to	the	nature	of	the	interventions,	therefore	this	criterion	was	not	utilised.		 Statistical	analyses	were	performed	using	Review	Manager	5.3	for	Mac.	For	outcomes	measured	on	continuous	scales,	the	post-treatment	mean	and	standard	deviation	in	the	intervention	and	control	groups	were	extracted	along	with	the	sample	size	in	each	group.	Where	these	data	were	presented	in	the	paper,	the	information	was	used	to	calculate	the	standardised	mean	difference	(SMD)	for	each	trial	in	order	for	different	outcome	scales	to	be	pooled.	SMD	is	a	summary	statistic	that	represents	the	size	of	the	intervention	effect	in	a	study	relative	to	the	variability	observed	in	that	study.	The	following	cut	offs	were	used	to	guide	interpretation	of	the	strength	of	effect:	0.2	represents	a	“small”	effect,	0.5	represents	a	“medium”	effect,	and	0.8	represents	a	“large”	effect	[14].	Due	to	absence	of	relevant	data	in	the	included	papers,	it	was	not	possible	to	take	into	account	differences	in	baseline	scores	between	treatment	groups,	in	the	calculation	of	SMD.	Where	outcomes	were	presented	as	proportions,	risk	ratios	were	calculated.	For	any	scale	where	an	increase	in	score	indicates	worse	outcome,	mean	scores	or	proportions	were	inverted	before	calculating	the	SMD	or	risk	ratio.	Acknowledging	the	heterogeneity	in	interventions,	random	effects	meta-analyses	were	performed	with	all	intervention	types	together	along	with	subgroup	meta-	analyses	for	each	intervention	type	separately.		Meta-analyses	were	also	performed	separately	for	short	and	long-term	outcomes.	Short-term	outcomes	were	defined	as	those	measured	less	than	18	months	after	the	intervention	ended,	and	long	term	outcomes	more	than	18	months	after	the	intervention	ended.	Heterogeneity	between	trials	was	assessed	using	the	I2	statistic.	In	order	to	understand	the	impact	of	study	quality	on	the	findings,	a	sensitivity	analysis	was	conducted	excluding	studies	perceived	to	have	the	highest	risk	of	bias	overall;	these	studies	comprised	those	with	a	risk	of	bias	for	allocation	concealment,	or	for	those	with	an	unclear	risk	of	bias	for	allocation	concealment,	those	studies	with	a	risk	of	bias	for	sequence	generation	or	masking	of	outcome	assessment	[8].	
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4.3 RESULTS	
	
4.3.1 Overview	From	9543	records,	13	records	reporting	11	studies	met	inclusion	criteria	for	the	review	(see	Figure	4.1).	The	reasons	for	excluding	full	text	articles	are	presented	in	Appendix	A	(ii).	
	
Figure	4.1	Flow	chart	of	study	selection	process		
Records	iden+ﬁed	
through	database	
searching	
9541	
Addi+onal	records	
iden+ﬁed	through	other	
sources	
2	
Records	screened	
8547	
Duplicate	records	excluded	
996	
Abstracts	of	ar+cles	
assessed	for	eligibility		
259	
Records	excluded	
8288	
Records	excluded	
TOTAL:	200	studies	
	
Not	LMIC	39	
Non	RCT	interven+on	study	43	
Facility	based	only	37	
No	English	full	text	33	
Descrip+on/	qualita+ve	only	17	
Conference	abstract/	thesis	
only	15	
Caregiver	outcomes	only	12	
Protocol	only	4	
Cannot	access	full	text	3	
Non-eligible	disorder	2	
Other	1	
	
Full	texts	of	ar+cles	
assessed	for	eligibility		
54	
RCTs	included	
11	studies	(13	papers)	
Records	excluded	
TOTAL:	41	studies	
	
Non-eligible	interven+on	39	
Retrospec+ve/	historical	
cohort	2	
	
	
Total	records	iden+ﬁed	
9543	
	
4.3.2 Study	characteristics	
	
4.3.2.1		Overview	Table	4.2	gives	a	summary	of	the	features	of	the	intervention	and	study	design	for	each	included	study.	Across	all	included	studies	there	were	a	total	of	1787	participants	with	a	median	sample	size	of	111,	ranging	from	45	to	326.	Five	studies,	reported	in	six	papers,	were	conducted	in	China	[15-20],	two	studies	were	conducted	in	India	[21,	22]	and	Iran	[23,	24],	one	study,	reported	in	two	papers,	was	conducted	in	South	Africa	[25,	26],	and	one	study	was	conducted	in	Turkey	[27].	All	studies	were	conducted	in	upper-middle	income	countries	apart	from	the	two	studies	based	in	India,	which	is	classified	by	the	World	Bank	as	lower-middle	income.	There	were	no	studies	conducted	in	low-income	countries.	
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Table	4.2	Summary	of	the	design	and	findings	of	included	studies	(continued	overleaf)		
	
Study	and	
setting		
Design		
and	follow	
up	period		
Participants	
[I=intervention	
C=control]		
Intervention	duration	and	content		 Personnel	
delivering	
intervention		
Community	
involvement		
Comparison	group		 Key	results		
Group	A:	Psychoeducation/	cognitive	retraining		
Hegde		 Individual			 Schizophrenia			 2	months.	(i)	Cognitive	retraining:		 Researcher			 None		 Drug	treatment	and		 Symptoms:	Positive	association	with		
2012	[22]		 		 n=	45			 home	visits	for	cognitive	retraining		 	 	 psychoeducation		 negative	symptoms.			
		 6	months		 [I=22,	C=23]		 tasks	and	(ii)	Psychoeducation:	3		 	 	 	 Cognition:	Positive	association		
India		 	 	 sessions	45-60min.	Medication.		 	 	 	 	
Li	2005		 Cluster		 Schizophrenia			 3	months.	Family	and	patient		 Trained	nurse			 None		 Medication/	standard		 Symptoms:	Positive	association	at	9		
[17]		 		 n=101			 psycho-education	in	hospital	(8h		 	 	 inpatient	care		 months;	no	association	at	3	months.		
		 9	months		 [I=46,	C=55]		 with	pt,	36	hrs	with	family)	and	then		 	 	 	 Functioning:	Positive	association	at		
China		 	 	 at	home	(2	hrs/month	for	3	months		 	 	 	 9	months;	no	association	at	3	months.			 	 	 post-discharge).	Phases:	establish		 	 	 	 Medication	adherence:	No			 	 	 trust,	assess	needs;	psychoeducation,		 	 	 	 association.			 	 	 develop	coping	skills.	Medication.		 	 	 	 Knowledge:	Positive	association			
Xiang		 Individual		 Schizophrenia		 4	months.	Family	psychoeducation		 Not	stated		 Health		 Monthly	drug		 Symptoms:	Positive	association		
1994	[18]		 multisite		 and	affective		 (family	visits,	workshop,	monthly		 	 education		 treatment			 Functioning:	Positive	association		
		 		 psychoses		 supervision).	Medication.		 	 through		 	 with	work	ability	and	poor	social		
China		 4	months			 n=77			 	 	 village	wired		 	 functioning.				 	 [I=36,	C=41]		 	 	 radio	network		 	 Medication	adherence:	Positive			 	 	 	 	 	 	 association		
Zhang		 Individual		 Schizophrenia		 18	months.	Family		 Counsellors			 None		 Outpatient	care	-		 Symptoms:	Positive	association			
1994	[19]		 		 n=83			 psychoeducation:	initial	home	visit,		 	 	 including	medication;		 Functioning:	Positive	association		
		 18	months		 [I=39,	C=39]		 then	3	monthly	group	sessions	or		 	 	 no	active	follow	up	for		 Readmission:	Positive	association		
China		 	 	 individual	counseling	in	outpatients		 	 	 non-	attenders		 Nb	All	analyses	included	only	those			 	 	 for	complex	problems;	non-attenders		 	 	 	 not	readmitted.				 	 	 had	home	visits.	Minimum	contact		 	 	 	 		 	 	 every	3	months.	Medication.		 	 	 	 	
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Table	4.2	continued		
Study	and	
setting		
Design		
and	follow	
up	period		
Participants	
[I=intervention	
C=control]		
Intervention	duration	and	content		 Personnel	
delivering	
intervention		
Community	
involvement		
Comparison	group		 Key	results		
Group	B:	Comprehensive	family/rehabilitation	intervention		
Cai	2015		 Individual		 Schizophrenia			 10	weeks.	Comprehensive	family		 Professional		 None		 Usual	care	(usually		 Symptoms:	No	association		
[20]		 multisite		 n=	256	[I=133,		 therapy:	(i)	Social	skills	training		 personnel		 	 monthly	outpatient		 Cognition:	Positive	association		(greater		
		 		 C=123]		 (medication	and	symptom		 	 	 appointment)		 improvements	since	baseline	compared		
China		 18	months			 	 management,	community	re-entry		 	 	 	 to	control	(p=0.002))			 	 	 support,	recreation	for	leisure	and		 	 	 	 		 	 	 social	independent	living	skills)	90–	 	 	 	 		 	 	 120	minutes/session,	2	sessions/		 	 	 	 		 	 	 week	for	10	weeks	(ii)	Family		 	 	 	 		 	 	 psychoeducation.	One	session/		 	 	 	 		 	 	 week	for	10	weeks.	Medication.		 	 	 	 	
Chatterjee		 Individual			 Schizophrenia			 12	months.	Collaborative		 Lay		 Referrals	to		 Facility	based	care.		 Symptoms:	Non-significant	association		
2014	[21]		 multisite		 n	=282	[I=187,		 community	based	care:	Home	visits		 community		 community		 Psychiatrist		 (p=0.08).			
		 		 C=95]		 fortnightly	for	7	months,	then		 health		 agencies:		 consultations.	Anti-	 Functioning:	Positive	association.		
India		 12	months		 	 monthly	for	5	months.	Psycho-	 workers		 address	social		 psychotic		 Significant	differences	in	PANSS	and			 	 	 education;	address	stigma	and		 	 inclusion,		 medication,		 IDEAS	at	rural	site,	but	not	at	others.			 	 	 discrimination;	adherence		 	 access	to	legal		 information	about		 Medication	adherence:	Positive			 	 	 management	strategies;	health		 	 benefits,		 illness,	encouraged		 association				 	 	 promotion;	rehabilitation	strategies		 	 employment		 medication		 Stigma,	knowledge	about			 	 	 to	improve	social/vocational		 	 	 adherence.			 schizophrenia,	caregiver	burden:	No			 	 	 functioning.	Medication.		 	 	 	 association.			
Ran	2015		 Cluster			 Schizophrenia			 9	months.	Psycho-educational		 Psychiatrists		 Local	village		 1.Medication	alone		 Symptoms:	Borderline	association	9		
[16]	[15]		 		 n=	326	[I=126,		 family	intervention	(i)	Family		 and	village		 broadcast		 2.	Control	(no		 months,	no	association	36	months.		
		 9	months		 C1=103,	2=97]		 education	1x/month:	information		 doctors		 network	used		 intervention,		 Functioning:	No	association	compared		
China		 and	14		 	 about	schizophrenia,	relapse		 	 for	health		 medication	neither		 to	medication	alone.	Medication			 years		 	 prevention,	treatment,	social		 	 education	for		 encouraged	nor		 adherence:	No	association	compared	to			 	 	 functioning	rehabilitation	(ii)	Family		 	 first	2	months.		 discouraged)		 medication	alone	at	9	months.	Positive			 	 	 workshops	3	monthly	(iii)	Crisis		 	 	 	 association	14	years.	Knowledge:			 	 	 intervention	support.	Medication.		 	 	 	 Positive	association	9	months.		
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Table	4.2	continued	
Study	and	
setting	
Design	
and	follow	
up	period	
Participants	
[I=intervention	
C=control]	
Intervention	duration	and	content	 Personnel	
delivering	
intervention	
Community	
involvement	
Comparison	group	 Key	results	
Group	C:	Assertive	community	treatment/	case	management/	home	after	care	
Botha	 Individual	 Schizophrenia	or	 12	months.	Assertive	community	 Key	worker	 Strengthening	 Community	mental	health	 12	months	Symptoms:	Positive	
2014	[25,	 	 schizoaffective	 treatment:	individual	caseload	max	 (social	worker	 access	to	 team:	caseload	250+,	 association	
26]	 12	 disorder	 35.	Visits	>50%	at	home,	fortnightly	or	 or	nurse),	 existing	 outpatient	appts	1-3	 Functioning:	Positive	association		 months	 n=	60	 according	to	need.	Focused	on	 supported	by	 community	 monthly;	no	active	follow	 Inpatient	days+readmissions:	
South	 and	36	 [I=34,	C=26]	 engagement	and	maintaining	 multi-	 resources	 up;	referral	to	allied	health	 Positive	association	
Africa	 months	 	 adherence;	referral	to	psychologist,	 disciplinary	 	 professionals.	Medication.	 Quality	of	life	and	depression:		 	 	 occupational	therapist;	access	to	 team	 	 	 No	association		 	 	 psychosocial	rehab	program.	 (psychiatrist,	 	 	 36	months	Inpatient	days	and		 	 	 Medication.	 psych	nurse)	 	 	 readmissions:	Positive		 	 	 	 	 	 	 association	
Sharifi	 Individual	 Schizophrenia,	 12	months.	Home	after	care	Monthly	 General	 Help	family	to	 Hospital	outpatient	service	 Symptoms:	Positive	association	
2012	[24]	 	 schizoaffective	 visits	with	extra	visits	in	first	3	 practitioner	 access	 (no	psychosocial	 Functioning:	No	association		 12	 disorder,	bipolar	 months.	Care	plan,	drug	prescription,	 and	social	 supportive	and	 component)	 Readmissions:	Positive	
Iran	 months	 n=130	 dose	adjustment,	psychoeducation,	 worker-	plan	 community	 	 association		 	 [I=66,	C=64]	 relapse	recognition,	referral	to	 reviewed	by	 resources.	 	 Quality	of	life:	No	association		 	 	 hospital.	Medication.	 psychiatrist	 	 	 Depression:	Positive	association	
Ghadiri	 Individual	 Schizophrenia,	 20	months.	Home	aftercare	(i)	 Not	stated	 Contact	with	 Usual	aftercare	including	 Symptoms:	Positive	association	
2015	[23]	 	 schizoaffective	 Treatment	follow	up	(home	 	 local	NGOs	and	 monthly	visits	by	 Inpatient	days	and		 20	 and	bipolar	 visits/telephone	and	monthly	 	 self	help	groups	 psychiatrist	 readmissions:	Positive	
Iran	 months	 disorder	 outpatient	visit)	(ii)	Family	 	 	 	 association		 	 n=120	 psychoeducation	(six	weekly	2-hr	 	 	 	 Depression:	Positive	association		 	 [I=60,	C=60]	 sessions),	(iii)	social	skills	training	(9	 	 	 	 		 	 	 monthly	visits).	Medication.	 	 	 	 	
Sungur	 Individual	 Schizophrenia	 24	months.	Optimal	case	 Psychiatrists,	 Referrals	to	 Routine	case	management	 Symptoms:	Positive	association	
2011	[27]	 	 n=100	 management:	psychoeducation,	 psychologist,	 voluntary	 (outpatient	clinic):	 Functioning:	Positive	association		 24	 [I=50,	C=50]	 adherence	strategies,	relapse	 psychiatric	 organisations	 psychoeducation,	 Quality	of	life:	Positive	
Turkey	 months	 	 recognition,	crisis	intervention,	family	 nurses,	 	 adherence	support,	crisis	 association		 	 	 intervention,	stress	management,	 supervised	by	 	 intervention,	day	hospital,	 Caregiver	burden:	Positive		 	 	 social/work	skills	training.	120	mins	 CBT	expert.	 	 referrals	to	rehab.	 association		 	 	 every	2	weeks	for	3	months	at	home.	 	 	 60min/month	for	3	m	then	 		 	 	 Then	45m	every	month	at	outpatient	 	 	 45m/month.	Medication.	 		 	 	 clinic.	Medication.	 	 	 	 	
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4.3.2.2 Home-based	care	components		
	 All	interventions	included	a	home-based	element,	a	psychoeducation	component,	and	in	all	studies	the	intervention	group	also	had	access	to	psychotropic	medication.	Only	the	South	African	study	by	Botha	et	al	did	not	explicitly	refer	to	family	involvement	in	the	intervention	delivery	[25,	26].	Aside	from	these	factors	the	content	and	structure	of	interventions	varied	between	studies.	Three	broad	groups	were	identified,	but	with	considerable	overlap	between	groups	and	variation	within	groups.	Group	A	consisted	of	largely	single-faceted	psychoeducation	interventions,	including	three	Chinese	studies,	Li	2005,	Xiang	1994	and	Zhang	1994	[17-19],	and	one	Indian	study,	Hegde	2012,	that	provided	cognitive	retraining	alongside	psychoeducation	[22].	Group	B	consisted	of	more	comprehensive	multi-faceted	interventions	including	components	such	as	family	intervention,	support	developing	social	and	independent	living	skills,	medication	adherence	support,	crisis	intervention	and	dealing	with	stigma.	This	group	included	the	Indian	COPSI	community-based	care	trial,	Chatterjee	2014	[21],	and	two	Chinese	RCTs,	Cai	2015	and	Ran	2015	[15,	16,	20].	Group	C	comprised	studies	focusing	on	engagement	with	care	following	discharge	from	inpatient	facilities,	alongside	other	elements	such	as	social	skills	training.	In	this	group	the	South	African	study,	Botha	2014,	was	based	on	an	assertive	community	treatment	model	[25,	26],	whilst	two	Iranian	RCTs,	Sharifi	2012	and	Ghadiri	2015,	assessed	home-	based	aftercare	services	[23]	[24],	and	a	Turkish	RCT,	Sungur	2011,	evaluated	optimal	case	management	[27].				
4.3.2.3 Community	involvement	components		In	five	studies,	in	South	Africa,	India,	Iran	and	Turkey,	individuals	were	supported	to	access	community	resources	and	organisations	including	legal	benefits,	employment	opportunities,	and	NGOs	[21,	23-27].	Two	Chinese	studies,	Xiang	1994	and	Ran	2015,	conducted	awareness-raising	about	mental	illness	through	local	radio	stations	[15,	16,	18].	Four	interventions	did	not	include	any	community	engagement	or	facilitation	of	support	outside	of	the	home-based	intervention	[17,	19,	20,	22].	Aside	from	referring	to	existing	community	agencies,	no	studies	incorporated	active	involvement	of	community	members	to	support	individuals	with	schizophrenia.				 		
100
4.3.2.4 Personnel	The	primary	personnel	delivering	the	intervention	varied	between	studies.	Only	in	one	study,	Chatterjee	2014,	was	the	intervention	delivered	by	trained	lay	community	health	workers	[21].	In	the	rest	of	the	studies	care	was	delivered	by	mental	health	professionals	(two	studies	[15,	16,	27]),	other	health	professionals	as	part	of	a	multi-disciplinary	team	(three	studies	[17,	24-26])	or	was	unspecified	or	unclear	(five	studies	[18-20,	22,	23]).	Interventions	were	delivered	for	a	median	period	of	12	months	(range	10	weeks	to	36	months).	The	evaluation	was	conducted	immediately	on	the	intervention	terminating	for	six	studies	and	between	6	months	to	13	years	after	the	intervention	ended	for	the	remaining	five.		
4.3.2.5 Comparison	Six	studies	compared	the	intervention	to	treatment	with	medication	provision	only	(typically	delivered	in	an	outpatient	clinic)	and	no	psychosocial	support	[17-20,	23,	24];	two	studies,	Chatterjee	2014	and	Hegde	2012,	specified	that	the	control	included	both	medication	and	psychoeducation	in	an	outpatient	setting	[21,	22];	and	the	South	African	and	Turkish	case	management	studies,	Botha	2014	and	Sungur	2011,	used	outpatient	care	delivered	by	a	community	mental	health	team	as	a	control	[25-27].	One	of	the	Chinese	family	intervention	studies	(Ran	2015,	Group	B)	consisted	of	three	arms,	comparing	(i)	a	psychoeducational	family	intervention	and	medication	(ii)	medication	only	and	(iii)	no	intervention	and	medication	neither	encouraged	or	discouraged	[15,	16].	In	this	review	only	the	intervention	effects	comparing	the	family	intervention	and	the	medication	only	arm	are	presented.		
4.3.2.6 Outcomes	assessed	A	wide	range	of	outcomes	were	assessed	including	symptoms	(ten	studies),	functioning	(eight	studies),	medication	adherence	(four	studies),	number	of	hospitalisations	(four	studies),	quality	of	life	(three	studies),	knowledge	about	schizophrenia	(three	studies),	depression	(two	studies),	family	burden	(two	studies),	cognitive	function	(two	studies),	length	of	hospital	stay	(two	studies),	and	stigma	and	discrimination	(one	study).	Clinical	symptoms	were	measured	with	the	Positive	and	Negative	Syndrome	Scale	(PANSS),	the	Brief	Psychiatric	Rating	Scale	(BPRS),	the	mania	rating	scale	and	the	Current	Psychiatric	Status	(CPS-50).	Functioning	was	measured	with	the	Social	and	Occupational	Functioning	
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Assessment	Scale	(SOFAS),	the	Social	Disability	Screening	Schedule	(SDSS),	the	Global	Assessment	of	Functioning	(GAF),	the	Global	Assessment	Scale	(GAS),	the	Indian	Disability	Evaluation	Assessment	Scale	(IDEAS)	and	‘working	ability’.	Depression	was	measured	using	the	Hamilton	Rating	Scale	for	Depression	and	the	Calgary	Depression	Scale.	Quality	of	life	was	measured	with	the	WHOQOL	(Quality	of	Life)-	BREF	and	the	Quality	of	Life	Scale.	Caregiver	burden	was	assessed	with	the	burden	assessment	schedule	and	the	Scale	for	the	Assessment	of	Family	Distress.		
4.3.2.7 Participants	and	design	There	were	some	differences	in	diagnoses	across	studies,	with	seven	studies	including	only	participants	with	schizophrenia	[15-17,	19-22,	27],	one	study	including	participants	with	schizophrenia	or	schizoaffective	disorder	[25,	26]	and	three	studies	including	participants	with	schizophrenia,	schizoaffective	disorder	or	bipolar	disorder	[18,	23,	24].	Nine	studies	used	an	individually	randomised	design	[18-27],	whilst	two	studies	used	a	cluster	randomised	design	[15-17].	Three	studies	were	conducted	across	multiple	sites	[18,	20,	21].				
4.3.3 Risk	of	bias			
	 Overall	studies	were	of	low	to	moderate	quality.	Table	4.3	summarises	the	risk	of	bias	for	each	included	study.	Ghadiri	2015,	Sharifi	2012,	Hegde	2012	and	Li	2005	were	rated	as	having	a	high	overall	risk	of	bias	[17,	22-24].	Hegde	2012	was	excluded	from	the	synthesis	of	results	due	to	the	high	risk	of	bias	and	the	very	low	sample	size	included	in	the	outcome	analysis	(n=12	in	treatment	group,	n=11	in	control	group)	[22].	The	findings	of	Sharifi	2012	are	not	included	in	the	meta-	analysis	due	to	incomplete	data	presented	in	the	paper	(no	denominator	is	given	for	outcome	data).	Allocation	concealment	was	adequately	described	in	only	one	study,	whilst	procedures	were	unclear	in	ten	studies.	Five	studies	were	assessed	to	have	a	high	risk	of	outcome	assessors	being	unblinded,	with	two	studies	having	a	low	risk	and	four	studies	having	an	unclear	risk.	The	risk	of	bias	in	relation	to	selective	reporting	was	difficult	to	assess	in	seven	studies,	whilst	one	study	(which	had	a	published	protocol	[28])	was	assessed	as	low	risk	and	three	studies	were	assessed	as	high	risk	(one	of	which	had	a	published	protocol	[29]).	
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Table	4.3	Quality	of	included	studies	
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Overall	risk	of	
bias	
Botha	2014	 	 	 	 	 	 	 	 	 	 	 	 Low/	unclear	
Cai	2015	 	 	 	 	 	 	 		 	 	 	 	 	 Low/	unclear	
Chatterjee	
2014	 	 	 	 	 	 	 	 	 	 	 	 	 Low	
Ghadiri	2015	 	 	 	 	 	 	 	 	 	 	 	 	 High	
Hegde	2012	 	 	 	 	 	 	 	 	 	 	 	 	 High	
Li	2005	 	 	 	 	 	 	 	 	 	 	 	 	 High	
Ran	2015	 	 	 	 	 	 	 	 	 	 	 	 Low/	unclear	
Sharifi	2012	 	 	 	 	 	 	 	 	 		 	 	 	 High	
Sungur	2011	 	 	 	 	 	 	 	 	 	 	 	 	 Low/	unclear	
Xiang	1994	 	 	 	 	 	 	 	 	 	 	 	 	 Low/	unclear	
Zhang	1994	 	 	 	 	 		 	 	 	 	 	 	 	 Low/	unclear		
4.3.4 Synthesis	of	results	
	
4.3.4.1 Symptoms	and	clinical	status	Amongst	the	seven	studies	that	reported	on	short-term	symptom	severity	the	pooled	SMD	across	all	intervention	types	was	0.95	(95%	CI	0.28,	1.61;	P	0.005;	I	2	=	95%;	n	=	862),	representing	a	strong	effect	(see	Figure	4.2).	Excluding	the	two	studies	with	a	high	risk	of	bias	reduced	the	effect	size	(though	this	remained	‘strong’),	and	the	precision	of	the	estimate	decreased	(SMD	0.80	(95%	CI	0.07,	1.53;	P	0.03;	I	2	=	94%;	n=676))	(see	Appendix	A	(iii)).		 Amongst	the	two	studies	that	reported	short-term	clinical	status	(Xiang	1994	[18]	and	Ran	2015	[16])	there	was	weak	evidence	of	an	effect;	the	pooled	risk	ratio	for	‘recovered	or	significantly	improved’	was	1.64	(95%	CI	0.78,	3.44;	n	=	306)	(see	Figure	4.3).	Ran	2015	also	reported	on	long-term	symptom	severity,	finding	no	difference	between	treatment	arms	at	14	years	follow-up	[15]	(SMD	0.16	(95%	CI	-	0.15,	0.47;	P	0.3;	n=165)	comparing	the	experimental	arm	and	medication	control	arm).	There	was	some	indication	that	Group	B	interventions	(multi-component	rehabilitation	interventions)	were	less	effective	at	reducing	symptoms	compared	to	Group	A	(psychoeducation	focused)	and	Group	C	(case	management)	interventions.	However	this	apparent	finding	should	be	viewed	with	caution	given	the	overlaps	between	intervention	type.	All	four	Group	C	studies	(including	Sharifi	2012	[24],	which	was	excluded	from	the	meta-analysis	due	to	insufficient	data)	found	a	strong	association	with	improvements	in	symptoms	or	clinical	status.	Whereas,	in	Group	B,	Cai	2015	found	no	impact	on	symptoms	[16]	and	Chatterjee	2014	found	a	non-significant	difference	in	PANSS	score	between	treatment	arms	(p=0.08)	[21].	
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Figure	4.2	Community-based	psychosocial	intervention	versus	usual	care:	impact	on	symptom	severity	
(short	term	outcomes)	
	
	
	
	
	
	
Figure	4.3	Community-based	psychosocial	intervention	versus	usual	care:	impact	on	proportion	
recovered	or	improved	(short	term	outcomes)	
	
	
	
4.3.4.2 Functioning	Amongst	the	five	studies	that	assessed	short-term	functioning	using	a	continuous	scale,	the	pooled	SMD	across	all	intervention	types	was	1.12	(95%	CI	0.25,	2.00;	P	0.01;	I	2	=	94%;	n	=	511),	representing	a	strong	effect	(see	Figure	4.4).	All	studies	in	this	group	were	high	quality	so	a	sensitivity	analysis	was	not	conducted.	However,	the	pooled	results	of	the	two	studies	that	measured	the	proportion	able	to	work	in	the	short-term	did	not	show	an	association;	the	pooled	risk	ratio	was	1.09	(95%	CI	0.85,	1.40;	n=306)	(see	Figure	4.5).	One	of	these	studies,	Ran	2015,	also	measured	functioning	and	work	ability	after	14	years,	but	did	not	find	an	effect.	Comparing	
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the	experimental	arm	and	medication	control	arm,	they	found	an	SMD	of	0.16	(95%	CI	–	0.15,	0.47;	P	0.3;	n=165)	for	functioning	and	a	risk	ratio	of	1.13	(95%	CI	0.93,	1.36)	for	work	ability	[15].	Once	again	the	Group	B	interventions	appeared	to	have	the	least	effect	on	functioning	and	work	ability.	Chatterjee	2014,	a	Group	B	study,	found	a	small	effect	on	functioning,	though	reductions	in	disability	were	more	prominent	in	the	rural	site	compared	to	the	two	better-resourced	urban	sites	[21].		
		
Figure	4.4	Community-based	psychosocial	intervention	versus	usual	care:	impact	on	functioning	(short	
term	outcomes)	
	
	
	
	
	
	
	
Figure	4.5	Community-based	psychosocial	intervention	versus	usual	care:	impact	on	ability	to	work	
(short	term	outcomes)	
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4.3.4.3 Readmissions	and	inpatient	days	Two	Group	C	(case	management)	studies,	Botha	2014	and	Ghadiri	2015,	reported	on	the	number	of	readmissions	and	number	of	days	in	hospital	in	the	short	term.	The	pooled	SMD	for	number	of	readmissions	was	0.68	(95%	CI	0.27,	1.09;	P	0.001;	I2	=33%;	n=167)	and	the	pooled	SMD	for	number	of	days	in	hospital	was	0.55	(95%	CI	0.24,	0.86;	P	0.0006;	I2	=0%;	n=167),	both	representing	a	medium	intervention	effect	(see	Figures	4.6	and	4.7).	The	intervention	effects	remained	when	Ghadiri	2015,	which	had	a	high	risk	of	bias,	was	excluded.	Zhang	1994	(Group	A:	psychoeducation)	also	found	a	positive	intervention	effect	on	the	proportion	with	no	hospital	readmissions	over	the	18-month	period	of	the	intervention	(risk	ratio	1.83;	95%	CI	1.27,	2.64;	n=51).		
		
Figure	4.6	Community-based	psychosocial	intervention	versus	usual	care:	impact	on	number	of	
readmissions	(short	term	outcomes)	
	
	
	
	
	
	
	
Figure	4.7	Community-based	psychosocial	interventions	versus	usual	care:	impact	on	number	of	days	
in	hospital	(short	term	outcomes)	
	
	
	
	 Botha	2014	[25]	also	reported	on	long	term	outcomes	at	2	years	after	the	intervention	terminated.	They	found	a	strong	effect	on	readmissions	(SMD	0.96;	95%	CI	0.40,	1.52;	P	0.0008;	n=	56)	and	a	medium	effect	on	days	in	hospital	(SMD	0.75;	95%	CI	0.20,	1.30;	P	0.007).	It	is	difficult	to	determine	if	Group	C	(case	
107
management)	interventions	confer	any	advantage	over	other	types	of	interventions	in	reducing	readmission	rates,	as	this	outcome	was	not	measured	for	any	Group	B	studies	and	only	one	Group	A	study.		
4.3.4.4 Medication	adherence	Two	group	A	(psychoeducation)	and	two	group	B	(multi-component	rehabilitation	intervention)	studies	reported	on	the	proportion	adherent	to	medication.	There	was	a	borderline	significant	effect	including	all	studies	(risk	ratio	1.24;	95%	CI	0.97,	1.57;	P	0.09;	I2	55%;	n=648)	(see	Figure	4.8).	However	the	precision	of	this	effect	was	reduced	with	the	exclusion	of	Li	2005,	which	had	a	high	risk	of	bias	(risk	ratio	1.33;	95%	CI	0.90,	1.97;	P	0.16;	I2=70%;	n=557)	(see	Appendix	A	(iii)).	No	studies	assessed	the	long-term	impact	on	medication	adherence.		
			
Figure	4.8	Community-based	psychosocial	intervention	versus	usual	care:	impact	on	medication	
adherence	(short	term	outcomes)	
	
	
	
	
4.3.4.5 Other	outcomes	Three	Group	C	(case	management)	studies	reported	on	quality	of	life	outcomes.	Botha	2015	and	Sharifi	2012	reported	that	there	was	no	observed	impact	on	quality	of	life	but	did	not	present	the	relevant	data	[24,	26].	However	Sungur	2011	found	a	strong	intervention	effect	on	quality	of	life	(SMD	2.05;	95%	CI	1.53,	2.57;	P	<0.001;	n=89)	[27].	
108
Of	the	two	studies	that	reported	caregiver	burden,	only	Sungur	2011	found	an	effect	(SMD	2.50;	95%	CI	1.93,	3.06;	P	<0.001)	[27].	No	impact	on	family	burden	was	observed	in	Chatterjee	2014	(Group	B);	insufficient	data	were	provided	to	calculate	the	SMD	[21].		 Two	studies,	Li	2005	(Group	A)	and	Ran	2015	(Group	B),	reported	significant	improvements	in	knowledge	and	beliefs	about	schizophrenia	[16,	17].	Li	2005	found	a	strong	intervention	effect	(SMD	1.04;	95%	CI	0.54,	1.55;	P	<0.001;	n=69).	Ran	2015	reported	favourable	differences	between	treatment	arms	for	six	out	of	eight	individual	items	covering	caregiver	beliefs	and	knowledge	[16].	No	impact	on	knowledge	was	observed	in	Chatterjee	2014	(Group	B)	(adjusted	mean	difference	0·34;	95%	CI	−0·28,	0·96;	insufficient	data	were	provided	to	convert	to	SMD)	[21].	Chatterjee	et	al	(Group	B)	were	the	only	study	to	evaluate	the	impact	on	stigma	and	discrimination;	they	did	not	demonstrate	an	intervention	effect	[21].				
4.4 DISCUSSION	
	
4.4.1 Summary	of	findings	Overall	community-based	psychosocial	interventions	in	LMICs	may	have	beneficial	impacts	for	people	with	schizophrenia	including	reducing	symptoms,	improving	functioning	and	reducing	hospital	readmissions.	Whilst	in	some	cases	there	was	a	substantial	impact	on	outcomes,	in	other	studies	such	as	Chatterjee	2014	the	impact	was	slight.	However	this	magnitude	of	impact	may	be	no	worse	than	community-based	programmes	in	high-income	countries	[21].	There	was	evidence	from	only	one	study,	of	assertive	community	treatment	in	South	Africa	[25],	that	positive	effects	could	endure	for	two	years	after	the	intervention	terminated.	Most	studies	did	not	evaluate	ongoing	effects.	Much	of	the	evidence	was	judged	to	be	of	low	or	unclear	quality,	meaning	conclusions	about	the	effectiveness	of	these	interventions	should	be	made	with	caution.		 The	nature	of	usual	care,	which	differed	considerably	between	studies	in	this	review,	should	be	taken	into	account	when	assessing	the	strength	of	the	evidence.	In	evaluations	where	usual	care	is	comprehensive	(for	example	medication,	psychoeducation	and	adherence	support	offered	by	psychiatrists	in	Chatterjee	
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2014	[21]),	smaller	gains	may	be	expected	from	the	provision	of	an	adjuvant	intervention	compared	to	evaluations	with	a	low	level	of	usual	care	(for	example	medication	only	in	the	Chinese	psychoeducation-focused	RCTs	[17-19]).	Chatterjee	et	al	also	pointed	to	the	greater	impact	on	disability	seen	amongst	the	sub-group	who	had	not	previously	had	access	to	high-quality	facility-based	care,	compared	to	those	who	had	[21].	However	this	supposition	does	not	necessarily	hold	true;	for	example	Sungur	2011	saw	some	of	the	biggest	effect	sizes	yet	had	one	of	the	most	comprehensive	packages	of	usual	care	(outpatient-based	case	management)	[27].		 Several	possible	mechanisms	for	the	impact	of	community-based	psychosocial	interventions	present	themselves.	Supported	engagement	with	treatment	and	an	improved	understanding	about	the	nature	of	the	illness	and	importance	of	medication,	by	both	caregivers	and	the	person	with	schizophrenia,	may	lead	to	improved	medication	adherence.	This	in	turn	may	result	in	improved	symptoms	and	therefore	lower	relapse	rates	and	fewer	hospitalisations.	Chatterjee	et	al	reported	a	trend	towards	improved	symptoms	with	improved	medication	adherence	[21],	a	pattern	that	has	been	identified	in	cohort	studies	in	other	LMICs	[30].	However	only	four	studies	included	in	this	review	assessed	medication	adherence	and	overall	there	was	a	borderline	intervention	effect.	The	challenges	of	intervening	to	improve	medication	adherence	have	been	noted	across	all	settings	and	are	not	exclusive	to	mental	disorders	[31].		 It	is	striking	that	all	types	of	interventions,	including	psychoeducation	on	its	own,	produced	a	positive	effect	on	functioning.	This	may	be	due	to	an	improvement	in	symptoms.	On	the	other	hand,	symptoms	and	functioning	are	not	necessarily	correlated	[8,	32-34].	Other	possible	pathways	to	improved	functioning	are	through	the	impact	of	improved	social	skills,	improved	self-esteem,	greater	caregiver	support,	reduced	self-stigma	or	discrimination,	or	an	increased	sense	of	empowerment.	However	there	was	almost	no	assessment	of	these	potential	intermediary	factors	in	the	included	studies.	Where	the	outcomes	of	quality	of	life,	family	burden	and	perceived	stigma	were	reported,	there	was	less	evidence	for	a	beneficial	effect	of	community-based	psychosocial	interventions.	
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4.4.2 Strengths	and	limitations	Strengths	of	this	study	include	the	exhaustive	search	strategy,	inclusive	inclusion	criteria	with	respect	to	intervention	content	and	the	robust	assessment	of	study	quality.	Capturing	and	synthesising	the	results	of	all	relevant	studies	that	share	the	core	elements	of	home-based	psychoeducation	for	schizophrenia	in	LMICs	is	a	strength	of	this	review.	On	the	other	hand,	the	interventions	varied	considerably	in	terms	of	content,	intensity,	duration	and	delivery	personnel;	the	utility	of	drawing	together	such	a	diverse	range	of	programmes	is	questionable.	The	interventions	were	divided	into	sub-groups	for	the	meta-analysis	but	there	was	variation	within	groups	and	overlap	between	groups.		 Whilst	the	search	strategy	captured	the	spectrum	of	intervention	content	that	may	be	defined	as	a	community-based	psychosocial	intervention,	rehabilitation	programmes	based	in	specialist	centres	(e.g.	[35])	were	excluded.	This	was	arguably	an	unhelpful	division,	which	would	not	reflect	the	integrated	programming	and	delivery	of	psychosocial	interventions	for	schizophrenia	in	many	settings.	Outpatient-clinic	based	psychosocial	interventions	also	represent	an	important	component	of	services	for	people	with	mental	illness	in	LMIC	[36].	There	is	a	growing	evidence	base	for	such	interventions	(e.g.	[37,	38])	that	also	requires	systematic	review.	Other	methodological	limitations	of	this	review	include	the	single	screening	of	records	and	exclusion	of	reports	not	published	in	English.				
4.4.3 Implications	Whilst	some	of	the	included	studies	discussed	the	feasibility	and	relevance	of	the	intervention	for	local	health	systems	and	other	LMICs	[21,	25],	for	many	studies	it	was	not	clear	how	or	whether	interventions	could	be	integrated	[17,	20].	Future	research	should	be	cognisant	of	the	wider	health	system,	as	well	as	the	broader	social	and	economic	setting.	All	but	one	of	the	included	interventions	were	delivered	by	trained	health	care	workers,	often	mental	health	specialists,	or	otherwise	by	researchers.	This	is	likely	to	reflect	the	upper	middle-income	setting	of	nearly	all	included	studies.	Even	in	the	COPSI	trial,	Chatterjee	2014,	in	which	community-based	support	was	delivered	by	lay	health	workers,	participants	received	care	from	psychiatrists	in	parallel	[39].	Moving	forward,	RCTs	of	
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community-based	psychosocial	interventions	are	needed	in	low-income	settings,	where	due	to	a	shortage	of	human	resources	the	most	appropriate	personnel	are	likely	to	be	non-specialist	or	lay	workers.		 Another	possible	gap	in	the	evidence	relates	to	the	scope	of	interventions.	All	interventions	in	this	review	focused	mainly	on	health	issues,	though	in	some	cases	touching	on	social	and	livelihood	elements	through	skills	training.	Furthermore	there	was	little	emphasis	on	community	mobilisation,	beyond	the	awareness-	raising	component	mentioned	in	two	studies.	Where	the	intervention	involved	supporting	access	to	community	resources,	there	was	no	detail	on	whether	or	how	participants	accessed	these	resources.	These	broader	community	mobilisation	and	rehabilitation	components	form	some	of	the	key	elements	of	CBR.	As	there	is	some	evidence	for	the	effectiveness	of	the	included	studies	without	these	broader	components,	it	is	arguable	that	these	elements	are	not	required	to	achieve	improvements	in	patient	outcomes.	However	it	is	possible	that	in	low-income	settings	with	few	formal	health	resources,	no	social	security	and	where	the	impact	of	inability	to	work	may	be	more	profound,	broader	efforts	to	draw	on	local	community	resources	and	to	address	livelihood	issues	may	have	more	relevance.	It	is	also	possible	that	community-based	psychosocial	interventions	may	have	the	greatest	potential	for	impact	in	settings	with	weaker	facility-based	care.		 Only	three	studies	assessed	outcomes	of	between	6	months	and	13	years	after	the	interventions	had	terminated	[15,	17,	20].	Such	study	designs,	which	give	valuable	information	on	how	to	shape	psychosocial	interventions	for	scaling	up,	should	be	utilised	where	possible	in	future	research.	Of	the	eleven	included	studies,	only	Chatterjee	2014,	is	known	to	have	conducted	in-depth	intervention	development	and	piloting	in	advance	of	the	full	evaluation	[40],	as	well	as	collecting	process	data	[21]	and	conducting	a	qualitative	analysis	alongside	the	trial	[41].	For	multi-	component	interventions,	theoretical	frameworks	for	the	process	of	change	need	to	be	developed	to	understand	which	elements	contribute	towards	any	impact	seen,	and	why	certain	elements	do	or	do	not	contribute	to	positive	effects	for	participants.	Full	process	evaluations,	as	well	as	parallel	qualitative	studies,	are	likely	to	be	required.	This	is	particularly	pertinent	in	low-resource	settings	where	low-intensity	interventions,	employing	only	the	most	effective	components,	may	be	more	feasible.	Alongside	a	general	need	for	high	quality	evaluations	of	
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community-based	psychosocial	interventions	for	schizophrenia,	future	studies	also	need	to	identify	and	evaluate	intermediate	outcomes	to	better	understand	the	mechanisms	through	which	these	interventions	achieve	their	impact.		 The	next	chapter	describes	the	development	of	a	CBR	intervention	for	people	with	schizophrenia	in	Ethiopia.	
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5 INTERVENTION	DEVELOPMENT	
	
	
5.1 INTRODUCTION	
	 The	previous	chapter	presented	a	systematic	review	of	the	effectiveness	of	community-based	psychosocial	interventions	for	people	with	schizophrenia	in	LMIC.	The	review	highlighted	the	need	for	high-quality	evaluations	of	such	interventions	in	low-income	countries.	As	the	only	study	identified	in	this	review	that	was	delivered	by	non-specialist	workers,	the	COPSI	trial	by	Chatterjee	et	al	[1]	offered	a	promising	framework	for	a	community-based	intervention	for	schizophrenia	in	Ethiopia.	However	the	potential	utility	of	expanding	to	a	broader	CBR	approach,	including	a	community	mobilisation	component,	was	also	identified.	The	current	chapter	presents	a	published	paper	on	the	rigorous	development	work	undertaken	to	design	a	CBR	intervention	for	people	with	schizophrenia	in	Ethiopia.	This	paper	represents	the	‘Development’	stage	of	the	MRC	framework	presented	in	Chapter	3	[2].	The	first	stages	of	the	theory	of	change	process	are	described	in	this	paper,	including	two	theory	of	change	workshops	and	the	development	of	an	initial	theory	of	change	map.	The	relevant	appendices	are	listed	in	Section	5.3.	
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5.2 RESEARCH	PAPER	
	
Notes	on	manuscript	
	
1. Page	3	of	manuscript	(Introduction):	The	‘community	awareness-raising’	component	
of	the	PRIME	mental	healthcare	plan	was	not	delivered	in	Sodo	district.	
2. Page	14	of	manuscript	(Summary	of	final	RISE	intervention):	The	text	should	indicate	
that	Phase	2	was	expected	to	last	approximately	four	months	and	Phase	3	was	
expected	to	last	approximately	six	months	(in	line	with	Figure	2	in	the	manuscript)	
3. Page	14	of	manuscript	(Summary	of	final	RISE	intervention):	The	text	should	indicate	
that	family	support	groups	were	also	a	planned	component	of	the	intervention.	
Further	details	are	provided	in	Chapter	6	(Section	6.3.7)	
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Abstract 
 
Background 
Community-based rehabilitation (CBR) is a multi-sectoral strategy to improve the function- 
ing and quality of life of people with disabilities. The RISE (Rehabilitation Intervention for 
people with Schizophrenia in Ethiopia) trial will evaluate the effectiveness of CBR for people 
with schizophrenia in Ethiopia. Nevertheless, the components of CBR that are both feasible 
and likely to prove effective in low and middle-income countries such as Ethiopia are 
unclear. 
 
Methods 
In this study intervention development work was undertaken to design a CBR intervention 
that is acceptable and feasible in the local context. The development work consisted of five 
phases. 1: Identify potential components of CBR for schizophrenia, 2: Situational analysis, 
3: Determine feasibility of CBR (Theory of Change workshops with experts and local stake- 
holders), 4: Determine acceptability of CBR (16 in-depth interviews and five focus group dis- 
cussions with people with schizophrenia, caregivers, health workers and community 
leaders) and 5: Synthesise results to finalise intervention. A Theory of Change map was 
constructed showing the causal pathway for how we expect CBR to achieve its impact. 
 
Results 
People with schizophrenia in rural Ethiopia experience family conflict, difficulty participating 
in work and community life, and stigma. Stakeholders perceived CBR to be acceptable and 
useful to address these problems. The focus of CBR will be on the individual developing the 
skills and confidence to perform their previous or desired roles and activities. To ensure 
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feasibility, non-health professionals will be trained to deliver CBR and provide supervision, 
rather than mental health specialists. Novel components of CBR for schizophrenia included 
family intervention and dealing with distressing symptoms. Microfinance was excluded due 
to concerns about stress and exploitation. Community mobilisation was viewed as essential 
to ensure the effectiveness and sustainability of CBR. 
 
Conclusion 
Extensive formative research using a variety of methods has enabled the design of a cultur- 
ally appropriate CBR intervention for people with schizophrenia that is acceptable and 
feasible. 
 
 
 
 
Introduction 
Many people with schizophrenia experience severe and chronic illness; in Ethiopia 38% had 
episodic symptoms and 19% had continuous symptoms over a 10-year period whilst 11.8% 
had complete remission after one episode [1]. Reflecting global patterns, in Ethiopia, people 
with schizophrenia have high levels of disability [2], family burden [3], stigma [4, 5], and mor- 
tality [6]. Despite this, the majority of people with schizophrenia in low and middle income 
countries (LMIC) do not have access to adequate care; in Ethiopia, the treatment gap is 90% 
[7]. Human rights violations also occur [8] and many are the victims of violence [9]. Treatment 
with antipsychotic medication alone is often not adequate to achieve functional recovery and 
social reintegration [11]. Psychosocial or psychiatric rehabilitation is recognised globally as an 
essential component of care for people with schizophrenia. Psychosocial rehabilitation is “a 
process that facilitates the opportunity for individuals.. .to reach their optimum level of inde- 
pendent functioning in the community”[ 12]. There is also increasing agreement that the man- 
agement of schizophrenia should be guided by the principle of recovery, in which the focus is 
on empowerment, self-direction, personal responsibility and hope [13, 14]. The WHO’s mental 
health Gap Action Programme (mhGAP) recommends that schizophrenia management 
should include psychosocial interventions, including community-based rehabilitation (CBR), 
where available, although evidence from LMIC settings is limited [ 15, 16]. CBR is a strategy 
that aims to reduce disability and improve the quality of life and social inclusion of people with 
disabilities. CBR echoes the ethos of psychosocial rehabilitation, particularly drawing on recov- 
ery values, whilst reflecting the particular needs of low-income settings [17]. 
Programmes cover one or more of the CBR pillars (health, education, livelihoods, social and 
empowerment), focused on facilitating individuals to access existing resources [17]. CBR is put 
into practice through the joint endeavours of people with disabilities, their caregivers, commu- 
nity members and public sector services e.g. health services [18]. There is a long-standing tradi- 
tion of CBR and a global network of CBR programmes, but these have historically focused on 
other disabilities. There is now increasing recognition that people with mental illnesses may 
receive substantial benefit from CBR. As such mental health has been incorporated into CBR 
programmes in Sri Lanka, India, West Africa, China and Latin America [17, 19–21]. A system- 
atic review found that aspects of CBR may improve clinical outcomes and functioning for 
schizophrenia, dementia and intellectual disabilities in LMICs [ 18]. There is evidence from 
randomised controlled trials (RCTs) to support the effectiveness of assertive community treat- 
ment (ACT) for people with schizophrenia in South Africa [22] and psycho-educational family 
interventions in China [23, 24]. However no RCTs of holistic packages of CBR for 
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schizophrenia that involved community mobilisation (defined as “a strategy which aims to 
engage community members and empower them for change or action”[17]) or that focused 
primarily on any pillar other than health, were included [18]. The more recent COmmunity 
care for People with Schizophrenia in India (COPSI) trial [25] found collaborative community 
care modestly improved disability and symptoms in people with schizophrenia [ 26]. Whilst 
influenced by CBR, the intervention did not include community mobilisation. 
In summary, CBR is a promising intervention for people with chronic and disabling schizo- 
phrenia (due to illness factors or structural factors which lead to drop out from care) particu- 
larly in low-income settings where treatment options for this group are limited. Yet there has 
been no systematic adaptation of comprehensive CBR for people with schizophrenia nor 
assessment of its effectiveness in low and middle-income countries. The Rehabilitation Inter- 
vention for people with Schizophrenia in Ethiopia (RISE) project aims to adapt CBR for people 
with schizophrenia in a rural Ethiopian setting and to assess its effectiveness. The RISE trial 
(NCT02160249) will determine whether CBR as an adjunct to facility-based care is superior to 
facility-based care alone in reducing disability in people with schizophrenia who remain symp- 
tomatic or disabled after six months of treatment. This will be the first comprehensive CBR 
programme for mental illness to be evaluated in a clinical trial in Africa. The intensive CBR 
intervention will be targeted at those with the greatest need. The rationale for this is (i) the aim 
of CBR is to reduce disability, so it is appropriate primarily for those who are disabled and (ii) 
to increase feasibility for scale-up by restricting the intervention to those most in need. RISE is 
nested in PRIME (Programme for Improving Mental healthcarE), a five-country research con- 
sortium, including Ethiopia, which aims to generate evidence on the integration of mental 
health into primary care in LMIC [27, 28]. As part of PRIME, primary care staff in Sodo dis- 
trict, Ethiopia, have been trained to deliver packages of care for people with schizophrenia 
including prescription of antipsychotic medication, follow-up, limited adherence support, 
basic psychoeducation and community awareness-raising [ 29]. Psychoeducation refers to the 
education of people with mental illness to increase their knowledge and understanding of their 
treatment and illness. This facility based care constitutes treatment as usual in the control arm 
of the RISE trial, and will be delivered in conjunction with CBR in the intervention arm. 
The importance of intervention development prior to testing complex mental health inter- 
ventions is widely acknowledged, particularly in LMIC [30–33]. This work helps to design an 
intervention that is acceptable and feasible to both its recipients and those delivering it, and is 
ultimately more effective. The particular benefits include: 
• Ensuring the intervention is appropriate to local resources and health services structures [32, 
 34]. 
• Identifying contextually-mediated barriers to delivery [33]. 
• Ensuring the cross-cultural applicability and relevance [30]. 
• Getting buy-in from national and local stakeholders [30]. 
This paper summarises the formative research used to design an acceptable, feasible and 
sustainable CBR intervention that is likely to be effective for people with schizophrenia in Ethi- 
opia, to be tested in a pilot and subsequently in the RISE trial. At the outset we acknowledged 
two key challenges. First, how to develop a CBR intervention in a setting with few public sector 
mental health resources. Second, how to strike the balance between an intervention which is 
likely to be effective and one that might realistically be scaled up in the context of limited 
resources in a rural LMIC setting. 
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1. Which components of CBR are likely to be effective at improving functioning for people 
with schizophrenia? 
2. Is CBR useful, acceptable and feasible from the perspective of people with schizophrenia 
and their caregivers? 
3. What health service structures exist and how can they support CBR? 
4. Is it possible to recruit, train and retain non-health workers to deliver CBR? 
5. What community resources are available and are they accessible to people with 
schizophrenia? 
6. Are community leaders willing and able to participate in CBR? 
7. How can the positive effects of CBR be sustained? 
 
 
 
Methods 
This study used a range of qualitative and participatory methodologies in five phases from Sep- 
tember 2012 to March 2014. Intervention development was guided by a Theory of Change 
approach [35] in conjunction with the Medical Research Council framework for complex inter- 
ventions [36]. The Theory of Change map provides a graphic representation of the causal path- 
ways through which the RISE intervention is expected to achieve its impact [ 35]. The map 
includes (i) the final outcome (improved functioning in people with schizophrenia), (ii) inter- 
mediate outcomes that are needed to achieve the final outcome, (iii) interventions which are 
needed to move from one outcome to the next, (iv) assumptions (the conditions which the 
causal pathway needs in order to progress), (v) rationale for each link in the pathway and (vi) 
indicators (to evaluate whether each outcome is achieved). Assumptions articulated by the 
Theory of Change formed the research questions to be answered. We refined the map through- 
out the process as assumptions were tested and turned into rationale, or the intervention design 
was modified to fulfil assumptions. 
 
Ethics statement 
The London School of Hygiene & Tropical Medicine Research Ethics Committee (reference 
6408) and the Addis Ababa University College of Health Sciences Institutional Review Board 
(reference 039/13/PSY) granted ethical approval. Written informed consent was obtained from 
all participants in the in-depth interviews and focus group discussions. Only people with 
schizophrenia who had stable illness were invited to participate. Prior to conducting the inter- 
views the psychiatrist assessed the individuals’ decision-making capacity. Only individuals 
judged to have decision-making capacity were included; these individuals continued to the 
consent process. Verbal informed consent was obtained from all participants in the Theory of 
Change workshops and recorded in the workshop notes. Individual written informed consent 
was not sought from workshop participants as the workshops were a participatory planning 
process; the workshops were not audio-recorded; vulnerable groups, i.e. people with schizo- 
phrenia or caregivers, were not included in the workshops; and the workshop outputs were two 
Theory of Change maps formed by group consensus (contributions were not attributed to indi- 
vidual participants). 
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Phase 1: Identification of potential components of CBR for schizophrenia 
Objectives. (i) Identify potential components of CBR and their likely effectiveness and (ii) 
describe how components could improve functioning. 
Methods. A literature review of CBR for schizophrenia in LMIC was conducted. Other 
psychosocial interventions were also reviewed because CBR consists of many elements that 
have typically been evaluated separately. We reviewed resources from the WHO (CBR Guide- 
lines) [17], COPSI [37], Rehabilitation And Prevention Initiative against Disabilities (RAPID) 
project, and other similar projects. RAPID is an Ethiopian CBR project for children with dis- 
abilities. RAPID is a local collaborator on RISE and is affiliated with CBM, an international dis- 
ability and development organisation. Site visits and in-depth consultation with the RAPID 
management team were conducted. The collated information was used to create a draft Theory 
of Change map for how the CBR components could improve functioning in people with 
schizophrenia. 
 
 
Phase 2: Situational analysis 
Objectives. (i) Describe the socio-demographic characteristics, health services and com- 
munity resources of Sodo and (ii) describe the situation of people with schizophrenia in this 
context. 
Methods. We drew on work conducted by the PRIME project in Sodo district, which has 
been described in detail elsewhere [33, 38– 40]. In brief it involved (i) reviewing a situational 
analysis, which comprised public domain data relating to population, health and social indica- 
tors; mental health policies and plans; mental health treatment coverage and district level ser- 
vices [38] (ii) reviewing resource mapping data collected using a semi-structured instrument to 
systematically quantify community assets, for example traditional healers and religious groups 
and [39] (iii) reviewing qualitative data on the acceptability and feasibility of task-sharing men- 
tal health services [33, 40]. In addition rich local data relating to prevalence [41], clinical course 
and outcome [1, 7, 10], disability [2], mortality [6, 42], access to health services [10], beliefs 
[43, 44], caregiver burden [3, 45], experiences of stigma [4, 5, 9] and use of traditional healers 
[43] relating to schizophrenia was reviewed. 
 
 
Phase 3: Evaluation of the feasibility of CBR 
Objectives. (i) Determine the feasibility of CBR components and delivery mechanisms 
and (ii) get local ‘buy-in’ for RISE. 
Methods. The scoping workshop and first Theory of Change workshop involved eight 
experts in CBR and mental health. The second Theory of Change workshop included twenty 
community leaders from Sodo, including representatives of microfinance, edir (traditional 
burial association), education, police, traditional healers and religious leaders. Each workshop 
lasted half a day; the expert workshops were facilitated in English and the community work- 
shop was facilitated in Amharic by an Ethiopian investigator (AF). At each workshop a large- 
scale (approximately 2 metres x 3 metres) draft Theory of Change map was presented to work- 
shop participants and the various components explained. The map was refined in real time by 
investigators by adding notes on colour-coded paper and linking arrows. Photographs were 
taken of the map at the end of each workshop to maintain a visual record of the discussion. In 
addition, detailed minutes were taken in English by an Ethiopian research assistant. Following 
the workshops these visual and written records were combined to update the Theory of Change 
map. 
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Phase 4: Evaluation of the acceptability of CBR 
Objectives. (i) Describe unmet needs of people with schizophrenia and (ii) determine the 
acceptability of CBR. 
Methods. We conducted 16 in-depth interviews and five focus group discussions (includ- 
ing 35 participants) with people with schizophrenia, caregivers, community and religious lead- 
ers, traditional healers, RAPID CBR workers, health extension workers and primary healthcare 
workers (see Table 1). Health extension workers are salaried community health workers 
engaged in health promotion and disease prevention. Participants were identified through the 
district health bureau (for staff), RAPID CBR project, and Butajira psychiatric outpatient clinic. 
Participants were purposively selected to ensure a spread of gender, work experience, type of 
community leader and functioning of people with schizophrenia. Topic guides covered key 
issues around acceptability and feasibility. The In-depth interviews and focus group discus- 
sions were conducted in Amharic by a male Ethiopian psychiatrist and a male Ethiopian PhD 
student (with a Psychology MSc). Both had experience in conducting interviews and discussion 
groups with people with schizophrenia and caregivers. The participants were contacted by tele- 
phone or face-to-face to invite them to participate; no potential participants refused to take 
part. The interviews were conducted at health centres and the research office in Butajira, a pri- 
vate room in Bui town, and the RAPID office in Adama. Participants were given information 
about the purpose of the study prior to the interviews, but no other relationship between the 
researchers and participants was established in advance. In-depth interviews lasted between 40 
and 60 minutes and focus-group discussions lasted between 60 and 120 minutes and all were 
audio-recorded. The investigator conducting the main analysis (LA) observed all interviews 
and focus groups. Debrief discussions with the interviewers were held immediately afterwards; 
initial impressions and observations were captured in field notes. No repeat interviews or par- 
ticipant checking was carried out. The audio-recordings were transcribed in Amharic, and 
then translated into English. A framework analysis was conducted; this approach is recognised 
as suitable for intervention development work as interviews are typically structured with clear 
a priori themes [46]. NVivo for Mac software was used to manage the data. A coding scheme 
was developed using a priori core themes based on the topic guide (e.g. ideal characteristics of a 
CBR worker); and subsequently sub-themes and new themes that emerged through reading the 
manuscripts. Two investigators indexed two transcripts using the codes developed. Discrepan- 
cies between applications of the coding scheme were discussed and adjustments were made 
where required. One investigator then indexed all transcripts using the final coding scheme. A 
matrix was created charting data relating to each theme against each participant. Finally, 
 
Table 1. In-depth interviews and focus group discussion participants. 
Stakeholder Number of in-depth 
interviews 
Number of focus group 
discussions 
 
People with schizophrenia (male) 3 0 
People with schizophrenia 
(female) 
2 0 
Caregivers (male) 1 1 (n = 8) 
Caregivers (female) 1 1 (n = 7) 
Community leaders (male) 7 0 
Health extension workers 0 1 (n = 8) 
Primary care workers 0 1 (n = 6) 
CBR workers 2 1 (n = 6) 
Total 16 5 (n = 35) 
doi:10.1371/journal.pone.0143572.t001 
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themes were summarised and interpreted, noting associations between themes and patterns 
relating to participant characteristics (e.g. gender). Further interviews and focus groups were 
conducted until data saturation was reached. 
 
Phase 5: Synthesis of results to finalise intervention 
Objectives.  (i) Finalise CBR content and delivery and (ii) develop CBR training materials. 
Methods. A three-day intervention-planning workshop involved Ethiopian psychiatrists, 
the CBM West Africa mental health advisor, CBM Ethiopia director, RAPID manager, and the 
senior health administrator for Sodo. The synthesised findings of Phases 1 to 4 were presented 
to participants, who decided the detailed content and structure of the intervention. The final 
Theory of Change map is presented in Fig 1. 
 
Results 
The following section details how the research questions were answered using the different 
methods, and how these findings contributed to the final intervention (see S1 Table for details). 
 Table 2 summarises the key themes generated from the in-depth interviews and focus group 
discussions (Phase 4). 
 
1. Which components of CBR are likely to be effective at improving 
functioning for people with schizophrenia? 
Potential components of CBR for schizophrenia were listed according to the CBR pillars 
(health, social, livelihood, empowerment and education- see Table 3); whilst many relate to 
health, other pillars were also represented. The strongest evidence related to psycho-education 
[47–52], family intervention [23, 24, 53, 54] and adherence support [55, 56]. Multi-component 
interventions were effective, but it was difficult to elucidate their ‘active ingredient/s’ from the 
results [19, 20, 26]. We took into account whether potential CBR components were likely to be 
effective for the ‘difficult to treat’ group who will participate in the RISE trial. Novel compo- 
nents of CBR for schizophrenia included family intervention, stress and anger management 
and dealing with distressing symptoms (e.g. hallucinations and delusions). A schema of how 
CBR components could improve functioning was incorporated into the Theory of Change map 
(Fig 1). Many components may act in synergy, and also through intermediate outcomes and 
positive feedback loops. For example rehabilitation focused on returning to farm work, as well 
as directly improving functioning, may improve the ability of individuals to pay for medication, 
which in turn improves symptoms and therefore functioning. Support with medication adher- 
ence is also likely to improve symptoms; together with a family intervention this will reduce 
the need for physical restraint, which would also lead to return to previous functional roles. 
There was strong support for community mobilisation from all stakeholders. Disability 
arises due to both illness and societal factors [ 57] so an intervention addressing both elements 
is indicated. There was consensus that community leaders have a powerful influence on the 
views of the community and are gatekeepers to community resources needed for CBR (“The 
community won’t believe in things that the leaders don’t believe in” (FGD 03, health extension 
worker)). This was an important finding given the strong influence of stigma on the experi- 
ences and social functioning of people with schizophrenia. Structured community mobilisation 
was therefore prioritised to maximise the effectiveness and sustainability of CBR. As shown on 
the theory of change map, identification and mobilisation of community resources are interme- 
diate outcomes that are necessary foundations for ensuring the sustainability of the family level 
interventions. 
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Fig 1. RISE Theory of Change map. 
doi:10.1371/journal.pone.0143572.g001 
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2. Is CBR useful, acceptable and feasible from the perspective of people 
with schizophrenia and caregivers? 
People with schizophrenia and caregivers were found to have a range of unmet needs and prob- 
lems. Issues included conflict within families, being estranged from friends, difficulty doing 
housework, farm work and business and problems with self-care. Many participants with 
schizophrenia and caregivers reported experiences of stigma and other types of participants 
were aware it was a common occurrence. Instances included being called names, being laughed 
at or gossiped about, losing friends, being discouraged from participating in social life, and not 
being trusted in the workplace or in other settings. One male caregiver reported, “No institu- 
tion, no organization invites persons with mental illness to participate... because they are people 
with problems, saying that they will ruin things.. . they will not perform the work properly" 
(FGD 01, male caregiver). Another caregiver explained, “They won’t accept their word. Even if 
he [her son with schizophrenia] speaks the truth, they would say, ‘he is a patient, don’t say any- 
thing back’. He is a patient. Now they say, ‘is he possessed by the devil?’” (FGD 02, female care- 
giver). Problems with participating in conventional community activities, for example drinking 
coffee with family and neighbours, attending church or mosque and attending weddings and 
funerals, were also reported. Participants named a variety of reasons for these problems, 
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Table 2. Summary of findings from in-depth interviews and focus group discussions. 
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Research question Theme Findings 
 
Which components of CBR are likely   to be Necessity of community Community leaders have powerful influence on the community’s 
effective? mobilisation element beliefs 
Community leaders are gatekeepers to community resources 
Is CBR useful, acceptable and feasible from the 
perspective of people with schizophrenia and 
caregivers? 
Current problems and needs Family conflict 
Estranged from friends and neighbours 
Difficulty doing housework, farm work and business 
Problems with self care 
Stigma and discrimination 
Problems participating in community activities 
High caregiver burden 	 CBR content CBR perceived as acceptable and useful overall 
Caregivers and community leaders thought returning to work as 
central to regaining functional role and economic status; people 
with schizophrenia concerned about stress. 
Personal experiences of physical restraint or awareness of the 
practice amongst most participants; best approach to address this 
felt to be improved access to mental healthcare 	 CBR delivery Most participants preferred home visits 
Some participants preferred CBR workers the same gender as 
participants; others had no preference 
Desirable characteristics of CBR workers included being caring, 
understanding and knowledgeable, and having a good 
understanding of the local community 
Is it possible to recruit, train and retain field 
workers to deliver CBR? 
Willingness of CBR workers Motivation to work with people with schizophrenia. 
Fears the work could be risky or stigmatizing 	 Ability of CBR workers Confident of ability to do work. 
Importance of field training, top-up training and peer supervision 
stressed 
What community resources are available   in Sodo Accessibility of community Problems accessing community resources due to stigma,  
and are they accessible to   people with resources problems with social interactions, lack of motivation and being 
schizophrenia?  symptomatic. 	 Role of edir (traditional burial 
association) 
Suggested role of edir included financial/material support, 
awareness raising, higher threshold for exclusion of people with 
schizophrenia when not contributing 
Are community leaders willing and able to 
participate in CBR? 
Willingness of community Community leaders report sense of responsibility to support 
people with schizophrenia. 
Caregivers sceptical that support will be available. 	 Willingness of traditional or 
religious healers to 
participate 
Healers reported willingness to signpost to health centre/ 
medication. 
Some reports of healers warning against medication use. Mixed 
views as to whether healers would receive education and change 
practices. 	 Willingness to work with 
either gender 
Community leaders state they are willing to work with CBR 
workers of either gender- skills are more important than gender 
doi:10.1371/journal.pone.0143572.t002 
 
 
 
 
 
 
 
 
PLOS ONE | DOI:10.1371/journal.pone.0143572 November 30, 2015 9/  19 
128
 
 
 
Table 3.  Potential components of community-based rehabilitation for schizophrenia. 
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HEALTH SOCIAL LIVELIHOOD EMPOWERMENT EDUCATION 
 
Psycho-education ++ Support with self-care + Facilitating access to social 
protection + 
Addressing human rights - Facilitating access to adult 
education - 
Adherence support ++ Social skills training + Supporting return to work + Individual stigma reduction 
strategies - 
Family intervention ++ Supporting return to social 
activities + 
Facilitating access to 
microfinance + 
Self-help initiatives + 
Relapse prevention plan + 	 Mobilising community 
support + 
Community-awareness raising 
- 
Support for distressing 
symptoms + 
Support accessing health 
services + 
Stress and anger 
management + 
 
Strength of evidence in literature review: 
(++) Strong evidence 
(+) Weak evidence/ part of multi-component study 
(-) Insufficient studies. 
 
doi:10.1371/journal.pone.0143572.t003 
 
including side effects of medication, being unwell or unmotivated, having poor social skills, 
and stigmatising attitudes of community members. The range of needs highlighted the require- 
ment for detailed needs assessments for participants. CBR would then be tailored accordingly, 
as opposed to a ‘one size fits all’ approach. Focusing on the participants’ expressed needs was 
perceived to be an important approach for maintaining engagement in the programme. 
Caregivers were found to have high burden relating to financial problems (often due to 
costs of treatment), fear for personal safety, stigma and problems with social life. One caregiver 
said, “We hide knives and tools from him because we are scared of him... Just in case he got 
upset all of a sudden.. .He might kill someone or he might destroy or burn someone’s property” 
(IV02, female caregiver). Several reported that they had become ill through caring: “We all 
became sick because of him” (IV03, male caregiver). In light of this, guidance on assessing and 
addressing caregiver problems was added to the intervention. 
All stakeholder groups viewed CBR as an acceptable and useful approach. First, because 
medication alone did not solve all problems; psychosocial support and rehabilitation were also 
needed. Second, because external ‘expert’ advice was likely to have greater influence on individ- 
uals with schizophrenia than advice from family members. Third, because an individual’s 
recovery could benefit the whole community, particularly if they could return to work. Finally, 
CBR was seen as empowering (“[CBR] is essential for people with mental illness.. ..to live on 
equal bases in terms of ways of thinking and attitude” (FGD 01, male caregiver). 
For many participants, support returning to work was crucial for improving functioning, 
economic status and reducing family burden. However there were mixed views from people 
with schizophrenia. One participant was keen to receive a business loan, whilst two others only 
wanted simple work, and found dealing with money stressful. Most people in Sodo are subsis- 
tence farmers, there is limited formal employment and no vocational rehabilitation facilities. 
Accordingly, it was decided that vocational rehabilitation, whilst important, would typically 
focus on developing skills required for returning to farm work or daily labouring. Due to con- 
cerns that microfinance (such as cooperative savings and loans schemes) may increase stress in 
participants [58, 59] or may result in exploitation, it was decided to exclude a microfinance 
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component from the RISE intervention. There was also particular backing for psycho-educa- 
tion, family support and support with adherence and accessing health services. Furthermore, 
the qualitative findings indicated that specific components were needed to address problems 
with day to day functioning (for example dressing independently) and participation in com- 
munity activities (to include support with regaining specific social skills). 
Some participants perceived self-help groups as useful for support and information sharing. 
There were examples of female caregivers and people with schizophrenia already meeting to 
discuss their problems. Together these findings suggested self-help initiatives could be a useful 
component, even without a savings and loans element. 
Most participants were aware of physical restraint of people with schizophrenia, with some 
speaking from personal experience. The reasons for restraint included protecting the individual 
(from themselves or others), protection of others, as a means to transport the person to the 
health centre, and as a means to force the individual to take medication. 
Consensus across stakeholder groups was that the best way to reduce chaining was to 
increase access to treatment. Community leaders felt the family should be educated about the 
harmful effects of chaining. There was concern amongst community leaders that unchaining 
may put other community members at risk. The decision was made to focus on avoiding chain- 
ing through access to treatment. The CBR worker should not instigate unchaining, but should 
work with the supervisor and health centre to ensure unchaining happens safely. In addition 
we would include pragmatic advice on how to restrain in a safe and dignified way, when it was 
needed as a last resort. 
There are 49 herbalists, 21 tanqway (‘sorcerers’) and 27 holy water sites across the district 
[39]. Holy water, which is used for bathing or drinking at sites associated with the Orthodox 
Church, is believed to have curative properties. Holy water use reflects a prevailing belief in 
Ethiopian culture that severe mental illness is attributable to supernatural forces, such as pos- 
session by spirits or the shadow cast by the ‘evil eye’ [43, 44, 60]. The use of holy water is sanc- 
tioned by the dominant religious authorities. A visit to a holy water site may last from days to 
months. Whilst the Orthodox priests based at these holy water sites may provide spiritual guid- 
ance to people with mental illness, they do not typically take on an active caring role with indi- 
viduals. However attendants based at holy water sites often house and feed holy water 
attenders for a fee paid by the family. In the current study holy water was used by several peo- 
ple with schizophrenia, often alongside taking medication. Primary care workers and commu- 
nity leaders also perceived tanqway to be commonly used. Previous research showed that 37% 
of people with schizophrenia in this area attend a traditional healer [7] and 30.9% of those 
obtaining treatment at Ammanuel Psychiatric Hospital in Addis Ababa had first sought help 
from priests or holy water sites [61]. There were experiences of medication being both encour- 
aged and discouraged by holy water priests, and a few experiences of being restrained or beaten 
for refusing to take holy water. Education about the risks and benefits of holy water and tradi- 
tional healing was included, with the focus on encouraging the use of medication alongside tra- 
ditional treatments. 
The high levels of poverty and long distances to roads, health centres and public transport 
meant participants would have difficulty travelling for CBR. The majority therefore wanted 
home visits, rather than visiting the health centre. There were no concerns about increased 
stigma resulting from home visits. Two people with schizophrenia who preferred CBR visits at 
the health facility wanted to be more active. CBR would therefore be delivered at home as stan- 
dard, with health facility visits offered as an alternative in order to maximise engagement. Peo- 
ple with schizophrenia and caregivers reported they could be flexible about the timing of visit. 
Nevertheless the importance of fitting around the participants’ schedules was emphasised, in 
order to minimise dropouts from the intervention. 
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Several caregivers and community leaders felt that the gender of the CBR workers did not 
matter; it was their skills that would be important. Others felt that CBR workers should be the 
same gender as their clients, as this would improve their relationship. It was decided that CBR 
workers of both genders would be recruited, whilst acknowledging that gendered allocation of 
CBR workers to participants would not be possible due to the cluster design of the RISE trial. 
Desirable characteristics of CBR workers included being caring, understanding and knowl- 
edgeable, and having a good understanding of the local community. CBR workers would there- 
fore be high school completers recruited from the immediate area. CBR worker competence 
evaluation would include communication skills. 
 
 
3. What health service structures exist and how can they support CBR? 
Primary care is delivered through eight health centres, staffed by health officers and nurses. 
The district’s first hospital is under construction. Most kebeles (sub-districts) are covered by 
one or two health extension workers. Health care costs are largely out-of-pocket with a free 
waiver available for the very poorest [38]. In mid-2014 primary care staff were trained in men- 
tal health diagnosis and treatment by PRIME. The health extension workers initially repre- 
sented a potential workforce to deliver CBR and the health centre staff represented potential 
collaborators. However it was ultimately decided CBR should be delivered by CBR workers, 
recruited and trained specifically for RISE, rather than health extension workers. The rationale 
was that HEWs would not have time to deliver CBR on top of their usual duties. In addition 
there were five kebeles without a health extension worker and concerns about further drop- 
outs. There was consensus that CBR should be linked to health centres but that primary care 
staff would have minimal capacity to support rehabilitation. Two RISE supervisors will cover 
eight CBR workers, using one-to-one supervision, group supervision and unannounced 
observed home visits. 
 
 
4. Is it possible to recruit, train and retain non-health workers to deliver 
CBR? 
Community leaders and experts predicted difficulty recruiting CBR workers willing to work 
with people with schizophrenia. A minority were concerned that CBR workers would not be 
able to provide psychosocial support. However, CBR workers (for physical disabilities), and 
health extension workers were motivated to do the work, stating it would be rewarding and 
clearly needed. Yet there were also fears that the work could be dangerous or stigmatizing for 
CBR workers. These concerns underlined that adequate safety procedures for CBR workers 
were an essential intervention for CBR to succeed (including risk assessment, provision of 
mobile phones, training to deal with challenging situations, and, where a risk is identified, joint 
visits with the supervisor), whilst conveying a balanced sense of the risks associated with work- 
ing with people with schizophrenia. It was decided to employ at least one male supervisor to 
maximise the safety of CBR workers. 
Health extension workers and CBR workers were confident that with training they could 
undertake CBR work for schizophrenia, emphasising that the core skills of CBR workers are 
generic. They stressed the importance of practical training, shadowing existing CBR workers, 
and top-up training. Both one-to-one and group supervision were recommended, with the lat- 
ter being particularly helpful for overcoming difficulties. The need for physically fit CBR work- 
ers was highlighted as there were no resources for car travel. Ability to walk long distances was 
therefore included in the recruitment criteria. 
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5. What community resources are available and accessible to people 
with schizophrenia? 
Each kebele in Sodo district has churches, religious groups, women and youth associations. 33 
kebeles have a government literacy programme, and most have a government microfinance ini- 
tiative. There are no mental health users groups or disabled people’s organizations [ 39]. The 
rich community resources suggested that CBR workers should do resource mapping when they 
first start work in a kebele. There were mixed views as to whether people with schizophrenia 
have problems accessing existing community resources. All kebeles have several edir. Although 
edir is ostensibly a burial association, there was agreement that it is “the most important com- 
munity mobilizing agent." (IV08, edir leader) and should be engaged as a conduit for social 
inclusion and stigma reduction. Possible examples of community mobilisation were identified, 
including church leaders vocalising public support for an individual or assisting the family to 
take them to the health facility; and edir groups or wealthy individuals mobilising funds from 
community members to provide food or shelter for people with mental illness. However there 
were mixed views about edir’s potential role as a provider of social protection or material sup- 
port. The intervention was therefore modified to indicate that financial support from edir 
should arise organically and not be demanded by the CBR worker. 
 
6. Are community leaders willing and able to participate in CBR? 
There were conflicting views as to whether community leaders would use their authority to 
support CBR without personal benefits. This was recognised as a key assumption to fulfil in 
order for the intervention to succeed. Female caregivers, based on their previous experiences, 
were sceptical that community leaders would provide support, whilst community leaders them- 
selves described a sense of responsibility and were keen to collaborate. The importance of first 
raising awareness amongst community leaders was highlighted, with emphasis to be made on 
the benefits for the whole community of an individual’s recovery. The success of community 
mobilisation would then be reliant on community members taking ownership of the issue and 
identifying for themselves the ways they could help people with schizophrenia. There were 
mixed views as to whether holy water priests would be receptive to education about schizo- 
phrenia and the extent to which this would change their practices. It was decided that engage- 
ment with holy water priests and traditional healers would be instigated only where the family 
perceived this as useful. Concerns were raised as to whether community leaders would engage 
with female CBR workers, but community leaders themselves reported that skills were more 
important than gender. 
 
7. How can the positive effects of CBR be sustained? 
RAPID uses a combination of skills transfer to caregivers, parent groups and CBR committees 
(consisting of leaders from a range of sectors) to ensure the positive effects of CBR continue 
once the CBR workers had left the area. As it would be unfeasible to create new structures to 
ensure sustainability, it was decided that edir groups should be encouraged to take ownership 
of CBR. Family support groups were incorporated in the intervention and skills transfer to 
caregivers was highlighted as a key principle of CBR. 
 
Summary of final RISE intervention 
The focus of the RISE CBR intervention will be on the individual developing the skills and con- 
fidence to perform their previous or desired roles and activities. These may relate to family life, 
work and community life. The intervention will be recovery oriented, emphasising hope and 
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the individual’s strengths. Fig 2 summarises the final intervention structure. Basic counselling 
and problem solving skills will be employed by CBR workers to deliver the intervention. The 
intervention is delivered in three phases. In Phase 1, lasting one to two months, there are 
weekly home visits and the focus is on engagement with the family and addressing core needs 
through compulsory modules such as “Understanding Schizophrenia”. Following a needs and 
risk assessment, structured goal setting will be used to support individuals to select appropriate 
goals from a pre-defined list. In addition to four core modules, the goal selection will determine 
which additional CBR components the individual will receive. In Phase 2, lasting approxi- 
mately five to six months, home visits are every two weeks and address the specific needs of the 
individual through optional modules such as “Getting Back to Work”. In Phase 3, lasting 
approximately four months, the emphasis is on preventing relapse as well as maintaining the 
progress made towards addressing specific needs. The three intervention phases reflect the 
changing needs of participants over 12 months. The transition between phases is conditional 
on achievement of goals rather than specific time points. 
Community mobilisation work will run alongside family-based components. Community 
mobilisation involves identifying local community resources and leaders, awareness-raising 
meetings at existing community groups (for example women’s saving groups) and targeted 
meetings with community leaders addressing specific needs of participants (for example identi- 
fying sources of food or financial support, or encouraging patients to attend the health centre). 
Whilst support with medication adherence is an important component, CBR workers will not 
prescribe or deliver medication. Indeed participants who are unable or unwilling to take anti- 
psychotic medication will nevertheless continue CBR and be supported to achieve goals related 
to functioning, which is the primary aim of the intervention. The five-week training pro- 
gramme for CBR workers will include 50% practical and 50% fieldwork, and will follow a train- 
ing manual adapted from the COPSI manual. 
 
 
Discussion 
This study is a systematic and theory-driven effort to design a CBR intervention for schizo- 
phrenia in a resource-poor setting. This preparatory work aimed at designing the RISE inter- 
vention is an innovative attempt to tailor CBR’s capacity to promote inclusion and improve 
access to essential services to the needs of people with schizophrenia. In doing so it aims to 
bridge the gap between health services and a more community-oriented development model of 
disability [34]. Whilst integration of mental health into existing CBR programmes has typically 
involved in-depth consultation work, this has not usually been theory-driven. The RISE CBR 
intervention has important differences compared to other models of community care for 
schizophrenia in LMIC. First, distinct from other interventions, such as COPSI [ 26] and a 
South African ACT programme [ 22], there is a substantial community mobilisation element. 
Our results indicate that community participation is likely to be essential for improving social 
inclusion, as well as having a role in improving medication adherence, reducing experiences of 
stigma and improving economic status. Utilising the CBR model, in which community mobili- 
sation is key, therefore represents a major strength of the RISE intervention. Second, there is 
no collaboration with mental health specialists [30, 33]. This reflects the reality in this setting 
that the majority of care for people with schizophrenia is delivered by primary care staff, who 
have themselves only recently been trained in mental health. Third, there is a more structured 
approach to setting goals for individuals and selecting intervention components compared to 
other interventions [26]. 
We compromised on immediate scalability to construct a feasible intervention. The use of 
specialist CBR workers instead of existing health extension workers means that additional 
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Fig 2. Overview of RISE intervention structure 
 
doi:10.1371/journal.pone.0143572.g002 
 
resources are required to scale up CBR, and as such RISE is a proof of concept study. This was 
a pragmatic approach given the widespread recognition that scaling up of mental healthcare 
cannot be done without extra resources. The RISE intervention is designed to be scalable with 
limited resources, for example only people with schizophrenia who are still unwell or disabled 
after six months access to facility-based care are included. The RISE trial will determine 
whether this intervention is cost-effective and therefore a potentially suitable investment for 
governments and other funders including the Ethiopian Ministry of Health. The collaboration 
between the Ministry of Health and PRIME (in which RISE is nested) could potentially pave 
the way for the scale up of CBR for schizophrenia. Furthermore, by utilising CBR workers 
(rather than existing health workers) and collaborating with CBM we have designed an inter- 
vention that meets the needs of, and is compatible with, CBR projects for other disabilities. 
This will provide evidence for integration of mental health into the large network of existing 
CBR projects run by NGOs. 
This study addresses a criticism of global mental health research by developing a socially 
and culturally relevant psychosocial intervention using participatory methods [62]. The Theory 
of Change approach allows assumptions and barriers to be articulated and tested using a range 
of research methods. The Theory of Change map gives a visual record of modifications to the 
intervention on the basis of the research findings. A set of indicators has been developed, 
including trial outcomes and process data. This gives us a theoretical framework that we can 
later use to identify which are the most important components of CBR as part of the formal 
evaluation in an RCT, allowing us to refine an effective intervention for scaling up. 
There may have been social desirability bias, particularly from community leaders, as there 
may be political pressure to express support of government initiatives. As PRIME, in which 
RISE is nested, is a collaboration with the Ethiopian Ministry of Health, community leaders 
may have felt compelled to champion CBR. This could explain their different opinion regard- 
ing community support compared to female caregivers, who are not susceptible to the same 
pressures. As the investigators are invested in the RISE project it is possible this led to a biased 
interpretation of the qualitative data, emphasising a favourable opinion of CBR amongst par- 
ticipants. While no meaningful ownership of the Theory of Change map can be claimed by 
stakeholders outside of the workshops, those who participated represented relevant stakehold- 
ers, and Theory of Change was undoubtedly a useful tool throughout the process. 
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Conclusion 
Extensive formative research using a variety of methods nested within a Theory of Change 
framework has enabled the design of a culturally appropriate complex mental health interven- 
tion that is acceptable and feasible to service users and providers. This CBR intervention will be 
finalised in a pilot and then tested in a cluster-randomised trial to determine its effectiveness 
and cost-effectiveness in improving functioning in people with schizophrenia in a rural district 
in Ethiopia. 
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S1	Table:	Summary	of	research	questions,	findings	and	impact	on	intervention	design	(continued	overleaf)		
	
Research	questions	and	
assumption		
Phase	
tested			
Finding		 Impact	on	intervention	design		
1.	Which	potential	components	of	CBR	are	likely	to	be	effective	at	improving	functioning	for	people	with	schizophrenia?		
CBR	can	improve	
functioning	in	people	
with	schizophrenia		
		
1		 Good	evidence	that	community	care,	psycho-education,	adherence	
support,	and	family	intervention	can	improve	functioning			
• Include	broad	range	of	CBR	components,	
which	may	contribute	directly	or	indirectly	
to	improved	functioning.		1,	3,	4		 Some	CBR	components	for	which	there	is	no	research	evidence	could	
contribute	to	improved	functioning	via	intermediate	outcomes			
A	community	
mobilisation	approach	is	
required	in	addition	to	
family-based	care		
1		 Community	mobilisation	is	advocated	by	WHO	CBR	guidelines	and	has	
been	shown	in	observational	studies	in	India	to	improve	functioning		
• Incorporate	community	mobilisation,	
targeting	leaders,	to	maximise	
effectiveness	of	family-based	components	
and	sustainability.		
3,	4		 Community	leaders	have	powerful	influence	on	views	and	behaviour	of	
community	and	may	be	gatekeepers	to	community	resources.			
2.	Is	CBR	useful,	acceptable	and	feasible	from	the	perspective	of	people	with	schizophrenia	and	their	caregivers?		
CBR	can	address	the	
needs	of	people	with	
schizophrenia		
2		 High	levels	of	disability,	stigma	and	family	burden.	Most	work	as	
subsistence	farmers.	Few	formal	employment	opportunities;	no	
vocational	rehabilitation	facilities.		
• Common	needs	will	be	addressed	in	core	
modules.	Modules	addressing	other	needs	
should	be	delivered	if	indicated	by	needs	
assessment	and	goal	setting.		
• Include	guidance	on	addressing	caregivers	
needs		
• Vocational	rehabilitation	to	focus	on	
returning	to	farm	work.		
3		 Needs	assessment	and	rehabilitation	plan	are	essential.	Return	to	work	
perceived	as	key	step	for	improving	functioning,	economic	status	and	
reducing	family	burden.		
4		 People	with	schizophrenia	and	caregivers	have	diverse	and	varied	needs.	
CBR	components	perceived	to	be	useful	for	addressing	needs.			
People		with	
schizophrenia	and	their	
caregivers	are	willing	and	
have	time	to	participate	
in	CBR		
4		 Near	universal	willingness	and	enthusiasm	to	participate.	General	
flexibility	and	no	concerns	about	not	having	time.			
CBR	workers	should	be	from	local	area,	have	a	caring	attitude	and	be	
knowledgeable.	Mixed	views	on	preferred	gender.		
• Recruit	CBRWs	from	local	area	of	both	
genders.		
• Incorporate	training	on	empathy	and	
building	trust.		
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S1	Table	continued		
The	benefits	of	
microfinance	outweigh	
the	risks		
1			 Some	evidence	that	microfinance	can	increase	stress			 • Facilitating	inclusion	in	existing	
microfinance	schemes	excluded	from	CBR		3		 Concerns	about	abuse	or	exploitation	of	people	with	schizophrenia		
4		 Microfinance	may	be	unacceptable	to	some	participants		
Self-help	initiatives	are	
perceived	to	be	beneficial			
4		 Self-help	groups	perceived	to	be	useful	for	moral	support	and	information	
sharing.			
• Family	support	groups	included	in	CBR.		
People	with	
schizophrenia	are	
commonly	chained	or	
restrained			
3		 Chaining	may	be	a	result	of	stigma	and	low	awareness.	Community	
leaders	could	help	to	reduce	chaining	by	raising	awareness.		
• CBR	should	address	chaining	but	focus	
should	be	on	accessing	treatment.			
• CBR	workers	should	not	initiate	unchaining	
but	should	refer	to	health	centre	and	
supervisor		
• CBR	workers	should	educate	families	on	
how	to	chain	safely.			
4		 Chaining	is	common	at	home	and	at	holy	water	sites.	The	best	way	to	
reduce	it	is	to	improve	access	to	treatment.	Community	leaders	
concerned	about	safety	issues	related	to	unchaining.		
TRHs	are	typically	used	as	
a	source	of	care	for	people		
with	schizophrenia			
2		 49	herbalists,	21	tanqway	(‘witch	doctors’)	and	27	holy	water	sites	across	
the	district.	37.4%	of	people	with	schizophrenia	attend	a	traditional	healer		
• Educate	family	about	risks	and	benefits	of	
TRH.	Do	not	forbid,	but	encourage	use	
alongside	medication.		3		 	Holy	water	use	is	common,	often	alongside	medication.			
4		 Should	aim	to	encourage	holy	water	use	alongside	medication.		
3.What	health	service	structures	exist	and	how	can	they	be	utilised	to	support	delivery	of	CBR?		
Health	extension	workers	
have	the	capacity	to	
deliver	CBR		
2		 HEWs	not	present	in	every	kebele		 • Recruit	and	train	a	new	cadre	of	worker,	
CBR	workers,	especially	for	this	project		3		 Consensus	that	HEWs	would	not	have	the	capacity	to	deliver	CBR	on	top	
of	current	work;	in	addition	high	rates	of	drop	out	from	HEW	posts.		
Health	centre	staff	have	
the	capacity	to	support	
CBR		
2		 Primary	care	staff	newly	trained	to	diagnose	and	treat	schizophrenia			 • Supervision	internal	to	RISE	rather	than	
from	the	health	centre.		
• Monitor	health	centre	attendance			
3		 CBR	should	be	linked	to	health	centres	but	primary	care	staff	will	have	
minimal	capacity	to	support	rehabilitation.	CBR	supervisors	should	
supervise	CBR	workers.		
Medication	is	available	at	
the	health	centre		
2		 PRIME	will	ensure	continuous	medication	supply	to	health	centres		 • CBRW	can	facilitate	free	medication	
certificate.		3		 Free	medication	certificate	available	for	minority	from	kebele	official		
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S1	table	continued	
4.	Is	it	possible	to	recruit,	train	and	retain	field	workers	to	deliver	CBR?	
CBR	workers	are	willing	to	
work	with	people	with	
schizophrenia	
3	 Concerns	potential	CBR	worker	recruits	may	be	afraid	to	do	home	visits	to	
people	with	schizophrenia.	Also	concerns	about	drop	out.	
• Comprehensive	safety	procedures	for	CBR	
workers	
• Training	to	give	a	balanced	sense	of	risk	
• Male	and	female	supervisors.	
4	 CBR	workers,	HEWs	and	primary	care	staff	motivated	to	work	with	people	
with	schizophrenia.	But	fears	the	work	could	be	risky	or	stigmatizing	
CBR	workers	will	have	
adequate	CBR	skills	
1	 Lay	people	previously	trained	as	CBR	workers	in	India	and	RAPID	 • Training	to	including	shadowing	existing	
CBR	workers	and	top-up	training.	
• Training	to	include	problem	solving	and	
communication	skills.	
• 1:4	ratio	of	supervisors	to	CBR	workers.	
One-to-one	sessions	and	group	
supervision.	
3	 Concerns	about	ability	to	train	non-specialists	to	deliver	CBR	for	
schizophrenia.	Importance	of	supervisors	doing	ongoing	assessment	of	
gaps	in	skills/knowledge.	Don’t	need	formal	counselling	training.	
4	 HEWS	and	CBR	workers	confident	they	could	do	CBR	for	schizophrenia.	
Importance	of	field	training,	top-up	training	and	peer	supervision	
CBR	workers	can	overcome	
logistical	issues	to	deliver	
CBR	
2	 Mainly	rural,	many	kebeles	remote	from	towns,	roads,	public	transport	 • Include	willingness/ability	to	walk	long	
distances	in	recruitment	criteria	3,4	 CBR	workers	need	to	be	strong,	fit	and	capable	of	walking	long	distances	
5.	What	community	resources	are	available	in	Sodo	and	are	they	accessible	to	people	with	schizophrenia?	
Existing	community	
resources	are	available	
2	 Rich	community	resources	e.g.	microfinance	and	literacy	schemes,	
Women’s	and	youth	associations,	churches,	mosques	and	informal	
religious	groups,	and	Edir	groups	(traditional	burial	association)	
• CBR	workers	to	conduct	resource	mapping	
when	they	start	working	in	a	kebele.	
• Potential	targets	for	social	inclusion	
identified	e.g.	edir,	mahaber	3	 Agreement	that	edir	is	a	powerful	social	structure.	Confirmation	of	
presence	and	activity	of	other	community	resources.	
Existing	community	
resources	can	be	accessed	
by	people	with	
schizophrenia	
3	 Mixed	views	on	whether	people	with	schizophrenia	have	problems	
accessing	community	resources.	May	be	opportunities	for	income	
generation	
• Assess	for	daily	labouring	opportunities.	
• CBR	worker	to	facilitate	access	to	
community	resources	May	need	to	liaise	
with	relevant	community/religious	leaders.	
• Support	with	social	skills	to	be	included.	
4	 Problems	accessing	community	resources	due	to	stigma,	problems	with	
social	interactions,	lack	of	motivation	and	being	symptomatic.			 		
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S1	table	continued	
Edir	support	will	be	
available	and	sustainable	
3	 Mixed	views	about	edir’s	role	as	a	provider	of	social	protection	or	material	
support.	New	unions	previously	formed	to	support	people	with	HIV-	
suggested	this	could	be	replicated	for	people	with	schizophrenia.	
• More	feasible	to	get	support	from	existing	
structures	i.e.	Edir,	than	to	encourage	
formation	of	new	structures.	
• support	from	Edir	should	arise	organically,	
not	be	expected	by	CBR	worker.	
4	 Suggested	role	of	Edir:	financial/material	support,	awareness	raising,	
higher	threshold	for	exclusion	of	people	with	schizophrenia	when	not	
contributing	
6.	Are	community	leaders	willing	and	able	to	participate	in	CBR?	
Community	leaders	will	
participate	in	CBR	without	
personal	benefits	
3	 Concerns	that	community	leaders	will	not	participate	in	CBR	 • Include	community	awareness	raising	and	
engagement	with	community	leaders	at	
start	of	intervention.	
4	 Community	leaders	report	sense	of	responsibility	to	support	people	with	
schizophrenia.	Caregivers	sceptical	support	will	be	available.	
Traditional	and	religious	
healers	will	participate	in	
CBR	without	perceiving	a	
conflict	of	interest	
3	 Traditional	and	religious	healers	and	CBR	workers	would	need	joint	
understanding	of	person	with	schizophrenia’s	needs.	Traditional	and	
religious	healers	may	not	be	willing	to	discuss	individuals.	
• Engagement	with	traditional	and	religious	
healers	to	be	instigated	where	the	
individual	and	family	perceived	this	as	a	
useful	adjunct	to	family	support	and	
general	community	awareness-raising.	
4	 Traditional	healer	states	willingness	to	signpost	to	health	
centre/medication.	Some	reports	of	traditional	and	religious	healers	
warning	against	medication	use.	Mixed	views	as	to	whether	Traditional	
and	religious	healers	would	receive	education	and	change	practices.	
Community	leaders	will	
be	willing	to	work	with	
male	and	female	CBR	
workers	
3	 Community	leaders	may	only	engage	with	male	CBR	workers	 • Recruit	on	basis	of	interest	and	post-	
training	competence,	not	gender	4	 Community	leaders	state	they	are	willing	to	work	with	CBR	workers	of	
either	gender-	skills	are	more	important	than	gender	
7.	How	can	the	positive	effects	of	CBR	be	sustained?	
CBR	can	continue	after	
the	CBR	worker	has	left	
1	 Issues	with	sustainability	identified	in	previous	study	 • Skills	transfer	to	caregiver.	
• Focus	on	Edir	to	ensure	sustainability	CBR	
committee	not	feasible.	
3	 RAPID	uses	CBR	committees	to	ensure	sustainability.	Transfer	of	skills	to	
caregiver	also	essential.	
CBR=	Community-based	rehabilitation;	RAPID=	Rehabilitation	And	Prevention	Initiative	against	Disabilities	Project;	Edir=	traditional	burial	association;	;	HEW=	Health	extension	
worker;	PRIME=	PRogramme	for	Improving	Mental	healthcare;	kebele=	sub-district			
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5.3 APPENDICES		
	
• Ethical	approval	for	intervention	development	(Appendix	B	(i))		
• Information	sheets	and	consent	forms	(Appendix	B	(ii))		
• Topic	guides	for	qualitative	interviews	(Appendix	B	(iii))						
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6 RISE	MATERIALS	
	
	
6.1 INTRODUCTION	
	 This	chapter	provides	further	details	on	the	delivery	of	the	RISE	CBR	intervention,	the	development	of	which	was	described	in	Chapter	5.	The	chapter	also	presents	the	materials	that	were	developed	to	train	the	CBR	workers	in	preparation	for	the	RISE	pilot	(Chapter	7).	Minor	adjustments	to	the	intervention	that	arose	from	piloting	will	be	presented	in	Chapter	7.				
6.2 METHODS	
	 A	list	of	CBR	worker	competencies	was	drawn	up	as	part	of	the	intervention	development	phase	and	reviewed	by	the	project	collaborators	(see	Table	6.1).	I	wrote	the	RISE	manual	using	the	COPSI	manual	as	an	initial	template	(http://www.sangath.com/images/file/COPSI%20Manual%20Nov%2019.pdf),	with	permission	of	its	authors.	The	COPSI	manual	was	extensively	adapted	to	cover	the	content	of	the	RISE	CBR	intervention,	the	RISE	CBR	worker	competencies,	and	to	ensure	appropriateness	for	the	Ethiopian	context.	Other	existing	materials	I	consulted	in	this	process	included	the	Mental	Health	Pocket	Guide	for	Health	Extension	Workers	produced	by	the	Ethiopian	Ministry	of	Health;	the	Mental	Health	and	Human	Rights	resource	pack	produced	by	the	Amaudo	Itumbauzo	CBR	project	in	Nigeria;	and	the	facilitator’s	guide	for	Psychosocial	Rehabilitation	Support	Group	Sessions	created	as	part	of	the	PRIME	project	in	South	Africa	[1].	A	large	proportion	of	the	final	RISE	manual	consisted	of	entirely	new	material.	UK	and	Ethiopian	psychiatrists,	who	had	expertise	in	CBR	or	community-based	care,	reviewed	the	RISE	manual	to	create	the	final	version.	A	concerted	effort	was	made	to	ensure	the	information	was	understandable	to	lay	persons	i.e.	CBR	workers.	To	reflect	the	lack	of	mental	health	training	of	CBR	workers,	the	intervention	delivery	was	highly	structured,	with	each	process	such	as	needs	assessment	divided	into	clear	sequential	steps.	Care	was	taken	to	acknowledge	the	range	of	explanatory	models	for	schizophrenia	that	exist	in	Ethiopia	(see	Chapter	2;	Section	2.8);	and	to	
144
ensure	that	advice	was	contextually	appropriate	(for	example	recognising	that	some	families	may	not	have	access	to	soap	for	self	care	activities).		 I	developed	the	training	programme	and	assessments	for	CBR	workers	from	scratch,	using	ideas	from	other	relevant	training	programmes	[1].	The	manager	at	the	Ethiopian	CBR	project	for	children	with	disabilities	(Rehabilitation	And	Prevention	Initiative	against	Disabilities	(RAPID))	also	gave	advice	on	how	to	deliver	the	training.	The	manual,	training	and	intervention	delivery	materials	were	translated	into	Amharic	by	Ethiopian	psychiatrists.		
Table	6.1	RISE	CBR	worker	competencies	(continued	overleaf)	
	
		 Competency		 Assessment			
1		 Administrative		 		
1a		 Able	to	complete	documentation	correctly		 Role	play		
2		 Professionalism		 		
2a		 Aware	of	and	adheres	to	cultural	norms	in	terms	of	dress	and	general	
behaviour		
Observation	by	trainers		
2b		 Demonstrates	good	time-keeping	and	attendance		 Observation	by	trainers		
2c		 Demonstrates	positive	attitude	towards	people	with	schizophrenia	
(i.e.	not	stigmatising)		
Observation	by	trainers		
2d		 Has	skills	to	maintain	own	wellbeing		 Observation	by	trainers	
Written	test	1		
3		 Communication	skills		 		
3a		 Able	to	build	trusting	relationship	with	person	with	schizophrenia	and	
their	family		
Role	play		
3b		 Able	to	deal	with	difficult	situations	e.g.	angry	person,	violent	person			 Written	test	1		
3c		 Has	good	listening	skills		 Role	play		
3d		 Is	able	to	explain	concepts	clearly,	check	for	understanding	etc		 Role	play		
3e		 Can	employ	a	problem	solving	approach		 Role	play		
4		 Referrals		 		
4a		 Aware	of	circumstances	in	which	to	contact	supervisor	for	support		 Role	play	
Written	test		
4b		 Aware	and	able	to	follow	procedures	for	the	following	scenarios:	
suicidal	intent,	neglect,	violent	victimisation	etc.		
Role	play	
Written	test		
4c		 Aware	and	able	to	follow	procedures	for	following	scenarios:	
identification	of	physical	or	mental	illness	in	community	member		
Role	play	
Written	test		
4d		 Aware	of	health	services	available	for	people	with	mental	illness		 Role	play	
Written	test		
5		 Assessment	and	review		 		
5a		 Able	to	assess	achievement	of	goals	on	an	on	going	basis		 Role	play	
Written	test		
5b		 Able	to	conduct	a	needs	assessment	for	people	with	schizophrenia	
and	caregivers	in	conjunction	with	supervisor		
Role	play	
Written	test		
5c		 Able	to	detect	distress	in	caregivers	on	an	on	going	basis		 Written	test	1		
5d		 Able	to	conduct	a	brief	risk	assessment			 Role	play			
5e		 Able	to	conduct	goal	setting	and	develop	a	rehabilitation	plan	in	
conjunction	with	supervisor		
Role	play		
6		 Knowledge		 		
6a		 Has	basic	knowledge	of	mental	disorders	including	depression,	
alcohol	use	disorder	etc		
Written	test		
6b		 Has	good	knowledge	of	schizophrenia	(aetiology,	course	etc)	and	
medical	treatment;	and	can	identify	people	with	schizophrenia			
Written	test		
6c		 Understands	the	impact	of	schizophrenia	in	terms	of	disability,	
stigma,	human	rights	abuses	and	family	burden		
Written	test		
7		 CBR	delivery		 		
7a		 Understands	and	is	able	to	explain	purpose	and	structure	of	CBR		 Role	play		
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	 programme	 	
7b	 Understands	structure	and	purpose	of	RISE	pilot	and	RISE	trial	 Written	test	1	
7c	 Able	to	give	information	on	schizophrenia	 Role	play	
7d	 Able	to	assess	reasons	for	not	accessing	medication	or	attending	
health	centre	and	apply	problem	solving	approach	to	address	this	
Role	play	
7e	 Able	to	give	information	on	how	to	deal	with	a	crisis	and	support	
development	of	crisis	management	plan	
Written	test	
7f	 Able	to	assess	reasons	for	not	taking	medication	and	apply	problem	
solving	approach	to	address	this	
Role	play	
7g	 Able	to	identify	early	warning	signs	with	family	and	develop	relapse	
prevention	plan	
Written	test	2	
7h	 Able	to	develop	plan	to	enable	improved	self-care	and	improve	
participation	in	household	tasks	
Written	test	1	
7i	 Able	to	deliver	family	intervention	 Written	test	1	
7j	 Able	to	sensitively	address	chaining	and	physical	abuse	and	take	
appropriate	steps	to	address	this	
Written	test	2	
7k	 Able	to	give	advice	for	dealing	with	distressing	symptoms	 Written	test	1	
7l	 Able	to	give	advice	for	dealing	with	stress	and	anger	 Written	test	1	
7m	 Able	to	give	advice	to	improve	healthy	behaviours	 Written	test	1	
7n	 Able	to	assess	reasons	for	poor	physical	health	and	use	problems	
solving	to	address	this	
Written	test	2	
7o	 Able	to	give	advice	on	dealing	with	stigma	and	discrimination	 Written	test	1	
7p	 Able	to	assess	reasons	for	reduced	participation	in	community	life	
and	apply	problem	solving	approach	to	address	this	
Written	test	1	
7q	 Able	to	assess	reasons	for	reduced	participation	in	vocational	
activities	and	apply	problem	solving	approach	to	address	this	
Written	test	2	
7r	 Able	to	assess	literacy	and	basic	skills	and	suggest	steps	to	improve	
them	
Written	test	1	
7s	 Able	to	transfer	skills	to	caregivers	in	order	for	family	to	continue	CBR	
after	end	of	programme	
Written	test	
7t	 Aware	of	procedures	for	ending	intervention	with	family	 Written	test	1	
8	 Community	mobilisation	 	
8a	 Able	to	form	good	relationships	with	community	leaders	and	HEWs	 Written	test	1,2	
8b	 Able	to	conduct	community	awareness-raising	 Written	test	2	
8c	 Able	to	engage	with	community	leaders	to	facilitate	CBR	 Written	test	1,2	
8d	 Able	to	maximise	sustainability	of	programme	through	community	
involvement	
Written	test	
9	 Family	support	group	 	
9a	 Able	to	organise	and	facilitate	support	groups	or	befriending	
arrangements	
Written	test	1,2	
	
	
6.3 INTERVENTION	OVERVIEW	
	
6.3.1			Structure	of	CBR	
	 The	RISE	CBR	intervention	involves	three	main	components:	(i)	Home	visits	by	CBR	workers.	It	is	anticipated	that	approximately	22	visits	should	be	made	over	12	months.	(ii)	Community	mobilisation;	and	(iii)	Family	support	groups.	The	intervention	is	delivered	in	three	phases	over	a	12-month	period:		 Phase	1	Intensive	engagement:	Months	~1	and	2	(weekly	home	visits)	Phase	2	Stabilisation:	Months	~3	to	6	(fortnightly	home	visits)	
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Phase	3	Maintenance:	Months	~	7	to	12	(monthly	home	visits)		 CBR	workers	are	expected	to	do	two	tasks	every	day.	For	example	two	home	visits,	or	one	home	visit	and	one	meeting	with	community	leaders.	Table	6.2	gives	an	overview	of	the	content	of	CBR	by	phase.	A	set	of	30	forms	are	used	by	CBR	workers	and	supervisors	to	document	CBR	delivery	(Appendix	C	(i)).	
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Table	6.2	Overview	of	RISE	CBR	intervention	(continued	overleaf)		
	
Phase		 Home	visits		 Community	mobilisation		 Family		support	
group		CBR	Review			 Goals		 Modules		
1		 CBR	Review	1:			
• Initial	Assessment			
• Needs	Assessment		
• Goal	setting	for	
Phase	1		
• Rehabilitation	plan		
• Risk	Assessment			
• Accompany	to	
health	centre		
		
Individual	and	caregiver	have	been	informed	
of	what	schizophrenia	is,	available	
treatments,	and	the	potential	for	recovery			
Understanding	
schizophrenia		
		
Task	1:	Meet	with	health	extension	worker/s	
Task	2:	Identify	key	community	leaders		
Task	3:	Identify	key	community	resources	Task	
4:	Ascertain	what	community	mobilisation	
relating	to	mental	illness	has	already	taken	
place	or	is	planned		
Task	5:	Meet	with	key	community	leaders	Task	
6:	Community	awareness-raising	events	Task	
7:	Identify	potential	employment	
opportunities	in	the	sub-district		
		
Individual	is	able	to	access	medication			 Improving	access	to	health	
services		
		
Individual	is	able	to	attend	health	centre	for	
mental	health	as	indicated	by	clinical	status			
Crisis	management	plan	is	in	place		 Preparing	for	a	crisis		
Person	with	schizophrenia	is	not	chained	or	
restrained			
Dealing	with	human	rights	
issues		
2		 CBR	Review	2:			
• Needs	Assessment			
• Goal	setting	for	
Phase	2			
• Risk	Assessment		
• Update	
rehabilitation	plan		
• Invite	to	Family	
Support	Group		
• Accompany	to	
health	centre		
		
Individual	is	willing	to	take	medication		 Supporting	individuals	to	
take	medication		
		
Task	8:	Individual	meetings	with	sub-district	
leaders		
Task	9:	Individual	meetings	with	Edir	leaders	
Task	10:	Individual	meetings	with	religious	
leaders		
Task	11:	Individual	meetings	with	traditional	
healer/	holy	water	priest/	attendant		
Task	12:	Demonstrate	progress	of	client/s	to	
community	leaders/	wider	community		
Task	13:	Community	awareness	raising	
consolidation		
Task	14:	Facilitate	employment	opportunities	
in	the	sub-district		
Task	15:	Individual	meetings	with	literacy	
group	leader		
		
Family		support	
group	active		Individual	has	strategies	to	remember	to	
take	medication		
Individual	feels	side	effects	are	improving		
Individual	feels	symptoms	are	improving		 Dealing	with	distressing	
symptoms		
Individual	is	able	to	access	health	services	for	
physical	and	sexual	health	needs	and	
contraception	when	required		
Improving	access	to	health	
services		
Individual	has	strategies	to	deal	with	stress	
and	anger		
Managing	stress	and	anger		
		
Individual	has	information	to	make	decisions	
about	health-related	behaviours			
Improving	physical	health		
Individual	has	good	physical,	sexual	and	
reproductive	health			
Individual	is	not	malnourished		
Individual	has	restored	participation	in	
livelihood	activities,	including	farm	work		
Getting	back	to	work		
		
148
	
	
	
	
	
Table	6.2	continued		
2			 		 Individual	participates	in	community	life		 Taking	part	in	community	
life		
		 		
Individual	participates	in	religious	activities	if	
they	are	important	to	the	individual		
Person	with	schizophrenia	is	able	to	interact	
socially	with	neighbours	and	friends		
Individual	has	improving	ability	to	do	
parenting	activities		
Improving	the	family	
environment		
		Individual	has	improved	relationship	with	
family	members		
Caregiver	has	improved	ability	to	cope		
Individual	has	improving	self-care		 Improving	day	to	day	
functioning		Individual	has	improving	ability	to	do	
household	tasks		
Individual	has	improving	self-esteem		 Dealing	with	stigma	and	
discrimination		Individual	does	not	feel	discriminated	against		
Individual	is	not	the	victim	of	physical,	sexual	
or	emotional	abuse		
Dealing	with	human	rights	
issues		
Individual	has	basic	literacy	skills		 Improving	literacy		
3		 CBR	Review	3:			
• Needs	Assessment			
• Goal	setting	for	
Phase	3		
• Risk	Assessment		
• Update	
rehabilitation	Plan			
• Accompany	to	
health	centre		
CBR	Review	4:		
• Continuing	Care	
Assessment		
Individual	has	relapse	prevention	plan			 Taking	control	of	your	
health		
Any	Phase	2	Community	Mobilisation	task		 Support	group	
active		
Any	Phase	2	goal		 Any	Phase	2	module		
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6.3.2 Home	visits		
	 Home	visits	should	last	around	30-90	minutes	and	the	caregiver	or	another	family	member	should	be	present	or	nearby.	At	the	initial	visit	CBR	workers	gather	information	on	the	participant’s	illness	and	home	situation	(see	Form	1	in	Appendix	C	(i)).	A	needs	assessment	(see	Form	4	in	Appendix	C	(i))	and	goal	setting	(see	Forms	5	and	6	in	Appendix	C	(i))	are	conducted	at	the	beginning	of	each	phase.	CBR	workers	support	participants	to	select	optional	goals	from	a	pre-	specified	list,	which	was	designed	to	incorporate	all	likely	areas	of	desired	change,	including	functioning,	symptoms	and	stigma	(See	Form	6	in	Appendix	C	(i)).	Table	6.2	lists	the	core	and	optional	goals	for	each	Phase.	The	indicated	modules	linked	to	the	selected	goals	are	then	delivered	over	the	course	of	the	phase.	All	documentation	relating	to	each	participant	is	filed	in	a	‘participant	logbook’.	All	home	visits	are	recorded	on	a	separate	Home	Visit	Form	(See	Figure	6.1).	At	each	visit	CBR	workers	should	do	the	following:			
• Check	general	health	and	symptoms		
• Check	and	record	progress	relating	to	on	going	goals			
• Use	a	problem	solving	approach	to	address	on	going	goals		
• Deliver	module/s:	selected	on	the	basis	of	the	remaining	goals.	Modules	usually	take	more	than	one	visit	to	complete.		
• Check	whether	the	participant	is	taking	medication	regularly		
• Do	a	brief	risk	assessment,	assessing	for	suicide	risk	and	recent	restraint		
• Give	tasks	to	complete	before	the	next	session		
• Plan	date	and	content	of	next	session																					 		
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Figure	6.1	RISE	home	visit	form	(continued	overleaf)	
	
Form	11:	Home	visit	Form		
	Individual		 		 CBR	worker		 		 Date		 		
Start	time		 		 Finish	time		 		 		
Phase	(tick)		
Phase	1		 		 Phase	2		 		 Phase	3		 		
Participants		 		 		
Who	was	present	at	the	home	
visit?	(tick)			
Individual		 		 		
Main	caregiver		 		
Supervisor		 		
Other		 		
If	other,	who?		 		
General		 		 		
Mental	health	and	symptoms		
		
		
Worse		 		 		
Same		 		
Better		 		
Your	comments	on	the	
individual’s	mental	health	
status		
		
Issues	or	questions	raised	
relating	to	previous	visit		
		
		
		
Other	issues	discussed		
		
		
		
Goal																							(write	in	à)		 			
Module/s	underway	this	
home	visit	to	achieve	goal		
1.		
2.		
Community	mobilisation	
tasks	and	other	tasks	
underway	or	planned	to	
achieve	goal		
1.		
2.		
Issues	and	problems		 		
		
Progress	on	goal	by	end	of	
home	visit	(Tick)		
Not	achieved		 		 		
Partly	achieved			 		
Achieved			 		
Goal																							(write	in	à)		 			
Module/s	underway	this	
home	visit	to	achieve	goal		
1.		
2.		
Community	mobilisation	
tasks	and	other	tasks	
underway	or	planned	to	
achieve	goal		
1.		
2.		
Issues	and	problems			
		
		
Progress	on	goal	by	end	of	
home	visit	(Tick)		
Not	achieved		 		 		
Partly	achieved			 		
Achieved			 		
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Goal	 (write	in	à)	 	
Module/s	underway	this	home	
visit	to	achieve	goal	
1.	
2.	
Community	mobilisation	tasks	
and	other	tasks	underway	or	
planned	to	achieve	goal	
1.	
2.	
Issues	and	problems	 	
Progress	on	goal	by	end	of	
home	visit	(Tick)	
Not	achieved	 	 	
Partly	achieved	 	
Achieved	 	
Medication	
Issues	with	medication	 	
Actions	to	deal	with	
medication	issues	
	
Risks	
Is	the	individual	chained?	(tick)	 Yes	 	 No	 	
If	yes,	actions	to	deal	with	
chaining	
	
Is	there	suicide	risk?	(tick)	 Yes	 	 No	 	
If	yes,	actions	to	deal	with	
suicide	risk	
	
Other	risks	and	actions	taken	 	
Follow	up	
Task	for	individual/	caregiver	
to	complete	before	next	
session	
	
Time	and	date	of	next	home	
visit	
	
Module	for	next	visit	 	
Issues	to	discuss	with	
supervisor	
	
Referrals	e.g.	to	health	centre	 	
Supervisor	review	
Date	reviewed	with	supervisor	 	
Actions	suggested	by	
supervisor	
	
Supervisor	signature	 	
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6.3.3 Terminating	CBR	
	 The	aim	is	to	continue	CBR	for	12	months	irrespective	of	improvements	in	functioning.	Participants	may	stop	participating	at	any	time,	though	the	CBR	worker	should	attempt	to	understand	the	reasons	for	quitting	and	if	possible	resolve	any	problems.	At	10	-11	months	CBR	workers	begin	discussing	the	progress	made	during	the	CBR	period,	and	the	upcoming	termination	of	CBR,	with	the	individual	and	family.	The	Continuing	Care	Assessment	(see	Form	9	Appendix	C	(i))	is	completed;	this	includes	the	identification	of	on	going	needs	and	formulation	of	a	plan	to	address	these	needs	once	CBR	has	terminated.				
6.3.4 Links	to	health	services	
	 CBR	workers	are	expected	to	attend	the	health	centre	with	the	participant	around	the	beginning	of	each	phase	(see	Form	2	in	Appendix	C	(i)).	The	aim	is	to	gain	an	understanding	of	the	participant’s	current	treatment	and	to	facilitate	discussion	between	the	participant	and	the	health	officers.	CBR	workers	should	also	refer	people	with	schizophrenia	to	the	health	centre,	in	addition	to	regular	appointments,	if	suicide	intent,	relapse	or	medication	side	effects	are	identified	(see	Form	14	Appendix	C	(i)).	CBR	workers	can	refer	to	health	extension	workers	for	contraception,	immunisations	and	other	community	health	needs.				
6.3.5 Dealing	with	risks	
	 At	the	beginning	of	each	phase	supervisors	conduct	a	risk	assessment	for	each	participant,	covering	risks	such	as	suicide,	sexual	violence	and	neglect	(see	Form	7	in	Appendix	C	(i)).	There	are	specific	protocols	for	the	CBR	worker	response	to	the	following	scenarios:		
• Individual	is	restrained	at	home	(see	Figure	6.2)	
• Relapse	
• Violent	victimisation	outside	of	home	
• Neglect	or	malnourished	
• Suicidal	ideation	
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• Suicide	attempt	
• Intimate	partner	violence	
• Children	at	risk	of	harm	
• Sexual	violence	
• Death	
• Emergency	hospital	admission	
• Individual	is	violent	or	aggressive		In	general	the	protocols	ensure	the	participant	is	able	to	access	mental	health	care,	and	indicate	a	psychiatric	nurse	review	if	this	is	not	possible.		
Figure	6.2	RISE	protocol	for	physical	restraint	
	
	
You	iden)fy	individual	is	restrained	at	home	
Address	reason	for	not	a,ending	health	centre.	This	may	include	
educa7ng	the	family	family	and/or	get	ﬁnancial	or	prac7cal	
community	support		
Your	supervisor	should	arrange	for	review	at	home	by	trial	
psychiatric	nurse	
Nurse	or	clinical	oﬃcer	will	
carry	out	clinical	assessment	
Check	the	individual	is	taking	medica7on	and	encourage	family	to	
take	individual	to	health	centre	
Arrange	a	joint	home	visit	with	your	supervisor.	If	they	have	not	
a,ended	the	health	centre,	at	the	visits	ﬁnd	out	why	not.		
If	the	individual	is	s7ll	restrained	
and/or	does	not	a,end	health	centre	
within	1	week	
Educate	the	family	to	minimise	harm	from	chaining	
Inform	your	supervisor	the	same	day	
If	the	individual	is	s7ll	restrained	
and/or	does	not	a,end	health	centre	
within	1	week	
6.3.6 Community	mobilisation	
	 Table	6.2	lists	the	community	mobilisation	tasks.	Core	tasks	should	be	completed	around	the	time	participants	are	in	Phase	1	and	optional	tasks	when	participants	are	in	Phase	2	and	3.	All	documentation	relating	to	each	sub-district	is	filed	in	a	‘sub-district	logbook’.	Figure	6.3	presents	one	section	of	the	sub-district	logbook,	which	is	designed	to	record	community	awareness-raising	events	(see	Appendix	C	(i)	Forms	10.1	to	10.11	for	full	logbook).	This	form	was	designed	to	be	used	by	CBR	workers	in	conjunction	with	the	relevant	section	in	the	RISE	manual.	
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Figure	6.3	RISE	form	for	community-awareness	raising	event	
	
Form	10.6:	Sub-district	Logbook	(Task	6:	Community	awareness	raising	
event/s)	
CBR	worker	 	 Supervisor	 	
Sub-district	 	 	
Date	 	
Location	 	
Number	of	participants	 	
Topic	 Tick	when	
discussed	
Comments	
Introduce	self	and	role	 	 	
Basic	explanation	of	
schizophrenia	
	 	
Causes	of	schizophrenia	 	 	
Possibility	of	recovery	 	 	
Importance	of	medication	 	 	
Need	for	community	support	 	 	
Importance	of	treating	people	
with	schizophrenia	well	and	as	
equals	
	 	
Importance	of	helping	people	
to	get	treatment	so	they	don’t	
need	to	be	chained	
	 	
Other	issues	raised	 	 	
Actions	agreed	 	 	
Date	and	time	of	subsequent	
meeting	if	arranged	
	 	
	
6.3.7 Family	support	groups	
	 CBR	workers	begin	trying	to	set	up	family	support	groups	from	Phase	2	onwards.	The	aim	is	to	set	up	one	group	for	each	sub-district.	These	groups	can	include	caregivers	and	people	with	schizophrenia	who	are	not	acutely	unwell.	Caregivers	and	people	with	schizophrenia	who	are	not	participating	in	CBR	(for	example	because	they	were	assessed	as	having	insufficiently	high	levels	of	disability)	may	also	participate.	Existing	networks	are	built	upon	where	possible.	There	is	no	savings	and	loan	element	anticipated;	instead	the	groups	provide	a	forum	for	
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discussing	problems	and	sharing	potential	solutions.	Meetings	are	held	at	a	mutually	convenient	location	and	time	and	are	expected	to	be	monthly.	CBR	workers	begin	by	leading	the	meetings,	but	attempt	to	transfer	leadership	to	a	participant	after	the	group	is	established.				
6.3.8 Supervision	
	 CBR	supervisors	and	an	intervention	coordinator	oversee	the	frequency,	content	and	quality	of	CBR.	Supervisors	conduct	monthly	unannounced	observed	CBR	sessions,	monthly	group	supervision,	and	individual	supervision	every	two	to	four	weeks.	Group	supervision	involves	CBR	workers	sharing	difficulties	and	discussing	ways	to	overcome	challenges.	Supervisors	also	attend	the	initial	visit,	needs	assessment	and	goal	setting	together	with	the	CBR	workers.	The	intervention	coordinator	supports	the	group	supervision	and	individual	supervision	sessions.	Top-up	training	sessions	are	given	by	the	intervention	coordinator	to	address	any	weak	areas	or	poor	practice	identified	by	the	supervisors.	A	project	psychiatric	nurse	can	be	contacted	directly	by	CBR	workers,	supervisors	and	the	intervention	coordinator	to	address	urgent	or	serious	clinical	issues	that	are	not	addressed	through	usual	care	at	the	health	centre.	The	psychiatric	nurse	and	intervention	coordinator	can	discuss	clinical	issues	with	a	designated	psychiatrist	when	required.		 At	the	beginning	of	each	phase	supervisors	conduct	a	CBR	worker	safety	assessment	for	each	participant,	for	example	assessing	the	remoteness	of	the	home	and	history	of	violence	in	the	participant	(see	form	24	in	Appendix	C	(i)).	Appropriate	measures	are	put	into	place	on	the	basis	of	the	assessment,	for	example	in	high	risk	cases	only	joint	visits	with	the	supervisor	are	allowed	until	the	risk	is	assessed	to	be	downgraded.				
6.4 RISE	MANUAL	
	 CBR	delivery	is	guided	by	a	200	page	manual	that	was	designed	to	cover	all	the	RISE	competencies	(see	Table	6.1;	see	Appendix	C	(ii)	for	the	full	manual).	
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Vignettes	were	used	to	illustrate	the	text;	these	were	based	on	experiences	reported	by	people	with	schizophrenia	in	the	intervention	development	phase,	presented	in	a	highly	anonymised	form.	The	RISE	manual	comprised	of	the	following	three	sections:		
SECTION	A:	Understand	what	schizophrenia	is	and	the	problems	it	causes	
	 This	section	includes	information	about	schizophrenia,	anti-psychotic	medications,	disability	and	human	rights.	See	Figure	6.4	for	an	example	chapter	from	Section	A.		
SECTION	B:	Learn	how	to	help	people	with	schizophrenia	and	their	families	
through	CBR	
	 This	section	includes	basic	counseling	and	problem	solving	skills,	needs	assessment,	goal	setting,	basic	risk	assessment,	steps	to	deliver	the	four	core	and	11	optional	modules	and	the	community	mobilisation	tasks.	See	Figure	6.5	for	an	example	chapter	from	Section	B.	Each	module	chapter	uses	the	format:		
• What	is	the	problem?	
• Why	does	this	problem	happen?	
• Why	is	it	important	to	help	with	this	problem?	
• How	can	we	help?		
SECTION	C:	Know	how	you	will	be	supported	to	deliver	CBR	
	 This	section	includes	CBR	worker	wellbeing,	supervision	structures	and	response	to	difficult	situations	such	as	suicidal	ideation.	A	step-by-step	guide	covering	section	B	in	a	briefer	format	was	also	provided	to	CBR	workers	for	use	on	home	visits.	
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Figure	6.4	RISE	manual	Chapter	4	(continued	overleaf)	
	
Chapter	4	Disabilities	related	to	schizophrenia	
What	is	disability?	
Disability	is	when	a	person	cannot	do	the	activities	that	we	would	normally	expect	them	to	do,	
given	their	age	and	social	circumstances.	Disability	can	include:		
• Problems	with	the	body,	for	example	blindness		
• Problems	with	doing	physical	activities,	for	example	walking		
• Problems	doing	usual	work	and	social	activities,	for	example	going	to	market.		
	
	
What	causes	disabilities?	
Disabilities	in	people	with	schizophrenia	are	caused	by	a	combination	of	the	social	
environment	in	which	the	person	lives	and	the	illness	itself.	For	example,		
• An	individual	may	not	be	allowed	to	vote	at	the	sub-district	meeting	because	of	stigma	
and	discrimination	in	the	community	(see	Chapter	6).	
• A	person	who	doesn’t	have	any	family	may	not	work	because	they	are	not	being	
encouraged	to	do	so.			
• Problems	with	self-care	may	result	from	lack	of	motivation,	a	symptom	of	the	illness.	
	
	
What	limitations	do	people	with	schizophrenia	have?	
People	with	schizophrenia	usually	experience	many	types	of	disability.	These	include:			
1. Problems	with	self-care	
This	includes	problems	with	washing,	dressing,	brushing	hair	and	eating	at	the	right	time.		
2. Problems	doing	household	tasks	
This	includes	problems	with	cooking,	washing	clothes,	chopping	wood	or	fetching	water.		
3. Problems	with	social	interactions	and	participating	in	community	life	
This	includes	problems	with	having	conversations	with	people	and	problems	attending	church,	
funerals	or	Edir	meetings.		
4. Problems	in	working	
This	includes	problems	doing	farm	work,	trading	or	business.		
5. Problems	in	looking	after	children	
This	includes	problems	giving	children	love,	feeding	and	clothing	them.		
6. Problems	with	marital	relationships	
This	includes	not	getting	on	well	and	arguing	a	lot.			
		
What	is	the	impact	of	having	disabilities?	
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Disability	may	be	more	upsetting	to	the	individual	than	the	symptoms	themselves.	For	
example,	finding	it	difficult	to	drink	coffee	with	others	may	be	more	distressing	than	
hearing	voices.	Disabilities	may	result	in	problems	with	money.	For	example,	having	
problems	with	farm	work	is	likely	to	mean	the	individual	has	less	money.	Disabilities	may	
also	have	a	big	impact	on	the	rest	of	the	family.	For	example	if	a	mother	with	schizophrenia	
finds	it	difficult	to	look	after	her	children,	other	family	members	may	need	to	help	out.	
These	family	members	may	then	have	trouble	looking	after	their	own	farm	properly	(see	
Chapter	5).	
		
Yosef’s	story		
Yosef	does	not	often	wash	or	dress	himself.	He	no	longer	helps	on	the	family’s	
farm.	He	does	not	contribute	to	Edir	anymore,	instead	he	relies	on	his	parent’s	
contributions.	He	doesn’t	have	any	friends	any	more	and	does	not	go	to	Church.		
	
How	do	we	assess	disabilities?	
You	will	learn	how	to	assess	what	kinds	of	disabilities	people	with	schizophrenia	have	as	
part	of	the	Needs	Assessment	(see	Chapter	12).	
	
How	do	we	work	with	individuals	to	improve	their	situation?	
The	aim	of	rehabilitation	is	to	work	with	individuals	to	improve	their	situation	so	they	are	
less	disabled	and	can	get	back	to	their	usual	activities.	Rehabilitation	should	be	an	
empowering	process.	This	means	the	needs	and	wishes	of	the	individual	are	at	the	centre	
of	the	work.	Rehabilitation	isn’t	about	‘doing	things’	to	or	for	people	who	are	disabled.	It	is	
about	working	together	to	improve	their	life	and	work	towards	recovery.	Recovery	can	
mean	different	things	to	different	people.	It	doesn’t	usually	mean	that	an	individual	is	
‘cured’	of	schizophrenia.	Instead	it	means	that	things	have	improved	in	a	way	that	is	
important	to	that	person.	You	will	see	that	all	of	CBR	is	focused	towards	rehabilitation.	
	
Summary	
• Disability	is	when	an	individual	cannot	do	the	activities	we	would	normally	expect	
• Disability	is	caused	by	a	combination	of	the	social	environment	and	the	illness	
• People	with	schizophrenia	can	have	problems	with:	self-care,	household	tasks,	
participating	in	community	life,	working,	looking	after	children	and	 marital	
relationships	
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Figure	6.5	RISE	manual	Chapter	26	(continued	overleaf)	
	
Chapter	26	Module:	Taking	part	in	community	life	
	
	
What	problems	do	people	with	schizophrenia	have	taking	part	in	community	life?		
It	is	common	for	people	with	schizophrenia	to	have	problems	doing	the	usual	activities	in	the	
community.	People		may		have		problems	with:	
• Attending	weddings	and	funerals	
• Drinking	coffee	with	friends	and	neighbours	
• Visiting	relatives	
• Taking	part	in	Edir	meetings	
• Participating	in	the	practical	activities	of	Edir	
• Participating	in	subdistrict	meetings	
• Attending	church	or	mosque	
• Participating	in	religious	groups,	such	as	mahaber	or	lika	
• Going	to	market	
• Participating	in	other	community	organisations,	such	as	the	Women’s	association	
	
	
Why	do	people	with	schizophrenia	have	problems	taking	part	in	community	life?	
• The	illness	makes	them	unmotivated	to	go	outside	
• The	illness	gives	them	problems	with	social	skills,	such	as	difficulties	starting	a	
conversation	or	taking	turns	to	speak	
• Medication	side	effects,	such	as	drowsiness,	make	it	difficult	to	get	the	energy	to	walk	
somewhere	and	socialise.	
• The	family	does	not	let	the	individual	attend	community	events	because	they	are	worried	
they	will	behave	strangely	or	do	something	embarrassing	
• Community	members	may	have	stigmatising	attitudes	towards	people	with	schizophrenia.	
This	means	they	may	ignore	the	individual,	not	allow	them	to	participate	in	activities,	not	
respect	their	opinion	or	even	shout	names	at	them.	
	
Why	is	it	important	to	take	part	in	community	life?	
	
To	feel	part	of	the	community	
	
Improve	their	sense	of	well-being	
Improve	their	self-confidence	
Reduce	stigma	towards	them	
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Reduce	burden	on	the	family	
	
Keep	the	person	engaged	in	useful			tasks	
Distract	from	distressing	symptoms	like	hallucinations	and			delusions.	
	
	
What	can	we	do	to	help	people	with	schizophrenia	take	part	in	community	life?	
Principles	
• Focus	on	the	areas	where	there	are	problems,	and	which	are	important	to	the	individual	
to	change	
• Establish	what	is	normal	for	the	household	and	the	individual	
• Involve	the	family	at	every	stage	of	the	process.	The	aim	is	for	them	to	be	able	to	support	
the	individual	to	do	the	activities	when	you	are	not	there.	
	
1. Explain	why	you	are	doing	this	module	
Explain	to	the	individual	and	family	that	problems	taking	part	in	community	life	are	common	
in	people	with	schizophrenia.	Give	reasons	why	people	with	schizophrenia	have	these	
problems.	
2. Discuss	what	problems	the	individual	has	
Discuss	what	problems	the	individual	has	had	taking	part	in	community	life	
3. Identify	the	activities	the	individual	wants	to	do	
Find	out	which	community	activities	the	individual	would	like	to	do	but	is	having	difficulty	with	
at	the	moment.	You	should	refer	back	to	the	latest	needs	assessment.	
4. Identify	barriers	and	suggest	ways	to	overcome	them	
You	should	discuss	with	the	individual	and	their	caregiver	why	they	think	they	are	having	
problems	taking	part	in	these	community	activities.	Look	at	the	Section	26.2	for	suggestions.	
The	most	appropriate	approach	for	helping	individuals	to	take	part	in	community	life	will	
depend	on	the	types	of	barriers.	You	should	also	use	the	problem	solving	approach	to	help	
you	(see	Section	10.5).	You	can	suggest	some	or	all	of	the	following:	
	
a. Improve	social	skills	
• Ask	the	individual	and	family	member	to	think	about	what	social	skills	they	need	to	do	the	
community	activities	they	would	like	to	be	involved	in.	These	might	include:	
o Greeting	others	
o Listening	to	others	
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o Asking	for	information	
o Expressing	an	opinion,	for	example	about	their	own	treatment.	
o Saying	sorry	when	this	is	needed	
o Eating	with	others	in	a	polite	way	
Now	discuss	with	the	individual	and	caregiver	which	things	the	individual	has	problems	with.	
Focus	on	these	things.	
• Ask	the	individual	to	practice	these	skills	with	you.	For	example,	
o Ask	them	to	show	you	how	they	would	greet	a	neighbour	they	met	at	church.	
o Ask	them	to	show	you	how	they	would	ask	the	price	of	something,	for	example	
cabbage	at	the	market	
• Give	encouragement,	including	smiles	and	praise,	when	the	individual	shows	they	can	do	the	
skill	
• Ask	the	individual	to	try	the	skills	in	a	real	life	situation	
	
	
b. Invite	neighbours	or	relative	for	coffee	
Suggest	that	the	family	invite	neighbours	or	relatives	to	the	home	to	drink	coffee.	This	can	be	a	
chance	to	practice	talking	to	familiar	people	in	a	familiar	environment.	
	
c. Family	member	accompanies	the	person	to	community	activities	
Suggest	that	a	family	member	goes	with	the	individual	to	the	community	activity	for	the	first	
few	times.	This	will	give	the	individual	more	motivation	and	confidence.	The	family	member	
may	be	worried	that	the	individual	will	behave	in	an	embarrassing	way.	Suggest	that	they	start	
with	activities	that	are	close	to	the	house	and	involve	fewer	people.	For	example	it	may	be	less	
stressful	to	go	to	the	grain	mill	together,	than	to	attend	a	funeral	with	many	guests.	
	
d. Engage	with	community	leaders	
With	the	help	of	the	individual	and	the	caregiver,	identify	key	people	within	the	community	who	
may	be	able	to	help	the	individual	to	get	back	to	usual	activities.	Consider:	
o Religious	leaders,	who	may	be	able	to	help	the	person	go	to	church,	mosque	or	a	religious	
group	(mahber	or	lika)	
o Edir	leaders,	who	may	be	able	to	help	the	person	contribute	to	Edir	and	participate	in	the	
Edir	activities	
o Leaders	of	Youth	Association,	Women’s	Association	or	sub-district	leaders,	who	may	be	
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able	to	help	the	person	attend	meetings	and	contribute	to	sub-district	affairs	
If	you	have	not	already	done	so,	it	may	be	appropriate	for	you	to	meet	with	the	leader	to	give	
them	information	about	schizophrenia	and	to	see	how	they	can	help.	See	Tasks	8,	9	and	10	in	
Community	Mobilisation	Chapter	31.	Alternatively	the	caregiver	may	be	willing	to	approach	
the	leader	independently.	
e. Use	approaches	from	other	modules	
Some	of	the	approaches	from	other	modules	may	also	contribute	towards	helping	individuals	
to	take	part	in	community	life,	for	example:	
• Community-awareness	raising	(see	Chapter	31),	which	aims	to	reduce	stigma	and	
discrimination	towards	people	with	schizophrenia	
• Improving	adherence	and	improving	side	effects	(see	Chapter	20)	
• Giving	the	individual	strategies	to	deal	with	stigmatising	attitudes	(see	Chapter	28)	
• Improving	the	attitude	of	the	family	towards	the	individual	(see	Chapter	25)	
• Dealing	with	distressing	symptoms	such	as	hallucinations,	lack	of	motivation	and	
problems	with	organisation	(see	Chapter	22)	
f. Acting	as	a	role	model	
The	way	you	behave	in	the	sub-district	can	have	a	big	impact	on	other	people’s	attitudes.	
When	you	see	the	individual	outside	whilst	not	in	a	home	visit,	greet	them,	as	you	would	do	
anyone	else.	Showing	the	community	that	the	individual	is	just	like	other	people	may	be	one	
way	to	reduce	stigma.	
You	can	use	Table	6	as	a	guide	for	which	approach	to	use	in	which	circumstances:	
Table	6	Approaches	to	support	individuals	to	take	part	in	community	life	
Problem	 Approach	
Lack	of	motivation	   Family	member	accompanies	
• Invite	neighbours	or	relatives	
• ‘Dealing	with	distressing	symptoms’	module		
Medication	side	effects	   Address	side	effects		
Problems	with	holding	a	
conversation	
• Practice	social	skills	
• Invite	neighbours	or	relatives	
	
The	family	does	not	let	the	
individual	attend	community	
events	
• ‘Improving	the	family	environment’	module		
• Invite	neighbours	or	relatives		
	
Stigma	and	discrimination	
from	community	
• Engage	with	community	leaders	
• Acting	as	a	role	model	
• ‘Dealing	with	stigma	and	discrimination’	module		
• Community	awareness	raising	task		
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5. Make	a	plan	
Discuss	with	the	individual	which	specific	community	activity	to	focus	on	first,	and	agree	the	
steps	to	start	participating	again.	Make	sure	everyone	knows	what	their	role	is.	
	
Follow	up	
Make	sure	you	follow	up	progress	on	participating	in	community	activities	at	the	next	home	
visit.	Discuss	what	strategies	were	tried	and	which	ones	helped.	Practice	social	skills	again	if	
you	agree	this	may	help.	If	relevant,	make	contact	with	community	leader	to	facilitate	
engagement	in	community	activities	
	
Sara’s	story	
Since	she	became	unwell	Sara	has	had	problems	visiting	her	sisters	in	the	
neighbouring	sub-district.	This	is	something	she	used	to	enjoy	a	lot.	Often	she	
doesn’t	go	because	she	doesn’t	have	the	energy	to	leave	the	house.	She	is	also	
worried	that	she	doesn’t	have	anything	to	say.	Berhan	discusses	with	Sara	and	
Alemu,	Sara’s	husband,	how	they	can	change	the	situation.	Sara	suggests	that	she	
could	invite	her	sisters	to	visit	her	first	of	all	as	this	will	require	less	energy.	Then	if	
this	goes	well,	Alemu	can	try	to	support	her	to	visit	them.	Berhan	helps	Sara	to	
practice	how	to	greet	people	and	how	to	start	a	conversation.	They	all	agree	to	try	
and	invite	the	sisters	within	the	next	two	weeks,	which	is	when	Berhan	will	visit	
again.	
	
Summary	
• Many	people	with	schizophrenia	have	problems	taking	part	in	community	life	such	as	
attending	church	or	funerals.	
• Helping	individuals	take	part	in	community	life	is	good	for	improving	self	confidence,	
reducing	stigma,	and	reducing	the	burden	on	the	family	
• Ways	to	help	individuals	take	part	in	community	life:	improve	social	skills,	invite	
neighbours	for	coffee,	family	member	accompanies,	and	engaging	community	leaders	
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	6.5 RISE	TRAINING		PROGRAMME	
	 The	RISE	training	programme	was	designed	to	address	the	knowledge	and	skills	needed	to	achieve	the	CBR	worker	competencies	(see	Table	6.1).	The	training	was	closely	tied	to	the	RISE	manual	(see	Section	6.4	and	Appendix	C	(ii)).	CBR	workers	received	five	weeks	training,	which	was	equally	split	between	classroom	teaching	and	fieldwork.	CBR	supervisors	participated	in	the	general	training,	and	I	also	gave	them	one-to-one	training	on	all	aspects	of	supervision.		 Classroom-based	training	was	delivered	in	Amharic	by	psychiatrists	and	coordinators	from	RAPID,	the	Ethiopian	CBR	project	supporting	children	with	disabilities.	I	directly	trained	all	RISE	trainers	to	deliver	their	sessions,	including	guidance	on	the	preferred	interactive	teaching	style.	See	Table	6.3	for	the	training	timetable.	Classroom	teaching	was	highly	structured	using	prepared	slides	and	included	small	group	activities,	such	as	role-plays,	whole	group	discussions,	viewing	specially	prepared	‘good’	and	‘bad’	communication	skills	videos,	and	quizzes.	Games	and	icebreakers	were	used	in	between	sessions.	Fieldwork	included	shadowing	trained	CBR	workers	at	the	RAPID	project,	observing	psychiatric	nurse	clinics	and	making	home	visits	to	persons	with	schizophrenia	who	were	part	of	the	Butajira	cohort.	Fieldwork	and	classroom	teaching	days	typically	alternated,	with	consecutive	days	covering	linked	topics	where	possible.	After	each	fieldwork	day	CBR	workers	had	half	a	day	to	discuss	their	experiences,	guided	by	the	trainers.	
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Table	6.3	RISE	training	timetable	(continued	overleaf)	
	 	 Method	 Session	 Trainer	
Week	1	 	
Monday	AM	 Classroom	 Introduction	to	training	 RISE	team	
Introduction	to	CBR	
CBR	for	schizophrenia	I	
Monday	PM	 CBR	for	schizophrenia	II	
CBR	for	schizophrenia	III	
Overview	of	RISE	pilot	and	trial	
Tuesday	AM	 Classroom	 Introduction	to	mental	illness	 Psychiatrist	
Introduction	to	schizophrenia	I	
Tuesday	PM	 Introduction	to	schizophrenia	II	
Medicines	for	schizophrenia	
Wednesday	
AM	
Classroom	 Disability	 RAPID	supervisor	
Impact	on	family	
Wednesday	
PM	
Stigma	
Human	rights	
Importance	of	the	community	
Thursday	AM	 Classroom	 Initial	visit	 Psychiatrist	
Communication	skills	
Thursday	PM	 Problem	solving	and	trusting	relationship	
Needs	assessment	
Friday	AM	 Classroom	 Goal	Setting	I	 Psychiatrist	
Goal	setting	II	
Friday	PM	 Assessment	 	 RISE	team	
Week	2	 	
Monday	AM	 Classroom	 Intro	to	RAPID	 RAPID	CBR	worker/	
supervisor	Monday	PM	 Practice	in	field	 Needs	assessment	and	goal	setting	
Tuesday	AM	 Discussion	 Needs	assessment	and	goal	setting	 RAPID	supervisor	
Tuesday	PM	 Classroom	 Daily	functioning	
Improving	physical	health	
Wednesday	
full	day	
Practice	in	field	 Daily	functioning	&	Improving	physical	health	 RAPID	CBR	worker/	
supervisor	
Thursday	AM	 Discussion	 Daily	functioning	&	Improving	physical	health	 RAPID	supervisor	
Thursday	PM	 Classroom	 Family	support	groups	
Dealing	with	stress	and	anger	
Friday	full	day	 Practice	in	field	 Family	groups	&	Dealing	with	stress	and	anger	 RAPID	CBR	worker/	
supervisor	
Saturday	AM	 Discussion	 Family	groups	&	Dealing	with	stress	and	anger	 RAPID	supervisor	
Saturday	PM	 Classroom	 Community	mobilisation	I	and	II	 	
Sunday	AM	 Classroom	 Community	life	 RAPID	supervisor	
Getting	back	to	work	
Week	3	 	 	 	
Monday	AM	 Practice	in	field	 Community	mobilisation	 RAPID	CBR	worker/	
supervisor	
Monday	PM	 Discussion	 Community	mobilisation	 RAPID	supervisor	
Tuesday	full	
day	
Day	off	 	 	
Wednesday	
full	day	
Assessment	 	 RISE	team	
Thursday	AM	 Classroom	 Understanding	schizophrenia	 Psychiatrist	
Preparing	for	a	crisis	
Thursday	PM	 Risk	assessment	
Dealing	with	human	rights	issues	
Friday	full	day	 Practice	in	field	 Understanding	schizophrenia	&	Preparing	for	a	crisis,	
risk	assessment,	human	rights	
Psychiatric	nurse	
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Table	6.2	continued	
Week	4	 	
Monday	AM	 Discussion	 Understanding	schizophrenia	&	Preparing	for	a	crisis,	
risk	assessment,	human	rights	
Psychiatrist	
Monday	PM	 Classroom	 Accessing	healthcare	
Supporting	individuals	to	take	medication	
Tuesday	full	
day	
Practice	in	field	 Accessing	healthcare	&	Supporting	medication	 Psychiatric	nurse	
Wednesday	
AM	
Discussion	 Accessing	healthcare	&	Supporting	medication	 Psychiatrist	
Wednesday	
PM	
Classroom	 Family	intervention	
Dealing	with	distressing	symptoms	
Thursday	full	
day	
Practice	in	field	 Family	intervention	&	distressing	symptoms	 Psychiatric	nurse	
Friday	full	day	 Day	off	 	 	
Saturday	AM	 Discussion	 Family	intervention	&	distressing	symptoms	 Psychiatrist	
Saturday	PM	 Classroom	 Taking	control	of	your	illness	 	
Dealing	with	stigma	
Week	5	 	
Monday	AM	 	 Documentation	 RISE	team	
Dealing	with	other	problems	
Monday	PM	 Classroom	 Improving	literacy	
CBR	worker	wellbeing	
Supervision	
Tuesday	full	
day	
Practice	in	field	 Taking	control	of	illness	&	Dealing	with	stigma	 Psychiatric	nurse	
Wednesday	
AM	
Discussion	
	
Classroom	Visit	
to	health	
centre	
Taking	control	of	illness	&	Dealing	with	stigma	 Psychiatrist	
RISE	team	
	
Wednesday	
PM	
Link	to	health	centre	
Dealing	with	difficult	situations	
Thursday	full	
day	
Revision	 	 RISE	team	
Friday	full	day	 Revision	 	 RISE	team	
	
	 Four	example	lesson	plans	are	presented	in	Figures	6.6,	Figure	6.7,	Figure	6.8	and	Figure	6.9	and	the	entire	training	outline	is	presented	in	Appendix	C	(iii).	Assessment	included	written	tests	in	the	form	of	multiple	choice	questions	and	vignettes	at	week	3	and	week	5,	observations	by	trainers,	self-reported	competence	assessments	and	standardised	role-play	assessments	at	weeks	1,	3	and	5	(see	Appendix	C	(iv)).	Psychiatrists	and	supervisors	assessed	CBR	competence	by	rating	role-plays	using	the	ENACT	scale	[2],	adapted	for	Ethiopia	(see	Appendix	C	(v)).	The	adaptation	and	piloting	of	the	ENACT	and	the	CBR	worker	competence	data	are	being	written	up	for	publication,	but	are	not	presented	in	detail	in	this	thesis.	CBR	workers	were	to	be	excluded	if	they	scored	<40%	on	the	post	training	written	test	or	rated	as	‘needs	improvement’	on	>20%	
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ENACT	items	on	the	final	role	play	assessment.	All	CBR	workers	were	above	these	thresholds	so	proceeded	to	the	pilot.		
Figure	6.6	RISE	training	session	'Disabilities	relating	to	schizophrenia'	
	
Disabilities	related	to	schizophrenia	(Wednesday	Week	1)	
Reference:	RISE	manual	Chapter	4	
Competencies	
• 6c:	Understands	the	impact	of	schizophrenia	in	terms	of	disability,	stigma,	human	rights	and	
family	burden	
Steps	 Resources	 Timing	
1.	 Tell	the	group	what	we	mean	by	disability	 Powerpoint	11	 5	mins	
2.	 Ask	the	trainees	what	types	of	disabilities	might	be	related	to	
schizophrenia.	Write	their	answers	on	the	flip	chart.	
Flip	chart	 15	mins	
3. Teach	the	following	points:	
• What	types	of	disabilities	people	with	schizophrenia	may	have.	
Use	the	examples	the	group	gave.	
• What	causes	disabilities	
Powerpoint	11	 15	mins	
4. Ask	the	trainees	to	read	Yosef’s	story.	Divide	into	groups	of	3.	One	
participant	should	read	the	vignette.	Each	group	should	discuss	
what	disabilities	Yosef	has	and	what	might	have	caused	them.	
5. Ask	for	feedback	on	from	each	group.	
Manual	 25	mins	
6. Teach	the	following	points:	
• Remind	the	group	what	we	mean	by	rehabilitation	and	
recovery	
Powerpoint	11	 5	mins	
7.	 Ask	the	group	what	recovery	might	mean	to	Yosef	 Flip	chart	 10	
8.	 Quiz	 Powerpoint	11	 5	
Total	 	 80	
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Figure	6.7	RISE	training	session	'Taking	part	in	community	life'	
	
Taking	part	in	community	life	(Sunday	Week	2)	
Reference:	RISE	manual	Chapter	26	
Competencies	
• 7p:	Able	to	assess	reasons	for	reduced	participation	in	community	life	and	apply	problem	
solving	approach	to	address	this	
Steps	 Resources	 Timing	
1.	 Ask	the	group	what	problems	people	with	schizophrenia	might	have	
with	taking	part	in	community	life.	Write	the	answers	on	the	flip	
chart.	
Flip	chart	and	
pen	
10	
2. Tell	the	group	about:	
• Common	problems	with	taking	part	in	community	life,	using	the	
group’s	examples	
• Why	people	with	schizophrenia	might	have	problems	with	taking	
part	in	community	life	
• Why	it	is	important	to	improve	problems	with	taking	part	in	
community	life	
PowerPoint	28	 10	
3. Describe	the	steps	to	improve	problems	taking	part	in	community	life	
• Principles	
• Explain	why	you	are	doing	this	module	
• Ask	for	problems	with	taking	part	in	community	life	
• Agree	what	community	activities	the	individual	wants	to	do	
• Discuss	barriers	and	do	problem	solving	to	decide	how	to	overcome	
problems	
PowerPoint	28	 15	
4. In	threes,	one	trainee	should	pretend	to	be	the	caregiver,	one	trainee	
the	person	with	schizophrenia	and	one	trainee	should	pretend	to	be	
the	CBR	worker.	Take	it	in	turns	to	take	each	role.	
The	CBR	worker	should	work	with	the	person	with	schizophrenia	to	
practice	the	following	social	skills:	
• Greeting	others	
• Asking	for	information	
• Expressing	an	opinion	
5.	After	each	 role	play	 the	 trainees	playing	 the	 caregiver	and	person	
with	schizophrenia	and	should	feedback	to	the	person	playing	the	
CBR	worker:	any	good	things	they	did,	any	thing	they	did	less	well,	
something	they	can	improve	on	for	next	time.	
Handout	18	 25	
6.	 Ask	each	group	to	make	one	comment	about	the	role	play	e.g.	what	
they	found	difficult.	
	 10	
7. In	groups	of	three	the	trainees	should	discuss	how	they	could	solve	
the	problem	vignettes.	Suggest	as	many	ways	as	you	can	think	of	to	
deal	with	the	following	problems.	Decide	which	are	not	good	
suggestions	and	which	are	good	suggestions.	Select	the	best	one	
1. Betty	used	to	go	to	market	but	doesn’t	anymore.	She	says	she	is	
too	tired	to	go.	
2. Daniel	used	to	vote	at	the	sub-district	meetings	but	doesn’t	any	
more.	Last	time	he	went	people	ignored	him.	
3. Henok	doesn’t	go	to	weddings	or	funerals	because	his	parents	
are	worried	he	will	shout	at	people	and	be	embarrassing.	
4. Solomon	used	to	contribute	to	Edir	by	making	payments	by	
himself	and	helping	with	the	tasks	at	funerals	e.g.	erecting	the	
tent.	His	family	say	he	shouldn’t	do	this	now	he	is	ill.	
5. Tigist	used	to	go	to	church	but	now	she	doesn’t	go.	She	doesn’t	
have	any	friends	in	the	sub-district	now	and	she	is	worried	she	
will	have	trouble	talking	to	people.	
Handout	19	 15	
8.	 Ask	each	group	to	feedback	their	suggestions	for	solving	the	
problems.	
	 10	
Total	 	 100	
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Figure	6.8	RISE	fieldwork	session	'Community	mobilisation	practice'	
	
Community	Mobilisation	Practice	(Monday	Week	3)	
Reference:	Chapter	31	
Competencies	
• 8a:	Able	to	form	good	relationships	with	community	leaders	and	health	extension	workers	
• 8b:	Able	to	conduct	community	awareness	raising	
• 8c:	Able	to	engage	with	community	leaders	to	facilitate	CBR	
• 8d:	Able	to	maximise	sustainability	of	programme	through	community	involvement	
• Trainees	should	accompany	RAPID	CBR	workers	to	a	community	mobilisation	activity	e.g.	
community	awareness	raising,	meeting	with	community	leader/head	teacher	
• They	should	observe	the	activity	and	discuss	some	of	the	following	points	with	the	CBR	worker	
o Previous	meetings,	awareness	raising	activities	
o Skills	needed	to	work	with	community	leaders	
o Skills	needed	to	give	information	to	the	community	
o Topic	discussed	
o Challenges	of	working	with	community	leaders	or	wider	community	
o Benefits	of	community	mobilisation	work	
o How/	whether	community	mobilisation	work	helps	CBR	to	continue	after	the	CBR	workers	
have	left	
• The	trainee	should	write	notes	so	they	can	remember	and	discuss	what	they	did	and	learnt	the	
following	day.	
	
	
Figure	6.9	RISE	training	session	'Community	mobilisation	discussion'	
	
Community	mobilisation	discussion	(Monday	Week	3)	
Reference:	Chapter	31	
Competencies	
• 8a:	Able	to	form	good	relationships	with	community	leaders	and	HEWs	
• 8b:	Able	to	conduct	community	awareness	raising	
• 8c:	Able	to	engage	with	community	leaders	to	facilitate	CBR	
• 8d:	Able	to	maximise	sustainability	of	programme	through	community	involvement	
Steps	 Resources	 Timing	
Ask	each	trainee	in	turn	to	share	with	the	group	their	experience	in	the	
field.	Use	the	following	prompts:	
• Describe	the	community	mobilisation	activity	they	observed	
• Topics	discussed	
• Benefits	and	challenges	of	the	work	
• Skills	needed	for	the	work	
• What	have	they	learnt;	how	can	they	use	the	information	in	their	own	
work	
• Anything	that	was	confusing	
• Anything	that	was	difficult	or	challenging	
• Any	thing	that	was	interesting	or	surprising	
Encourage	the	group	to	ask	each	other	questions	and	discuss	amongst	
themselves	
Flip	chart	 120	
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6.6 CONCLUSION	
	 This	chapter	has	given	an	overview	of	the	RISE	CBR	worker	training	and	the	CBR	intervention	delivery	structure	and	content.	The	next	chapter	will	describe	the	implementation	of	this	intervention	in	a	12	month	pilot	study.				
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7 THE	RISE	PILOT	STUDY	
	
	
7.1 INTRODUCTION	
	 Chapter	5	presented	the	intervention	development	work	undertaken	to	design	a	CBR	intervention	for	schizophrenia	that	is	acceptable,	feasible	and	culturally	appropriate	for	the	Ethiopian	context.	Chapter	6	described	the	structure	and	content	of	the	RISE	CBR	intervention	in	more	detail.	This	chapter	describes	a	12	month	pilot	of	this	intervention,	representing	the	‘Feasibility	and	piloting’	phase	of	the	MRC	framework	[1].	Structured	using	the	theory	of	change	framework,	this	chapter	explores	how	and	why	the	RISE	CBR	intervention	may	improve	functioning,	as	well	as	its	acceptability	and	feasibility	in	practice,	and	details	the	adjustments	made	to	the	intervention	in	preparation	for	an	cluster	randomised	trial	(Chapter	8).				
7.2 METHODS	
	
7.2.1 Setting	
	 This	study	was	set	in	Sodo	district	in	Southern	Ethiopia,	which	is	described	in	Chapter	3	(Section	3.3)	and	Chapter	5.	Sodo	district	is	the	setting	for	the	Ethiopian	arm	of	the	PRIME	project	[2],	which	involves	the	integration	of	mental	health	services	into	primary	care.	At	the	start	of	the	pilot	study	primary	care	staff	could	only	refer	complex	cases	to	the	psychiatric	nurse-	led	outpatient	clinic	in	Butajira	hospital,	which	lies	30km	away	in	the	neighbouring	district.	During	the	pilot	study	a	new	psychiatric	nurse-led	outpatient	clinic	was	set	up	at	the	general	hospital	in	Bui.	Fluphenazine	depot	injections	were	sometimes	available	at	these	clinics.	Psychiatric	nurses	at	these	clinics	could	also	refer	patients	to	Ammanuel	Psychiatric	Hospital	in	Addis	Ababa;	however	these	referrals	are	rarely	made	in	practice.	There	was	no	free	medication	provision	by	PRIME,	hence	at	the	start	of	this	study	health	care	costs	were	out-of-pocket	with	a	fee	waiver	available	for	the	poorest,	given	at	the	discretion	of	sub-district	officials.	From	December	2014	people	with	schizophrenia	were	invited	by	PRIME	to	access	this	new	service	and	
175
were	followed	up	in	the	12	month	PRIME	cohort	study	[3].	RISE	pilot	participants	were	recruited	at	the	baseline	of	this	cohort	study.				
7.2.2 Participants	
	 This	pilot	study	was	conducted	between	December	2014	and	December	2015.	The	participants	were	ten	people	with	schizophrenia	and	their	families	living	in	four	sub-districts	of	Sodo.	Only	one	participant	per	CBR	worker	was	selected	because	this	was	perceived	to	be	an	appropriate	initial	workload	for	the	newly	trained	CBR	workers,	as	well	as	a	suitable	sample	size	for	the	in-depth	analysis	planned.	The	four	sub-districts	were	selected	for	convenience;	they	were	all	linked	to	the	health	centre	that	saw	the	earliest	implementation	of	mental	health	into	primary	care,	and	cohort	study	recruitment,	by	PRIME.	In	the	selected	sub-districts,	the	intervention	coordinator	assessed	consecutive	PRIME	cohort	recruits	for	RISE	pilot	eligibility	by	reviewing	data	routinely	collected	at	PRIME	baseline	(see	Appendix	D	(i)).	There	were	no	specific	exclusion	criteria.	Participants	meeting	all	of	the	following	criteria	were	included:		 1) Participant	in	PRIME	cohort	study		 2) Resident	in	sub-district	for	>6	months	and	no	immediate	plans	to	leave	the	sub-	district		 3) Has	a	primary	caregiver	who	is	willing	to	participate	in	the	study		 4) Age	≥18	years		 5) Diagnosis	of	schizophrenia	spectrum	disorder	(schizophrenia,	schizoaffective	disorder	or	schizophreniform	disorder)	using	DSM-IV	criteria	(assessed	using	the	Operational	Criteria	for	Research	(OPCRIT)	[4])	[5]	and		 6) Evidence	of	enduring	or	disabling	illness	demonstrated	by	one	or	more	of	the	following:		 (i) Brief	Psychiatric	Rating	Scale	–	Expanded	version	(BPRS-E)	score	≥52	[6]		 (ii) 36-item	WHODAS	2.0	score	≥35	[7]	
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(iii) Continuous	illness	over	the	preceding	six	months,	assessed	using	the	Life	Chart	Schedule	(LCS)	[8]		 (iv) Symptomatic	in	three	or	more	out	of	the	last	six	months,	assessed	using	the	Longitudinal	Interval	Follow-up	Evaluation	(LIFE)	[9]	or		 (v) Clinical	Global	Impression	(CGI)	score	≥	four	(at	least	moderately	ill)	[10].		 Details	of	these	instruments	are	provided	in	Table	7.1.	The	final	criterion	allowed	us	to	include	the	group	expected	to	benefit	the	most	from	CBR	and	also	reflects	the	threshold	at	which	CBR	could	realistically	be	offered	in	this	resource-constrained	setting.	Eligible	participants	were	given	information	about	the	study	by	the	intervention	coordinator	in	a	way	appropriate	to	the	participants’	literacy	level.				
7.2.3 CBR	workers	and	supervisors	
	 The	CBR	workers	were	recruited	to	the	following	essential	criteria:	(1)	completed	tenth	grade	education	(secondary	school),	(2)	resident	in	Sodo	district,	and	(3)	interest	in	community	work.	Previous	experience	of	community	work	and	high	attainment	in	school	examinations	were	desirable.	Degree	level	applicants	were	excluded.	There	were	220	applications	in	response	to	local	adverts,	which	were	ranked	and	50	selected	for	examination	using	the	criteria.	The	examination	included	multiple-choice	questions	on	appropriate	ways	to	support	people	with	schizophrenia.	Twenty	applicants	proceeded	to	the	interview	on	the	basis	of	ranked	scores,	from	which	12	successful	applicants	were	finally	selected.	One	CBR	worker	dropped	out	after	two	weeks	training.	Due	to	a	misdiagnosis	at	PRIME	cohort	recruitment,	one	CBR	worker	exclusively	supported	a	man	with	intellectual	disability	during	the	RISE	pilot,	hence	his	data	are	not	reported	in	this	chapter.	Of	the	ten	CBR	workers	presented	here	there	was	an	equal	gender	split	and	half	had	some	experience	in	health	or	community	work,	though	none	had	mental	health	experience.	CBR	workers	received	a	salary	equivalent	to	health	extension	workers	(approximately	£60/	month)	and	a	transport	allowance.	One	male	and	one	female	supervisor	were	recruited	to	the	minimum	criteria	of	a	diploma	level	qualification	and	experience	in	community	work;	they	received	a	salary	of	approximately	£180/month.	The	intervention	coordinator	had	an	MSc	in	Pharmacology.	
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7.2.4 CBR	delivery	and	supervision	
	 Two	or	three	CBR	workers	were	based	in	each	sub-district	and	each	CBR	worker	supported	one	person	with	schizophrenia	and	their	caregiver	over	a	12	month	period.	The	CBR	intervention	and	supervision	arrangements	are	described	in	detail	in	Chapter	6.	CBR	supervisors	and	CBR	workers	used	public	transport	(carts	or	minibuses)	to	travel	to	participants’	home	or	travelled	on	foot.	All	participants	received	both	CBR	and	usual	care	at	the	health	centre.	During	the	pilot	I	provided	close	support	to	the	CBR	supervisors	and	the	intervention	coordinator	as	the	pilot	was	considered	part	of	the	training	period	for	CBR	workers,	supervisors	and	the	intervention	coordinator.	As	such	I	was	present	at	all	group	supervision	meetings	and	some	individual	supervision	meetings.	My	role	was	to	observe	and	guide	supervision	to	ensure	intervention	fidelity	and	participant	safety.	By	the	midpoint	of	the	pilot	period,	as	expected,	the	intervention	coordinator	had	largely	taken		over	this	role,	though	I	continued	to	provide	input	when	required.	I	also	continued	to	interact	with	CBR	workers	and	supervisors	at	the	fortnightly	to	monthly	feedback	meetings	throughout	the	pilot	period	(see	Section	7.2.6.3).				
7.2.5 Theory	of	change	
	 Theory	of	change	was	used	to	guide	the	evaluation	of	the	pilot.	Figure	7.1	presents	the	RISE	theory	of	change	map	that	was	produced	prior	to	the	pilot	(see	Appendix	D	(ii)	for	the	detailed	version);	this	was	a	refined	version	of	the	theory	of	change	map	presented	in	Chapter	5.	This	pre-pilot	theory	of	change	map	identified	‘Sustained	improved	functioning	in	people	with	schizophrenia’	as	the	desired	long-	term	outcome	(yellow	box	in	Figure	7.1).	Intermediate	outcomes	included	those	related	to	the	programme	delivery	(green	boxes	in	Figure	7.1)	and	causal	pathways	to	improved	functioning	(blue	boxes	in	Figure	7.1).	In	addition	thirteen	assumptions	were	identified,	for	example	‘1b:	CBR	can	address	the	needs	of	people	with	schizophrenia’	(orange	boxes	in	Figure	7.1).	Assumptions	represent	what	needs	to	be	in	place,	or	‘true’,	in	order	to	proceed	through	intermediate	outcomes	and	ultimately	to	achieve	the	final	outcome.	Assumptions	were	grouped	into	three	overarching	research	questions.	
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1. Is	the	RISE	CBR	intervention	acceptable?	2. Is	the	RISE	CBR	intervention	feasible?	3. Can	the	RISE	CBR	intervention	produce	an	impact	and	if	so,	how?		 The	pilot	evaluation	was	designed	to	answer	these	research	questions	and	to	test	the	assumptions.	The	evaluation	was	also	responsive;	issues	emerging	early	on	in	the	pilot	were	explored	in	more	depth	at	the	later	stages	of	data	collection.	
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Figure	7.1	Pre-pilot	theory	of	change	
map	
Engagement,	training	and	programme	set	up	 CBR	programme	delivery	and	intermediate	outcomes	
Community	
resources	
and	leaders	
are	known		
Community		is	engaged	in	CBR	
CBR	
workers	are	
competent	
Sustained	
improved	
func<oning	
	
é Self	care	
é  Livelihood	
ac<vi<es	
é  Domes<c	
tasks	
é  Social	life	
éIndependence	
	
Long	term	outcome	
Model	of	
care	is	
acceptable	
Needs,	
goals	and	
risks	are	
known	
CBR	workers	
and	
supervisors	in	
post	
CBR	
workers	
deliver	
CBR	as	
intended		
	On-going	
community		
support	
Community-based	
Rehabilita<on	
Interven<on	for	people	
with	Schizophrenia	in	
Ethiopia	(RISE)	
People	with	schizophrenia	and	family	are	engaged	in	CBR	for	intended	dura<on	and	intensity	
People	with	
schizophrenia	
and	caregiver	
iden<ﬁed	
1a	
1b	
1d	
1e	
1c	2a	
2b	
2c	
2d	
3a	
3b	
3c	
Assump<ons	
1.	Is	the	RISE	CBR	interven<on	acceptable?		
1a	People	with	schizophrenia	and	caregivers	are	willing	and	have	
5me	to	par5cipate	
1b	CBR	can	meet	the	needs	of	people	with	schizophrenia	
1c	CBR	workers	are	willing	to	work	with	people	with	schizophrenia	
1d		Community	leaders	willing	to	support	CBR		
1e	Tradi5onal	and	religious	healers	are	willing	to	support	CBR	
2.	Is	the	RISE	CBR	interven<on	feasible?	
2a	Non-specialists	can	be	trained	to	deliver	CBR	for	people	with	
schizophrenia	
2b	CBR	workers	can	overcome	logis5cal	challenges	to	deliver	CBR	
2c	Primary	care	staﬀ	are	suppor5ve	of	CBR	
2d	An5-psycho5c	medica5on	is	accessible	
2e	Edir	support	will	be	available	and	sustainable	
3.	Can	the	RISE	CBR	interven<on	produce	an	impact	and	
if	so,	how?		
3a	CBR	can	improve	func5oning	in	people	with	schizophrenia		
3b	A	community	mobilisa5on	approach	is	needed	in	addi5on	to	
home-based	care	
3c	Family	support	groups	are	perceived	to	be	useful	
	
	
	
	
	
	
		
AQend	
facility-based	
care	for	
mental	
health	
Can	aﬀord	
an<-
psycho<c			
medica<on	
	Improved	
economic	status	
Social	
inclusion	
Improved	
physical	
health	
Reduced	use	
of	violence	+	
restraint	
	Reduced	
s<gma	
AQend	facility-
based	care	for	
physical	health	
Physical,	
reproduc<ve	
health	needs	and	
substance	abuse	
iden<ﬁed	
Family	can	
cope		
Improved	
symptoms		
Increased	
understanding	
of		illness	
Returns	to	
farm	work/	
employment	
	Adhere	to	
medica<on	
alongside	
tradi<onal	
medicine	
2e	
	On-going	
family	support	
	7.2.6 Data	collection	and	analysis	
7.2.6.1 Quantitative	Quantitative	data	collection	took	place	at	baseline,	six	and	12	months.	Trained	lay	data	collectors	interviewed	people	with	schizophrenia	using	a	structured	questionnaire	comprising	the	following	assessment	tools:	an	adapted	version	of	subscale	1	(unfair	treatment)	of	the	Discrimination	and	Stigma	Scale-12	(DISC-12)	[11],	an	adapted	version	of	the	Client	Service	Receipt	Inventory	(CSRI)	to	determine	health	facility	use	[12,	13],	questions	about	episodes	and	duration	of	physical	restraint,	the	Alcohol	Use	Disorders	Identification	Test	(AUDIT)	to	detect	hazardous	drinking	[14]	and	an	amended	version	of	the	Patient	Health	Questionnaire-	9	(PHQ-9)	[15,	16]	to	measure	depression.	Data	collectors	administered	a	structured	questionnaire	to	caregivers	which	comprised	of	the	Involvement	Evaluation	Questionnaire	(IEQ)	to	measure	caregiver	burden	[17]	and	the	proxy-reported	36-item	WHODAS	2.0	[7,	18]	to	measure	disability	amongst	people	with	schizophrenia.	A	psychiatric	nurse	rated	the	CGI	to	determine	the	overall	clinical	impression	[10],	the	BPRS-E	to	measure	symptom	severity	[6]	and	the	LCS	to	determine	illness	course	[8].	Details	of	the	instruments	are	summarised	in	Table	7.1	and	the	instruments	are	presented	in	Appendix	E	(vii).	All	instruments	have	been	validated	or	adapted	for	use	in	Ethiopia,	including	translation	into	Amharic.	Trained	research	assistants	verified	questionnaires	immediately	after	data	collection,	and	any	missing	items	or	discrepancies	were	clarified	with	the	participants.	At	baseline,	data	were	double	entered	onto	an	Epidata	Entry	Version	3.1	database.	Six	and	12-month	data	were	entered	onto	an	Epidata	EntryClient	(Version	v2.0.4.16)	database	and	managed	using	Epidata	Manager	v2.0.6.52.	Descriptive	summaries	of	socio-demographic	and	outcome	data	were	prepared	using	Stata	Version	12	[19].	All	databases	were	password	protected	and	only	accessible	to	authorised	personnel.	All	forms	and	questionnaires	that	include	patient	data	were	anonymised,	identifiable	only	through	the	unique	identification	number.				
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	Table	7.1	Pilot	quantitative	instruments	(continued	overleaf)	
Outcome	 Instrument/s	
Lay	data	collector:	patient-reported		
Depression	(see	
Appendix	E	(vii);	pages	
425-426	Volume	II)	
	
	
The	Patient	Health	Questionnaire-	9	(PHQ-9)	[15,	16]	incorporates	DSM-IV	depression	diagnostic	criteria	with	other	leading	major	depressive	symptoms.	Each	item	is	rated	as	‘0’	(not	at	all)	to	‘3’	(nearly	every	day).	The	item	‘Feeling	bad	about	yourself’	was	excluded	at	baseline	as	part	of	the	initial	adaptation	for	Ethiopia	by	PRIME,	but	reintroduced	at	midline	and	endline.	This	item	was	excluded	from	summary	scores	at	all	time	points	to	allow	time	points	to	be	compared.	Possible	range	for	the	adapted	version	is	0	to	24	with	higher	scores	indicating	greater	severity.	
Health	service	
utilisation	(see	
Appendix	E	(vii);	pages	
428-429	Volume	II)	
An	adapted	version	of	the	Client	Service	Receipt	Inventory	(CSRI)	[12,	13],	developed	for	PRIME,	was	used	to	enquire	systematically	about	the	utilisation	of	biomedical	and	traditional	services	and	associated	costs	(direct	and	indirect).	
Physical	restraint	
(see	Appendix	E	(vii);	
pages	430-431	Volume	
II)	
A	set	of	questions	on	the	duration,	frequency,	perpetrator	and	reasons	for	physical	restraint.	At	baseline	episodes	in	the	participant’s	lifetime	were	recorded.	Episodes	in	the	last	six	months	were	recorded	at	midline	and	endline.	
Alcohol	use	(see	
Appendix	E	(vii);	pages	
432-433	Volume	II)	
The	Alcohol	Use	Disorders	Identification	Test	(AUDIT)	is	a	10-item	tool,	which	was	used	to	detect	hazardous	drinking	[14].	Possible	score	range	is	0-40	with	higher	scores	indicating	greater	severity.	
Discrimination		
(see	Appendix	E	(vii);	
pages	434-436	Volume	
II)	
Measured	using	subscale	1	(unfair	treatment)	of	the	Discrimination	and	Stigma	Scale	Version	12	(DISC-12)	[11].	Original	version	includes	21	items	asking	the	participant	if	they	have	experienced	different	types	of	discrimination	relating	to	their	mental	illness.	All	items	are	rated	on	a	4-point	likert	scale	(0	‘Not	at	all’	to	3	‘A	lot’).	Due	to	PRIME’s	initial	adaptation	of	DISC-12	for	Ethiopia,	at	baseline	the	DISC-12	did	not	include	items	relating	to	‘Unfair	treatment	in	accessing	welfare	benefits’	and	‘Privacy’.	These	items	were	introduced	at	midline	and	endline	but	these	items	were	excluded	from	summary	scores	at	all	time	points	to	allow	time	points	to	be	compared.	
Lay	data	collector:	caregiver-reported		
Disability		(see	
Appendix	E	(vii);	pages	
442-447	Volume	II)	
	
36-item	WHODAS	2.0	[7].	Six	domains:	understanding	and	communication,	getting	around,	self-care,	getting	along	with	people,	life	activities	and	participation	in	society.	Total	scores	are	converted	to	compute	a	0-100	range	summary	with	higher	scores	indicating	higher	levels	of	disability.	At	baseline	data	collection,	both	people	with	schizophrenia	and	caregivers	could	contribute	to	the	WHODAS	responses,	due	to	different	procedures	utilised	by	PRIME	at	that	time	point.	At	midline	and	endline	only	caregiver	responses	were	used.	
Caregiver	burden	
(see	Appendix	E	(vii);	
pages	461-468	Volume	
II)		
Involvement	Evaluation	Questionnaire	(IEQ)	[17].	This	is	a	31-item	questionnaire	assessing	aspects	of	caregiving	including	tension,	worrying,	urging	and	supervision.	All	items	are	scored	on	5-point	Likert	scales	(0	never	to	4	always).	A	27-item	sumscore	can	be	computed	(range	0	to	108).	
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	Table	7.1	continued	
Psychiatric	nurse-rated	instruments	
Symptom	severity	
(see	Appendix	E	(vii);	
pages	402-411	Volume	
II)		
Brief	Psychiatric	Rating	Scale-	Expanded	version	(BPRS-	E)	[6].	Focuses	on	symptoms	of	psychosis,	but	also	has	items	covering	the	symptom	domains	of	somatic	concerns,	anxiety,	depression	and	mania.	Each	symptom	is	rated	along	a	seven-point	severity	continuum	(1	to	7).	Total	score	is	obtained	by	adding	the	ratings	for	each	of	the	24	items.	Range	is	24	to	168	with	higher	score	indicating	greater	severity.	
Clinical	impression	
(see	Appendix	E	(vii);	
pages	412	Volume	II)		
Clinical	Global	Impression	(CGI)-	illness	severity	[10].	Rated	on	a	seven	point	score	ranging	from	1,	when	the	patient	is	assessed	to	have	no	illness,	to	7,	when	the	patient	is	among	the	most	severely	ill.	The	scale	is	completed	entirely	based	on	clinical	judgment.		
Relapse	(see	Appendix	
E	(vii);	pages	413	
Volume	II)		
Life	Chart	Schedule	(LCS)	[8].	The	symptoms	section	will	be	administered	in	order	to	determine	the	course	type	and	number	of	relapses.	
 
7.2.6.2 Qualitative		Qualitative	data	were	collected	at	two	months	and	12	months	into	the	pilot.	A	total	of	40	in-depth	interviews	(IDIs)	were	conducted	with	21	individuals	comprising	people	with	schizophrenia,	caregivers,	supervisors,	primary	care-based	health	officers	and	community	members	(see	Table	7.2).	Two	focus	group	discussions	(FGDs)	were	held	with	the	10	CBR	workers	at	two	months	and	two	FGDs	were	held	at	12	months.	The	topic	guides	addressed	the	research	questions,	namely	the	acceptability,	feasibility	and	perceived	impact	of	CBR,	with	specific	questions	guided	by	the	assumptions	and	issues	arising	from	on	going	process	data	collection	(see	Appendix	D	(iii)).	Two	people	with	schizophrenia,	both	with	co-morbid	intellectual	disability,	were	assessed	not	to	have	the	cognitive	capacity	to	participate	in	IDIs.	Two	caregivers	and	a	man	with	schizophrenia	declined	to	participate	in	IDIs	at	two	months	despite	having	given	consent	at	recruitment.	This	individual	with	schizophrenia	participated	at	12	months;	however	an	additional	caregiver	did	not	wish	to	participate	at	12	months	as	their	relative	with	schizophrenia	had	died	during	the	pilot.	All	ten	CBR	workers	and	the	two	supervisors	were	included.	The	two	health	officers	who	provided	facility-based	mental	health	care	to	participants	were	included.	Three	community	members	engaged	in	CBR-	a	priest,	a	health	extension	worker	and	a	businessman-	were	selected	purposively	to	ensure	coverage	of	different	roles.	All	participants	received	modest	remuneration	for	their	time	and	transportation	costs	(with	the	exception	
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	of	CBR	participants	for	the	two	month	interviews).	The	IDIs	and	FGDs	were	conducted	in	Amharic	by	an	Ethiopian	research	assistant	with	a	social	work	Masters	who	had	experience	in	qualitative	work	with	people	with	schizophrenia	and	caregivers	[20].	IDIs	and	FGDs	were	conducted	at	participants’	homes	or	in	a	research	office.	IDIs	lasted	between	11	and	140	minutes	(mean	46	minutes).	The	audio-recordings	were	transcribed	in	Amharic,	and	then	translated	into	English.		I	discussed	and	clarified	any	ambiguous	translations	or	cultural	references	with	the	research	assistant.	To	triangulate	the	data	the	linked	patient,	caregiver,	and	CBR	worker	interviews	for	two	months	and	endline	were	read	in	concert.	The	aim	was	to	construct	a	narrative	for	each	participant,	whilst	acknowledging	that	no	single	version	of	events	could	be	considered	the	‘truth’.	Note	was	made	of	changes	and	contradictions	in	experiences	and	opinions	over	time	and	between	linked	persons	with	schizophrenia,	caregivers,	CBR	workers	and	community	members.	A	thematic	analysis	was	conducted,	using	NVivo	for	Mac	software	to	manage	the	data	[21,	22]. After	independently	coding	two	transcripts,	Charlotte	Hanlon	and	I	discussed	differences	and	made	adjustments	to	the	coding	scheme.	I	indexed	all	transcripts	using	the	final	coding	scheme,	then	collated	the	codes	into	themes.	The	coding	framework	was	based	around	a	priori	high-level	themes	aligned	with	the	assumptions,	for	example	‘Assumption	1a:	People	with	schizophrenia	and	caregivers	are	willing	and	have	time	to	participate	in	CBR’.	An	inductive	approach	was	employed	to	identify	sub-themes,	in	this	case	specific	reasons	for	participation	and	non-participation.	Attention	was	paid	to	the	tension	between	expected	sub-themes	and	those	not	anticipated,	as	well	as	associations	with	participant	characteristics.	Deviant	cases	were	identified	and	incorporated	into	the	framework.	I	used	a	contexualist	approach,	retaining	focus	on	reported	experiences,	but	trying	to	understand	how	the	social	context	shaped	those	experiences	and	the	way	they	were	spoken	about.	
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	Table	7.2	Number	of	participants	in	IDIs	and	FGDs	
Participant	type	 2	months	 12	months	
IDIs	 FGDs	 IDIs	 FGDs	
Men	with	schizophrenia	 4	 0	 5	 0	
Women	with	schizophrenia	 3	 0	 3	 0	
Male	caregivers		 1	 0	 1	 0	
Female	caregivers		 7	 0	 6	 0	
CBR	supervisors		 2	 0	 2	 0	
CBR	workers	 1	 2	(n=10)	 0	 2	(n=10)	
Health	officers	 2	 0	 0	 0	
Community	members		 0	 0	 3	 0	
Total	 20	 2	(n=10)	 20	 2	(n=10)	
 
7.2.6.3 Process	data	Process	data	were	compiled	using	a	range	of	sources	to	determine	the	fidelity,	quality	and	intensity	of	intervention	delivery	[23].	Sources	included	(i)	Implementer	self-report:	Fortnightly	to	monthly	review	meetings	in	which	CBR	participants’	progress	and	barriers	faced	were	discussed	with	each	CBR	worker.	These	were	recorded	on	an	excel	spreadsheet,	which	was	checked	by	the	intervention	coordinator	for	accuracy,	(ii)	Documentary	analysis	of	CBR	worker	completed	‘sub-district’	logbooks,	‘participant’	logbooks	and	supervisor’s	logbook,	comprising	the	completed	intervention	delivery	forms	described	in	Chapter	6	and	presented	in	Appendix	C	(i).	Data	on	quantitative	measures	of	implementation	were	extracted	onto	process	data	forms	(see	Appendix	E	(v))	and	double	entered	onto	Epidata	EntryClient	databases	and	(iii)	structured	observations	of	CBR	workers	using	the	adapted	ENACT	to	assess	CBR	quality	[24].	The	full	ENACT	data	is	not	presented	in	this	thesis.	A	descriptive	analysis	of	process	data	was	conducted	using	Stata	version	12.		
7.2.7 Data	synthesis	Qualitative,	quantitative	and	process	data	were	synthesised	to	provide	detailed	understandings	of	how	the	intervention	was	delivered	in	practice,	in	particular	to	
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	explore	the	extent	to	which	each	theory	of	change	assumption	was	met	and	the	barriers	to	meeting	the	assumptions.	For	any	assumptions	that	were	not	initially	met,	iterative	adjustments	were	made	to	the	delivery	model	or	intervention	content	as	appropriate,	to	ensure	that	the	final	intervention	package	was	acceptable,	feasible,	and	ultimately	likely	to	lead	to	improvements	in	functioning.	Furthermore,	where	assumptions	were	not	fully	met	in	the	pilot,	improvements	were	made	to	the	trial	evaluation	plans	for	the	assessment	of	acceptability,	feasibility	or	impact.		
7.2.8 Ethical	considerations		Ethical	approval	was	obtained	from	the	LSHTM	Research	Ethics	Committee	and	the	Addis	Ababa	University	College	of	Health	Sciences	Institutional	Review	Board	(see	Appendix	D	(iv)).	Written	consent	to	participate	was	sought	from	each	participant.	If	a	person	with	schizophrenia	was	deemed	not	to	have	capacity	to	consent,	permission	was	sought	from	the	caregiver	and	assent	from	the	person	with	schizophrenia.	Only	the	two	participants	with	co-morbid	intellectual	disability	were	assessed	to	not	have	the	capacity	to	consent.	Where	the	participant	was	unable	to	write,	a	thumb	impression	was	recorded,	along	with	the	signature	of	a	witness	to	confirm	accurate	explanation	of	the	study.	See	Appendix	D	(v)	for	the	information	sheets	and	consent	forms.		
7.3 RESULTS	
7.3.1 Overview	The	CBR	participants	were	five	male	and	five	female	people	with	schizophrenia	aged	between	19	and	60	years.	All	female	participants	were	illiterate	whilst	male	participants	had	between	five	and	eight	years	of	school	education.	All	caregivers	were	female	(wives,	mothers,	sisters	and	a	daughter)	except	one	male	benefactor	who	was	unrelated	to	the	participant.	Two	participants	did	not	have	active	caregivers.	The	median	duration	of	illness	was	10	years	(range	1	to	30	years)	and	two	participants	had	co-morbid	intellectual	disability.	Half	of	participants	were	
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	treatment	naïve	prior	to	the	pilot	commencing;	only	one	participant	was	actively	taking	medication	at	the	start	of	the	pilot.	Key	process	and	quantitative	data	are	presented	in	Tables	7.3,	7.4	and	7.5.	Linked	identification	(ID)	numbers	are	used	for	people	with	schizophrenia,	CBR	workers	and	community	members;	‘B’	and	‘E’	indicate	baseline	(2-month)	and	endline	(12-month)	qualitative	interviews	respectively.	For	clarity	qualitative,	quantitative	and	process	findings	are	summarised	for	each	of	the	13	assumptions,	grouped	into	the	three	research	questions.	Adjustments	to	the	intervention	and	trial	evaluation	that	were	made	on	the	basis	of	these	findings	are	summarised	at	the	end	of	each	set	of	assumptions.	Tables	7.6,	7.7	and	7.8	contain	a	summary	of	the	research	questions,	assumptions,	findings	and	adjustments.			
7.3.2 Research	question	1:	Is	the	RISE	CBR	intervention	acceptable?	
7.3.2.1 Assumption	1a:	People	with	schizophrenia	and	caregivers	are	willing	
and	have	time	to	participate	in	CBR		Participants	received	21	home	visits	on	average	(range	17-	27	visits)	(see	Table	7.3).	This	almost	matched	the	anticipated	total	of	22	visits	because	although	visits	reduced	or	stopped	during	periods	of	disengagement,	CBR	workers	tended	to	‘catch	up’	and	do	additional	visits	once	participants	were	engaged	again.	
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	Table	7.3	CBR	participant	process	data	
ID	 Months	
CBR	
received	
Number	
home	
visits		
Optional	
modules	
undertaken/	
optional	
modules	
indicated	
(%)*	
Optional	goals	
achieved	
/optional	
goals	selected	
(%)*	
Meetings	
with	
community	
members	
relating	to	
participant	
Referrals	to	
health	
centre/	
heath	
extension	
worker	
1		 12	 22	 5/7	(71.4)	 8/11	(73)	 1	 2	
2	**	 12	 21	 5/5	(100)	 4/9	(44)	 0	 2	
3	**	 10***	 17	 5/5	(100)	 2/10	(20)	 0	 1	
4	 8	 19	 4/5	(80)	 1/8	(13)	 3	 2	
5		 12	 17	 5/5	(100)	 8/9	(89)	 10	 1	
6		 11	 19	 4/4	(100)	 6/8	(75)	 0	 0	
7		 12	 24	 7/7	(100)	 8/8	(100)	 5	 1	
8		 11	 27	 7/7	(100)	 7/11	(64)	 4	 4	
9		 12	 23	 4/5	(80)	 6/9	(67)	 1	 1	
10		 12	 22	 6/7	(85.7)	 5/6	(83)	 0	 2	
Mean	 11.2	 21.1	 5.4/5.7	
(91.7)	
5.5/8.9	(62)	 2.4	 1.6	
*All	participants	started	all	core	modules	and	achieved	all	four	core	goals	**Co-morbid	intellectual	disability	***	Participant	(ID	3)	died	during	pilot	period	The	majority	of	CBR	participants	reported	welcoming	the	service,	at	least	initially,	usually	because	they	felt	CBR	was	of	clear	benefit.	Several	suggested	it	was	a	relief	to	get	support.	By	the	end	of	the	pilot	most	CBR	workers	and	participants	described	a	good	relationship,	with	several	describing	close	bonds	like	friends	or	family.	
“[The	caregiver]	received	us	warmly.	I	also	had	a	very	good	relationship	with	
both	of	them.	We	had	a	very	good	time.	We	were	like	friends	[…]	I	regret	that	I	
didn’t	have	pictures	taken	with	[the	CBR	participant]	before	he	left	for	Addis	for	
work.”	(male	CBR	worker	-8-E)		For	one	caregiver,	the	fact	the	CBR	worker	was	from	the	local	area	was	an	important	foundation	for	their	relationship.		
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	“Interviewer:	Was	[the	CBR	worker]	the	kind	of	person	you	can	put	your	trust	in?	
Respondent:	Yes.	We	have	become	family.	She	is	from	this	area.	She	knows	many	
things	about	us.	It	is	difficult	for	a	person	who	lives	far	away	[from	us]	to	
understand	our	situation.”		(female	caregiver-10-E)	CBR	workers	felt	that	a	trusting	relationship	was	essential	for	engagement	with	CBR	and	led	to	positive	outcomes.	Most	CBR	participants	said	they	could	rely	on	the	CBR	worker,	with	one	caregiver	emphasising	the	importance	of	confidentiality.	
“[The	CBR	worker]	told	us	that	we	can	count	on	him	and	call	him	when	we	
experience	some	problems.	He	told	us	that	he	will	try	to	solve	the	problem	by	
cooperating	with	us	[…]	Other	individuals	might	not	keep	the	secret	
confidentially.	For	example,	if	they	heard	that	he	has	mental	illness,	they	may	say	
that	he	is	“crazy”	[...]	It	is	better	to	tell	[the	CBR	worker]	and	get	advice	from	him.	
This	is	because	he	is	a	teacher	and	will	keep	the	secret	confidential.”		(female	caregiver-7-E)	The	majority	of	CBR	participants	were	happy	to	receive	regular	visits	at	home,	with	several	caregivers	saying	they	disregarded	the	time	cost	and	potential	stigma	as	long	as	CBR	was	helpful.	
“I	didn’t	worry	about	shortage	of	time,	because	[CBR]	was	very	useful	for	me	[…]	
It	is	for	our	own	good.	I	would	be	very	happy	to	learn	the	whole	day,	let	alone	for	
two	hours”		(female	caregiver-1-E)	However,	some	participants	also	disengaged	for	short	periods	for	various	reasons:	some	stayed	away	from	home	for	several	weeks,	either	in	Addis	Ababa	visiting	relatives	or	at	holy	water	sites	to	receive	treatment	for	schizophrenia	or	musculoskeletal	problems.	One	CBR	worker	felt	that	the	tapered	reduction	to	monthly	home	visits	damaged	the	close	relationship	with	the	participant	and	made	engagement	harder	to	maintain.	For	three	participants,	clashes	over	the	CBR	workers’	recommendation	to	take	medication	contributed	to	unwillingness	to	participate	in	CBR.	These	participants	felt	that	CBR	workers	ignored	valid	concerns	about	side	effects	and	‘nagged’	them	to	continue	medication	in	a	way	that	one	older	man	felt	was	infantilising.		
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	“[The	CBR	worker]	reminded	me	to	take	the	medication	properly,	but	I	was	not	
happy	with	her	reminder…	I	thought	she	considered	me	as	a	child.	However	I	
understood	that	it	is	helpful”		(man	with	schizophrenia	-1-B)		According	to	the	CBR	workers	these	issues	were	largely	resolved	by	minimising	the	emphasis	on	medication	and	allowing	home	visits	to	continue	without	conflict.	However	in	one	case	these	disagreements	led	to	a	complete	break	down	of	trust	and	contributed	to	the	participant	quitting	CBR	at	around	eight	months.		
“It	is	boring	when	such	advice	is	given	repeatedly.	I	think	the	advice	you	got	once	
could	help	you	in	your	life	[…]	When	[the	CBR	worker]	nags	me	repeatedly,	I	tell	
him	that	I	don’t	want	to	continue	[CBR	]	.....	He	always	created	stress	in	my	life.”		(woman	with	schizophrenia	-4-E)	A	further	two	participants	withdrew	at	11	months,	both	of	whom	had	demonstrated	considerable	improvements	in	functioning	since	the	pilot	commenced.	In	one	of	these	cases,	CBR	was	terminated	as	the	participant	moved	to	Addis	Ababa	for	work.	The	other	man,	whose	social	and	livelihood	functioning	rose	appreciably	during	the	pilot,	with	apparent	contribution	from	CBR,	explained:		
“I	didn’t	return	[the	CBR	worker’s]	calls	because	I	thought	‘I	have	recovered	from	
my	illness’.	I	have	also	completed	the	lesson	that	was	planned	for	one	year	[…]	I	
have	recovered	because	of	the	medication	that	was	prescribed.	There	are	doctors	
here.	I	can	go	to	them,	if	my	illness	relapses.”		(man	with	schizophrenia	-6-E)	A	minority	of	participants	complained	that	CBR	visits	were	too	long	and	interrupted	their	work,	with	the	potential	to	lose	customers	or	livestock.	
“When	I	am	at	the	farm	with	the	oxen…I	feel	irritated	when	[the	CBR	worker]	
came	because	thirty	minutes	is	too	much	for	me…	The	farm	work	is	a	tiresome	
work	as	it	needs	much	dedication	[…]	Unless	the	discussion	with	her	is	after	the	
harvest	work,	it	will	be	too	long”		(man	with	schizophrenia	-1-E)		It	was	often	easier	for	female	participants	to	take	part	as	they	could	do	domestic	tasks,	such	as	handicrafts,	whilst	simultaneously	talking	with	the	CBR	worker.	In	several	cases	CBR	workers	successfully	adjusted	visit	timings	to	fit	in	with	
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	participants’	schedules	or	reduced	the	frequency	of	visits.	Nevertheless	there	were	some	complaints	that	CBR	sessions	were	too	boring	or	that	the	information	was	easy	to	forget.	Several	participants	requested	written	materials	to	refer	back	to.	One	man	with	schizophrenia	did	not	like	to	meet	alone	with	the	female	CBR	worker,	due	to	his	concerns	that	they	would	be	suspected	of	having	a	romantic	relationship.	Only	one	participant	expressed	serious	concerns	that	he	could	be	stigmatised	by	home	visits;	he	counteracted	this	by	telling	neighbours	they	were	for	political	purposes.		
“When	people	ask	me	why	[CBR	workers]	are	coming	to	my	house,	I	tell	them	that	
I	am	a	member	of	ihadig	[the	ruling	political	party]	and	that	I	am	being	
interviewed.	They	will	be	afraid.”		(man	with	schizophrenia	-6-E)	Several	CBR	workers	reported	initial	difficulties	finding	a	caregiver	willing	to	engage	in	CBR,	despite	caregivers	having	been	recruited	at	baseline.	Whilst	for	some	this	was	resolved	with	careful	negotiations,	two	participants	had	minimal	family	input.	One	of	these	participants	successfully	completed	12	months	of	CBR.	CBR	workers	were	trained	to	directly	ask	participants	at	each	home	visit	if	they	were	experiencing	suicidal	thoughts	or	had	recently	been	restrained.		Whilst	CBR	participants	said	it	was	acceptable	to	discuss	these	sensitive	topics,	CBR	workers	themselves	were	divided.	Overall	it	was	felt	that	enquiring	carefully,	or	indirectly,	was	the	most	appropriate	approach.		In	general	CBR	participants	could	not	perceive	any	negative	effects	of	community	mobilisation	work.	However,	one	man	with	schizophrenia	was	unhappy	with	information	about	schizophrenia	being	given	to	the	wider	community,	suggesting	this	could	result	in	interference	from	outsiders.	
“I	should	know	these	things	[about	mental	illness].	I	don’t	care	if	the	society	
knows	[this	information]	or	not.	If	you	teach	elders,	when	something	happens	...	
in	my	family,	they	will	come	to	negotiate	[with]	us.	At	that	time	when	I	talk	loudly	
they	will	say,	“you	are	mad”.	I	am	not	happy	with	them	being	taught.”		(man	with	schizophrenia	-8-E)	One	optional	community	engagement	task,	to	invite	people	with	schizophrenia	to	describe	their	experience	of	recovery	in	a	public	forum,	was	not	carried	out	in	any	
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	sub-district.	This	was	due	to	difficulty	identifying	a	participant	who	had	time	and	who	was	willing	and	confident	to	speak	in	public.	The	supervisors	felt	that	this	activity	could	have	had	a	powerful	impact	on	public	attitudes.		
7.3.2.2 Assumption	1b:	CBR	can	address	the	needs	of	people	with	
schizophrenia	All	participants	achieved	all	core	goals,	which	related	to	understanding	schizophrenia,	accessing	health	services,	preparing	a	crisis	management	plan	and	not	being	restrained.	Achieving	these	goals	took	longer	than	the	anticipated	one	to	two	months;	nine	participants	had	however	achieved	the	core	goals	by	three	months.	Participants	selected	on	average	nine	optional	goals	(range	6-11)	over	the	12	month	period,	of	which	on	average	5.5	(62%)	were	achieved	(range	13-100%)	(see	Table	7.3).	There	was	initially	a	tendency	to	select	more	goals	than	would	be	achievable	in	the	time	frame.	The	most	commonly	selected	goals	were	strategies	to	deal	with	stress	and	anger	(which	5/6	participants	achieved),	participation	in	community	life	(which	4/7	achieved)	and	participation	in	livelihood	activities	(which	6/6	achieved).	Three	participants	selected	the	goal	to	improve	literacy,	however	none	of	them	started	the	relevant	module.	This	was	due	to	a	lack	of	local	literacy	groups	and	prioritisation	of	other	goals.	Desired	improvements	in	functioning	were	often	tied	to	a	wish	to	fulfil	gendered	roles,	generally	domestic	tasks	for	women	and	earning	income	to	support	the	family	for	men.		The	lowest	proportions	of	optional	goals	were	achieved	by	the	two	participants	with	co-morbid	intellectual	disability	(2	out	of	10	goals	and	4	out	of	9	goals	achieved)	and	the	participant	who	quit	at	8	months	(1	out	of	8	goals	achieved).	At	the	beginning	of	the	intervention	the	caregivers	of	both	women	with	co-morbid	intellectual	disability	reported	particularly	high	hopes	for	change	(“When	I	first	
saw	[the	CBR	worker],	I	thought	as	my	daughter	[has]	got	mercy	from	God.		That	was	
my	first	impression.”	Female	caregiver-2-B).	These	families,	and	some	others,	expected	complete	recovery	after	a	few	weeks	of	taking	anti-psychotic	medication. The	caregivers	and	CBR	workers	later	expressed	disappointment	that	the	expected	transformation	had	not	materialised.	The	majority	of	participants	demonstrated	agency	in	relation	to	CBR	participation,	disengaging	if	the	service	did	not	meet	their	needs,	and	articulating	concerns	in	the	
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	interviews.	A	few	participants	were	seemingly	passive,	particularly	at	baseline	interviews,	implying	that	they	only	participated	as	CBR	was	not	doing	any	harm,	or	that	they	did	not	have	the	right	to	question	the	trained	CBR	worker.		
“I:	What	should	she	improve	in	her	teaching?		
R:	What	could	I	say?	She	is	a	trained	worker	…	I	simply	accepted	what	she	told	
me.”	(woman	with	schizophrenia	-10-B)	There	was	an	almost	unanimous	expectation	that	the	CBR	project	would	provide	financial	support	or	free	medication,	despite	explanations	to	the	contrary	at	recruitment.	This	expectation	reportedly	arose	from	a	culture	of	hand-outs	by	NGOs	and	the	receipt	of	a	time	compensation	payment	at	baseline	data	collection,	which	took	place	immediately	before	recruitment	to	the	pilot.	Given	the	crippling	poverty	in	which	many	participants	lived,	the	inability	of	CBR	to	provide	financial	support	created	significant	disappointment	and	confusion.	Indeed,	lack	of	funds	prevented	participants	from	accessing	many	things	that	CBR	workers	were	advocating:	proper	nutrition,	capital	to	start	up	a	small	business,	and	most	crucially	anti-psychotic	medication.	One	supervisor	noted	the	powerful	effect	of	poverty	on	people’s	capabilities	to	respond	to	advice.	
“We	didn’t	expect	perfection.	But	we	thought	[the	CBR	participants]	were	capable	
of	implementing	what	we	taught	them.	[Before	CBR]	they	were	not	aware	that	
they	had	to	take	the	medication	for	their	illness.	We	thought	they	would	take	the	
medication,	if	we	had	taught	them	that	they	have	to	take	the	medication.	But	
they	may	not	be	able	to	take	the	medication,	even	if	they	wanted	to,	if	they	don’t	
have	money.	Your	expectation	will	change	when	you	go	to	their	houses	and	
observe	their	life	situation.”		(female	supervisor-E)	Several	CBR	workers	spent	the	first	few	weeks	negotiating	with	participants	to	continue	CBR	despite	this	perceived	gap.	In	most	cases	participants	finally	accepted	what	CBR	could	offer	and	were	happy	to	continue.	However	in	one	case	these	issues,	along	with	disagreements	about	medication	(see	Section	7.3.2.1),	contributed	to	the	participant	withdrawing	from	the	programme.	
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	“I	went	there	two,	three	times	and	taught	them	about	the	illness	and	the	
medication.	I	didn’t	bring	any	financial	benefit.	Then	after	[that]	their	attitude	
has	changed	[…]	The	[CBR	participant]	directly	told	us	that	she	won’t	continue	
CBR	unless	[financial]	aid	is	given	to	her	[…]	She	was	saying	that	her	child	is	sick	
and	we	are	only	teaching	about	medication	and	tell	her	to	bring	medication.	She	
was	complaining	[that	we	were]	not	doing	anything	for	her.”		(male	CBR	worker	-4-B)	Even	at	endline	interviews	several	CBR	participants,	CBR	workers	and	community	leaders	raised	the	provision	of	financial	aid	or	free	medication	as	an	area	for	improvement,	despite	the	various	gains	that	had	proved	achievable	without	it	being	available.	 
7.3.2.3 Assumption	1c:	CBR	workers	are	willing	to	work	with	people	with	
schizophrenia	CBR	workers	were	willing,	and	in	some	cases	highly	motivated,	to	work	with	people	with	schizophrenia,	provided	they	received	on-going	training	and	supervision.	None	of	the	selected	CBR	workers	withdrew	from	the	programme.	There	was	a	shift	towards	improved	attitudes	towards	people	with	schizophrenia	over	time,	including	minimised	fears	of	violence	and	increased	expectations	of	recovery,	through	the	experience	of	working	with	this	group	during	the	pilot.		
“my	perception	of	a	mentally	ill	person	has	changed	after	I	visited	[the	CBR	
participant]	[…].	My	confidence	was	very	little	at	the	start.	I	used	to	think	that	
mentally	ill	people	always	carried	daggers	to	hurt	people.	But	when	I	entered	the	
house,	I	understood	that	he	is	not	that	kind	of	person.	I	have	learned	a	lot	from	
this.	I	have	learnt	that	a	mentally	ill	person	can	recover	from	his	illness	if	the	ill	
person	gets	proper	treatment.”		(male	CBR	worker-	8-E)		However	procedures	to	ensure	CBR	safety,	for	example	risk	assessments,	were	still	felt	to	be	important	by	supervisors.	In	addition,	two	CBR	workers	noted	that	whilst	not	all	people	with	schizophrenia	are	violent,	there	are	cases	where	this	is	true.	Some	CBR	workers	and	supervisors	described	stressful	situations,	often	related	to	participants	wanting	to	quit	CBR	or	medication,	and	also	sadness	at	the	difficult	circumstances	of	participants,	or	worry	they	would	not	improve.	Peer	support,	which	took	place	in	group	supervision	sessions,	but	also	during	informal	meetings,	
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	was	clearly	appreciated	by	several	CBR	workers.	Talking	with	other	CBR	workers	was	a	chance	to	gain	new	perspectives	on	how	to	overcome	problems,	or	simply	a	relief	to	discuss	issues.	
7.3.2.4 Assumption	1d:	Community	leaders	are	willing	to	support	CBR	without	
benefits	for	themselves	Meetings	with	community	leaders	(community	mobilisation	task	5)	were	held	in	all	four	sub-districts,	though	most	CBR	workers	initially	encountered	difficulties	arranging	them.	Some	community	leaders	were	too	busy,	whilst	others	were	suspicious	the	project	was	related	to	a	political	opposition	party	and	awaited	permission	from	the	district	health	bureau.	Several	CBR	workers	felt	community	leaders	were	expecting	a	financial	benefit	from	participation,	though	this	was	never	made	explicit.	Most	CBR	workers	felt	this	expectation	was	resolved	by	piggybacking	onto	existing	gatherings,	for	example	official	sub-district	meetings.	
“It	took	[the	community	leaders]	a	long	time	to	accept	what	we	were	doing.	We	
had	a	very	big	challenge	to	do	the	work	because	it	was	election	time.	We	made	
the	[sub-district]	chairman	participate	in	our	discussion	and	he	approved	of	the	
work	we	were	doing	and	gave	us	a	letter	of	permission.	Then	we	started	doing	
the	work	after	two	months. We	faced	many	problems	at	the	start,	but	we	
succeeded	finally.”		(male	CBR	worker	-8-E)	Awareness-raising	events	with	general	community	members	(community	mobilisation	task	6)	were	held	in	all	sub-districts	(mean	five	meetings	per	sub-district;	range	2-7),	as	part	of	planned	meetings	for	Women’s	groups,	edir	(burial	association)	groups	and	sub-district	development	meetings,	with	up	to	100	participants	attending.	CBR	workers	had	a	generally	positive	reception	with	active	participation	from	attendees,	though	some	participants	only	warmed	to	CBR	after	understanding	the	benefits	to	their	community.	Several	participants	stressed	the	importance	of	CBR	workers	maintaining	anonymity	of	CBR	participants	when	speaking	at	public	meetings.		Targeted	mobilisation	of	community	figures	(community	mobilisation	tasks	8	to	11)	was	attempted	for	six	participants,	including	with	a	priest,	government	officials,	a	judge,	an	agricultural	worker,	a	health	extension	worker,	an	edir	leader	and	a	businessman;	these	efforts	led	to	actual	support	being	provided	for	four	
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	participants	(see	Section	7.3.6.2).	The	three	community	members	interviewed	were	universally	positive	about	their	encounters	with	CBR.	Giving	support	was	portrayed	as	a	gratifying	experience,	especially	when	improvements	were	seen	in	the	CBR	participants’	wellbeing	and	apparent	life	chances.		
“You	feel	happy	when	you	help	someone	whose	economy	is	below	you.	When	you	
see	improvement	in	the	person	you	are	helping,	you	will	be	satisfied.	I	am	very	
glad	since	I	have	helped	him.	I	got	happiness.”		(male	benefactor-7-E)	All	three	community	members	had	made	some	sacrifice-	whether	time,	money,	or	broken	property-	but	none	perceived	this	as	a	real	hardship,	despite,	in	one	case,	the	unease	of	other	community	members.	
“Some	of	them,	because	they	don't	know	[about	mental	illness],	some	ask	why	I	
talk	with	[the	man	with	schizophrenia],	“he	is	crazy,	he	has	lost	his	mind	why	
would	you	talk	to	him?”	When	they	say	such	kinds	of	things,	[I	say]	no	this	is	not	
right.	We	should	show	them	love,	include	them	in	any	society,	include	them	in	
social	activities.”		(priest-5-E)	
7.3.2.5 Assumption	1e:	Traditional	and	religious	healers	are	willing	to	
support	CBR	No	traditional	healers	were	identified	during	resource	mapping	by	CBR	workers.	Furthermore,	there	was	no	known	use	of	traditional	healers	by	any	participants	during	the	pilot.	Whilst	two	people	with	schizophrenia	visited	holy	water	sites,	these	were	located	outside	of	Sodo	district.	There	was	therefore	little	potential	for,	and	no	attempt	at,	targeted	CBR	engagement	with	traditional	or	religious	healers.			
7.3.3 Intervention	adjustments	to	maximise	acceptability		The	recommended	duration	of	Phase	1	was	extended	to	three	months	(from	one	to	two	months),	to	give	enough	time	for	the	important	but	sometimes	slow	processes	of	building	a	solid	relationship	with	participants	and	the	wider	community	and	developing	a	clear	understanding	of	what	CBR	could	and	could	not	offer.	This	also	gave	more	time	to	address	the	core	goals.	Phase	2	could	also	be	extended	from	four	
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	to	five	months	to	give	more	time	to	achieve	optional	goals.	CBR	worker	refresher	training	was	given	to	encourage	a	focus	on	fewer	more	pertinent	and	achievable	goals;	in	particular	to	focus	on	maintaining	progress	on	goals	in	Phase	3,	rather	than	embarking	on	several	new	areas.	Relapse	prevention	became	an	optional	module	for	Phase	2,	to	recognise	the	differing	needs	of	participants.	In	addition,	how	to	strike	the	balance	between	realism	and	hope	in	recovery	was	covered;	and	the	potential	impact	of	co-morbid	intellectual	disability	on	the	likely	magnitude	of	changes	in	functioning.	At	consent	and	the	initial	visit	greater	emphasis	was	made	on	the	inability	of	CBR	to	provide	financial	support,	to	try	to	prevent	misunderstanding	and	resentment	later	on.	Medication	subsidy	by	the	RISE	project	was	considered	(to	be	implemented	in	both	arms	of	the	trial);	but	this	was	ruled	out	due	to	insufficient	funds	within	the	research	project	and	an	inability	to	identify	an	alternative	source	of	funding	(including	from	the	district	health	bureau).	Microfinance	was	not	seriously	considered	as	an	addition	to	the	CBR	intervention.	This	was	thought	not	to	be	a	sustainable	or	scalable	approach	to	CBR	delivery,	as	well	as	being	beyond	the	financial	and	logistical	capacity	of	the	project	to	implement.	Furthermore,	at	recruitment	to	the	pilot	a	considerable	source	of	stress	for	one	CBR	participant	was	his	difficulty	repaying	a	previous	loan	from	a	government	microfinance	scheme;	this	validated	concerns	raised	during	the	intervention	development	(see	Chapter	5).	This	meant	that	a	rotating	savings	and	credit	association,	which	theoretically	can	be	run	without	external	financial	input	(see	Chapter	2,	Section	2.7.1),	was	also	discounted.		Several	further	adjustments	were	made	to	maximise	participant	engagement	in	CBR,	including	altering	the	frequency,	duration,	timing	and	location	of	visits	to	fit	with	the	needs	of	participants	and	allowing	seasonal	adjustments.	For	example,	whilst	Phase	1	may	be	extended,	home	visits	could	also	be	held	fortnightly	if	participants	preferred	this.	However,	there	was	no	compulsory	reduction	in	the	total	number	of	visits,	as	several	participants	clearly	found	benefits	from	more	intensive	support.	CBR	workers	were	encouraged	to	ring	ahead	of	visits	if	possible	and	telephone	contact	between	monthly	visits	in	Phase	3	became	standard.	It	was	decided	that	whilst	initial	engagement	from	a	named	caregiver	was	required,	CBR	
197
	should	continue	if	the	caregiver	disengaged,	on	the	basis	that	those	without	active	caregivers	were	likely	to	be	most	vulnerable.		Refresher	training	was	given	to	CBR	workers	to	emphasis	aspects	of	the	recovery-oriented	model	of	care,	such	as	collaborative	goal-setting.	In	particular	additional	training	was	given	on	striking	a	balance	between	encouraging	medication	adherence	and	accepting	the	person	with	schizophrenia’s	wishes	if	they	did	not	want	to	or	could	not	afford	to	take	it.	It	was	clarified	with	CBR	workers	that	people	with	schizophrenia	can	continue	CBR	despite	not	being	willing	or	able	to	take	medication.	As	the	existing	goal	setting	framework	did	not	adequately	capture	important	but	less	tangible	activities	such	as	leading	the	family,	a	new	potential	goal	‘The	person	with	schizophrenia	can	fulfil	their	family	role'	was	added.	Finally,	written	materials	were	created	for	participants	to	aid	recall	of	information	covered	in	home	visits.		Community	mobilisation	meetings	were	limited	to	those	attached	to	another	planned	meeting,	in	order	to	ensure	better	attendance	and	minimise	expectation	of	per	diem	amongst	community	leaders.	The	optional	activity	to	share	personal	experiences	of	recovery	in	a	public	forum	(community	mobilisation	task	12)	was	retained	in	the	intervention	design	despite	not	being	implemented	in	the	pilot;	it	was	felt	from	a	larger	pool	of	people	with	schizophrenia	with	a	longer	duration	of	treatment	willing	and	able	candidates	might	be	identified.	Similarly,	it	was	decided	to	retain	the	module	‘Improving	literacy’	on	the	basis	that	adult	literacy	groups	may	be	available	in	other	sub-districts	(as	identified	in	the	intervention	development	phase).		
7.3.3.1 Changes	to	the	evaluation	of	acceptability		A	structured	assessment	of	the	extent	to	which	CBR	had	met	the	participants’	needs	was	added	to	the	trial	evaluation	plan	(see	Appendix	E	(v)).			
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	7.3.4 Research	question	2:	Is	the	RISE	CBR	intervention	feasible?	
7.3.4.1 Assumption	2a:	Non-specialists	can	be	trained	to	deliver	CBR	for	
people	with	schizophrenia	Competence	varied	between	CBR	workers	but	overall	was	good.	CBR	workers	completed	all	required	assessments	(including	needs	assessments,	goal	setting	and	rehabilitation	plans)	for	all	participants	at	each	phase	(with	the	exception	of	the	participant	who	quit	at	eight	months).	Overall,	CBR	workers	undertook	91.7%	of	indicated	modules	(i.e.	those	linked	to	the	selected	goals),	suggesting	competence	at	selecting	the	appropriate	components	of	CBR	for	participants	(see	Table	7.3).	Many	participants	seemed	to	consider	CBR	workers	as	experts,	describing	them	as	knowledgeable,	able	to	explain	clearly	and	give	constructive	advice.	
“The	CBR	worker	has	both	the	ability	to	understand	and	explain	issues.	…okay…	
he	both	explains	in	a	way	which	is	understandable	to	us	and	listens	and	
understands	what	we	tell	him.	…eh…	we	even	ask	him	[that]	which	is	not	clear	to	
us..”		(man	with	schizophrenia-6-B)	Most	CBR	participants	described	the	calm	and	pleasant	manner	of	the	CBR	workers,	as	well	appreciating	their	ability	to	listen	(“she	asked	me	how	I	am	feeling	
and	I	told	her	what	I	really	feel”	(female	caregiver-1-B)). However,	using	repeated	ENACT	assessments,	some	weak	areas	were	identified	across	CBR	workers	including:	using	a	problem-solving	approach,	assessing	physical	health	and	substance	use,	conducting	a	basic	risk	assessment	and,	as	described	above,	giving	advice	and	seeking	feedback	on	the	advice	given,	without	lecturing	the	participant	(see	Section	7.3.2.1).	The	CBR	workers	who	supported	participants	with	co-morbid	intellectual	disability	criticised	the	lack	of	training	on	the	different	treatment	and	communication	issues	for	this	group.	However	in	general	problems	with	competence	were	not	a	barrier	to	successful	CBR	delivery.		Direct	contact	between	the	CBR	workers	and	the	study	psychiatric	nurse	was	uncommon,	with	only	two	referrals	over	12	months,	one	for	suicidal	ideation	and	one	for	relapse.	Apart	from	these	occasions	all	mental	health	care	was	received	through	usual	facility-based	care.	Most	facility-based	care	was	delivered	at	the	health	centre,	with	two	referrals	to	the	psychiatric	nurse	led	outpatient	clinic.	
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	Contact	between	the	CBR	workers	and	CBR	supervisors	was	less	frequent	than	planned;	CBR	workers,	on	average,	had	ten	individual	supervision	sessions,	received	5.4	unannounced	observed	home	visits	and	attended	eight	group	supervision	sessions	(compared	to	an	anticipated	minimum	of	12	sessions	of	each	supervision	mode).	The	supervisors	and	some	CBR	workers	felt	that	supervision	had	an	important	role	in	guiding	CBR	workers;	three	CBR	workers	said	supervisors	were	responsive	and	available.	Most	CBR	workers	and	supervisors	described	a	convivial	rapport,	more	similar	to	a	peer	relationship	than	exhibiting	a	clear	hierarchy	(“The	relationship	between	the	CBR	workers	and	me	is	not	like	a	worker	
and	a	boss.	Rather	it	is	a	brotherly	sisterly	relation.”	(female	supervisor-B)). But	there	were	indications	from	both	sides	that	this	did	not	always	function	well	for	CBR	delivery. On	the	one	hand,	one	supervisor	felt	that	CBR	workers	did	not	always	ask	for	support	in	a	timely	manner.		
“The	CBR	workers	were	not	informing	us	when	they	faced	challenging	situations.	
They	were	trying	to	solve	them	on	their	own….	We	constantly	told	them	to	call	
and	notify	us	of	the	challenging	situations	they	encounter	and	not	to	wait	until	
we	meet	after	a	week	or	two.	We	constantly	reminded	them	that	it	would	be	
difficult	for	us	to	control	these	kinds	of	situations,	if	we	didn’t	act	on	time.”	(female	supervisor-	E)		On	the	other	hand,	one	CBR	worker	indicated	her	supervisor	did	not	contribute	much	to	her	work	and	was	often	unavailable	(“I	don’t	get	the	support	that	I	need	on	
the	time	I	need	it”	(female	CBR	worker-9-E)).	Another	CBR	worker	commented	that	whilst	supervisors	were	good	at	identifying	skill	gaps,	refresher	training	was	slow	to	materialise.	
7.3.4.2 Assumption	2b:	CBR	workers	can	overcome	logistical	challenges	to	
deliver	CBR	CBR	workers	raised	some	practical	challenges	with	delivering	CBR.	However,	long	distances	between	households,	difficult	terrain	and	patchy	public	transport	were	issues	that	were	largely	manageable	in	the	pilot	due	to	the	low	workload	and	narrow	geographical	area.	Instead,	concerns	were	raised	that	these	logistical	issues	would	be	more	problematic	when	the	intervention	was	delivered	on	a	larger	scale.	Lack	of	transportation	emerged	as	a	particular	issue	for	attending	community	meetings,	which	typically	began	at	6am	before	CBR	workers	were	able	
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	to	reach	the	site.	Problems	with	the	phone	network	sometimes	made	it	difficult	to	arrange	home	visits	and	supervision	meetings.	Despite	these	issues	there	was	strong	support	for	home	visits	from	CBR	workers	and	supervisors	to	encourage	engagement	and	to	best	understand	the	family	environment.		
“Their	house	is	the	best	place	to	meet	[CBR	participants].	You	can	observe	their	
family	relationships,	if	you	go	to	their	house.	You	can	observe	their	agreements	
and	disagreements	physically.	You	can	give	them	practical	advice,	if	you	know	
how	they	are	living.	Going	to	their	houses	is	also	very	useful	to	meet	their	
neighbours	and	do	community	work.”		(female	supervisor-E)	
7.3.4.3 Assumption	2c:	Primary	care	staff	are	supportive	of	CBR	CBR	workers	accompanied	participants	to	primary	care	appointments	on	average	twice	over	12	months	(range	1-3	times).	Some	caregivers	and	people	with	schizophrenia	expressed	a	preference	for	attending	the	health	centre	with	the	CBR	worker	present	as	they	appreciated	support	to	explain	issues	and	make	requests	to	health	officers	about	their	treatment.	In	addition,	CBR	workers	made	fourteen	referrals	to	the	health	centre	relating	to	eight	participants	for	medication	reviews,	often	due	to	side	effects,	physical	illness,	relapse	and	suicidal	ideation	(see	Table	7.3).	Health	centre	staff	described	a	productive	working	relationship	with	CBR	workers,	which	enhanced	the	quality	of	care	they	could	provide	by	improving	follow	up.	No	negative	impact	of	CBR	on	their	work	was	reported,	though	one	health	officer	felt	the	CBR	worker’s	role	was	initially	unclear.	
“[CBR	workers]	don’t	have	negative	influence	on	our	work.	But,	I	think	their	
presence	is	useful	for	us	to	give	better	treatments	to	patients	[…]	We	have	a	very	
good	relationship…they	directly	come	to	us	when	they	encounter	problems	and	
need	our	help.”		(health	officer)	However	one	CBR	worker	felt	that,	in	contrast	to	the	aims	of	CBR,	health	officers	were	narrowly	focused	on	medication	and	did	not	consider	the	broader	social	needs	of	people	with	schizophrenia.	
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	“Even	the	way	we	discuss	with	the	health	staff	is	not	right	as	they	always	focus	on	
the	need	for	medication.	They	instead	don’t	see	the	issue	from	other	dimensions.	
They	don’t	see	the	issue	from	multiple	perspectives”.		(male	CBR	worker-	4-E)	
7.3.4.4 Assumption	2d:	Anti-psychotic	medication	is	accessible	There	were	various	difficulties	with	the	accessibility	of	anti-psychotic	medication.	The	majority	of	CBR	participants	reported	that	medication,	particularly	the	depot	injection,	was	not	affordable.	In	some	cases	this	led	to	gaps	in	medication	access	or	worries	about	how	this	could	be	maintained	and	the	impact	on	the	person	with	schizophrenia.		
“Now	the	main	problem	is	the	boy	refuses	to	take	the	[oral]	medicine	and	the	
injection	is	expensive	and	I	am	poor	and	a	newcomer	to	the	town,	I	have	no	one	
to	help	me	[...]	the	medicine	had	[brought]	improvement.	Now	my	problem	is	the	
money	to	buy	the	medicine.	I	have	no	capacity.	The	boy	who	was	having	
improvement	is	going	to	be	ill”		(female	caregiver-8-B)	At	least	two	participants	had	initially	bought	medication	using	the	time	compensation	payment	they	received	at	baseline	data	collection.		As	this	was	a	one-off	payment	they	could	not	afford	to	purchase	medication	on	an	on	going	basis.	Four	CBR	workers	endeavoured	to	obtain	the	medication	fee	waiver	for	their	participant,	none	of	which	were	successful.	According	to	one	CBR	worker	disagreement	amongst	officials	as	to	who	deserved	support	underlay	these	difficulties.	Only	one	male	CBR	participant	stated	that	he	did	not	wish	to	receive	free	medication.	Several	participants	also	reported	frustration	at	medication	not	always	being	available	at	the	health	centre	or	not	being	dispensed	due	to	a	lack	of	a	pharmacist,	or	a	lack	of	receipts,	or	because	the	person	with	schizophrenia’s	caregiver	had	not	accompanied	them.	Only	one	caregiver	remarked	that	the	health	centre	would	be	geographically	inaccessible	during	the	rainy	season.	CBR	participants	who	were	required	to	attend	the	hospital	in	the	neighbouring	district	faced	some	problems,	including	difficulty	making	the	journey	whilst	acutely	unwell,	lack	of	public	transport	and	lack	of	funds	to	pay	for	transport.	All	participants	reported	medication	side	effects,	most	commonly	drowsiness	and	weakness	but	also	reduced	appetite.	These	effects	were	frequently	intolerable,	
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	particularly	as	the	impeded	the	physical	labour	on	which	livelihoods,	and	cohesive	households,	often	depended.		
“The	tablet	they	were	giving	me…made	me	clumsy	and	unable	to	work	[...]	It	
makes	you	drowsy	and	you	will	doze	off	in	your	seat.	If	you	take	it	at	night,	it	will	
make	you	sleep	until	noon.	Do	you	think	my	wife	will	stay	with	me	if	I	can’t	
provide?”		(man	with	schizophrenia	-6-E)	Side	effects	resulted	in	interrupted	adherence	despite	medication	also	conferring	benefits.	Others	stopped	medication	once	they	felt	well,	or	because	they	saw	no	positive	impact,	and	one	participant	feared	addiction.	One	CBR	participant	interrupted	medication	whilst	at	holy	water,	believing	the	two	treatments	were	not	compatible	(“You	can’t	pin	your	hope	on	two	things”	(female	caregiver-10-E)).	Another	stopped	medication	altogether	due	to	her	family’s	strong	belief	that	the	illness	was	caused	by	spirit	possession,	along	with	a	lack	of	perceived	impact	on	her	symptoms.		
7.3.4.5 Assumption	2e:	Edir	(burial	association)	support	will	be	available	and	
sustainable	There	were	no	examples	of	edir	(burial	association)	groups	providing	practical	or	financial	support	for	CBR	participants,	as	had	been	anticipated.	This	was	due	to	a	lack	of	firm	interest	or	engagement	from	edir	groups	or	in	other	cases	people	with	schizophrenia	and	caregivers	not	wishing	to	be	the	recipients	of	support	from	such	organisations.	CBR	workers	also	felt	this	potential	aspect	of	CBR	was	not	emphasised	in	the	training.	Edir	groups	were	however	used	as	a	hub	to	raise	awareness	about	schizophrenia.		
 
7.3.5 Intervention	adjustments	to	maximise	feasibility		To	support	physical	access	to	CBR	workers	and	participants	in	remote	locations,	the	transport	allowance	for	CBR	workers	was	augmented	and	increased	access	to	the	project	vehicle	was	planned	for	supervisors	in	the	trial.	In	addition,	due	to	the	long	journeys	on	foot,	the	average	number	of	participants	per	CBR	worker	in	the	trial	was	reduced	from	ten	to	eight	to	ensure	feasibility.	CBR	worker	refresher	
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	training	was	given	on	weaker	areas,	including	risk	assessment,	problem	solving	and	communication	skills.	A	more	compact	step-by-step	guide	was	produced	for	CBR	workers,	including	protocols	for	managing	difficult	situations.	Intervention	forms	were	amended	iteratively	to	improve	usability,	including	the	addition	of	specific	prompts	to	assess	physical	health	and	substance	abuse	on	the	home	visit	form.		A	more	thorough	orientation	on	the	aims	and	structure	of	CBR	was	prepared	for	health	centre	staff;	however	no	attempts	were	made	to	include	health	officers	in	CBR	itself,	for	example	setting	rehabilitation	goals,	as	this	was	not	perceived	to	be	feasible.	A	better	understanding	of	how	to	access	or	advocate	for	the	medication	fee	waiver	was	established.	As	discussed	above,	medication	subsidy	was	considered	but	ultimately	ruled	out.	Edir	support	was	eliminated	as	a	CBR	strategy;	instead	efforts	were	focused	on	mobilising	support	from	individuals.	
7.3.5.1 Changes	to	evaluation	of	feasibility		Additional	questions	were	added	to	the	adherence	measure	to	determine	if	medication	unavailability	and	unaffordability	acted	as	barriers	to	adherence,	and	if	the	participant	had	accessed	free	medication.			
7.3.6 Research	question	3:	Can	the	RISE	CBR	intervention	produce	an	
impact	and	if	so,	how?	
7.3.6.1 Assumption	3a:	CBR	can	improve	functioning	in	people	with	
schizophrenia	
Changes	in	functioning	
Overview	
Most	CBR	participants	began	the	study	with	high	levels	of	disability	(baseline	median	WHODAS	49.6	(IQR	(interquartile	range)	26.0,	61.0),	which	decreased	considerably	over	the	12-month	pilot	period	(endline	median	WHODAS	14.2	(IQR	1.3,	40.5))	(see	Table	7.4).	However,	the	two	women	with	co-morbid	intellectual	disability	did	not	experience	substantial	improvements,	and	one	of	these	
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	participants	died	during	the	pilot	due	to	a	physical	illness.	Amongst	those	with	improvements,	changes	were	seen	in	livelihood	activities,	domestic	activities,	social	participation	and	self-care,	though	several	barriers	to	achieving	change	were	identified.	In	general	there	was	good	agreement	between	qualitative,	quantitative	and	process	data.		
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Table	7.4	CBR	participant	quantitative	data	relating	to	disability,	clinical	state,	depression	and	alcohol	use		
CBR		
participant	ID	
Disability	(WHODAS	total)	 Clinical	global	impression	 Depression	(PHQ-9	total)	 Alcohol	use	(AUDIT	total)	
0	m	 6	m	 12	m	 0	m	 6	m	 12	m	 0	m	 6	m	 12	m	 0	m	 6	m	 12	m	
1	 15.2	 0	 59.4	 Missing		 2	 4	 2	 3	 9	 7	 15	 10	
2	*	 70.9	 79.4	 70.0	 7	 5	 5	 11	 9	 2	 0	 2	 0	
3	*	 58.3	 93.8	 Participant	died		 4	 7	 Participant	died		 13	 19	 Participant	died		 0	 0	 Participant	died		
4	 45.7	 20.2	 2.6	 4	 2	 1	 13	 5	 13	 5	 5	 7	
5	 61.0	 51.6	 21.5	 3	 3	 4	 10	 12	 8	 22	 13	 2	
6	 26.0	 12.8	 Participant	refused		 5	 2	 Participant	refused		 15	 2	 Participant	refused		 27	 4	 Participant	refused		
7	 24.2	 28.9	 0	 6	 4	 2	 4	 11	 1	 3	 6	 4	
8	 62.8	 8.2	 14.0	 7	 1	 2	 12	 1	 4	 0	 16	 3	
9	 41.9	 3.8	 0	 6	 3	 2	 6	 0	 1	 4	 4	 0	
10	 53.5	 34.1	 14.5	 4	 2	 1	 10	 7	 3	 0	 0	 0	
Median	
(interquartile	
range)	or	%		
49.6	
(26.0,	
61.0)	
24.5	
(8.2,	
51.6)	
14.2	
(1.3,	
40.5)	
0%	
borderline		
/normal		
50%		
borderline		
/normal		
62.5%		
borderline		
/normal		
10.5	
(6,13)	
6	
(2,11)	
3.5	
(1.5,8.5)	
3.5	
(0,7)	
4.5	
(2,13)	
2.5	
(0,5.5)	
*Co-morbid	intellectual	disability
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Table	7.5	CBR	participant	quantitative	data	relating	to	health	facility	use,	discrimination,	physical	restraint	and	caregiver	burden	
CBR	
participant	
ID	
Health	facility	use	(number	visits	
for	mental	health	in	previous	3	
months)		
Discrimination	(total	DISC-12)	 Physical	restraint**	 Caregiver	burden	(IEQ	total)	
0m	 6m	 12m	 0	m	 6	m	 12	m	 0m	 6m	 12m	 0	m	 6	m	 12	m	
1	 3	 1	 1	 2	 0	 0	 Yes	 No	 Yes	 35	 48	 59	
2	*	 2	 3	 1	 0	 3	 0	 No	 No	 No	 69	 56	 47	
3	*	 1	 0	 Participant	died		 2	 0	 Participant	died		 No	 No	 Participant	died		 43	 21	 Participant	died		
4	 0	 2	 2	 29	 11	 7	 No	 No	 No	 37	 19	 22	
5	 1	 3	 2	 35	 34	 24	 Yes	 No	 No	 Missing		 27	 33	
6	 1	 0	 Participant	refused		 1	 0	 Participant	refused		 Yes	 No	 No	 61	 26	 Participant	refused		
7	 0	 2	 3	 0	 0	 0	 No	 No	 No	 37	 21	 36	
8	 0	 3	 0	 4	 4	 0	 No	 Yes	 No	 70	 27	 28	
9	 0	 3	 1	 0	 0	 0	 No	 No	 No	 56	 16	 16	
10	 0	 1	 0	 2	 0	 0	 Yes	 No	 No	 46	 55	 15	
Median	
(IQR)	or	%	
50%	≥1	
visit	
80%	≥1	
visit	
75%	≥1	
visit	
2	(0,4)	
70%	any	
discrimination	
0	(0,4)	
40%	any	
discrimination	
0	(0,3.5)	
25%	any	
discrimination	
40%	 10%	 10%	 46	
(37,61)	
26.5	
(21,48)	
30.5	
(19,41.5)	
*Co-morbid	intellectual	disability
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Livelihood	activities		
	Some	CBR	workers	bemoaned	the	lack	of	formal	employment	opportunities	or	capital	to	start	small	businesses	and	one	reported	that	people	with	schizophrenia	were	routinely	excluded	from	employment	or	microfinance	initiatives.			
“When	we	talk	to	the	[sub-district]	management	about	giving	[CBR	
participants]	jobs	in	cooperatives,	they	ask	us	if	they	have	fully	recovered	and	
become	normal.	They	think	they	will	not	pay	their	credit	back	if	they	haven’t	
recovered	fully	from	their	illness	and	become	normal.	If	they	want	to	raise	
cattle,	for	instance,	they	will	not	be	given	land.”			
	(male	CBR	worker-4-E)			Despite	these	barriers,	through	the	support	of	the	CBR	workers	five	participants	started	new	income-generating	activities,	including	selling	farm	produce,	handicrafts	and	local	alcohol,	and	daily	labouring,	whilst	two	more	continued	or	intensified	previous	work.	One	man	needed	considerable	persuasion	to	stop	begging,	which	was	proving	relatively	lucrative.	All	types	of	participants	felt	participating	in	livelihood	activities	to	be	the	most	important	possible	change.	This	was	sometimes	difficult	to	achieve	or	sustain,	in	one	case	because	of	alcohol	dependence,	in	others	due	to	medication	side	effects.	Some	CBR	workers	stressed	that	work	goals	should	be	realistic,	tailored	and	desirable	to	participants,	for	example	incorporating	more	breaks	than	usual	and	based	around	existing	skills	where	possible,	an	opinion	reached	in	some	cases	through	initially	setting	sights	too	high.			
	
Domestic	tasks		
	Greater	participation	in	household	tasks,	such	as	preparing	food	and	fetching	water,	was	reported	for	three	female	participants	and	one	unmarried	man.	However	the	caregivers	of	the	two	women	with	co-morbid	intellectual	disability	were	disappointed	in	the	lack	of	progress	in	domestic	work.	Two	female	participants	also	began	actively	caring	for	their	infants.						
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“Previously	[the	CBR	participant]	even	didn’t	breastfeed	her	baby,	instead	she	viewed	
him	as	a	wild	beast.	…Now	she	is	caring	by	feeding	him	properly.	In	the	past	she	
wasn’t	able	to	prepare	food.	When	we	went	to	her	home,	we	found	her	asleep.	There	
were	so	many	problems	related	to	her	life.	Now	she	got	all	these	improvements	of	
feeding	her	children	properly	and	doing	household	activities.”		(male	CBR	worker-4-B)	
Improved	independence	and	social	life	Some	participants	developed	increased	independence,	manifested	for	two	women	as	being	able	to	safely	leave	the	house	unaccompanied.	For	others	independence	meant	being	able	to	earn	money,	buy	their	own	food	and	support	themselves	and	their	family.	Drinking	coffee	with	others	and	attending	church	and	social	occasions	such	as	weddings	and	funerals	were	highlighted	as	important	changes	in	social	functioning	achieved	by	several	participants.	Improvements	in	social	interactions,	in	particular	peacefully	greeting	and	listening	to	others,	were	also	noted.	
“What	was	amazing	was,	[the	CBR	participant]	was	not	attending	wedding	
ceremonies,	or	mahber	[social	religious	meetings].	She	was	also	not	going	to	church.	
Now	she	has	started	going	to	church.	I	have	seen	her	at	the	church	on	Christmas	and	
Epiphany.	This	is	a	pleasant	change.”		(female	CBR	worker-10-E)	
Improved	self	care	Self	care,	including	the	maintenance	of	personal	hygiene	and	wearing	clothes	properly,	reportedly	improved	in	all	eight	participants	where	this	had	been	a	problem	initially.	In	some	cases	the	change	was	dramatic.		
“I	used	to	grow	my	beard	for	more	than	one	year	and	my	hair	was	infested	with	pests,	
because	I	didn’t	wash	it	for	four	or	five	months	[…]	I	wasn’t	changing	my	clothes.	But	
now	I	have	started	washing	my	clothes	and	my	hair.	The	[CBR]	training	has	helped	
me	to	become	a	better	person.”		(man	with	schizophrenia	-5-E)	
Likelihood	of	enduring	improvements	in	functioning	
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At	endline,	although	several	CBR	participants	felt	sad	that	CBR	was	finishing,	most	felt	confident	they	could	maintain	the	progress	they	had	made.	In	striking	contrast,	several	CBR	workers	were	pessimistic	that	positive	impacts	on	functioning	would	endure	after	home	visits	stopped.	CBR	workers	suggested	that	ongoing	family	and	community	support	was	essential	for	gains	in	wellbeing	to	be	maintained.	Some	felt	this	would	not	be	sustained	due	to	the	long	duration	of	illness	and	a	lack	of	ongoing	motivation	from	the	caregivers.	
"for	the	positive	impact	[of	CBR]	to	continue	for	the	future,	I	don’t	think	it	will	
continue.	It	is	because	the	gaps	are	visible.	…eh…	As	the	time	in	between	visiting	their	
home	is	becoming	longer,	the	gap	will	be	wider.	…eh…	The	care	[her	family]	give	to	
her	when	I	go	there	is	different	from	when	I	am	not	there.	When	I	go	there	they	care	
for	her	a	lot	but	when	I	went	there	by	chance,	it	was	not	good.	Though	they	give	her	
care	and	attention	[now],	I	think	this	will	continue	with	minimal	commitment.”		(female	CBR	worker-2-E)	
How	CBR	improves	functioning	The	pathways	to	improved	functioning	differed	between	participants	and	the	type	of	functioning,	with	anti-psychotic	medication	and	CBR	work	at	the	individual,	family	and	community	level	having	varying	degrees	of	influence.	However,	general	conclusions	can	be	drawn	(indicated	in	the	blue	boxes	on	the	post-pilot	theory	of	change	-	Figure	7.2).	In	many	cases	intermediate	outcomes,	and	improved	functioning,	seem	to	have	a	positive	influence	on	each	other;	this	is	represented	on	the	theory	of	change	map	by	two-way	arrows.	
Increased	understanding	of	mental	illness	and	human	rights	As	a	direct	result	of	psychoeducation	delivered	by	CBR	workers,	several	participants	reported	an	improved	understanding	of	the	symptoms,	causes	and	treatment	of	schizophrenia,	with	particular	appreciation	of	the	potential	benefits	of	medication.	Some	CBR	workers	stressed	that	understanding	increased	gradually	over	time,	alongside	improvements	in	the	person	with	schizophrenia.		
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Increased	family	stability	and	care;	and	reduced	caregiver	burden	Involving	family	members	in	CBR	was	seen	to	be	central	to	improving	functioning.	Several	CBR	workers	and	supervisors	noted	that	the	family	environment	was	pivotal	in	shaping	the	illness	experience	of	people	with	schizophrenia,	for	better	or	worse.	Until	these	often	disruptive	and	strained	environments	were	stabilised,	it	was	found,	improvements	in	participants	were	difficult.	
“There	is	a	huge	disagreement	between	family	members	and	that	has	an	impact	on	
the	mentally	ill	patient.	It	is	the	problem	within	the	family	that	makes	the	patient	to	
be	disturbed,	angry,	go	out	of	the	house,	avoid	themselves,	not	care	for	themselves,	
not	eat	food	and	not	keep	their	hygiene.”		(male	supervisor-E)	In	several	instances	CBR	workers	acted	as	mediators	in	family	conflicts,	in	some	cases	involving	community	elders	to	arbitrate.		
“	[the	man	with	schizophrenia]	was	expelled	from	home	because	he	kicked	his	mother	
[…]	He	was	roving	the	streets	and	was	unable	to	stay	at	home	because	of	his	illness.	
But	his	family	didn’t	understand	that.	But	the	family	relationship	improved	
significantly	after	I	gave	them	the	lesson	from	the	module	about	interpersonal	
relationships	in	the	family	[...]	he	asked	for	her	forgiveness	and	they	started	living	
together	happily	[…]	I	always	feel	happy	about	the	improvements	we	saw.”		(male	CBR	worker	-8-E)	In	one	case	the	CBR	worker	negotiated	household	tasks	to	be	divided	fairly	between	the	participant	and	other	family	members,	drawing	on	their	growing	understanding	of	the	illness	to	ensure	the	participant	was	given	sufficient	rests.	By	the	end	of	the	pilot	most	caregivers	described	strategies	they	had	learnt	to	avoid	aggravating	their	relative,	including	communicating	calmly,	removing	or	avoiding	stressors	and	telling	them	of	plans	in	advance.	
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“This	person	is	sick	and	we	prepare	how	to	pass	the	time	of	the	illness.	We	know	how	
to	manage	the	relapse.	I	know	my	husband’s	behaviour	more	than	anyone.	When	he	
feels	angry,	I	pass	that	with	a	smile.	I	also	take	the	children	away	from	him.”		(female	caregiver-1-B)	Aided	by	CBR	workers,	some	caregivers	began	facilitating	self	care	for	the	first	time,	for	example	by	buying	the	person	with	schizophrenia	soap	or	encouraging	them	to	wash.	Improvements	in	self-care	seemed	to	be	related	to	caregivers	appreciating	that	people	with	schizophrenia	deserve	to	be	clean	as	much	as	them	giving	practical	guidance	and	the	individual	being	less	symptomatic.	In	some	cases	family	members	also	had	a	role	in	supporting	social	participation.		A	linked	and	important	impact	of	improved	functioning	was	the	reduction	in	caregiver	burden.	IEQ	scores	reduced	between	baseline	and	six	months,	and	then	plateaued	at	12	months	(median	46.0	(baseline)	vs	26.5	(six	months)	vs	30.5	(12	months)	(see	Table	7.5)).	Several	caregivers	described	relief	from	the	constant	worry	about	their	relative	that	came	with	improvements	in	their	health.	There	was	also	less	need	to	supervise	their	relative	through	fear	of	them	harming	themselves	or	others,	or	simply	becoming	upset	due	to	being	left	alone,	meaning	daily	tasks	could	be	completed	more	easily.	Others	welcomed	the	increased	contribution	to	communal	work.	
“Now	his	condition	is	improved.	He	can	move	by	himself.	Earlier,	I	had	a	fear	of	[him]	
committing	suicide	or	hurting	others.	Now,	I	didn’t	fear	that	much	[…]	Earlier	not	
only	he,	but	also	I,	couldn’t	go	out	of	the	home.	But	now	thanks	to	God	I	can	go	
anywhere.”		(female	caregiver-8-E)	
Increased	access	to	mental	healthcare	and	increased	anti-psychotic	medication	
adherence	For	many	families	CBR	had	a	role	in	improving	access	to	mental	health	care,	which	meant	being	reviewed	by	health	officers	at	the	health	centre	and	accessing	anti-psychotic	medication.	At	baseline	half	of	participants	reported	making	one	or	more	visits	to	a	health	facility	in	the	last	three	months;	this	increased	to	80%	at	6	
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months	and	75%	at	12	months	(see	Table	7.5).	CBR	workers	took	practical	steps	to	improve	access,	including:	showing	participants	where	and	how	to	buy	medication,	reminding	them	to	attend	follow	up,	checking	if	medication	was	available	at	the	health	centre	and	escorting	them	to	appointments.	CBR	workers	were	sometimes	successful	in	encouraging	the	wider	family	to	accompany	people	with	schizophrenia	on	this	journey	to	the	health	facility;	this	was	particularly	important	when	travel	to	the	outpatient	clinic	in	the	neighbouring	district	was	required.	Early	on	in	the	pilot	there	was	optimism	that	this	support	alone	would	be	sufficient	to	result	in	improved	access.	
“most	of	[the	CBR	participants]	didn’t	have	a	belief	that	schizophrenia	could	be	
treated	through	modern	treatment	…	There	was	no	habit	to	go	to	the	health	centre.		
Even	those	who	went	there	interrupted	it	[…]	However	now	as	they	got	awareness	
from	CBR,	they	follow	their	appointment	properly.	Therefore	they	now	understood	
that	the	treatment	has	an	important	impact	on	their	health.”		(male	supervisor-B)	As	discussed	above,	issues	around	affordability	and	acceptability	of	medication	later	became	apparent.	In	three	cases,	CBR	workers	tried	to	address	these	issues	by	successfully	facilitating	local	benefactors	or	extended	family	members	to	purchase	medication	where	the	participants	could	not	afford	it.	CBR	workers	also	advised	caregivers	how	to	support	adherence,	and	directly	reminded	and	encouraged	participants.	However	supervisors	felt	that	a	concerted	effort	was	needed	to	keep	participants	adherent	in	spite	of	disabling	side	effects;	few	participants	consistently	took	medication	through	the	pilot.	Family	members	also	learnt	how	to	recognise	and	respond	to	relapse.	
“We	know	when	the	illness	is	about	to	relapse.	She	will	start	getting	upset	easily	and	
she	will	also	start	talking	to	herself.	We	will	give	her	the	medication,	if	we	have	it	at	
home.	Or,	we	will	go	out	to	the	health	centre	to	bring	the	medication	[…]	Her	lesson	
has	changed	us	a	lot.	It	is	a	big	deal	for	us,	to	know	where	to	take	her	[when	her	
illness	relapses].”	(female	caregiver-10-E)	
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Reduced	relapse	and	symptoms	The	proportion	assessed	as	normal	or	borderline	on	the	CGI	(clinical	global	impression)	rose	from	zero	at	baseline	to	62.5%	at	endline	(Table	7.4);	this	change	was	also	reflected	in	the	BPRS-E	(baseline	median	52.5	(IQR	39,	62)	vs	endline	median	25.2	(24,	59.5)	(see	Appendix	D	(vi)).	Furthermore,	the	proportion	assessed	as	having	no	psychotic	episodes	in	the	last	six	months	on	the	LCS	rose	from	0%	at	baseline	to	62.5%	at	endline	(see	Appendix	D	(vi)).	For	many	participants,	simply	taking	medication	had	resulted	in	them	becoming	‘healthy’	or	‘well’.	Whilst	a	priest	spoke	of	one	man	with	schizophrenia	gaining	a	‘peaceful	and	free	mind’	through	treatment,	for	most	CBR	workers	and	caregivers	being	healthy	was	associated	with	a	reduction	in	behaviours	such	as	collecting	objects,	shouting	insults,	throwing	stones,	wandering	away	from	home	and	talking	to	themselves.	Three	caregivers	emphasised	that	medication	enabled	their	relative,	and	therefore	the	whole	family,	to	sleep	better.	In	many	cases	improvements	in	symptoms	led	to	better	functioning.	For	example,	for	two	participants	a	reduction	in	persecutory	ideas	made	socialising	easier	whilst	labouring	or	farm	work	became	possible	for	others.		The	median	PHQ-9	(depression)	scores	decreased	over	the	pilot	from	10.5	(IQR	6,13))	at	baseline	to	3.5	(IQR	1.5,8.5)	at	endline	(Table	7.4).	A	‘see-sawing’	effect	was	seen	in	two	participants,	with	scores	either	much	higher	or	lower	at	six	months,	compared	to	baseline	and	endline.	It	was	difficult	to	directly	tally	these	patterns	with	the	participants’	accounts	in	qualitative	interviews.	One	man	described	the	value	of	improved	functioning,	as	well	as	strategies	suggested	by	the	CBR	worker,	to	cope	with	suicidal	thoughts.		
“I	used	to	get	depressed	when	I	sit	at	home.	I	used	to	cry	and	go	outside	the	house.	
These	things	have	reduced	now.	I	have	built	my	own	house	and	have	started	making	
my	bed	and	living	like	other	people	[…]	When	I	was	sitting	alone	at	night,	I	used	to	
think	that	it	would	be	better	if	I	hang	myself	or	throw	myself	into	a	river	than	live	like	
this.	But	I	have	significant	improvements	after	[the	CBR	worker]	advised	me	to	go	
outside,	watch	TV	and	relax,	when	I	feel	low	and	bad	ideas	come	to	my	mind.”		(man	with	schizophrenia	-5-E)	
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By	the	end	of	the	pilot	several	people	with	schizophrenia	reported	feeling	calmer	and	less	stressed.	This	was	attributed	in	part	to	improvements	in	the	family	environment	and	taking	medication,	but	also	to	stress	and	anger	management	strategies	learnt	from	the	CBR	worker.	
“[the	CBR	worker]	has	told	me	to	go	outside	the	house	when	me	and	my	wife	start	
fighting.	But	she	has	almost	stopped	nagging	me	after	his	advice.	I	also	go	outside,	
when	I	see	changes	in	her	face.	Both	of	us	calm	down	when	I	get	back	home.”		(man	with	schizophrenia	-6-E)	
Increased	income	Increased	participation	in	livelihood	activities	brought	various	benefits:	improved	self-esteem,	reduced	caregiver	burden,	a	shift	in	community	attitudes,	but	perhaps	most	importantly	income.	Increased	income	in	turn	brought	the	ability	to	pay	for	food,	to	support	the	wider	family	and	to	make	financial	contributions	to	community	organisations;	however	only	one	CBR	participant	explicitly	mentioned	that	increased	income	allowed	them	to	purchase	medication.	The	role	of	the	CBR	worker	varied.	In	one	case	they	identified	a	local	grain	mill	owner	interested	in	employing	their	participant,	in	another	case	they	directly	guided	the	participant	to	plan	and	undertake	farming	activities;	in	other	cases	the	CBR	worker	simply	encouraged	and	monitored	handicraft	or	alcohol	production.	
“What	I	did	for	my	patient	was	to	make	her	do	the	job	she	was	doing	in	the	past.	So,	
she	started	distilling	araki	[local	gin]	to	cover	her	household	expenses.	Doing	some	
work	will	help	them	generate	income	and	they	will	be	happy	because	they	will	be	
able	to	do	whatever	they	want.	They	will	not	expect	anything	from	anyone.	This	time	
the	community	will	start	thinking	that	they	can	take	care	of	themselves	and	do	some	
work.”		(female	CBR	worker-10-E)	
Improved	physical	health	and	appearance	CBR	workers	had	some	successes	in	supporting	physical	wellbeing.	For	example	two	people	with	schizophrenia	were	referred	to	the	health	centre	for	musculoskeletal	problems	that	were	proving	a	barrier	to	undertaking	physical	
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labour.	Yet	one	woman	with	schizophrenia,	whose	family	were	highly	resistant	to	the	CBR	worker’s	efforts	to	facilitate	treatment,	ultimately	died	of	an	undiagnosed	physical	illness.	Three	of	the	four	male	participants	who	exhibited	problem	drinking	cut	down	during	the	course	of	the	pilot	(baseline	median	AUDIT	3.5	(IQR	0,	7)	vs	endline	2.5	(0,	5.5)),	with	some	indications	that	simple	advice	from	the	CBR	workers	played	a	role	(see	Table	7.4).		
Increased	social	inclusion	At	baseline,	seven	of	the	participants	reported	any	experience	of	discrimination;	by	endline	only	the	two	participants	who	initially	had	the	highest	scores	continued	to	report	discrimination	(Table	7.5).	The	qualitative	data	indicated	that	for	some	people	with	schizophrenia	social	non-participation	was	apparently	a	personal	choice-	albeit	one	shaped	by	their	illness-	driven	by	a	dislike	of	crowds	and	noise,	or	disputes	with	neighbours.	However	there	were	some	reports	of	social	exclusion	due	to	the	stigmatising	attitudes	of	community	members.	The	priest	described	how	a	change	in	attitudes	had	reduced	social	exclusion.		
“Before,	[the	man	with	schizophrenia]	was	considered	to	be	crazy	and	he	wasn't	
allowed	to	participate	in	any	activities	in	the	community.	But	today	he	participates	in	
activities	the	community.	They	take	care	of	him	[…]	He	is	healed	and	today	he	is	
healthy	and	is	now	working	[…]	he	wasn't	invited	to	weddings,	or	to	attend	funerals	
[...]	However,	today	the	community	supports	him,	the	community	has	embraced	him,	
lovingly	gets	close	to	him	and	gives	him	advice.”		(priest-5-E)Notably	the	account	of	the	man	supported	by	this	priest	directly	contradicted	the	priest’s	own	account.	For	this	man,	whose	social	isolation	apparently	endured	despite	improvements	in	symptoms	and	functioning,	re-integration	was	problematic	due	to	his	single	status.	He	believed	this	in	turn	was	due	to	persistent	negative	perceptions	the	community	had	of	him	as	a	result	of	domestic	violence	inflicted	on	his	ex-wife	whilst	he	was	unwell.	According	to	this	man,	CBR	had	not	assisted	with	the	social	exclusion	he	experienced;	this	was	also	reflected	in	his	DISC	score,	which	remained	high	at	the	end	of	CBR,	despite	some	improvement	(see	Table	7.5).	
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“The	medication	and	the	[CBR]	education	have	helped	me	a	lot	in	my	recovery	[...]	
But,	I	have	to	start	a	social	life	[…]	I	am	living	alone.	I	don’t	go	to	anyone’s	funeral	
and	no	one	will	bury	me	if	I	die	[…]	No	one	invited	me	to	attend	their	weddings	and	
no	one	will	tell	me	to	go	with	them	to	mourn	for	a	dead	person	[…]	No	one	invites	me	
because	I	am	living	alone	and	I	don’t	have	a	social	life	[...]	I	don’t	have	edir	and	other	
social	life.	I	don’t	go	to	other	people’s	houses	to	drink	coffee	[…]	I	am	lonely.”		(man	with	schizophrenia	-5-E)	In	a	similar	pattern,	one	woman	with	schizophrenia	described	being	unable	to	attend	church	as	she	was	too	scared	to	go	alone	and	her	sisters	did	not	accompany	her;	this	contradicted	the	local	health	extension	worker	and	her	caregiver	who	both	reported	she	had	started	attending.	
Decreased	stigma	and	abuse	In	some	cases	there	were	important	shifts	in	the	negative	attitudes	of	caregivers,	which	increased	the	dignity	and	respect	with	which	they	treated	their	family	member	and	in	one	case	ended	physical	abuse.	At	baseline,	four	participants	reported	ever	having	been	restrained.	During	the	pilot	there	were	two	instances	of	physical	restraint	(of	one	and	three	days	duration)	indicated	in	the	qualitative	and	quantitative	data.	In	one	case	the	CBR	worker	helped	to	resolve	the	situation	by	negotiating	with	the	caregiver	and	encouraging	access	to	treatment.	
“They	told	me	[the	man	with	schizophrenia]	was	tied	up	because	he	was	fighting	with	
[the	caregiver]	over	taking	some	household	property	outside	the	house	[…]	They	tied	
[the	man	with	schizophrenia]	up	on	Monday	night.	I	went	there	at	the	appointment	
time	on	Tuesday.	So,	I	met	[the	caregiver],	talked	to	her	and	listened	about	him.	We	
took	[the	man	with	schizophrenia]	to	the	appropriate	place	and	he	was	released.	So,	
[CBR]	visits	are	very	important.	The	burden	she	was	carrying	was	heavy.	We	told	her	
that	he	was	showing	the	symptoms	of	mental	illness	and	that	he	will	get	better	if	he	is	
taken	to	the	hospital	and	takes	his	medication	properly	and	had	him	released.”	(male	CBR	worker	-8-E)	This	man	was	also	the	only	participant	who	described	learning	strategies	to	deal	with	stigmatising	comments.	
217
215	
“I	benefited	from	[the	CBR	worker’s]	education	[…]	The	CBR	worker	taught	me	that	
whatever	someone	says	to	me,	I	don’t	have	to	respond	to	him.	Arguments	will	affect	
my	health	condition.”		(man	with	schizophrenia	-8-E)	
Increased	self	esteem	and	hope	Increased	self	esteem	and	a	growing	sense	of	hope	that	life	could	improve	seemed	to	underpin	sustained	changes	in	functioning;	whilst	functioning	–	participation	in	work,	social	life	or	improved	self	care-	likewise	fostered	a	feeling	of	self-worth.	For	some	people	with	schizophrenia	the	fact	of	receiving	support	at	all,	and	therefore	feeling	valued,	whether	by	family,	CBR	workers	or	community	members,	appeared	to	have	an	independent	effect	on	wellbeing.	Often	the	knowledge	that	the	illness	could	improve	was	transformational,	whilst	for	others	the	CBR	workers	themselves	were	great	motivators.		
“[the	CBR	worker]	tells	me	I	will	get	better.	She	motivates	me	to	be	strong	[…]	If	she	
didn’t	come	I	would	be	ill,	I	would	be	in	bed…If	she	wouldn’t	come	who	would	teach	
me	this	whole	thing?	[…]	She	makes	me	feel	better”		(woman	with	schizophrenia	-9-E)	Self-esteem	manifested	in	various	ways	including	participants	taking	pride	in	their	appearance	and	work,	feeling	equal	to	others	(such	as	not	accepting	donations	of	left	over	food),	and	being	assertive	at	home	and	in	the	community.	
“When	he	eats	he	wants	to	get	good	food	[...]	when	he	goes	to	parties	he	doesn’t	
accept	leftovers,	he	wants	good	food	and	he	wants	to	be	seated	and	served	like	
normal	people.	He	says	he	is	not	less	than	anyone,	he	is	fine”		(male	caregiver-7-E)	
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7.3.6.2 Assumption	3b:	A	community	mobilisation	approach	is	needed	in	
addition	to	home-based	care	Community	mobilisation	work	had	three	linked	areas	of	positive	impact:		increased	awareness	about	mental	illness,	identification	of	previously	untreated	psychosis	and	increased	support	for	people	with	schizophrenia.	CBR	workers,	community	leaders	and	two	caregivers	felt	that	CBR	had	increased	understanding	about	mental	illness	amongst	the	general	population,	in	particular	that	difficult	behaviours	may	be	a	symptom	of	schizophrenia,	and	that	the	illness	is	treatable.	Several	participants	suggested	that	visibly	improved	functioning	in	people	with	schizophrenia,	through	work	or	attending	church,	was	a	turning	point	in	changing	community	attitudes.	There	was	general	agreement	that	improved	community	attitudes	can	furthermore	potentially	have	a	profound	impact	on	reducing	mistreatment	and	social	exclusion.	However,	few	participants,	and	no	people	with	schizophrenia,	provided	concrete	examples	of	awareness	affecting	inclusion.	However	one	caregiver	did	imply	that	raised	awareness	meant	she	received	support	from	neighbours	that	would	otherwise	have	been	absent.		
“When	he	was	ill	in	the	past,	he	used	to	get	drunk	and	speak	louder.	The	people	in	the	
neighbourhood	heard	him	and	they	used	to	care	and	feel	pity	for	me.	They	
understood	that	taking	care	of	a	patient	is	very	difficult.	So	if	the	people	had	the	
awareness	about	the	illness	and	understood	the	symptoms	of	the	illness,	they	will	
help.”		(female	caregiver-6-E)	Several	participants	reported	that	the	local	presence	of	CBR	had	meant	other	people	with	schizophrenia,	who	were	not	enrolled	in	the	CBR	programme,	had	accessed	treatment	for	the	first	time.	This	occurred	as	a	result	of	public	awareness-raising	meetings,	CBR	workers	being	seen	making	home	visits	or	through	family	networks.	
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“We	have	a	credit	association	of	about	23	women	in	our	neighbourhood.	[The	CBR	
worker]	asked	us	if	there	are	mentally	ill	members	in	our	families	and	advised	us	to	
take	the	ill	people	to	the	health	centre.	The	women	also	gave	her	information	about	
the	[mentally	ill	people]	in	their	houses	or	in	their	neighbourhood.	One	of	the	women,	
for	instance,	told	her	that	her	brother	is	mentally	ill.	[The	CBR	worker]	told	her	to	
take	him	to	the	health	centre	and	he	is	showing	significant	improvement	now.”		(female	caregiver-1-E)	There	were	four	participants	for	whom	CBR	workers	mobilised	tangible	community	support.	In	one	case	the	CBR	worker	identified	and	supported	local	businessmen	to	provide	a	house,	regular	funds	for	food	and	medication,	and	employment	opportunities	to	a	man	who	was	initially	homeless.	
“[The	man	with	schizophrenia]	has	a	person	helping	him	with	food,	there	is	another	
person	who	covers	his	expense	for	his	medication,	another	person	also	gave	him	a	
place	to	stay.	There	are	also	people	who	are	arranging	to	help	him	get	a	job.	The	CBR	
worker	has	played	a	big	role	in	arranging	for	…people	to	help	him	in	every	aspect	
and	make	him	become	successful	and	profitable;	a	very	huge	role	in	helping	them	get	
free	treatment.	It	is	because	of	the	CBR	worker’s	role	that	these	opportunities	were	
created	for	him.”		(male	supervisor-E)	In	another	case	a	local	priest	contacted	by	the	CBR	worker	became	an	important	source	of	moral	support	and	advice,	as	well	as	mediating	in	a	conflict	between	the	participant	and	his	brother.	One	supervisor	commented	that	participants	were	more	likely	to	listen	to	the	advice	of	respected	community	elders	than	CBR	workers.	In	a	third	case	a	local	judge	took	on	an	advocacy	role	requesting	a	medication	fee	waiver	for	a	CBR	participant,	as	well	as	giving	him	a	small	loan	to	start	up	a	business.	In	the	final	case	the	local	health	extension	worker	invited	a	participant	to	live	in	her	home	for	several	weeks,	supporting	her	with	medication	and	social	activities,	until	relations	with	the	participant’s	family	improved	sufficiently	for	her	to	return	home.	Linking	with	health	extension	workers	also	proved	useful	for	identifying	the	homes	of	CBR	participants,	accessing	community	leaders	and,	in	one	case,	facilitating	access	to	nutritional	support	for	the	infant	of	a	woman	with	schizophrenia.	Those	providing	support	had	generally	had	minimal	
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previous	involvement	in	the	CBR	participant’s	life,	which	had	been	enhanced	and	formalised	by	CBR.	
“I	used	to	feel	very	sad	when	I	saw	[the	man	with	schizophrenia]	in	the	street…	I	used	
to	give	him	some	food	or	some	small	things	and	encouraged	him.	I	was	giving	him	
some	unsustainable	support	[…]	There	was	no	fixed	thing.	I	used	to	forget	him	and	
pass	him.	But	now	there	is	someone	in	the	middle	who	can	ask	for	him	and	arrange	
for	us	to	meet”		(benefactor-7-E)	In	parallel	to	successes	with	community	mobilisation,	CBR	workers	also	faced	some	difficulties	in	changing	attitudes,	accessing	or	sustaining	support	from	elders.	For	example	the	support	with	medication	payments	described	above	reportedly	stopped	after	six	months,	despite	the	efforts	of	the	CBR	worker.	It	was	also	difficult	to	find	benefactors	anywhere	except	the	wealthier	urban	areas.
7.3.6.3 Assumption	3c:	Family	support	groups	are	perceived	to	be	useful	
despite	not	having	a	savings	and	loans	element	There	was	limited	success	in	implementing	family	support	groups.	Only	one	sub-district	set	up	a	group,	which	ended	after	three	meetings.	One	of	the	participants	did	report	that	it	had	been	useful,	feeling	it	was	a	relief	to	discuss	her	problems.	
“[the	family	support	group]	was	good.	It	is	good	to	get	relief.	I	think	it	is	helpful	for	us	
as	it	gives	us	relief	from	our	daily	suffering…yes…	It	is	even	very	helpful	and	
refreshing	as	we	meet.	Is	it	not	good	to	rest?”		(woman	with	schizophrenia	-4-E)	The	lack	of	a	savings	and	loan	element	was	not	given	as	a	reason	for	lack	of	participation.	Instead	there	were	either	too	few	participants	in	a	sub-district,	participants	did	not	feel	comfortable	discussing	their	personal	lives	or	the	person	with	schizophrenia	was	too	ill	to	be	left	unattended.	Of	note	is	that	two	caregivers	and	a	participant	had	all	informally	discussed	the	benefits	of	medication	with	other	families	affected	by	schizophrenia,	only	one	of	which	was	participating	in	CBR.	
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7.3.7 Intervention	adjustments	to	maximise	impact	It	was	envisaged	that	adjustments	aimed	at	improving	acceptability	and	feasibility	would	also	have	knock-on	benefits	for	the	impact	of	CBR.	CBR	worker	refresher	training	was	given	to	encourage	a	focus	on	fewer	more	pertinent	and	achievable	goals;	in	particular	to	focus	on	maintaining	progress	on	goals	in	Phase	3,	rather	than	embarking	on	several	new	areas.	Relapse	prevention	became	an	optional	module	for	Phase	2,	to	recognise	the	differing	needs	of	participants.	In	addition,	how	to	strike	the	balance	between	realism	and	hope	in	recovery	was	covered;	and	the	potential	impact	of	co-morbid	intellectual	disability	on	the	likely	magnitude	of	changes	in	functioning.	Community	mobilisation	was	maintained	as	a	compulsory	component	of	CBR,	with	no	major	adjustments.	Family	support	groups	were	designated	as	an	optional	component	of	CBR,	depending	on	the	wishes	of	participants	in	each	sub-district.		
7.3.7.1 Changes	to	the	evaluation	of	impact	To	better	understand	pathways	to	improved	functioning,	a	focus	on	concepts	of	recovery	and	perceived	barriers	and	facilitators	to	recovery	was	incorporated	into	the	trial	qualitative	evaluation.		
7.3.8 Summary	of	results	The	results	were	summarised	in	a	revised	post-pilot	theory	of	change	(see	Figure	7.2)	(see	Appendix	D	(vii)	for	detailed	version).	Assumptions	that	were	met	(shown	to	be	correct)	were	converted	to	rationale	(purple	boxes	in	Figure	7.2).	Assumptions	that	were	not	fully	met	due	to	substantial	barriers	and	those	which	the	pilot	evaluation	were	not	able	to	adequately	evaluate	(such	as	those	that	required	assessment	at	scale	or	through	randomisation)	were	retained;	these	outstanding	assumptions	represent	areas	for	monitoring	in	the	trial	(orange	boxes	in	Figure	7.2).	A	refined	conceptual	framework	for	the	pathways	through	which	CBR	impacts	on	functioning	was	also	included	in	the	theory	of	change	(blue	boxes	in	Figure	7.2).
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Table	7.6	Research	question	1:	Summary	of	assumptions,	main	findings	and	adjustments	to	trial	intervention	
Assumption	 Main	findings	 Adjustments	to	intervention	 Conclusion	
Research	question	1:	Is	the	RISE	CBR	intervention	acceptable?	
1a:	People	with	
schizophrenia	and	
caregivers	are	
willing	and	have	
time	to	participate	
in	CBR		
Process:	Three	participants	dropped	out	before	12	months	(1	x	8	
months,	2	x	11	months).	Mean	home	visits	21	(range	17-27)	
Qualitative:	Most	welcomed	CBR;	Close	relationships	often	
formed	with	CBR	workers.	Disengagement	due	to	improved	
functioning,	disagreements	over	medication	use,	and	participants	
visiting	holy	water/	relatives.	Some	issues	about	home	visits	
interfering	with	work-	for	men.	Some	issues	with	engaging		
suitable	caregiver.	Some	participants	wanted	written	information.	
Community	mobilisation	generally	acceptable.		
Extend	Phase	1	to	3	months.	Adjust	frequency,	
duration	&	location	of	visits	to	fit	needs	of	
participants.	Maintain	phone	contact	between	visits.	
Provide	written	materials	for	CBR	participants.	Top	
up	training	on	recovery	model-	balance	between	
encouraging	medication	and	accepting	if	cannot	or	
will	not	take	it.	Clarify	that	participants	can	continue	
CBR	despite	not	taking	medication.	CBR	worker	
training	on	focusing	on	fewer	more	achievable	goals.	
Assumption	shown	to	be	
correct	and	converted	to	
rationale,	as	majority	
received	adequate	CBR.	
Monitor	in	trial	(process	and	
qualitative)	as	increased	
flexibility	may	be	more	
difficult	at	scale.		
1b:	CBR	can	meet	
the	needs	of	people	
with	schizophrenia		
Process:	All	participants	achieved	all	core	goals.	Between	6-11	
optional	goals	selected,	of	which	between	1-8	achieved.	Tendency	
to	select	too	many	goals,	not	achievable	in	time	frame.	Some	
caregivers	disappointed	in	slow	progress,	especially	if	comorbid	
intellectual	disability.		
Qualitative:	Participants	often	wanted	to	resume	gendered	family	
role.	Poverty	was	a	major	issue	which	CBR	could	not	directly	
address-	leading	to	some	disengagement	with	CBR.		
Better	explanation	on	lack	of	financial	support.	Add	
extra	potential	goal	‘Person	with	schizophrenia	can	
fulfill	family	role'.	Top	up	training	to	ensure	focus	on	
fewer	more	achievable	goals.	Focus	on	maintaining	
goals	in	phase	3,	rather	than	starting	several	new	
ones.	Trial	evaluation:	Add	focused	qualitative	
interviews	around	recovery.	Add	endline	process	
assessment	on	whether	CBR	met	need.		
Keep	as	assumption	as	
unresolved	issues	around	
impact	of	CBR	in	particular	
the	ability	of	CBR	to	alleviate	
poverty	(quantitative	and	
qualitative)		
1c:	CBR	workers	are	
willing	to	work	with	
people	with	
schizophrenia			
Process:	No	CBR	worker	withdrawals.		
Qualitative:	Attitudes	changed	over	time	(concerns	about		
violence	more	realistic;	increased	expectation	of	recovery).	Group	
supervision	helpful.		
Assumption	shown	to	be	
correct	and	converted	to	
rationale.		
1d:	Community	
leaders	willing	to	
support	CBR	without	
benefits	for	
themselves		
Process:	Awareness	raising	and	meetings	with	community	leaders	
conducted	in	all	sub-districts.	Targeted	mobilisation	of	community	
leaders	attempted	for	six	participants.		
Qualitative:	Initial	difficulty	arranging	meetings.	Some	community	
leaders	implied	per	diem	needed	for	meetings	exclusively	for	CBR.	
Otherwise	community	figures	happy	to	participate.		
Only	do	community	meetings	attached	to	another	
planned	meeting-	better	attendance	and	minimize	
expectation	of	per	diem.	For	individual	engagement	
target	those	unlikely	to	ask	for	personal	benefit.		
Assumption	shown	to	be	
correct	and	converted	to	
rationale.	Monitor	at	scale	in	
trial		(qualitative		and	
process)		
1e:	Traditional	
healers	willing	to	
support	CBR			
Process:	No	CBR	engagement	with	traditional	healers-	holy	water	
sites	out	of	district.		
Keep	as	assumption	and	
monitor	in	trial	(qualitative	
and	process)		
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Table	7.7	Research	question	2:	Summary	of	assumptions,	main	findings	and	adjustments	to	trial	intervention	
Assumption	 Main	findings	 Adjustments	to	intervention	 Conclusion	
Research	question	2:	Is	the	RISE	CBR	intervention	feasible?	
2a:	Non	
specialists	can	be	
trained	to	deliver	
CBR	for	people	
with	
schizophrenia	
Process:	All	CBR	workers	retained.	Some	variation	in	abilities.	Areas	
needing	additional	training:	risk	assessment,	physical	
health/substance	use	assessment;	problem	solving,	eliciting	
feedback,	normalisation	of	feelings,	coping	mechanisms;	comorbid	
intellectual	disability.	Supervision	frequency	less	than	anticipated	
(mean	10	individual	sessions,	8	group	sessions,	5.4	unannounced	
visits)	Qualitative:	Participants	happy	with	manner	&	knowledge	of	
CBR	workers.	CBR	workers	and	supervisors	mostly	happy	with	
training	and	support;	sometimes	slow	response	to	difficult	situations.	
Top	up	training	given	on	weak	areas	and	how	to	
support	people	with	comorbid	intellectual	disability.	
Produced	more	compact	step-by-step	guide	with	
difficult	situation	flow	charts,	added	details	about	
side	effects.	Improved	forms-	made	easier	to	use.	
Keep	supervision	expectations	the	same.	
Assumption	shown	to	be	
correct	and	converted	to	
rationale.	
2b:	CBR	workers	
can	overcome	
logistical	
challenges	to	
deliver	CBR	
Process	and	qualitative:	Time	consuming	to	access	some	households	
due	to	long	distances	and	shortage	of	public	transport.	Difficulty	
arranging	visits/	supervision	due	to	telephone	network	problems.	
Importance	of	home	visits	to	ensure	engagement	and	understand	
family	environment.	
Increase	transport	allowance	for	CBR	workers	and	
increase	access	to	project	vehicle	for	supervisors.	
Reduce	average	number	of	participants	per	CBR	
worker	for	trial.	
Keep	as	assumption.	Need	to	
monitor	in	trial	as	greater	
number	participants	per	CBR	
worker	and	longer	distances.	
2c:	Primary	care	
staff	are	
supportive	of	
CBR	
Process:	CBR	workers	accompanied	to	health	centre	twice	on	average	
over	12	months.	14	referrals	to	health	centre	for	8	participants.	
Qualitative:	Health	officers	good	relationship	with	CBR	workers	once	
understand	each	roles.	Feel	CBR	is	beneficial.	
At	project	start	give	orientation	to	CBR	project	and	
CBR	workers,	with	clearer	explanation	of	
expectations.	
Assumption	shown	to	be	
correct	and	converted	to	
rationale.	
2d:	Anti-	
psychotic	
medication	is	
accessible	
Process:	Medication	supply	issues	at	health	centre;	can't	prescribe	
without	receipt.	
Qualitative:	Difficulties	affording	medication.	Attempts	to	access	
medication	fee	waiver	unsuccessful.	Many	problems	with	side	
effects,	commonly	reported	weakness	which	caused	problems	with	
doing	farm	work	which	needed	to	survive.	Some	issues	with	not	
taking	alongside	holy	water.	
Gain	better	understanding	of	how	to	access	
medication	fee	waiver.	
Trial	evaluation:	Additional	medication	adherence	
questions	to	assess	affordability	and	availability	
Keep	as	assumption	and	
monitor	in	trial	(qualitative,	
process	and	quantitative)	
2e:	Edir	support	
will	be	available	
and	sustainable	
Process:	Edir	groups	used	for	awareness	raising	but	no	financial	
support.	Groups	and	some	CBR	participants	not	interested.	
Qualitative:	Individual	businessmen	used	as	benefactors	in	urban	
area.	Some	doubts	about	sustainability.	
Edir	support	not	included	as	component;	focusing	
efforts	on	individuals	may	be	more	successful.	
Remove	assumption.	Amend	
community	support	to	
include	businessmen.	
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Table	7.8	Research	question	3:	Summary	of	assumptions,	main	findings	and	adjustments	to	trial	intervention	
	
Assumption	 Main	findings	 Adjustments	to	intervention	 Conclusion	
Research	question	3:	Can	the	RISE	CBR	intervention	have	an	impact	and	if	so,	how?	
3a:	CBR	can	 Quantitative:	Substantial	improvements	in	disability,	symptoms,	 Envisage	that	adjustments	to	improve	acceptability	 Keep	as	assumption.	
improve	 alcohol	use,	depression,	discrimination	and	caregiver	burden	over	the	 and	feasibility	will	lead	to	improvements	in	impact.	 Monitor	in	trial	
functioning	in	 pilot	period.	 	 (quantitative)	as	randomised	
people	with	 Qualitative:	Increased	understanding	about	mental	illness	preceded	 	 evaluation	required	
schizophrenia	 increased	family	support	and	access	to	healthcare.	This	led	to	 	 		 increased	functioning	by	improving	symptoms,	decreasing	 	 		 stigma/abuse	and	social	inclusion	and	increasing	income.	Improved	 	 		 livelihood	most	important	outcome	for	many.	Increased	hope	and	 	 		 self-esteem	underpinned	and	sustained	functioning	progress.	Overly	 	 		 ambitious	goals	in	some	cases.	 	 	
3b:	A	community	 Process:	Improved	attitudes	and	knowledge	from	awareness-raising	 No	major	adjustments.	 Assumption	shown	to	be	
mobilisation	 led	in	some	cases	to	signposting	other	people	with	schizophrenia	to	 	 correct	and	converted	to	
approach	is	 health	centre.	Tangible	support	facilitated	for	4	participants	 	 rationale.	Monitor	specific	
required	in	 (medication,	housing,	moral/spiritual	support,	food).	Financial	 	 aspects	in	trial	(qualitative	
addition	to	 support	from	community	was	only	available	in	urban	area	for	people	 	 and	process)	
home-based	care	 with	schizophrenia	with	obvious	needs.	 	 	
3c:	Family	 Process:	1	group	set	up-		3	meetings.	 Family	support	groups	were	designated	as	an	 Keep	as	assumption	and	
support	groups	 Qualitative:	One	woman	with	schizophrenia	found	it	relieved	stress.	 optional	CBR	component	depending	on	the	wishes	of	 monitor	in	trial	(qualitative	
are	perceived	to	 Groups	not	set	up	as	too	few	participants;	did	not	want	to	discuss	 participants	in	each	sub-district.	 and	process)	
be	useful	despite	 problems;	too	ill	to	attend.	 	 	
not	having	 	 	 	
savings	and	loans	 	 	 	
element	 	 	 	
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	7.4 DISCUSSION	
7.4.1 Strengths	and	limitations	Using	a	mixed	methods	approach	this	pilot	study	produced	rich	insights	on	the	acceptability,	feasibility	and	potential	impact	of	CBR	for	schizophrenia	in	Ethiopia	over	a	12	month	period.	A	particular	strength	of	this	study	was	the	inclusion	of	all	of	the	key	players	implicated	in	CBR:	people	with	schizophrenia,	caregivers,	CBR	workers,	supervisors,	community	members	and	primary	care	staff.	In	several	cases	triangulation	laid	bare	discrepancies	between	narratives,	with	people	with	schizophrenia	tending	to	offer	less	positive	accounts	of	the	acceptability	and	impact	of	CBR.	This	highlighted	the	importance	of	incorporating	service	user	perspectives,	including	those	who	have	disengaged	from	the	service,	in	the	development	and	evaluation	of	mental	health	interventions.	Furthermore,	in	a	relatively	nascent	field	in	which	there	is	a	propensity	to	gather	views	on	hypothetical	services	[20,	25],	this	study	joins	a	small	group	of	reports	investigating	acceptability	and	feasibility	in	the	practical	application	of	complex	mental	health	interventions	in	LMICs	[26,	27].	Another	key	strength	of	this	study	was	the	systematic	use	of	a	theoretical	framework,	theory	of	change,	to	guide	the	MRC	approach	to	developing	and	evaluating	complex	interventions.	I	identified	and	tested	assumptions	for	how	the	intervention	will	work,	and	using	the	findings	I	refined	the	intervention	for	evaluation	in	a	cluster	randomised	trial.	Both	the	pilot	evaluation	and	intervention	design	were	responsive	[23],	allowing	emerging	questions	to	be	investigated,	and	the	findings	to	be	acted	upon.	For	example,	during	feedback	meetings	CBR	workers	raised	concerns	about	the	sensitivity	of	suicide	risk	assessments;	this	issue	was	then	explored	in	qualitative	interviews	with	CBR	participants,	and	the	CBR	workers	were	subsequently	given	refresher	training	guided	by	the	findings.	Moreover,	adjustments	were	made	to	the	trial	evaluation	to	better	explore	the	likely	pathways	to	improved	functioning.	For	example,	more	incisive	questions	on	impediments	to	medication	access	were	incorporated	into	trial	data	collection,	as	this	was	identified	as	a	key	issue	for	CBR	impact	in	the	pilot.	There	are	some	limitations	to	this	study.	There	is	a	likelihood	of	observer	bias	as	the	investigators	and	some	respondents	were	internal	to	the	project	and	had	a	
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	vested	interest	in	the	intervention’s	success.	The	qualitative	interviewer	may	have,	consciously	or	unconsciously,	led	people	with	schizophrenia	and	caregivers	to	express	supportive	views	of	CBR.	CBR	workers	themselves	may	have	reported	positive	outcomes	to	demonstrate	their	competence	in	order	to	secure	their	employment.	I	attempted	to	analyse	the	qualitative	data	dispassionately;	however	there	may	have	been	a	tendency	to	emphasise	positive	responses.	This	may	have	been	compounded	by	low	expectations	amongst	people	with	schizophrenia	and	caregivers;	the	“sense	that	‘any	mental	health	care’	was	something	to	be	grateful	for”	has	previously	been	identified	amongst	service	users	in	rural	Ethiopia	[20].	A	further	bias	favouring	CBR	may	have	arisen	due	to	the	close	relationships	with	CBR	workers;	participants	may	have	tried	to	avoid	‘getting	them	into	trouble’.	These	concerns	are	allayed	to	some	extent	by	the	clear	criticisms	of	CBR	that	several	people	with	schizophrenia	and	CBR	workers	voiced	and	that	are	incorporated	into	the	analysis.	However,	no	community	members	who	were	unwilling	to	participate	in	CBR	were	interviewed;	this	may	have	given	a	skewed	impression	of	acceptability	from	the	perspective	of	this	group.	In	relation	to	CBR	impact,	potential	bias	was	somewhat	mitigated	through	triangulation	with	quantitative	outcomes,	which	generally	showed	good	agreement.		However,	another	limitation	of	this	study	is	the	inability	to	make	conclusive	judgements	on	the	impact	of	CBR.	Positive	changes	may	be	expected	over	time,	irrespective	of	any	additional	support;	improvements	were	seen	over	time	even	in	the	control	arm	of	the	COPSI	trial	[28].	In	particular	it	is	not	possible	to	determine	what	changes	were	attributable	to	CBR	rather	than	simply	medication.	Half	of	participants	were	treatment	naïve	prior	to	the	pilot	commencing.	Our	results	suggest	that	CBR	effects	little	change	without	facility-based	care	in	place,	but	it	is	equally	possible	that	facility-based	care	or	medication	produces	an	impact	irrespective	of	CBR	provision.	The	role	of	the	trial	will	be	to	determine	the	effectiveness	of	facility-based	care	alone	versus	facility-based	care	plus	CBR.	Furthermore	the	trial	analysis	will	help	to	elucidate	the	potential	mediating	role	of	medication	adherence	(and	other	intermediate	outcomes)	on	the	causal	pathway	through	which	CBR	impacts	on	functioning.	A	final	limitation	was	the	use	of	both	patient	and	caregiver	responses	in	the	completion	of	the	baseline	WHODAS,	in	contrast	to	the	proxy	(caregiver)	only	responses	used	at	midline	and	endline.	However,	as	people	with	schizophrenia	in	this	setting	have	been	found	to	report	
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	lower	levels	of	disability	in	comparison	to	their	caregivers	(Kassahun	Habtamu,	personal	communication)	this	discrepancy	would	most	likely	serve	to	underestimate	the	apparent	decrease	in	WHODAS	score	at	midline	and	endline	compared	to	baseline.			
7.4.2 Conceptual	framework	for	improved	functioning	Despite	the	limitations	described	above,	some	tentative	conclusions	can	be	made	as	to	the	potential	effect	of	CBR	on	the	lives	of	people	with	schizophrenia.	This	study	found	that	overall	the	RISE	CBR	intervention	may	have	a	positive	impact.	A	heightened	understanding	of	mental	illness	and	human	rights	seemed	to	lead	to	enhanced	family	support	and	increased	access	to	mental	health	care.	These	fundamental	changes	may	have	paved	the	way	for	decreased	stigma,	increased	social	inclusion,	improved	physical	health	and	appearance,	reduction	in	symptoms,	and	increased	income.	Intermediate	steps	to	improved	functioning	were	often	valued	as	positive	outcomes	in	their	own	right.	Improvements	in	functioning	and	psychotic	and	depressive	symptoms	were	reflected	in	both	quantitative	and	qualitative	data.	Improved	functioning	appeared	to	be	sustained	by	increased	self-esteem	and	vice	versa.		The	pilot	findings	prompted	four	major	changes	to	the	conceptual	framework	illustrating	how	CBR	may	improve	functioning	(compare	Figures	7.1	and	7.2).	First,	a	recognition	that	there	is	rarely	a	set	sequence	of	intermediate	outcomes	that	produce	improved	functioning.	Instead,	whilst	some	changes	are	more	fundamental	than	others,	it	is	likely	that	most	outcomes	positively	affect	each	other	and	synergistically	lead	to	improvements	in	functioning.	This	is	reflected	in	the	elimination	of	distinct	pathways	and	the	bi-directional	arrows	introduced	throughout	the	conceptual	framework.	Second,	increased	hope	and	self-esteem	was	a	new	intermediate	outcome	that	had	not	been	acknowledged	prior	to	the	pilot.	The	fact	that	CBR	workers	recognised	the	importance	of,	and	managed	to	increase,	hope	amongst	participants	indicates	that	CBR	can	successfully	utilise	a	recovery-oriented	model	of	care	[29,	30].	The	empowerment	of	people	with	mental	illness	has	been	identified	as	an	important	“non-specific”	characteristic	of	successful	mental	health	interventions	in	LMIC	[31].		
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	Third,	increased	involvement	in	decision-making	about	care	was	included	as	an	intermediate	outcome	alongside	increased	access	to	mental	health	care.	For	some	participants,	medication	was	needed	alongside	CBR	to	impact	functioning.	However,	excessive	persuasion	to	take	medication	by	CBR	workers,	despite	the	individual	being	unable	or	unwilling	to	do	so,	represented	one	of	the	least	acceptable	elements	of	the	intervention.	The	inclusion	of	this	intermediate	outcome	recognises	the	importance	of	respecting	the	wishes	of	people	with	schizophrenia	with	regards	to	the	treatment	they	receive,	despite	the	limited	choices	available,	to	ensure	engagement	with	care	and	to	minimise	stress.	These	issues	will	be	discussed	in	more	detail	in	Chapter	9	(Section	9.2.2.2).	Fourth,	increased	family	stability	and	care	was	included	as	an	intermediate	outcome,	as	an	adjustment	from	‘The	family	can	cope’	in	the	pre-pilot	framework.	This	reflects	the	powerful	influence	that	the	family	environment	was	found	to	have,	for	better	or	worse,	on	the	person	with	schizophrenia,	shifting	from	a	perception	that	families	are	simply	parallel,	and	passive,	victims	of	the	illness.	This	study	showed	that	families	are	central	to	the	success	of	the	CBR	intervention,	in	terms	of	facilitating	engagement	with	the	CBR	worker	and	supporting	rehabilitation	and	access	to	medication.	This	finding	aligns	with	calls	to	consider	the	person	with	mental	illness	and	their	family	as	the	unit	of	intervention	delivery	in	the	rural	Ethiopian	context	[32].	There	was	some	indication	that	CBR	workers	successfully	supported	families	to	reduce	expressed	emotion	and	that	this	brought	palpable	benefits	to	people	with	schizophrenia.	The	prominence	of	this	effect	fits	in	with	the	fact	that	family	intervention	has	the	some	of	the	strongest	evidence	of	effectiveness	across	all	types	of	psychosocial	interventions	for	schizophrenia	in	any	setting	[33].			
7.4.3 Assumptions	that	were	shown	to	be	correct	Six	of	the	assumptions	relating	to	intervention	performance	were	found	to	be	well	founded,	and	were	therefore	converted	to	rationales	in	the	theory	of	change	(see	purple	boxes	in	Figure	7.2).	Most	of	these	rationales	related	to	acceptability,	reflecting	the	overall	willingness	of	people	with	schizophrenia,	caregivers,	CBR	workers,	community	members	and	health	centre	staff	to	participate	in	or	support	
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	CBR	(rationales	1a,	1c	and	1d).	As	in	other	similar	studies,	concerns	about	the	safety	of	community	health	workers	delivering	home	care	to	people	with	mental	illness	were	raised	in	the	planning	stages	[25,	34],	but	did	not	materialise	as	an	issue	in	practice	[34]	(rationale	1c).	This	may	reflect	the	safety	procedures	implemented	in	the	pilot,	but	also	the	small	group	of	participants,	amongst	whom	there	were	no	incidents	of	aggressive	behaviour.	The	reduction	in	stigmatising	attitudes	towards	people	with	schizophrenia	seen	in	CBR	workers	after	starting	work	echoes	evidence	that	social	contact	is	the	most	powerful	means	of	reducing	stigma	in	the	short	term	[35].	The	health	officers’	perception	of	community-level	mental	health	workers	as	useful	rather	than	a	threat	or	hindrance	(rationale	2c)	is	perhaps	not	surprising	as	CBR	addressed	a	need	for	outreach	work	identified	by	primary	care	staff	in	Sodo	[25].	However	the	importance	of	clarifying	the	role	of	community	health	workers,	raised	here,	had	also	previously	been	highlighted	in	studies	examining	the	acceptability	of	task-shifting	for	other	mental	disorders	from	the	perspective	of	primary	care	staff	[36].	Although	there	were	some	major	challenges	relating	to	acceptability	from	the	perspective	of	people	with	schizophrenia,	it	was	felt	these	were	surmountable	with	adjustments	to	the	intervention,	in	particular	through	supplementary	training	for	CBR	workers	on	how	to	communicate	about	medication	and	increased	flexibility	in	the	mechanics	of	intervention	delivery,	such	as	timing	and	frequency	of	sessions	(rationale	1a).	Instances	of	disengagement	towards	the	end	of	CBR	may	not	have	reflected	a	lack	of	acceptability,	but	rather	that	CBR	had	reached	its	natural	conclusion	for	those	individuals;	indeed	it	may	be	indicative	of	CBR’s	success	that	one	participant	was	functioning	well	enough	to	leave	for	Addis	Ababa	to	find	work.	Potential	stigma	was	a	concern	for	a	minority	of	participants,	similar	to	findings	from	the	COPSI	pilot	in	India	[26].	Disengagement	due	to	time	constraints,	of	both	people	with	schizophrenia	and	caregivers,	was	a	more	significant	issue	in	this	pilot.	The	importance	for	acceptability	of	community	workers,	in	this	case	CBR	workers,	being	from	the	local	area	reflected	findings	from	formative	studies	relating	to	common	mental	disorders	[36].	The	confirmation	that	non-specialists	can	be	trained	to	deliver	CBR	for	schizophrenia	(rationale	2a)	supports	findings	from	the	COPSI	pilot,	trial	and	earlier	linked	studies	in	India	[26,	28,	37,	38].	This	work	also	adds	to	a	growing	
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	body	of	evidence	for	common	mental	disorders	in	other	LMIC	[39-41].	The	fact	that	in	the	RISE	pilot	this	was	achieved	without	routine	clinical	review	or	supervision	by	psychiatrists,	unlike	other	comparable	studies	[28,	39-41],	could	represent	a	significant	and	novel	achievement.	Thorough	training	is	likely	to	have	been	important	[25,	36]	and	CBR	workers	may	have	also	benefited	from	the	highly	structured	nature	of	the	intervention.	Yet	my	own	involvement	in	CBR	worker	supervision	(see	Section	7.2.4)	arguably	made	a	substantial	contribution	to	CBR	worker	competence.	The	trial,	throughout	which	I	will	have	no	direct	supervisory	role,	will	allow	us	to	determine	whether	the	non-specialist	supervision	arrangements	are	truly	feasible.	It	was	decided	the	assumption	that	community	mobilisation	is	required	was,	on	balance,	well	founded	(rationale	3b).	An	unexpected	benefit	of	this	work	was	that	people	with	previously	untreated	psychosis	were	identified	and	sign-posted	to	the	health	facility.	Gains	in	social	inclusion,	and	the	potential	role	of	the	community,	were	contested	findings	in	this	study,	and	therefore	demand	particular	attention	in	the	trial	qualitative	evaluation.		
7.4.4 Assumptions	not	yet	confirmed	Six	assumptions	could	not	be	confirmed	using	the	pilot	data	and	therefore	remain	areas	for	assessment	in	the	trial.	First	was	the	assumption	(1b)	that	CBR	can	meet	participants’	needs.	Poverty	was	the	foremost	problem	for	most	pilot	participants;	the	lack	of	immediate	and	tangible	financial	benefit	from	CBR	was	a	key	acceptability	issue,	prompting	several	participants	to	question	the	purpose	of	participation.	It	was	clear	that	whilst	expectations	may	be	low	amongst	participants,	for	most	this	did	not	translate	into	‘blind’	unquestioning	engagement	if	needs	are	not	met.	This	validates	the	assertion	of	Padmanathan	et	al	that	people	with	mental	illness	in	LMIC	are	unlikely	to	engage	in	psychosocial	interventions	that	do	not	meet	their	needs	[36].	However,	her	supposition	that	interventions	that	have	been	designed	for	cross-cultural	applicability,	as	RISE	was,	will	inevitably	meet	the	needs	of	participants	does	not	take	into	account	the	potency	of	external	factors	such	as	the	absence	of	employment	opportunities.	In	a	trial	of	collaborative	care	for	common	mental	disorders	in	India,	lay	health	counsellors	initially	
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	encountered	complaints	that	they	were	not	offering	financial	support	to	participants	or	addressing	social	difficulties	[42].	In	that	setting	the	issue	was	overcome	by	improving	referral	systems	to	welfare	schemes	and	other	agencies	[42].	Yet	in	a	low-income	setting	such	as	Ethiopia	the	absence	of	social	security	or	even	local	NGOs	who	can	offer	additional	support	means	participants	are	wholly	reliant	on	the	CBR	programme	to	meet	their	needs.		In	this	study	there	was	some	evidence	that	the	person	with	schizophrenia’s	basic	needs	can	be	addressed	through	identifying	willing	benefactors,	but	these	were	seen	as	precarious	links	requiring	intensive	input	and	there	was	uncertainty	about	their	sustainability.	These	interventions	were	also	only	possible	in	urban	areas	where	there	are	wealthy	donors	available.	In	many	rural	areas	there	may	be	rich	community	resources	in	terms	of	social	and	cultural	life	[43],	but	very	few	‘spare’	financial	and	material	resources	to	tap	into.	The	RISE	CBR	intervention	did	not	attempt	to	establish	new	formal	structures	at	the	sub-district	level	to	continue	aspects	of	CBR	after	the	pilot	was	completed.	Such	efforts,	which	are	proposed	by	the	WHO	CBR	guidelines	[44],	were	deemed	at	the	intervention	development	stage	to	be	unfeasible	for	the	time	frame	of	the	RISE	pilot.	Yet	in	the	pilot	there	was	also a	lack	of	interest	from	existing	social	organisations,	such	as	edir	(burial	association)	groups,	in	providing	financial	support	(assumption	2e).	Some	participants	expressed	disinterest	in	receiving	support	from	edir;	perhaps	a	more	discrete	means	of	support	would	have	been	more	attractive.	There	was	little	firm	data	to	fully	explore	this	issue.	For	whatever	reason	this	arose,	the	inability	of	CBR	workers	to	link	their	efforts	to	a	permanent	social	forum	or	structure	may	have	important	implications	for	sustainability.	Other	attempts	by	CBR	workers	to	circumvent	the	hardship	of	participants,	by	accessing	the	medication	fee	waiver,	were	also	unsuccessful.	Though	there	were	several	successes	in	supporting	income-generation,	important	challenges	also	emerged	including	a	lack	of	formal	employment	opportunities	(meaning	one	participant	moved	to	the	capital	city	to	work).	A	key	threat	to	the	feasibility	of	CBR	was	the	absence	of	continuously	available	and	affordable	medication	with	an	acceptable	side	effect	profile	(assumption	2d).	This	issue	represents	another	external	factor	that	proved	insurmountable	for	CBR	workers	in	the	pilot.	The	logistics	of	intervention	delivery	(assumption	2b)	require	
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	further	evaluation	at	scale.	There	are	indications	that	CBR	can	improve	functioning	(assumption	3a),	but	a	randomised	evaluation	remains	essential.	A	larger	pool	of	participants	may	also	provide	the	opportunity	to	evaluate	the	utility	of	family	support	groups	(assumption	3c)	and	acceptability	of	CBR	for	traditional	and	religious	healers	(assumption	1e).		The	lack	of	engagement	with	traditional	healers,	such	as	herbalists	or	tanqway	(who	are	‘sorcerers’	and	are	distinct	from	Orthodox	Christian	healers	such	as	holy	water	priests),	was	surprising	given	previous	findings	that	they	are	numerous	in	this	district	[43];	and	tanqway	in	particular	are	consulted	for	psychotic	illness	in	all	parts	of	Ethiopia	(see	Section	2.9.3).	Possible	reasons	why	CBR	workers	did	not	identify	any	traditional	healers	(for	example,	for	inclusion	in	awareness-raising)	include	that,	by	chance,	no	healers	were	present	in	the	pilot	sub-districts;	because	this	group	tends	to	remain	hidden	from	public	life;	or	possibly	due	to	reluctance	by	CBR	workers	to	engage	with	this	group.	People	with	schizophrenia	may	have	been	less	likely	to	seek	treatment	from	healers	during	the	pilot	as	formal	mental	healthcare	was	newly	available	in	the	district,	and	promoted	by	CBR.	It	is	also	conceivable	that	participants	hid	their	use	of	traditional	healers	from	CBR	workers	due	to	taboo	or	concern	that	CBR	workers	would	discourage	this.	It	should	be	noted	that	two	participants	did	openly	use	holy	water,	but	the	sites	were	outside	of	the	participants’	sub-districts	so	CBR	workers	did	not	attempt	to	engage	with	them.	In	the	pilot	CBR	workers	were	restricted	to	conducting	community	mobilisation	work	within	their	allocated	sub-district	to	maintain	comparability	to	the	trial	intervention	(which	would	be	restricted	in	this	way	to	avoid	contamination	between	clusters	(see	Chapter	8)).			
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	7.5 CONCLUSION	
Overall	CBR	is	an	acceptable	approach	for	people	with	schizophrenia	in	rural	Ethiopia.	CBR	is	likely	to	be	feasible	but	this	requires	further	evaluation	on	a	larger	scale.	CBR	may	have	the	capacity	to	improve	functioning	in	people	with	schizophrenia	through	maximising	family	and	community	support,	facilitating	access	to	mental	health	services	and	anti-psychotic	medication,	facilitating	income-generating	activities	and	increasing	hope	and	self-esteem.	However	some	of	the	contextual	factors	that	shape	illness	experience,	including	poverty	and	inaccessible	anti-psychotic	medication,	seem	to	be	beyond	the	capacity	of	CBR	to	overcome.	This	may	limit	the	potential	impact	of	CBR	on	the	lives	of	people	with	schizophrenia	in	rural	Ethiopia.		
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	8 RISE	TRIAL	PROTOCOL	
8.1 INTRODUCTION		
The	previous	chapter	presented	the	RISE	pilot,	which	generated	evidence	on	the	acceptability	and	feasibility	of	CBR	for	schizophrenia	in	practice.	This	chapter	contains	a	published	protocol	for	a	cluster	randomised	controlled	trial	to	evaluate	the	RISE	CBR	intervention.	This	trial,	which	aims	to	determine	the	effectiveness	of	CBR,	will	represent	the	‘Evaluation’	phase	of	the	MRC	framework	[1].	The	RISE	trial	began	in	September	2015,	nine	months	into	the	12	month	RISE	pilot.		The	trial	evaluation	plans	were	refined	using	the	post-pilot	theory	of	change	map	(see	Figure	7.2	in	Chapter	7),	which	outlines	the	hypothesised	pathway	through	which	the	intervention	works	and	impacts	on	the	primary	outcome	of	the	trial	(functioning).	Table	8.1	indicates	how	each	intermediate	outcome	on	this	pathway	will	be	evaluated	in	the	trial	with	one	or	more	indicators.	Achievement	of	indicators	will	be	assessed	using	qualitative,	quantitative	and	process	data.	A	theory	of	change	approach	is	beneficial	because	it	combines	the	process	and	outcome	evaluations	and	can	therefore	assess	not	just	whether,	but	how	and	why	the	intervention	had	the	observed	effect.	Conversely	if	no	effect	is	seen	this	approach	helps	to	distinguish	between	intervention	failure	and	implementation	failure.		The	main	section	of	this	chapter	is	the	published	trial	protocol	(Section	8.2).	Supplementary	information	is	then	presented	on	the	following	subjects:	how	the	trial	methods	were	piloted,	and	what	changes	were	implemented	to	arrive	at	the	final	methods	described	in	the	protocol;	additional	elements	of	the	statistical	analysis	plan	to	assess	the	validity	of	the	theory	of	change;	and	potential	limitations	to	the	trial	design	(Section	8.3).	
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Table	8.1	Trial	indicators	for	the	RISE	theory	of	change	(continued	overleaf)		
	
Theory	of	change	
intermediate	outcome		
Indicator		 Trial	data	type		 Data	source		
Pr
im
ar
y	
ou
tc
om
e	
	
Se
co
nd
ar
y	
ou
tc
om
e	
	
Q
ua
lit
at
iv
e	
	
Pr
oc
es
s	
		
CBR	workers	and	
supervisors	are	in	post		
10	CBR	workers	and	two	supervisors	retained	for	18	month	
duration	of	trial		
		 		 		 ✓		 Staff	recruitment	data		
People	with	schizophrenia	
and	caregivers	are	
identified		
182	participants	identified	across	54	sub-districts;	on	average	
2-	3	eligible	and	consenting	participants	identified	in	each	
sub-district		
		 		 		 ✓		 Participant	recruitment	data		
Community	resources	and	
leaders	are	known			
Community	engagement	tasks	2	and	3	(identify	community	
resources	and	leaders)	completed	in	all	sub-districts	within	
three	months		
		 		 		 ✓		 Sub-district	logbook		
Community	engagement	tasks	5	and	6	(meetings	with	
community	leaders	and	awareness	raising	events)	completed	
in	all	sub-districts	within	three	months		
		 		 		 ✓		 Sub-district	logbook		
Community	is	engaged	in	
CBR			
		
Good	quality	engagement	with	community	leaders		 		 		 ✓		 		 Endline	IDI	with	community	leaders;	
FGD	with	CBR	workers		
≥1	individual	mobilisation	of	community	leader/	member	in	
each	sub-district	(tasks	8-11)			
		 		 		 ✓		 Sub-district	logbook		
CBR	model	of	care	
acceptable	to	CBR	workers	
and	participants		
Reported	acceptability	of	model	of	care	by	CBR	workers	and	
participants		
		 		 ✓		 		 Endline	IDIs	with	participants	and	
FGDs	with	CBR	workers		
Needs,	goals	and	risk	
relating	to	participants	are	
known		
		
Needs	assessment,	goal	setting,	risk	assessment	and	
rehabilitation	plan	completed	for	each	participant	at	
beginning	of	Phases	1,	2	and	3			
		 		 		 ✓		 Participant	logbooks		
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Table	8.1	continued		
Theory	of	change	
intermediate	outcome		
Indicator		 Trial	data	type		 Data	source		
Pr
im
ar
y	
ou
tc
om
e	
	
Se
co
nd
ar
y	
ou
tc
om
e	
	
Q
ua
lit
at
iv
e	
	
Pr
oc
es
s	
		
CBR	workers	are	
competent		
No	CBR	worker	rated	as	‘needs	improvement’	on	any	ENACT	
items			
		 		 		 ✓		 ENACT	assessments	at	baseline		and	
12	months		
CBR	workers	deliver	CBR	
as	intended		
		
All	CBR	workers	have	minimum	of	10	observed	unannounced	
home	visits			
		 		 		 ✓		 Supervisor	logbooks		
All	CBR	workers	have	minimum	of	12	face	to	face	supervision	
sessions		
		 		 		 ✓		 Supervisor	logbooks		
CBR	workers	attend	80%	group	supervision	sessions		 		 		 		 ✓		 Supervisor	logbooks		
Supervision	perceived	to	be	useful	and	of	appropriate	
frequency		
		 		 ✓		 		 Endline	CBR	worker	FGD		
People	with	schizophrenia	
are	engaged	in	CBR	for	
intended	duration	and	
intensity		
		
90%	participants	receive	all	core	modules	in	first	3	months		 		 		 		 ✓		 Participant	logbooks		
Participants	undertake,	on	average,	90%	modules	indicated	
by	goal	setting		
		 		 		 ✓		 Participant	logbooks		
All	participants	continue	to	receive	CBR	visits	for	12	months		 		 		 		 ✓		 Participant	logbooks		
Participants	receive	approximately	22	home	visits	over	12	
months	(ideal	CBR	receipt)		
		 		 		 ✓		 Participant	logbooks		
Participants	receive	10	or	more	home	visits	over	12	months	
(minimum	adequate	CBR	receipt)		
		 		 		 ✓		 Participant	logbooks		
On	going	family	support		 Continuing	Care	Form	completed	for	all	participants	by	12	
months		
		 		 		 ✓		 Participant	logbooks		
Family	and	CBR	worker	feel	family	are	able	to	continue	
support	by	12	months		
		 		 ✓		 		 Endline	CBR	worker	FGD	and	
participants	IDI			
On	going	community	
support		
Reported	on	going	community	support	at	12	months				 		 		 ✓		 		 Endline	CBR	worker	FGD,	participants	
IDI,	community	members	IDI					
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Table	8.1	continued	
Theory	of	change	
intermediate	outcome	
Indicator	 Trial	data	type	 Data	source	
Pr
im
ar
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e	
Q
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lit
at
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e	
Pr
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s	
Improved	understanding	
of	mental	illness	and	
human	rights	
Reported	improvement	in	understanding	directly	or	indirectly	
attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	
Improved	family	stability	
and	care	and	reduced	
caregiver	burden	
Perceived	improvement	in	family	burden,	family	stability	and	
care	directly/indirectly	attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	
Lower	FIS	Burden,	IEQ	scores	(worrying	and	tension	
subscales)	and	caregiver	PHQ-9	scores	in	the	intervention	
compared	to	the	control	arm	
	 ✓ 	 	 IEQ,	FIS	Burden,	Caregiver	PHQ-9	12	
months	
Higher	IEQ	scores	(urging	and	supervision)	in	the	intervention	
compared	to	the	control	arm	
	 ✓ 	 	 IEQ	12	months	
Improved	access	to	mental	
healthcare	and	increased	
medication	adherence	
Increased	%	with	≥1	visit	to	health	facility	for	mental	health	in	
last	3	months	in	intervention	compared	to	control	arm	
	 ✓ 	 	 Adapted	 CSRI	 baseline	 and	 12	
months	
Reported	attendance	to	facility	for	mental	health	directly	or	
indirectly	attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	
Medication	fee	waiver	obtained	when	required	 	 	 ✓ 	 Endline	CBR	worker	FGD	
Reported	ability	to	pay	for	anti-psychotic	medication	directly	
or	indirectly	attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	
Lower	%	stop	taking	medication	because	unaffordable	&	
greater	%	received	anti-psychotic	medication	for	free	in	
intervention	compared	to	control	arm	
	 ✓ 	 	 Adapted	 medication	 adherence	
questions	at	12	months	
Greater	proportion	adhering	to	medication	sometimes	or	
always	in	intervention	arm	compared	to	control	arm	
	 ✓ 	 	 Medication	adherence	question		 		
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Table	8.1	continued	
Theory	of	change	
intermediate	outcome	
Indicator	 Trial	data	type	 Data	source	
Pr
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Q
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s	
Reduced	stigma	and	abuse	
against	people	with	
schizophrenia	
Perceived	reduction	in	stigma,	violence	and	use	of	restraint	
directly	or	indirectly	attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI,	community	members	IDI	
Reduced	incidence	of	restraint	in	last	6	months	in	
intervention	arm	compared	to	control	arm	
	 ✓ 	 	 Restraint	questions	12	months	
Social	inclusion	of	people	
with	schizophrenia	
Perceived	improvement	in	social	inclusion	after	12	months	
directly	or	indirectly	attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI,	community	members	IDI	
Lower	DISC-12	scores	in	intervention	arm	compared	to	
control	arm	
	 ✓ 	 	 DISC-12	12	months	
Improved	physical	health	
and	appearance	
Perceived	improvement	in	physical	health	after	12	months	
directly	or	indirectly	attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	
Greater	BMI	in	intervention	arm	compared	to	control	arm	 	 ✓ 	 	 BMI	12	months	
Lower	AUDIT	scores	in	intervention	arm	compared	to	control	
arm	
	 ✓ 	 	 AUDIT	12	months	
Reported	attendance	to	facility	for	physical	health	directly	or	
indirectly	attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	12	months	
Increased	%	with	≥1	visit	to	health	facility	for	physical	health	
in	last	three	months	in	intervention	arm	compared	to	control	
arm	
	 ✓ 	 	 Adapted	 CSRI	 baseline	 and	 12	
months	
Increased	income	 Perceived	improvement	in	income	or	economic	status	directly	
or	indirectly	attributable	to	CBR	
	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	
Greater	economic	activity	in	intervention	arm	compared	to	
control	arm	
	 ✓ 	 	 Economic	activity	12	months		 		
244
	 245	
Table	8.1	continued	
Theory	of	change	
intermediate	outcome	
Indicator	 Trial	data	type	 Data	source	
Pr
im
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s		
Improved	symptoms	and	
reduced	relapse	
Perceived	improvement	in	symptoms	directly	or	indirectly	
attributable	to	CBR	
	 	 ✓ 	 	 Endline	CBR	worker	FGD,	participants	
IDI		
Lower	BPRS-E,	CGI,	PHQ-9	scores	in	intervention	arm	
compared	to	control	arm	
	 ✓ 	 	 	 BPRSE,	CGI	and	PHQ-9	12	months	
Fewer	relapses	in	last	6	months,	measured	by	LCS	and	LIFE,	in	
intervention	arm	compared	to	control	arm	
	 ✓ 	 	 	 LCS	and	LIFE	12	months	
Increased	involvement	in	
decision	making	about	
care	
Perceived	greater	ability	to	enact	desired	treatment	choices	
directly	or	indirectly	attributable	to	CBR		
	 	 ✓ 	 	 Endline	CBR	worker	FGD,	participants	
IDI		
Reported	use	of	medication	alongside	traditional	medicine,	if	
desired,	directly	or	indirectly	attributable	to	CBR	
	 	 ✓ 	 	 Endline	CBR	worker	FGD,	participants	
IDI		
Increased	self	esteem	and	
hope	
Perceived	improvement	in	hope	and/	or	self-esteem	directly	
or	indirectly	attributable	to	CBR	
	 	 ✓ 	 	 Endline	CBR	worker	FGD,	participants	
IDI	
Lower	PHQ-9	scores	in	intervention	arm	compared	to	control	
arm	
	 ✓ 	  	 PHQ-	9	12	months	
Sustained	improved	
functioning	
WHODAS	scores	20%	lower	in	intervention	arm	compared	to	
control	arm	at	12	months	
✓ 	 	 	 	 WHODAS	12	months	
Perceived	improvement	in	functioning	directly	or	indirectly	
attributable	to	CBR	
	 	 ✓ 	 	 Endline	CBR	worker	FGD,	participants	
IDI		IDI:	In-depth	interview,	FGD:	Focus	group	discussion,	ENACT:	Enhancing	Assessment	of	Common	Therapeutic	factors	rating	scale,	FIS:	Family	interview	schedule,	IEQ:	Involvement	Evaluation	Questionnaire,	PHQ-9:	Patient	Health	Questionnaire,	DISC:	Discrimination	and	Stigma	Scale-12,	CSRI:	Client	Service	Receipt	Inventory,	AUDIT:	Alcohol	Use	Disorder	Identification	Test,	BPRS-E:	Brief	Psychiatric	Rating	Scale-	Expanded	version,	CGI:	Clinical	Global	Impression,	LCS:	Life	Chart	Schedule,	LIFE	Chart:	Longitudinal	Interval	Follow-up	Evaluation,	WHODAS:	WHO	Disability	Assessment	Schedule	
8.2 RESEARCH	PAPER	
The	Standard	Protocol	Items:	Recommendations	for	Interventional	Trials	(SPIRIT)	statement	is	found	in	Appendix	E	(i).			Ethical	approvals	for	the	trial	are	found	in	Appendix	D	(iv).	Minor	corrections	on	manuscript:			
1. Page	2:	Mortality	was	incorrectly	reported	as	two	times	greater	than	general
population;	this	should	read	‘three	times	greater’	[2]
2. Page	4:	Literacy	rates	in	Sodo	were	incorrectly	reported	as	45%;	this	should	read
‘51%’[3]
3. Page 6: inclusion criteria (4) should state ‘aged 18 years or older’
4. Page	6:	inclusion	criteria	inclusion	criteria	(6)	(b)	should	read	‘patient	or	proxy-	
reported	WHODAS	≥35’
5. Page	9:	Involvement	Evaluation	Questionnaire
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Intervention for people with Schizophrenia 
in Ethiopia (RISE): study protocol for a 
cluster randomised controlled trial 
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Abstract 
Background: Care for most people with schizophrenia is best delivered in the community and evidence-based 
guidelines recommend combining both medication and a psychosocial intervention, such as community-based 
rehabilitation. There is emerging evidence that community-based rehabilitation for schizophrenia is effective at 
reducing disability in middle-income country settings, yet there is no published evidence on the effectiveness in 
settings with fewer mental health resources. This paper describes the protocol of a study that aims to evaluate the 
effectiveness of community-based rehabilitation as an adjunct to health facility-based care in rural Ethiopia. 
Methods: This is a cluster randomised trial set in a rural district in Ethiopia, with sub-district as the unit of 
randomisation. Participants will be recruited from an existing cohort of people with schizophrenia receiving 
treatment in primary care. Fifty-four sub-districts will be randomly allocated in a 1:1 ratio to facility-based care plus 
community-based rehabilitation (intervention arm) or facility-based care alone (control arm). Facility-based care 
consists of treatment by a nurse or health officer in primary care (antipsychotic medication, basic psychoeducation 
and follow-up) with referral to a psychiatric nurse-led outpatient clinic or psychiatric hospital when required. Trained 
community-based rehabilitation workers will deliver a manualised community-based rehabilitation intervention, with 
regular individual and group supervision. We aim to recruit 182 people with schizophrenia and their caregivers. 
Potential participants will be screened for eligibility, including enduring or disabling illness. Participants will be recruited 
after providing informed consent or, for participants without decision-making capacity, after the primary caregiver 
gives permission on behalf of the participant. The primary outcome is disability measured with the 36-item WHO 
Disability Assessment Schedule (WHODAS) version 2.0 at 12 months. The sample size will allow us to detect a 20 % 
difference in WHODAS 2.0 scores between treatment arms with 85 % power. Secondary outcomes include change in 
symptom severity, economic activity, physical restraint, discrimination and caregiver burden. 
Discussion: This is the first trial of community-based rehabilitation for schizophrenia and will determine, as a proof of 
concept, the added value of community-based rehabilitation compared to facility-based care alone in a low-income 
country with scarce mental health resources. 
Trial registration: Clinical Trials.gov Identifier NCT02160249. Registered on 3 June 2014. 
Keywords: Schizophrenia, Psychosis, Community-based rehabilitation, Disability, Cluster randomised trial, Ethiopia, 
Low-income country 
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Background 
Schizophrenia can be a severe, chronic and disabling 
condition, which places a high social and economic bur- 
den on individuals [1], families [2] and society. The major- 
ity of people with schizophrenia in sub-Saharan Africa do 
not have access to adequate care [3]. Over half of the 
people with schizophrenia in Ethiopia experience continu- 
ous or episodic illness over a 10-year period [4], where the 
treatment gap is estimated to be 90 % [5, 6]. Mortality is 
high; the standardised mortality ratio for people with 
schizophrenia in Ethiopia is twice that of the general 
population [7]. People with schizophrenia are also likely to 
experience stigma and discrimination [8, 9] and human 
rights violations [10]. 
According to global consensus, supported by scientific 
review of the evidence and the experience of mental 
health system experts, a comprehensive mental health sys- 
tem includes both community- and hospital-based com- 
ponents of care [11, 12] and should incorporate both 
medication and psychosocial interventions [13, 14]. Rela- 
tively low-intensity psychosocial community-based pro- 
grammes, which are likely to be most feasible, have been 
shown to be effective in low- and middle-income country 
(LMIC) settings [15–17]. To date such programmes have 
typically involved four groups: the patient, family mem- 
bers, a community-based non-specialist key worker and a 
psychiatrist [14]. In particular, the World Health Organi- 
sation’s (WHO’s) mental health Gap Action Programme 
(mhGAP) recommends community-based rehabilitation 
(CBR) as an adjunct to medication for schizophrenia [18]. 
CBR is a general approach with the aim to improve the 
quality of life and social inclusion of people with disabil- 
ities [19] and is typically delivered by trained lay workers 
from the local community. Key pillars of a CBR 
programme include interventions that promote health, 
education, livelihood, and social life. In addition there is a 
cross-cutting emphasis on empowerment, such as support- 
ing people with disabilities to make their own decisions. 
CBR is put into practice through the joint endeavours of 
people with disabilities, their caregivers, community mem- 
bers and relevant governmental and non-governmental 
services, including health services [20]. 
CBR programmes have traditionally focussed on people 
with physical disabilities. There is increasing recognition 
that people with mental disorders may also receive benefit 
from a service model that integrates mental health and 
economic development [21, 22]. CBR may impact on clin- 
ical and disability outcomes in people with schizophrenia 
by improving understanding of the illness, increasing ad- 
herence to antipsychotic medication, reducing stigma and 
improving social functioning. 
Globally there are a few examples of CBR programmes 
for people with mental disorders [17, 23–30]. A systematic 
review found that CBR may improve clinical outcomes 
 
and functioning for schizophrenia, dementia and intellec- 
tual disabilities in LMICs [20]. However, no randomised 
controlled trials (RCTs) of CBR for schizophrenia that in- 
volved community mobilisation (defined as ‘a strategy 
which aims to engage community members and empower 
them for change or action’ [19]), or focussed primarily on 
any CBR pillar other than health, were included [20]. Fur- 
thermore, there were no studies set in countries defined 
by the World Bank as being low-income [20]. The more 
recent COmmunity care for People with Schizophrenia in 
India (COPSI) trial [31], a study from India (a middle- 
income country), found that collaborative community care 
modestly improved disability and symptoms in people 
with schizophrenia [17]. The greatest effects were seen in 
rural areas with fewer formal mental health resources. 
Whilst influenced by CBR, the intervention did not in- 
clude community mobilisation, and participants had ac- 
cess to psychiatrists as a key component of care. 
To our knowledge there has been no previous rando- 
mised trial investigating the impact of a comprehensive 
CBR programme,  including  both  home-based  care  and 
a structured community mobilisation element, on out- 
comes in people with schizophrenia. Furthermore, the 
effectiveness of CBR for schizophrenia has not previ- 
ously been examined in a low-income setting, such as 
Ethiopia, which has minimal formal mental health re- 
sources. Currently, most people with schizophrenia in 
rural Ethiopia will never have access to a psychiatrist, 
psychiatric nurse or other mental health professional. 
However, mental health care is being scaled up in 
Ethiopia by training general health workers, largely in 
primary care, to deliver care for people with mental dis- 
orders. This process illustrates the Ethiopian Ministry of 
Health’s efforts to improve access to mental health care 
[32]. 
Extensive formative research using a variety of 
methods nested within a Theory of Change  framework 
has enabled the design of a culturally and contextually 
appropriate CBR intervention for people with schizo- 
phrenia that is acceptable and feasible to service  users 
and providers in rural Ethiopia [33, 34]. The CBR inter- 
vention, which includes home-based care, community 
mobilisation and family support groups, has been 
piloted. This paper presents the protocol for the Re- 
habilitation Intervention for  people  with  Schizophrenia 
in Ethiopia (RISE) project, a cluster randomised trial, 
which will evaluate the effectiveness of this CBR 
intervention. 
 
Objectives 
Primary objective 
To evaluate the effectiveness of CBR as an adjunct to 
facility-based care (FBC), compared to FBC alone, in re- 
ducing  disability  related  to schizophrenia  at  12 months, 
249
Asher et al. Trials (2016) 17:299 Page 3 of 14 
 
 
 
 
measured by the WHO Disability Assessment Schedule 
(WHODAS) version 2.0 in patients with evidence  of 
poor response or lack of engagement in care over the 
preceding  6 months. 
 
Secondary objectives 
 
1. To evaluate the effectiveness of CBR plus FBC 
compared to FBC alone in reducing clinical 
symptoms, reducing relapse, increasing medication 
adherence, improving economic activity, reducing 
physical restraint, reducing discrimination, and 
improving nutritional status in people with 
schizophrenia. 
2. To evaluate the effectiveness of CBR plus FBC 
compared to FBC alone in reducing family burden, 
stigma and depression, and improving economic 
activity in caregivers of people with schizophrenia 
3. To explore the acceptability and feasibility of CBR 
from the perspective of (1) those receiving the 
treatment, (2) their families, and (3) those delivering 
the treatment. 
 
4. To determine the cost-effectiveness of CBR plus 
FBC compared to FBC alone. 
5. To investigate the process through which CBR 
achieves its impact. 
 
Primary hypothesis 
People with schizophrenia who receive CBR in addition 
to FBC will experience greater reductions in disability 
compared to those who receive only FBC, to the order     
of 20 % absolute difference in WHODAS 2.0 score be- 
tween groups, over a 12-month   period. 
 
Methods 
Study design 
The design is a cluster randomised controlled trial with 
sub-district (pre-defined  administrative  unit  consisting 
of several villages together) as the unit of randomisation. 
The study flow chart is presented in Fig. 1. From 58 sub-
districts in the study district, four sub-districts were sites 
for the pilot and the remaining 54 sub-districts will be 
included for the actual trial; 27 will be randomly allo- 
cated  to  the  intervention  arm  (FBC  plus  CBR)  and 27 
 
 
Fig. 1 RISE flow chart 
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randomly allocated to the control arm (FBC alone). In 
total, 182 participant dyads (patients and their caregivers) 
will be recruited. On average there will be 3.4 participant 
dyads per sub-district. 
Cluster randomisation is the chosen method of ran- 
domisation because first, CBR includes community-level 
elements and family support groups, based on sub- 
districts, so individual randomisation is not possible; sec- 
ond, it is logistically more convenient to  concentrate 
CBR workload in fewer sub-districts; and third there is 
increased acceptability if all participants in a sub-district 
are allocated to either intervention or control arms. This 
paper follows the Standard Protocol Items: Recommen- 
dations for Interventional Trials (SPIRIT) recommenda- 
tions for trial protocols (see Additional file  1). 
 
Setting 
The trial will take place in Sodo district, Gurage Zone, 
Southern Nations, Nationalities and Populations Region 
(SNNPR) in Ethiopia. The administrative town of Sodo, 
Bui, lies 100 km from Addis Ababa. Sodo district has a 
population of 170,000 persons in 58 sub-districts: four 
urban and 54 rural. Most people live in one-room mud 
and straw houses and work as  subsistence farmers. 
About 45% of the population are literate and the major- 
ity are Orthodox Christian by  religion. 
There is a psychiatric nurse-led outpatient clinic at the 
general hospital in Bui. There is a similar unit at Butajira 
hospital, which is 30 km away from Bui in the neigh- 
bouring district. Primary health care is delivered through 
eight primary health care centres staffed by health offi- 
cers and general nurses. Each health centre oversees 
between four and 11 health posts, staffed by two health 
extension workers (HEWs). Each health post covers a 
sub-district, with a population of 2800–5000 people. 
Health care costs are largely out-of-pocket with a free 
waiver available for the poorest; in practice a tiny minor- 
ity of the population are likely to be in receipt of this 
waiver. 
 
Context of the study 
The RISE trial is nested in PRIME (PRogramme for Im- 
proving Mental healthcarE). PRIME is a multicountry re- 
search consortium that aims to generate evidence on the 
implementation and scaling up of packages of care for 
priority mental disorders in primary health care  in 
LMICs [35, 36]. As part of the PRIME project, a com- 
prehensive mental health care plan was developed for 
Ethiopia [37–39] and, from December 2014, facility- 
based care for schizophrenia was embedded in primary 
health care centres in Sodo district. Health officers and 
nurses were trained in the detection and treatment of 
schizophrenia, including the prescription of anti- 
psychotic   medication   and   psychoeducation.    Training 
 
followed the WHO’s mhGAP and evidence-based guide- 
lines [18, 40], adapted for the Ethiopian context. PRIME 
identified people with schizophrenia in Sodo using the 
Butajira key informant method [41] and, from December 
2014, began following up those invited to access FBC in   
a 12-month treatment cohort. A subsample of the  
PRIME cohort participants will be recruited to the RISE 
trial at the PRIME 6-month data collection. The ration- 
ale for recruiting into the trial  after  participants  have  
had 6 months access to FBC is that if this intervention 
were scaled up in a resource-poor setting such as 
Ethiopia, it would only be made available for those with 
enduring illness or poor treatment   outcomes. 
 
Interventions 
Facility-based care 
FBC will be available to all participants in the RISE trial. 
The frequency of contact with FBC will be determined  
by clinical need. Within formal health care, FBC is a 
three-tier system, but the majority of care will be deliv- 
ered at tier 1, which is primary care (Table   1). 
 
Community-based  rehabilitation 
Intervention  development 
The CBR intervention was constructed through in-depth 
intervention development work as described in detail 
elsewhere [34, 42]. The work included a literature  re- 
view, situational analysis [43, 44], an intervention devel- 
opment workshop, participatory meetings, qualitative 
interviews with a range of stakeholders, including people 
with schizophrenia, their caregivers, psychiatrists and 
community leaders, and collaboration with an existing 
CBR project, RAPID (Rehabilitation And Prevention Ini- 
tiative against Disabilities). RAPID is an Ethiopian CBR 
project for children with  disabilities. 
 
CBR worker recruitment and training 
Eleven CBR workers were recruited according to the cri- 
teria: (1) completed tenth grade education (secondary 
school), (2) resident in Sodo district, and (3) interest in 
community work. Training lasted for 5 weeks and com- 
prised an equal split of classroom teaching and  field 
work, including home visits to people with schizophrenia 
and on-the-job training at RAPID. Psychiatrists and CBR 
trainers from RAPID delivered the training. Competency 
was assessed using role-plays and patient vignettes. 
 
Pilot 
A 12-month pilot was conducted. The pilot included ten 
people with schizophrenia and their families living  in  
four sub-districts not involved in the main  trial.  The 
aims of the pilot were to determine the acceptability and 
feasibility of the CBR intervention and to refine the 
intervention    and    trial    design    as    needed.      Major 
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Table 1 Facility-based care three-tier system for the treatment of mental illness 
Location Staff Tasks Referral 
Tier 1: primary care 
Eight health centres across 
Sodo district 
 
 
 
 
 
 
 
 
 
Tier 2: general secondary care 
Health officers 
and nurses 
• Prescribe antipsychotic medication (oral haloperidol 
or chlorpromazine) and monitor response 
• Manage side-effects 
• Monitor suicide risk 
• Review physical health 
• Screen for substance misuse 
• Provide basic psychoeducation 
(information about schizophrenia) 
• Provide regular follow-up 
• Refer to tier 2 in the following scenarios: 
o Active suicidal intent 
o Inadequate oral intake of fluid or food 
o Risk of violence to others and/or risk 
of serious self-neglect 
o Persistently non-adherent to  medication 
o Acutely disturbed and not 
manageable at home 
o Pregnancy/breastfeeding 
o Medical complications 
o Unmanageable side-effects 
Psychiatric outpatient clinic at 
Butajira Hospital 
 
Tier 3: specialist care 
Ammanuel Psychiatric 
Hospital, Addis Ababa 
Psychiatric nurse  • Specialist review 
• Initiate depot injection where required 
 
 
 
Psychiatrist • Specialist review 
• Inpatient admission where  required 
• Refer to tier 3 when inpatient care is 
required 
• Refer back to tier 1 for follow-up 
 
 
• Refer back to tier 1 and/or tier 2 for 
follow-up 
 
 
 
adjustments to the intervention and trial design were 
made prior to the trial starting. Minor adjustments may 
be made to the latter components of the CBR interven- 
tion on the basis of pilot findings. 
 
Trial CBR delivery 
One or two CBR workers will be attached to each health 
centre and each will cover two or three  sub-districts.  
Each CBR worker will have approximately eight people 
with schizophrenia under their care. The  delivery  of 
CBR for schizophrenia will be the only task for the CBR 
workers. CBR delivery will commence immediately after 
recruitment   into   the   trial   and   will   continue   for    
12 months. The CBR visits will take place at the partici- 
pants’ home and last 30–90 minutes. The intervention is 
delivered in three phases (Table  2). In phase 1, lasting 2 
to 3 months, there are weekly home visits and the focus   
is on engagement with the family and addressing core 
needs through compulsory modules such as ‘Under- 
standing Schizophrenia’. In phase 2, lasting approxi- 
mately 5 to 6 months, home visits are every 2 weeks and 
address the specific needs of the individual through op- 
tional modules such as ‘Getting Back to Work’. In phase 
3, lasting approximately 4 months, the emphasis is on 
preventing relapse as well as maintaining the progress 
made towards addressing specific needs. CBR workers 
conduct community mobilisation work and may run 
family support groups alongside the home visits. The de- 
tailed content of CBR at each phase of the intervention   
is described in Table 1. Flexibility will be encouraged ac- 
cording to the needs of the individual participant  and  
their caregiver. CBR delivery will be guided by a manual 
that outlines steps for the delivery of each module and 
community   engagement   task,   procedures   for  referral 
and how to deal with difficult situations, for example, 
suicidal ideation. Two supervisors will maintain an over- 
view of the frequency, content and quality of the home 
visits by CBR workers for each participant. Supervision 
will include monthly unannounced observed sessions, 
with individual face-to-face supervision and group 
supervision every 2 to 4 weeks. Unannounced visits will 
take place only with the prior permission of participants. 
The trial coordinator will attend group supervision 
monthly and conduct a paper-based review of all cases 
every 2 weeks with each supervisor. The coordinator will 
ensure the on-going fidelity of CBR delivery and guide 
top-up training sessions for CBR workers where 
required. 
 
Selection and randomisation of clusters 
We will aim to include all 54 sub-districts in Sodo dis- 
trict (after excluding the four pilot sub-districts). The 
randomisation of sub-districts into CBR plus FBC and 
FBC arms will be stratified by health centre. A minimisa- 
tion algorithm [45] will be employed to ensure balance 
for (1) urban/rural location, (2) number of potential 
participants (i.e. cases of schizophrenia in the PRIME 
cohort) in the sub-district, and (3) mean WHODAS 2.0 
score in the sub-district at PRIME cohort baseline. All 
these factors may potentially impact on the primary out- 
come. PRIME cohort baseline WHODAS 2.0 scores will 
only provide an estimate of the disability level of poten- 
tial participants as this data will not be available for the 
entire pool of trial participants and will not represent 
disability levels at the time of recruitment. The alloca- 
tion sequence will be generated randomly from the set     
of optimal sequences [46]. An independent  statistician 
will generate the allocation list for sub-districts. This    list 
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Table 2 RISE community-based rehabilitation (CBR) intervention  outline 
Phase Months Visits  
Assessment and family 
CBR activities 
Community  mobilisation 
 
Family-level interventions 	 	 	 engagement 	 	
1: Intensive ~1–3 Weekly • Developing therapeutic • Resource mapping for sub-district, e.g. Core modules: 
engagement 	 	 alliance with family 
• Needs assessment 
churches, schools, edir groups (traditional 
burial association), Women’s Association, 
• Understanding schizophrenia 
• Improving access to health care 	 • Risk assessment literacy groups, religious groups and • Dealing with human rights issues 
• Goal setting for phase 1 traditional healers • Preparing for a crisis 
• Rehabilitation plan • Initial awareness-raising and mobilisation, 	
 
 
 
 
2: Stabilisation ~4–8 Fortnightly  • Update needs assessment 
• Risk assessment 
• Goal setting for phase 2 
• Update rehabilitation plan 
 
 
 
 
 
 
 
 
 
 
 
 
3: Maintenance  ~9–12   Monthly • Update needs 
assessment 
• Risk assessment 
• Goal setting for phase 3 
• Update rehabilitation 
plan 
• Prepare for termination 
• Continuing care 
assessment 
targeting health extension worker, 
community leaders and traditional  healers 
• Awareness raising meeting/s with general 
public in sub-district 
• Facilitate access to relevant community 
resources 
• Consolidate mobilisation and awareness 
raising 
 
 
 
 
 
 
 
 
 
 
 
 
• Consolidate access to community 
resources 
• Consolidate awareness raising and 
mobilisation 
 
 
 
 
Optional modules: 
• Supporting individuals to take 
medication 
• Improving the family environment 
(coping skills, marital problems) 
• Improving day-to-day functioning 
• Taking part in community life 
• Getting back to work 
• Dealing with distressing symptoms 
• Dealing with stigma and discrimination 
• Improving physical health 
• Dealing with stress and anger 
• Improving literacy 
• Family support groups 
• Taking control of your illness (relapse 
prevention  and management) 
Core module: 
• Taking control of your illness (relapse 
prevention and management) if not 
completed in phase 2Optional 
modules 
• Any of the phase 2 modules 
 
 
 
is will be kept securely by the trial coordinator and uti- 
lised to determine allocation status of new   recruits. 
 
Participant inclusion criteria 
There are no specific exclusion  criteria.  Participants 
must meet all of the following criteria to be included: (1) 
be a participant in the PRIME cohort study or not en- 
gaged in FBC but resident in Sodo district, (2) have been 
resident in the sub-district for more than 6 months and 
have no immediate plans to leave the sub-district,  (3) 
have a primary caregiver who is willing to participate in 
the study, (4) be aged 18 years older, (5) have a diagnosis 
of schizophrenia spectrum disorder (schizophrenia, schi- 
zoaffective disorder or schizophreniform disorder) using 
Diagnostic and Statistical Manual of Mental Disorders, 
version four (DSM-IV) [47] criteria, and (6) have evi- 
dence of enduring or disabling illness demonstrated by 
one or more of the following: (a) Brief Psychiatric Rating 
Scale – Expanded version (BPRS-E) score ≥52 (equiva- 
lent to at least ‘moderately ill’ on the Clinical Global Im- 
pression  (CGI)  scale)  [48],  (b)  36-item  WHODAS  2.0 
score ≥35, (c) have continuous illness over the   preceding 
6 months, as assessed using the Life Chart Schedule 
(LCS), (4) be symptomatic in 3 out of the last 6 months, 
as assessed using the LIFE chart, or  (e)  have  a  CGI 
score ≥3 (at least ‘mildly ill’). The final criterion allows  
us to include the group expected to benefit  the  most  
from CBR and also reflects the threshold at which CBR 
could realistically be offered in this resource-constrained 
setting. 
 
Participant flow 
Participant identification 
PRIME aimed to detect all people with schizophrenia in 
Sodo by training key informants (HEWs and community 
leaders) to identify possible cases. This method was suc- 
cessful at identifying people with psychosis in previous 
Ethiopian studies, including in the neighbouring district 
[41, 49, 50]. Possible cases of schizophrenia were invited 
to their health centre for diagnosis and treatment. If they 
attended, a psychiatric nurse conducted a diagnostic 
interview  using  the  OPCRIT  (Operational  Criteria   for 
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Research), an operational criteria checklist for psychotic 
and affective illness [51, 52]. The OPCRIT facilitated the 
nurse to determine if participants had a DSM-IV diagno- 
sis. Substantial inter-rater reliability and convergent valid- 
ity of the OPCRIT has been demonstrated in  other 
settings [53] and there is good experience of using 
OPCRIT in a clinical trial of schizophrenia in the neigh- 
bouring district [54]. All confirmed cases of schizophrenia 
spectrum disorders were offered FBC and, where they 
consented, were recruited into the PRIME cohort. Prior to 
RISE recruitment a psychiatrist conducted an additional 
paper-based diagnosis review of all PRIME cohort partici- 
pants using the clinical instruments completed at baseline, 
including the OPCRIT. Where the  psychiatrist  deemed 
the diagnosis unclear, a repeat clinical assessment by the 
psychiatric nurse will be completed prior to RISE 
recruitment. 
 
Participant  recruitment 
Participants for the RISE trial will be primarily recruited 
from people who were identified and received a diagno- 
sis of a  schizophrenia  spectrum disorder at the baseline 
of the PRIME cohort and their caregivers, and were liv- 
ing in the sub-districts selected  to  participate  in  the 
RISE trial. However, we will recruit from up to  four  
pools of potential participants, known as recruitment 
levels. 
Level 1 recruitment comprises recruitment from the 
PRIME cohort at the 6-month data collection interview, 
which takes place at the health centre. Level 2 recruit- 
ment comprises recruitment from PRIME cohort drop- 
outs, i.e. those who do not attend the PRIME 6-month 
data collection. Level 3 recruitment comprises recruit- 
ment from those who were identified by key informants 
but have never attended FBC. This group had some 
baseline data collected through a home visit by PRIME 
as part of a non-engagement study. Level 4 recruitment 
comprises recruitment from those individuals who were 
identified by key informants as potential cases with 
schizophrenia after the recruitment for the PRIME co- 
hort had ended. Level 1 recruitment will take place at 
consecutive pairs of health centre catchment areas, de- 
termined by the PRIME data collection schedule. For 
levels 2, 3 and 4 recruitment, all sub-districts will be 
covered equally to avoid unequal recruitment by treat- 
ment arm. RISE recruitment will take place either at the 
health centre at PRIME data collection or at a follow-up 
visit at the participant’s home. 
The aim of incorporating non-PRIME cohort partici- 
pants is that these non-engagers in care are  likely  to  
have more complex needs, and be  more  symptomatic  
and disabled. They are, therefore,  the  individuals  who 
are likely to receive the most benefit from CBR. Some of 
these individuals will not be accessing care because   they 
 
are currently well, and will be excluded from the trial 
using the standard recruitment criteria. 
Within each CBR worker area, the transition from one 
recruitment level to the next will continue until approxi- 
mately eight participants have been recruited for each 
CBR worker. The aim is to ensure CBR workers have 
equal workloads, to ensure CBR delivery is as uniform   
as possible. If it is not possible to recruit eight partici- 
pants in any particular CBR worker area (after exhaust- 
ing all recruitment levels), recruitment will continue at 
other CBR worker areas whilst aiming to keep the num- 
ber of participants per CBR worker as equal as possible. 
Recruitment will proceed to the next recruitment level/s 
until a maximum of 12 participants per CBR worker are 
recruited. This is because the maximum feasible workload 
for CBR workers is expected to be 12 participants. There 
may be slight adjustments to the number of participants 
recruited per CBR worker depending on drop-out of CBR 
workers or other unforeseen factors. 
 
Recruitment procedures 
The recruitment procedures for each of these groups 
will be detailed in dedicated Standard Operating Proce- 
dures (SOPs). Potential participants in the PRIME co- 
hort will have their eligibility for the RISE trial checked 
by the trial coordinator or trial nurse using PRIME 6- 
month data (i.e. WHODAS 2.0, BPRS-E, CGI, LIFE 
chart and LCS). Eligible participants will be invited to 
join the RISE trial by a trial nurse. They will be given in- 
formation about the trial in a way appropriate to the 
participants’ literacy level, which may include verbal in- 
formation. The trial nurse will then conduct the consent 
procedures. 
Participants not in the PRIME cohort will have an initial 
consent taken, before data is collected on the eligibility in- 
struments, including the diagnostic interview. Those who 
are eligible will then be consented to take part in the RISE 
trial. Those who consent (or, for those without decision- 
making capacity, whose caregiver consents on their be- 
half) will complete the full RISE baseline data collection. 
 
Allocation 
The randomisation of sub-districts to intervention and 
control arms will take place before recruitment. The ra- 
tionale is that it is necessary to commence delivery of    
the CBR intervention  immediately  after  recruitment. 
The trial coordinator will keep the sub-district allocation 
list secure on a password-protected document. To re-  
duce selection bias, the potential participant will not be 
informed of the allocation of their sub-district until after 
they have consented to participate and all baseline data 
collection is complete. The trial nurse will also be blind   
to the allocation. The trial coordinator will assign a 
unique  trial  identifier  (ID)  to  each  new  participant and 
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Table 3 Summary of outcome measures 
Outcome Instrument 
 
Psychiatric nurse-administered interview with  patient 
Symptom severity Brief Psychiatric Rating Scale – Expanded version (BPRS- E) [62]. A 24-item instrument 
focussing on psychotic symptoms, but also covering somatic concerns, anxiety, 
depression and mania. Individual BPRS-E items and total score are sensitive to change 
in persons with persistent schizophrenia [63]. The scale has been previously used in 
Ethiopia [64] and has recently been shown to have good inter-rater reliability (>0.8 
comparing psychiatric nurses and psychiatrists) in this setting (personal communication, 
Dr Charlotte Hanlon) [65]. As the scale is clinician-rated this allows for sociocultural 
sensitivity. Inter-rater and test-retest reliability as well as internal consistency are also 
high in high-income settings [66] 
Clinical impression Clinical Global Impression (CGI). A widely used assessment tool, comprising three 
scales, to determine overall illness severity and efficacy of intervention [67] 
Relapse Life Chart Schedule (LCS) including course type and relapses [68]. 
Longitudinal Interval Follow-up Evaluation: DSM-IV version (LIFE). A semi-structured 
interview to determine the subject’s psychiatric course since the last interview [69]. 
Satisfactory validation has been conducted in Ethiopia and the reliability data is 
currently being analysed. Any necessary adjustments will be made on the basis of 
the inter-rater reliability assessments (personal communication, Dr Girmay Medhin) 
Lay data collector-administered interview with the patient 
Disability Patient-reported 36-item WHODAS (Disability Assessment Schedule) 2.0 [55]. 
A validated indigenous functioning scale, specific to the Ethiopian context [70] 
Economic activity Measure covering current employment, subsistence farming work,  income, and 
hunger due to lack of resources 
Discrimination Section 1 of the Discrimination and Stigma Scale-12 (DISC-12) [71] 
Medication adherence Adapted Morisky Medication Adherence Scale (MMAS) [72]. This scale has previously 
been utilised for antipsychotic medication adherence [31, 73]. Good construct 
validity has been demonstrated in Ethiopia (personal communication, Dr Charlotte 
Hanlon) [65]). 
A 5-point nominal scale measuring frequency of adherence [31] 
Health service use and costs including engagement with 
FBC for schizophrenia and physical health conditions 
 
 
Access to community interventions (including CBR 
components) 
An adapted version of The Client Service Receipt Inventory (CSRI) will enquire 
systematically about the costs (direct and indirect) of help-seeking from biomedical, 
traditional and religious healers [74, 75]. The CSRI has been translated into Amharic 
and found to be acceptable and feasible [76] 
Including person administering the component, and satisfaction 
Physical restraint In the preceding 1 and 6 months. Includes assessment of duration, perpetrator, 
setting and reason for restraint 
Nutritional status Measurement of weight (kg) and height (m) will be carried out [77] and body mass 
index (weight in kg/(height in m)2) calculated 
Depression The Patient Health Questionnaire- 9 (PHQ-9). A 9-item scale which scores each of 
the 9 DSM-IV criteria for depressive disorders as ‘0’ (not at all) to ‘3’ (nearly every 
day) [78]. Shown to be valid in the Ethiopian setting [79] 
Alcohol use disorder The AUDIT (Alcohol Use Disorders Identification Test) is a ten-item tool to detect 
hazardous drinking [80] 
Social support Oslo-3 Social Support Scale [81] 
Serious adverse events Occurrence of serious adverse events (for example, suicide attempt and 
hospitalisation for medical emergency) in the last 6 months 
Lay data collector interview with the primary caregiver 
Patient disability The 36-item WHODAS 2.0 proxy version will assess functional impairment from the 
caregiver’s perspective [82, 83] 
Economic activity of caregiver Employment, subsistence farming work, income, and hunger due to lack of 
resources 
Caregiver burden The Burden Section of the WHO ‘Family Interview Schedule’. This scale, covering 
financial strain and work difficulties has been previously used in Ethiopia for persons 
with schizophrenia [2]. 
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Table 3 Summary of outcome measures (Continued) 
 
 
 
A scale developed for PRIME will quantify the time burden of caring for their 
relative with schizophrenia, the type of work that was stopped or reduced and the 
amount of money lost. The Involvement Engagement Questionnaire (IEQ) will be 
used as an additional measure to assess caregiver burden. 
Caregiver depression PHQ-9 [78, 79] 
Stigma Section of the WHO ‘Family Interview Schedule’; previously used in Ethiopia [8] 
Patient medication adherence The 5-point nominal scale developed for the COPSI study will be used [31] 
CBR community-based rehabilitation, DSM-IV Diagnostic and Statistical Manual of Mental disorders, version four, FBC facility-based care 
 
 
will determine the allocation of  all  new  recruits  using 
the secure allocation list. Recruitment and  participant 
flow will be closely monitored by the trial coordinator 
and  any  protocol deviations recorded  and reported. 
 
Outcome assessments 
Quantitative 
All outcomes are individual-level and will be assessed at 
6 and 12 months (Table 3). Baseline RISE data will be 
extracted from 6-month PRIME cohort data and  6- 
month RISE data will be extracted from  12-month 
PRIME cohort data. Twelve-month RISE data will be 
collected independently of the PRIME  cohort.  Trained 
lay data collectors will collect all data except for symp- 
tom severity, clinical course, overall clinical impression 
of illness severity and improvement, and medication, for 
which a trained psychiatric nurse will be used. Patient 
outcomes will be collected with the caregiver present ac- 
cording to participant preference and when the patient 
does not have the capacity to answer questions inde- 
pendently. Data will be collected directly from the pa- 
tient where possible (except for caregiver-reported 
outcomes). Items will be recorded as missing in the sce- 
nario that the caregiver is not present due to patient re- 
fusal, and the patient is unable or unwilling to respond. 
Quality will be assured through systematic observations   
of data collection by a research assistant (for lay data 
collectors) or psychiatrist (for psychiatric nurse data col- 
lectors), and by verification of all patient record forms. 
Regular meetings will be held to provide  feedback  to 
data collectors. 
In order to reduce information bias data collectors will 
be masked to sub-district allocation; participants will be 
requested not to divulge treatment allocation to data 
collectors; participants from different  sub-districts  will  
be allocated to each data collector; identical methods for 
follow-up will be employed in each arm; and those in- 
volved in data analysis will be masked to sub-district 
allocation. 
Loss to follow-up will be minimised by reminding par- 
ticipants to attend the interview shortly before they are 
due, either by telephone or by a home visit. Participants 
who do not attend will receive a home visit to ask them 
 
to attend at an alternative time. Data collection will take 
place at  the health centre except for participants who  
do not attend after three invitations. These participants 
will receive a home visit for data collection. Partici- 
pants will receive a modest fee for transport and time 
compensation. 
The primary outcome is proxy report of patient dis- 
ability which will be measured with the 36-item WHO 
DAS (Disability Assessment Schedule) 2.0 [55], through 
interviewing the caregiver. WHODAS 2.0 was developed 
as single generic instrument for assessing health status 
and disability relating to a range of health conditions 
across cultures and settings. It covers understanding and 
communication, getting around, self-care, getting along 
with people, life activities and participation in society. 
Sociocultural adaptation and validation (convergent val- 
idity, construct validity and responsiveness to change) of 
the WHODAS 2.0 in persons with schizophrenia  has 
been completed in Ethiopia (personal communication, 
Kassahun Habtamu). Issues arising during the adaptation 
included items not having  obvious  direct translations  
and representing uncommon experiences in the rural 
Ethiopian setting (for example, ‘staying by yourself for a 
few days’). These issues were largely resolved through it- 
erative adjustments to the translation following piloting. 
The proxy WHODAS 2.0 interview is designed to be an- 
swered by a friend, relative or carer. The rationale for 
using the proxy version for the primary outcome is that 
this may give a more valid picture of disability level. A 
separate study in the neighbouring district found that 
whilst scores from patient- and proxy-reported versions 
are moderately correlated, there is a difference, with the 
caregiver scores tending to be higher (greater disability) 
(personal communication, Kassahun Habtamu). Patients 
may not have enough insight to answer accurately and, 
therefore, underreport disability. They may also be too 
unwell to answer all questions, increasing the amount of 
missing data. Table 3 lists the  secondary  outcomes, 
which include patient-reported WHODAS 2.0, symptom 
severity, relapse, medication adherence, economic activ- 
ity in the patient and caregiver, discrimination, health 
service use and costs, physical restraint, nutritional sta- 
tus, caregiver burden, caregiver depression and   caregiver 
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stigma. All instruments have been adapted for use in 
Ethiopia; further details on validation and reliability are 
also given in Table 3. 
 
 
Process data 
Process data will be  compiled using  a range  of sources 
to determine the quality and intensity of intervention 
delivery. These include (1) CBR worker ‘sub-district’ 
logbooks, including type and number of community en- 
gagement tasks completed, (2) CBR worker ‘participant’ 
logbooks including home visit forms (modules under- 
taken,  duration  and  travel  time)  and  assessment forms, 
(3) monthly observation of CBR visits by supervisor and 
completion of the ENACT (Enhancing Assessment of 
Common Therapeutic factors) rating scale [56] adapted 
and validated for the Ethiopian context. The adapted 
ENACT assesses communication skills, engagement with 
the individual, family and community, assessment of 
medication adherence, physical health,  substance  use 
and suicide risk assessment, (4) observation of  CBR 
home visits by an external clinician (psychiatric nurse or 
psychiatrist) to complete the ENACT, providing an inde- 
pendent assessment of CBR worker skills, (5) CBR 
worker competency assessment by supervisor (rating of    
1 to 3 given for each of 47 CBR competencies, e.g. ability 
to conduct community awareness raising meeting), (6) 
CBR worker self-assessed competency form, (7) super- 
visor logbook including number of supervision sessions 
attended, (8) health centre records to determine fre- 
quency of contact with participant, and (9) participant- 
reported structured assessment of the extent to which  
CBR met their needs. 
 
 
Qualitative 
In-depth interviews (IDIs) will be conducted at baseline 
and 12 months with a sub-sample of patients and care- 
givers to gather information on the impact of CBR and 
other factors on the experience of illness and recovery. 
Around eight to ten participant dyads from each treat- 
ment arm will be included depending on when theoret- 
ical saturation is reached. After gaining separate 
informed consent, interviews will be audio-taped, tran- 
scribed in Amharic and then  translated  into  English 
prior to conducting a thematic analysis. IDIs will be con- 
ducted with four to eight community leaders to under- 
stand their role in CBR and their perception of its 
potential impact. IDIs and FGDs will be conducted with 
CBR workers and supervisors to understand their ex- 
perience of delivering CBR and its perceived impact on 
participants. One or two focus groups will also be held 
with health centre nurses to understand their experience   
of working with CBR workers. 
 
Power calculation 
We estimate that 182 participant dyads (mean 3.4 partic- 
ipants/sub-district) will be available for recruitment. As- 
suming that there is 23 % attrition, the final sample size 
for analysis will be 140 participant dyads in 54 sub- 
districts (mean 2.6 participants/sub-district). This  sam- 
ple size will allow us to detect a 20 % absolute difference 
in WHODAS 2.0 scores  between  treatment  arms  with 
85 % power and 5 % significance, assuming a k (coeffi- 
cient of variation) of 0.14 and a within-cluster standard 
deviation (SD) of 16. The value of k was extracted from 
symptom severity data by sub-district from an RCT in 
Butajira evaluating trimethoprim as an adjuvant treat- 
ment for schizophrenia (k = 0.11) [57]. A more conserva- 
tive estimate of k has been used to account for the 
potential therapist effect; each CBR worker will cover 
around three sub-districts and CBR intensity and quality 
may differ by CBR worker. The mean WHODAS 2.0 in 
intervention and control arms and  within-cluster  SD 
were derived from an Indian study of people with 
schizophrenia [58]. 
The estimate of 182 participant dyads available for re- 
cruitment was arrived at using (1) the total adult population 
of Sodo district, (2) the local prevalence of schizophrenia 
(0.05 %) [59], (3) an estimate that 60 % of cases will be de- 
tected and agree to participate in the PRIME cohort, (4) 
an assumption that 70 % of cases will be eligible for RISE, 
based rates of continuous illness found in a previous study 
in the neighbouring district of Butajira [5], and (5) an as- 
sumption that approximately 80 % of eligible cases will 
agree to participate, based on previous recruitment rates   
in the Butajira cohort study [5]. 
 
 
Data management 
All data collection and management will follow Good 
Clinical Practice (GCP) guidelines and SOPs. Each par- 
ticipant has a unique ID that will enable all data  re-  
ported for each participant to be identified. Blinding will 
be maintained during data collection, entry,  processing 
and primary data analysis. Data is collected on paper 
Patient Report Forms (PRF) and double entered onto 
electronic Case Report Forms on EpiData Entry Client 
(2.0.7.22). Data will be managed using EpiData Data 
Manager (2.0.8.56). 
All databases will be password-protected and only access- 
ible to authorised personnel. Data cleaning based on fre- 
quency distributions and logic checks will follow standard 
procedures with reference to source documents as required. 
The data system is designed to ensure that all data changes 
are documented and that there is  no undocumented  dele- 
tion of entered data, i.e. an audit trail will be in place. Sys- 
tematic checks will be carried out to ensure that the audit  
trail   is   functioning   correctly.   Data   and   all appropriate 
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documentation will be stored for a minimum of 5 years 
after the completion of the study, including the follow-up 
period. 
 
Data analysis 
Data analysis will take place using Stata, version 13. The 
primary outcome analysis will be masked until the ana- 
lysis is finalised and approved by all investigators. 
Adequate CBR will be defined as having received a mini- 
mum of ten home visits by a CBR worker. We will not 
define adequate treatment for the FBC arm a priori. 
Sociodemographic and clinical characteristics (including 
WHODAS 2.0 score) of eligible PRIME cohort partici- 
pants who did and did not consent to RISE will be com- 
pared using chi-square tests and t tests. Loss-to-follow-up 
will be compared by treatment arm at 6 and 12 months to 
assess bias due to loss to follow-up. Of those who en- 
rolled, descriptive summaries of sociodemographic and 
clinical characteristics, presented by treatment arm, will 
be produced for baseline data. CBR worker characteristics 
such as age, gender, education level and post-training 
competency will be described. 
Endpoint data will be  analysed  under  intention-to- 
treat assumptions. An individual-level analysis will be 
conducted using a multilevel, mixed-effects regression 
model to compare the WHODAS 2.0 score between 
treatment arms, accounting for clustering at sub-district 
and CBR worker levels. The WHODAS 2.0 distribution 
will determine the model used. If zero-inflation is de- 
tected, a zero-inflated negative binomial model will be 
considered [60]. Adjustment will be made for baseline 
WHODAS 2.0 score and covariates unbalanced at base- 
line. Logistic regression will be used to assess which 
baseline variables are associated with missing outcome 
data. Baseline variables that predict  missing  outcome 
will be included in the regression models as fixed covari- 
ates to meet the assumption that outcome data is miss-   
ing at random. Multiple  imputation  methods  will  then 
be used for participants with missing outcome   data. 
Sensitivity analyses will include a complete case ana- 
lysis and a complier average causal effect (CACE) ana- 
lysis [61]. We will also assess whether there is a dose- 
response relationship between degree of adherence to 
CBR (i.e. number of sessions) and the primary outcome. 
A further analysis will be undertaken to  understand 
which the active components of CBR are. Process data    
on which CBR components were received, and in what 
quantity, will be utilised. Potential correlations between 
different components will be taken into   account. 
Exploratory sub-group analyses by baseline symptom 
severity and antipsychotic medication  adherence  will 
be completed, although the  study will not be  powered  
to investigate such differential effects. A longitudinal 
analysis   will   be   conducted   using   a random-effects 
 
model. Three levels (CBR worker, sub-district and indi- 
vidual) and two time points (6 and 12 months) will be 
included. Secondary and tertiary outcomes will be ana- 
lysed using mixed-effects linear regression models or 
logistic regression depending on the data   type. 
 
Cost-effectiveness  analysis 
Direct costs of the treatment will be estimated by deriv- 
ing a monetary value for each component of the treat- 
ment based on actual costs, and applying these to each 
individual based on the process indicators, which reflect 
the actual uptake of the treatment. Other  health  care 
costs and other patient- or family-borne costs will be 
computed and compared at 6 and 12 months, and sub- 
sequently related to changes in disability and clinical 
symptoms. Incremental cost-effectiveness ratios will be 
calculated to illustrate the extra cost incurred (if any) to 
produce a unit improvement in the main outcome of 
disability-adjusted life years (DALYs) calculated from the 
36-item WHODAS 2.0. In the event that dominance is   
not shown, i.e. the intervention is more effective but the 
costs are also more than the FBC group, incremental cost-
effectiveness ratios will be computed, together with their 
confidence intervals (using bootstrapping tech- niques to 
overcome expected skewness of cost data). Cost-
effectiveness acceptability curves will also be derived in 
order to show the probability of any cost-effective ad- 
vantages for the FBC plus CBR group at a range of ‘will- 
ingness to pay’ threshold levels. 
The results from the quantitative and qualitative work 
will be combined to give an overall assessment of the 
intervention effectiveness. 
 
Trial management and  monitoring 
The trial is sponsored by the London School of Hygiene 
and Tropical Medicine. A Data Safety and Monitoring 
Board (DSMB) has been convened to assure the con- 
tinuing safety of research participants. A clinical monitor 
will carry out onsite monitoring visits prior to the trial 
commencing, at recruitment, and at 6-month and 12- 
month follow-up. The trial coordinator will carry out day-
to-day monitoring and will also review recruitment rates, 
withdrawals and losses to follow-up. All protocol 
violations will be recorded and included in  reports  of 
trial findings. 
 
Confidentiality 
Trial-related assessments will take place in private loca- 
tions. A unique ID number will be linked to patient de- 
tails in hard and soft copy formats that are kept  in 
secure locations. Signed consent forms will be kept se- 
curely in a locked cupboard. All documentation that in- 
cludes patient data will be anonymised, but identifiable 
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through the ID number. Names of patients will not be 
quoted  or published. 
 
Discussion 
Human rights violations and the high disability burden     
of schizophrenia make the condition a priority area for 
public health action. The importance of rehabilitation 
services for schizophrenia in scaling up mental  health 
care is recognised by the WHO [18] and the Ethiopian 
government [32]. There is emerging evidence that CBR 
for schizophrenia is effective at improving disability out- 
comes in middle-income settings, yet there is no evi- 
dence on whether CBR can work in a setting with even 
fewer mental health resources, such as Ethiopia.  The 
RISE trial will determine the added value of CBR com- 
pared to FBC alone. This will help to determine, for 
scaling-up services, the importance of a dedicated re- 
habilitation service in addition to  FBC. 
 
Trial status 
Recruitment complete; trial  ongoing. 
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seek consent from the caregiver because this study relates directly to 
schizophrenia, a debilitating clinical condition from which the patient suffers, 
and it is expected that the study may produce a benefit to the participant. This 
benefit is anticipated to outweigh the risks, which are thought to be minimal. 
Signed participant consent will be obtained and recorded using a form that 
is in compliance with GCP guidelines and the Helsinki Declaration. Where 
the participant is unable to write, a thumb impression will be recorded, 
along with a witness’s signature. 
The right of the participant to refuse to participate without giving reasons 
will be respected. Distress due to participation in the study or unwillingness 
to participate in the trial will be monitored by the trial staff and CBR workers. 
If these circumstances are detected and cannot be resolved through 
discussion with the CBR supervisor or other trial staff the participant will not 
be recruited or will be withdrawn. All participants are free to not participate 
or to withdraw at any time without giving reasons and without prejudicing 
their further treatment. Patients unable to consent for themselves will be 
given opportunities to do so when they are clinically stable. 
 
Author details 
1Centre for Global Mental Health, Department of Population Health, London 
School of Hygiene and Tropical Medicine, London, UK. 2Department of 
Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa 
University, Addis Ababa, Ethiopia. 3Centre for Global Mental Health, Health 
Services and Population Research Department, Institute of Psychiatry, 
Psychology and Neuroscience, King’s College London, London, UK. 4MRC 
Tropical Epidemiology Group, Department of Infectious Disease 
Epidemiology, London School of Hygiene and Tropical Medicine, London, 
UK. 5Department of Pharmacology, St Paul’s Hospital Millennium Medical 
College, Addis Ababa, Ethiopia. 6Aklilu Lemma Institute of Pathobiology, 
Addis Ababa University, Addis Ababa, Ethiopia. 7Public Health Foundation of 
India, New Delhi, India. 8Sangath, Goa, India. 9Centre for Affective Disorders, 
Department of Psychological Medicine, Institute of Psychiatry, Psychology 
and Neuroscience, King’s College London, London, UK. 
 
Received: 20 November 2015 Accepted: 3 June 2016 
259
Asher et al. Trials (2016) 17:299 Page 13 of 14 
 
 
 
 
References 
1. Kebede D, Alem A, Shibre T, Negash A, Deyassa N, Beyero T, et al. Short-term 
symptomatic and functional outcomes of schizophrenia in Butajira, Ethiopia. 
Schizophr   Res. 2005;78(2-3):171–85.  doi:10.1016/j.schres.2005.05.028. 
2. Shibre T, Kebede D, Alem A, Negash A, Deyassa N, Fekadu A, et al. 
Schizophrenia: illness impact on family members in a traditional 
society—rural Ethiopia. Soc Psychiatry Psychiatr Epidemiol. 2003;38(1):27–34. 
3. Saxena S, Thornicroft G, Knapp M, Whiteford H. Resources for mental health: 
scarcity, inequity, and inefficiency. Lancet. 2007;370(9590):878–89. 
4. Shibre T, Medhin G, Alem A, Kebede D, Teferra S, Jacobsson L, et al. Long- 
term clinical course and outcome of schizophrenia in rural Ethiopia: 10-year 
follow-up of a population-based cohort. Schizophr Res. 2015;161(2-3):414–20. 
doi:10.1016/j.schres.2014.10.053. 
5. Alem A, Kebede D, Fekadu A, Shibre T, Fekadu D, Beyero T, et al. Clinical 
course and outcome of schizophrenia in a predominantly treatment-naive 
cohort in rural Ethiopia. Schizophr Bull. 2009;35(3):646–54. 
6. Fekadu A, Thornicroft G. Global mental health: perspectives from Ethiopia. 
Glob  Health  Action.  2014;7:25447. doi:10.3402/gha.v7.25447. 
7. Fekadu A, Medhin G, Kebede D, Alem A, Cleare AJ, Prince M, et al. Excess 
mortality in severe mental illness: 10-year population-based cohort study 
in rural Ethiopia. Br J Psychiatry. 2015;206(4):289–96. doi:10.1192/bjp.bp. 
114.149112. 
8. Shibre T, Negash A, Kullgren G, Kebede D, Alem A, Fekadu A, et al. 
Perception of stigma among family members of individuals with 
schizophrenia and major affective disorders in rural Ethiopia. Soc Psychiatry 
Psychiatr  Epidemiol. 2001;36(6):299–303. 
9. Assefa D, Shibre T, Asher L, Fekadu A. Internalized stigma among patients 
with schizophrenia in Ethiopia: a cross-sectional facility-based study. BMC 
Psychiatry.  2012;12:239. doi:10.1186/1471-244x-12-239. 
10. Drew N, Funk M, Tang S, Lamichhane J, Chávez E, Katontoka S, et al. Human 
rights violations of people with mental and psychosocial disabilities: an 
unresolved  global  crisis.  Lancet. 2011;378(9803):1664–75. 
11. Thornicroft G, Alem A. Antunes Dos Santos R, Barley E, Drake RE, Gregorio G, 
et al. WPA guidance on steps, obstacles and mistakes to avoid in the 
implementation of community mental health care. World Psychiatr. 
2010;9(2):67–77. 
12. Thornicroft G, Tansella M. The balanced care model: the case for both 
hospital- and community-based mental healthcare. Br J Psychiatr. 
2013;202(4):246–8.  doi:10.1192/bjp.bp.112.111377. 
13. Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW, et al. 
The 2009 schizophrenia PORT psychosocial treatment recommendations and 
summary statements. Schizophr Bull. 2010;36(1):48–70. doi:10.1093/schbul/ 
sbp115. 
14. Patel V. Universal health coverage for schizophrenia: a global mental health 
priority. Schizophr Bull. 2015. doi:10.1093/schbul/sbv107. 
15. van Ginneken N, Tharyan P, Lewin S, Rao GN, Meera SM, Pian J, et al. Non- 
specialist health worker interventions for the care of mental, neurological 
and substance-abuse disorders in low- and middle-income countries. 
Cochrane Database Syst Rev. 2013;11:CD009149. doi:10.1002/14651858. 
CD009149.pub2. 
16. Patel V, Araya R, Chatterjee S, Chisholm D, Cohen A, De Silva M, et al. 
Treatment and prevention of mental disorders in low-income and 
middle-income countries. Lancet. 2007;370(9591):991–1005. doi:10.1016/ 
s0140-6736(07)61240-9. 
17. Chatterjee S, Naik S, John S, Dabholkar H, Balaji M, Koschorke M, et al. 
Effectiveness of a community-based intervention for people with 
schizophrenia and their caregivers in India (COPSI): a randomised controlled 
trial.  Lancet.  2014. doi:10.1016/s0140-6736(13)62629-x. 
18. WHO. mhGAP Intervention Guide for mental, neurological and substance 
use disorders in non-specialized health settings. Geneva: World Health 
Organization;  2011. 
19. WHO. Community based rehabilitation: CBR guidelines. Geneva: World 
Health Organization; 2010. 
20. Iemmi V, Gibson L, Blanchet K, Suresh Kuman K, Rath S, Hartley S, et al. 
Community-based rehabilitation for people with disabilities in low and 
middle-income countries: a systematic review. Campbell Syst Rev. 
2015;11:15. 
21. Raja S, Underhill C, Shrestha P, Sunder U, Mannarath S, Wood SK, et al. 
Integrating mental health and development: a case study of the BasicNeeds 
Model in Nepal. PLoS Med. 2012;9(7):e1001261. doi:10.1371/journal.pmed. 
1001261. 
22. Raja S, Boyce WF, Ramani S, Underhill C. Success indicators for integrating 
mental health interventions with community-based rehabilitation projects. 
Int J Rehabil Res. 2008;31(4):284–92.  doi:10.1097/MRR.0b013e3283013b0b. 
23. Cohen A, Eaton J, Radtke B, George C, Manuel BV, De Silva M, et al. Three 
models of community mental health services in low-income countries. Int J 
Ment Heal Syst. 2011;5(1):3.  doi:10.1186/1752-4458-5-3. 
24. Chatterjee S, Patel V, Chatterjee A, Weiss HA. Evaluation of a community- 
based rehabilitation model for chronic schizophrenia in rural India. Br J 
Psychiatr. 2003;182:57–62. 
25. Chatterjee S, Pillai A, Jain S, Cohen A, Patel V. Outcomes of people 
with psychotic disorders in a community-based   rehabilitation 
programme in rural India. Br J Psychiatr. 2009;195(5):433–9. doi:10.1192/ 
bjp.bp.108.057596. 
26. Botha UA, Koen L, Joska JA, Hering LM, Oosthuizen PP. Assessing the 
efficacy of a modified assertive community-based treatment programme in 
a developing country. BMC Psychiatry. 2010;10:73. 
27. Dias A, Dewey ME, D’Souza J, Dhume R, Motghare DD, Shaji KS, et al. The 
effectiveness of a home care program for supporting caregivers of persons 
with dementia in developing countries: a randomised controlled trial from 
Goa, India. PLoS  One. 2008;3(6):e2333.  doi:10.1371/journal.pone.0002333. 
28. Gavrilova SI, Ferri CP, Mikhaylova N, Sokolova O, Banerjee S, Prince M. 
Helping carers to care—The 10/66 Dementia Research Group’s randomized 
control trial of a caregiver intervention in Russia. Int J Geriatr Psychiatry. 
2009;24(4):347–54. doi:10.1002/gps.2126. 
29. Ran MS, Xiang MZ, Chan CL, Leff J, Simpson P, Huang MS, et al. 
Effectiveness of psychoeducational intervention for rural Chinese families 
experiencing schizophrenia—a randomised controlled trial. Soc Psychiatry 
Psychiatr  Epidemiol.  2003;38(2):69–75. doi:10.1007/s00127-003-0601-z. 
30. Zhang M, Wang M, Li J, Phillips MR. Randomised-control trial of family 
intervention for 78 first-episode male schizophrenic patients. An 18-month 
study in Suzhou, Jiangsu. Br J Psychiatry Suppl. 1994;24:96–102. 
31. Chatterjee S, Leese M, Koschorke M, McCrone P, Naik S, John S, et al. 
Collaborative community based care for people and their families living 
with schizophrenia in India: protocol for a randomised controlled trial. Trials. 
2011;12(1):12. 
32. Federal Democratic Republic of Ethiopia Ministry of Health. National 
Mental Health Strategy 2012–2015. Addis Ababa: Ministry of Health; 2012. 
33. Asher L, Fekadu A, Hanlon C, Mideksa G, Eaton J, Patel V, et al. 
Development of a community-based rehabilitation intervention for people 
with schizophrenia in Ethiopia. PLoS One. 2015;10(11):e0143572. 
doi:10.1371/journal.pone.0143572. 
34. De Silva MJ, Breuer E, Lee L, Asher L, Chowdhary N, Lund C, et al. Theory 
of Change: a theory-driven approach to enhance the Medical Research 
Council’s framework for complex interventions. Trials. 2014;15(1):267. 
doi:10.1186/1745-6215-15-267. 
35. Lund C, Tomlinson M, De Silva M, Fekadu A, Shidhaye R, Jordans M, et al. 
PRIME: a programme to reduce the treatment gap for mental disorders in 
five low- and middle-income countries. PLoS Med. 2012;9(12):e1001359. 
doi:10.1371/journal.pmed.1001359. 
36. De Silva MJ, Rathod SD, Hanlon C, Breuer E, Chisholm D, Fekadu A, et al. 
Evaluation of district mental healthcare plans: the PRIME consortium 
methodology. Br J Psychiatr. 2015. doi:10.1192/bjp.bp.114.153858. 
37. Mayston R, Alem A, Habtamu A, Shibre T, Fekadu A, Hanlon C. 
Participatory planning of a primary care service for people with severe 
mental disorders in rural Ethiopia. Health Policy Plan. 2015. doi:10.1093/ 
heapol/czv072. 
38. Fekadu A, Hanlon C, Medhin G, Alem A, Selamu M, Giorgis TW, et al. 
Development of a scalable mental healthcare plan for a rural district in 
Ethiopia.  Br J  Psychiatr.  2015. doi:10.1192/bjp.bp.114.153676. 
39. Hailemariam M, Fekadu A, Selamu M, Alem A, Medhin G, Giorgis TW, et al. 
Developing a mental health care plan in a low resource setting: the 
theory of change approach. BMC Health Serv Res. 2015;15(1):429. doi:10. 
1186/s12913-015-1097-4. 
40. WHO. mhGAP Mental Health Gap Action Programme: scaling up care for 
mental, neurological and substance use disorders. Geneva: WHO; 2008. 
41. Shibre T, Kebede D, Alem A, Negash A, Kibreab S, Fekadu A, et al. An 
evaluation of two screening methods to identify cases with schizophrenia 
and affective disorders in a community survey in rural Ethiopia. Int J Soc 
Psychiatry. 2002;48(3):200–8. 
42. Asher L, Fekadu A, Hanlon C, Mideksa G, Eaton J, Patel V et al. Development 
of a community-based rehabilitation intervention for people with 
260
Asher et al. Trials (2016) 17:299 Page 14 of 14 
 
 
 
 
schizophrenia in Ethiopia. PLoS One. 2015;10(11):e0143572. doi: 10.1371/ 
journal.pone.0143572. eCollection 2015. 
43. Hanlon C, Luitel NP, Kathree T, Murhar V, Shrivasta S, Medhin G, et al. 
Challenges and opportunities for implementing integrated mental health 
care: a district level situation analysis from five low- and middle-income 
countries.  PLoS  One.  2014;9(2):e88437. doi:10.1371/journal.pone.0088437. 
44. Selamu M, Asher L, Hanlon C, Medhin G, Hailemariam M, Patel V, et al. 
Beyond the biomedical: community resources for mental health care in 
rural Ethiopia. PLoS One. 2015;10(5):e0126666. doi:10.1371/journal.pone. 
0126666. 
45. Carter BR, Hood K. Balance algorithm for cluster randomized trials. BMC 
Med  Res  Methodol.  2008;8:65. doi:10.1186/1471-2288-8-65. 
46. Raab GM, Butcher I. Balance in cluster randomized trials. Stat Med. 
2001;20(3):351–65. 
47. American Psychiatric Association. Diagnostic and statistical manual of mental 
disorders. 4th ed. Washington: American Psychiatric Association;  1994. 
48. Gonda T, Deane FP, Murugesan G. Predicting clinically significant change in 
an inpatient program for people with severe mental illness. Aust N Z J 
Psychiatry.  2012;46(7):651–8. doi:10.1177/0004867412445527. 
49. Shibre T, Teferra S, Morgan C, Alem A. Exploring the apparent absence of 
psychosis amongst the Borana pastoralist community of Southern Ethiopia. 
A mixed method follow-up study. World Psychiatr. 2010;9(2):98–102. 
50. Fekadu A, Shibre T, Alem A, Kebede D, Kebreab S, Negash A, et al. Bipolar 
disorder among an isolated island community in Ethiopia. J Affect Disord. 
2004;80(1):1–10. doi:10.1016/s0165-0327(02)00345-2. 
51. Opcrit Homepage. MRC Social, Genetic and Developmental Psychiatry Centre, 
Institute of Psychiatry, Kings College London. http://sgdp.iop.kcl.ac.uk/opcrit/. 
Accessed 15 Nov 2015 
52. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational 
criteria in studies of psychotic illness. Development and reliability of the 
OPCRIT system. Arch Gen Psychiatry. 1991;48(8):764–70. 
53. Brittain PJ, Stahl D, Rucker J, Kawadler J, Schumann G. A review of the 
reliability and validity of OPCRIT in relation to its use for the routine clinical 
assessment of mental health patients. Int J Methods Psychiatr Res. 
2013;22(2):110–37.  doi:10.1002/mpr.1382. 
54. Fekadu A, Mesfin M, Medhin G, Alem A, Teferra S, Gebre-Eyesus T, et al. 
Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): 
study protocol for a double-blind randomized placebo-controlled trial. Trials. 
2013;14:406.  doi:10.1186/1745-6215-14-406. 
55. WHO. Measuring health and disability: Manual for WHO Disability Assessment 
Schedule (WHODAS 2.0). Geneva: World Health Organization; 2010. 
56. Kohrt BA, Jordans MJ, Rai S, Shrestha P, Luitel NP, Ramaiya MK, et al. 
Therapist competence in global mental health: development of the 
ENhancing Assessment of Common Therapeutic factors (ENACT) rating 
scale. Behav Res Ther. 2015;69:11–21. doi:10.1016/j.brat.2015.03.009. 
57. Shibre T, Alem A, Abdulahi A, Araya M, Beyero T, Medhin G, et al. Trimethoprim 
as adjuvant treatment in schizophrenia: a double-blind, randomized, 
placebo-controlled clinical trial. Schizophr Bull. 2010;36(4):846–51. 
58. Srinivasa Murthy R, Kishore Kumar KV, Chisholm D, Thomas T, Sekar K, 
Chandrashekari CR. Community outreach for untreated schizophrenia in 
rural India: a follow-up study of symptoms, disability, family burden and 
costs. Psychol Med. 2005;35(3):341–51. 
59. Kebede D, Alem A, Shibre T, Negash A, Fekadu A, Fekadu D, et al. Onset 
and clinical course of schizophrenia in Butajira-Ethiopia—a community-based 
study. Soc Psychiatry Psychiatr Epidemiol. 2003;38(11):625–31. 
60. Sousa RM, Dewey ME, Acosta D, Jotheeswaran AT, Castro-Costa E, Ferri CP, 
et al. Measuring disability across cultures—the psychometric properties of 
the WHODAS II in older people from seven low- and middle-income 
countries. The 10/66 Dementia Research Group population-based survey. Int 
J Methods Psychiatr Res. 2010;19(1):1–17.   doi:10.1002/mpr.299. 
61. Hewitt CE, Torgerson DJ, Miles JN. Is there another way to take account of 
noncompliance in randomized controlled trials? CMAJ. 2006;175(4):347. 
doi:10.1503/cmaj.051625. 
62. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical 
implications of Brief Psychiatric Rating Scale scores. Br J Psychiatr. 
2005;187:366–71. doi:10.1192/bjp.187.4.366. 
63. Burlingame GM, Seaman S, Johnson JE, Whipple J, Richardson E, Rees F, et 
al. Sensitivity to change of the Brief Psychiatric Rating Scale - Extended 
(BPRS-E): an item and subscale analysis. Psychol Serv. 2006;3(2):77–87. 
64. Youngmann R, Zilber N, Workneh F, Giel R. Adapting the SRQ for Ethiopian 
populations: a culturally-sensitive psychiatric screening instrument. Transcult 
Psychiatry.  2008;45(4):566–89. doi:10.1177/1363461508100783. 
65. Hanlon C, Alem A, Medhin G, Shibre T, Ejigu DA, Negussie H, et al. Task 
sharing for the care of severe mental disorders in a low-income country 
(TaSCS): study protocol for a randomised, controlled, non-inferiority trial. 
Trials. 2016;17(1):76. doi:10.1186/s13063-016-1191-x. 
66. Burlingame GM, Dunn TW, Chen S, Lehman A, Axman R, Earnshaw D, et al. 
Selection of outcome assessment instruments for inpatients with severe 
and persistent mental illness. Psychiatr Serv. 2005;56(4):444–51. doi:10.1176/ 
appi.ps.56.4.444. 
67. Mortimer AM. Symptom rating scales and outcome in schizophrenia. Br J 
Psychiatry. 2007;191(50):s7–14. doi:10.1192/bjp.191.50.s7. 
68. WHO. The Life Chart Schedule. Geneva: World Health Organization; 1992. 
69. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, et 
al. The Longitudinal Interval Follow-up Evaluation. A comprehensive method 
for assessing outcome in prospective longitudinal studies. Arch Gen 
Psychiatry. 1987;44(6):540–8. 
70. Habtamu K, Alem A, Hanlon C. Conceptualizing and contextualizing 
functioning in people with severe mental disorders in rural Ethiopia: a 
qualitative study. BMC Psychiatry. 2015;15:34.    doi:10.1186/s12888-015-0418-9. 
71. Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M. Global pattern of 
experienced and anticipated discrimination against people with 
schizophrenia: a cross-sectional survey. Lancet. 2009;373(9661):408–15. 
doi:10.1016/s0140-6736(08)61817-6. 
72. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a 
self-reported measure of medication adherence. Med Care.  1986;24(1):67–74. 
73. Sweileh WM, Ihbesheh MS, Jarar IS, Sawalha AF, Abu Taha AS, Zyoud SH, et 
al. Antipsychotic medication adherence and satisfaction among Palestinian 
people with schizophrenia. Curr Clin Pharmacol. 2012;7(1):49–55. 
74. Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, 
editor. Measuring mental health needs. London: Gaskell; 2001. 
75. Chisholm D, Sekar K, Kishore K, Saeed K, James S, Mubbashar M, et al. 
Integration of mental health care into primary care: demonstration of 
cost-outcome study in India and Pakistan. Br J Psychiatry. 2000;176:581–8. 
76. Mogga S, Prince M, Alem A, Kebede D, Stewart R, Glozier N, et al. Outcome 
of major depression in Ethiopia: population-based study. Br J Psychiatry. 
2006;189:241–6. 
77. WHO Expert Committee. Physical status: the use and interpretation of 
anthropometry. Geneva: WHO; 1995. 
78. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression 
severity measure. J Gen Intern Med. 2001;16(9):606–13. 
79. Hanlon C, Medhin G, Selamu M, Breuer E, Worku B, Hailemariam M, et al. 
Validity of brief screening questionnaires to detect depression in primary 
care in Ethiopia. J Affect Disord. 2015;186:32–9.    doi:10.1016/j.jad.2015.07.015. 
80. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development 
of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative 
project on early detection of persons with harmful alcohol consumption—
II. Addiction (Abingdon, England). 1993;88(6):791–804. 
81. Dalgard OS, Dowrick C, Lehtinen V, Vazquez-Barquero JL, Casey P, Wilkinson 
G, et al. Negative life events, social support and gender difference in 
depression: a multinational community survey with data from the ODIN 
study. Soc Psychiatry Psychiatr Epidemiol. 2006;41(6):444–51. doi:10.1007/ 
s00127-006-0051-5. 
82. Ustun TB, Chatterji S, Kostanjsek N, Rehm K, Kennedy C, Epping-Jordan J, et 
al. Developing the World Health Organization Disability Assessment 
Schedule 2.0. Bull World Health Organ. 2010;88:815–23. 
83. Rehm J, Ustun TB, Saxena S, Nelson CB, Chatterji S, Ivis F, et al. On the 
development and psychometric testing of the WHO screening instrument 
to assess disablement in the general population. Int J Methods Psychiatr 
Res.  1999;8(2):110–22. 
261
8.3 SUPPLEMENTARY	INFORMATION	
	
8.3.1 Piloting	of	trial	methods	
	
8.3.1.1 Overview		
	 The	piloting	of	several	trial	procedures	took	place	during	the	RISE	pilot;	these	included	application	of	the	inclusion	criteria,	process	data	collection	and	estimation	of	attrition.	Other	aspects	could	not	be	fully	piloted	until	the	PRIME	cohort	6	month	data	collection	commenced,	including	outcome	data	collection	and	data	management.	Twenty	eight	standard	operating	procedures	(SOPs)	were	created	to	guide	the	step-by-step	implementation	of	all	aspects	of	the	trial,	such	as	informed	consent	and	adverse	event	management	and	reporting.	Adjustments	to	the	protocol	or	SOPs	were	made	where	necessary	to	maximise	feasibility.	Additional	training	was	given	to	trial	staff	where	issues	were	identified.		
8.3.1.2 Estimation	of	available	sample	size	and	attrition		
	 Whilst	PRIME	cohort	recruitment	was	still	on	going	it	was	recognised	that	detection	and	recruitment	rates	of	people	with	schizophrenia	spectrum	disorder	in	Sodo	district	were	lower	than	expected.	As	a	result	of	this	the	additional	recruitment	levels	three	and	four,	as	described	in	the	protocol,	were	added	to	identify	people	with	schizophrenia	who	were	not	initially	recruited	to	the	PRIME	cohort.	Furthermore, as	discussed	in	Chapter	7,	there	were	some	instances	of	both	disengagement	from	CBR	and	refusal	to	participate	in	endline	data	collection	in	the	pilot.	The	estimated	attrition	rate	was	therefore	increased	from	15%	to	23%	in	the	sample	size	calculation.		
8.3.1.3 Appropriateness	of	inclusion	criteria	and	consent	procedures		
	 After	assessing	eligibility	for	the	RISE	pilot,	the	recruiting	psychiatric	nurse	was	asked	to	give	their	opinion	as	to	whether	each	eligible	and	non-eligible	individual	would	have	benefited	from	receipt	of	CBR	(see	Appendix	E	(ii)).	There	was	perfect	agreement	between	the	inclusion	criteria	results	and	the	nurse’s	opinion;	hence	no	changes	were	made	to	the	eligibility	criteria	on	this	basis.	However,	due	to	lower	than	expected	numbers	of	PRIME	cohort	recruits	with	RISE-eligible	diagnoses	(231	participants	compared	to	324	expected	participants),	a	slightly	lower	threshold	
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was	given	for	the	criteria	‘Evidence	of	enduring	or	disabling	illness’	in	the	trial	compared	to	the	pilot.	The	CGI	threshold	was	adjusted	from	4	(moderate	illness)	to	3	(mild	illness).	The	final	version	of	the	eligibility	assessment	forms	are	presented	in	Appendix	E	(iii).		 A	psychiatric	nurse	was	found	to	have	incorrectly	applied	the	OPCRIT	diagnostic	assessment	at	the	PRIME	cohort	baseline.	This	participant	was	initially	recruited	to	the	RISE	pilot;	the	error	was	revealed	due	to	concerns	raised	by	the	CBR	supervisor	at	the	first	CBR	visit,	after	which	the	individual	received	a	repeat	clinical	assessment.	This	assessment	indicated	a	diagnosis	of	intellectual	disability	only,	as	opposed	to	schizophrenia	with	co-morbid	intellectual	disability.	As	a	result	of	these	issues,	and	as	described	in	the	protocol,	an	additional	paper-based	diagnostic	assessment	was	implemented	prior	to	the	trial	recruitment.	Whilst	a	repeat	clinical	assessment	was	conducted	where	a	discrepancy	was	found,	psychiatrist-led	clinical	diagnostic	assessments	were	not	possible	for	all	potential	trial	participants	due	to	resource	constraints.		 Information	sheets	and	consent	forms	for	the	trial	recruitment,	the	initial	consent	for	non-PRIME	cohort	participants	and	the	qualitative	study	are	presented	in	Appendix	E	(iv).	Informed	consent	procedures	were	found	to	be	acceptable	and	feasible.		
8.3.1.4 Data	collection	and	management	
	 Process	data	collection	forms	were	tested	during	the	RISE	pilot.	Minor	modifications	were	made	to	increase	ease	of	use.	The	final	version	of	the	process	data	collection	forms	for	participants,	sub-districts	and	CBR	workers	are	presented	in	Appendix	E	(v).	Topic	guides	for	the	qualitative	interviews	are	presented	in	Appendix	E	(vi).		 The	trial	patient	report	form	for	endline	data	collection	is	presented	in	Appendix	E	(vii).	All	instruments	were	translated	into	Amharic	prior	to	use.	PRIME	baseline	questionnaires	and	PRIME	6	month	questionnaires	completed	prior	to	trial	recruitment	were	reviewed	for	systematic	errors	and	missing	data.	Several	erroneous	patterns	were	found	which	were	then	addressed	in	targeted	refresher	training	for	data	collectors	prior	to	trial	recruitment.	
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Furthermore,	once	trial	baseline	data	collection	commenced,	entered	data	were	reviewed	for	systematic	errors	by	checking	the	frequency	and	distribution	of	each	variable	and	consistency	between	linked	variables.	In	general	there	were	low	levels	of	missing	data,	skip	rules	were	correctly	applied	and	data	appeared	to	be	internally	consistent.	However	there	was	a	tendency	for	the	distribution	of	the	Butajira	functioning	scale	data	to	cluster	at	the	extremes	of	the	ordinal	scale	i.e.	at	0	“none”	(no	problems	with	functioning)	or	5	“cannot	do	task”.	On	the	basis	of	these	findings,	which	were	supported	by	research	assistant	observations	of	data	collection,	additional	training	was	given	to	data	collectors.	It	was	noteworthy	that	a	similar	clustering	effect	was	not	seen	with	WHODAS	data,	which	may	reflect	the	greater	emphasis	on	this	outcome	in	the	data	collector	training,	including	the	need	to	specify	the	five	possible	responses	to	the	participant	for	each	of	the	36	items.	Due	to	concerns	that	data	collectors	may	be	unmasked,	resulting	in	detection	bias,	at	the	end	of	each	endline	assessment	the	assessors	will	be	asked	whether	they	have	become	unmasked	to	participant	allocation	during	the	course	of	the	assessment.	Furthermore	to	minimise	bias	the	primary	outcome	(proxy-reported	WHODAS)	is	the	first	instrument	administered	in	the	participant	interviews.		 A	RISE	data	management	manual	was	created.	Once	trial	data	management	procedures	commenced,	minor	adjustments	were	made	to	the	Epidata	databases	and	additional	training	was	given	to	data	entry	clerks	to	address	arising	issues.				
8.3.2 Supplementary	statistical	analysis	plan	
	 Further	details	were	added	to	the	statistical	analysis	plan	to	evaluate	the	validity	of	the	theory	of	change.	These	secondary	analyses	will	be	carried	out	whether	or	not	the	primary	analysis	indicates	that	CBR	has	an	impact	on	disability	as	they	may	give	useful	insights	into	the	reasons	for	a	null	result.		 First,	to	evaluate	the	hypothesised	causal	pathways	to	improved	functioning,	a	mediation	analysis	is	planned.	Midline	(6	month)	data	will	be	used	for	potential	mediators	and	endline	(12	month)	data	for	disability,	in	order	to	elucidate	the	temporal	relationship	between	mediators	and	the	primary	outcome.	This	is	pertinent	given	the	potential	for	reciprocal	relationships	between	mediators	(intermediate	outcomes)	and	disability,	for	example	between	income	and	
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disability	(see	Figure	7.2	in	Chapter	7).	In	the	first	instance	this	analysis	will	involve	adjusting	for	potential	mediators	one	at	a	time	in	the	regression	examining	the	impact	of	CBR	on	disability,	measured	with	the	WHODAS-36.	The	potential	mediators	are	family	stability	and	care	(IEQ),	access	to	mental	health	care	(adapted	CSRI),	medication	adherence	(adapted	Morisky	scale),	discrimination	(DISC-12),	income	(economic	activity	measure)	and	symptom	severity	(BPRS-E).	The	PHQ-9	may	be	considered	as	a	proxy	measure	for	increased	hope.	If,	for	example,	an	observed	association	between	intervention	arm	and	disability	is	attenuated	when	symptom	severity	is	adjusted	for,	this	may	indicate	that	symptom	severity	lies	on	the	causal	pathway	to	reductions	in	disability.	Multiple	mediators	that	are	hypothesised	to	be	part	of	the	same	pathway	may	then	be	considered	in	one		model,	such	as	medication	adherence	and	symptom	severity.	Examining	the	causal	mechanisms	of	CBR	could	have	an	important	role	in	refining	the	intervention	for	further	evaluation	or	scale	up.	For	example,	if	CBR	was	found	to	act	in	large	part	through	the	pathway	of	increased	medication	adherence	that	could	lend	support	to	an	intervention	more	narrowly	focused	on	medication	access	and	adherence	support.		 Second,	within	the	intervention	arm,	an	analysis	will	be	undertaken	to	determine	the	quantity	and	components	of	CBR	that	are	needed	to	impact	on	functioning.	This	will	entail	creating	categories	of	exposure	to	CBR	components,	such	as	community	mobilisation	present/absent	and	family	support	group	present/absent.	The	impact	on	disability	of	exposure	to	these	components	will	be	examined	using	regression	models.	The	impact	on	disability	of	the	number	of	home	visits	received	will	also	be	examined,	as	described	in	the	protocol	paper.	The	mediation	models	described	above	may	then	be	incorporated	into	this	analysis.	This	analysis	could	help	to	determine	the	importance	of	including	broader	CBR	components	in	a	scaled	up	intervention.	For	example,	if	participants	who	were	linked	to	community	mobilisation	had	significant	improvements	in	functioning	compared	to	those	who	were	not,	this	could	indicate	that	a	robust	community	mobilisation	element	is	an	important	CBR	component.	However,	the	quantity	of	home	visits	or	community	mobilisation	provided	by	CBR	workers	may	be	correlated	with	disability	or	severity	of	illness,	particularly	for	optional	components.	It	would	therefore	be	important	to	adjust	for	baseline	disability	and/	or	symptom	severity.	
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8.3.3 Potential	limitations	
	 It	is	argued	in	the	published	protocol	that	using	the	proxy-reported	WHODAS	will	give	a	more	valid	representation	of	disability	compared	to	the	patient-reported	version.	However,	there	are	drawbacks	to	utilising	a	proxy-reported	outcome.	First,	this	is	a	less	patient-centred	approach	in	which	the	caregivers’	views	are	arguably	valued	above	those	of	the	person	with	schizophrenia.	Second,	some	of	the	disability	reported	by	caregivers	may	be	related	to	stigmatising	attitudes	towards	people	with	mental	illness,	expressed	as	low	expectations	of	their	relative’s	functional	capacity.	Third,	is	the	possibility	that	the	caregiver	has	not	observed	the	full	spectrum	of	the	individual’s	behaviour	so	is	unable	to	accurately	report	on	functioning	[4].	The	latter	issue	is	arguably	of	less	importance	in	the	rural	Ethiopian	setting	where	family	members	often	reside	in	a	one-roomed	home.	However	it	should	not	be	disregarded	given	the	issues	of	caregiver	disengagement	identified	in	the	pilot.		 We	attempted	to	mitigate	the	possibility	of	recruiting	participants	without	a	diagnosis	of	schizophrenia	spectrum	disorder.	Ideally	inter-rater	reliability	of	the	OPCRIT	would	have	been	determined,	comparing	psychiatric	nurse	and	psychiatrist	ratings.		 Some	intermediate	outcomes	on	the	theory	of	change	map	were	assessed	mainly	with	qualitative	rather	than	quantitative	data:	‘Understanding	of	mental	illness	and	human	rights’,	‘Involvement	in	decision-making	about	care’	and	‘Increased	self-	esteem	and	hope’.	Bonnell	et	al	argue	it	is	difficult	to	assess	causal	relationships	in	the	evaluation	of	complex	interventions	using	only	qualitative	data	[5].	Whilst	‘Increased	self-esteem	and	hope’	may	be	measured	with	the	PHQ-9,	this	instrument	is	designed	to	measure	depression	and	is	arguably	not	a	valid	measure	of	this	construct.	Instruments	to	assess	aspects	of	personal	recovery	such	as	these	have	been	developed	in	the	UK	[6].	However	careful	development	or	adaptation	work	would	be	needed	prior	to	utilising	such	quantitative	instruments	in	the	Ethiopian	context.	In	the	meantime	these	issues	and	experiences	arguably	lend	themselves	well	to	an	exploratory	qualitative	approach.	
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Another	limitation	to	the	evaluation	relates	to	the	lack	of	cluster-	level	outcomes,	specifically	on	awareness	about	mental	illness	and	attitudes	towards	people	with	schizophrenia	amongst	the	general	population.	This	information	could	have	enabled	greater	insights	into	the	potential	impact	of	CBR	on	public	attitudes,	and	also	the	influence	of	this	factor	on	outcomes	for	individuals	with	schizophrenia.				
8.4 CONCLUSION	
	 This	chapter	has	presented	a	protocol	for	a	cluster	randomised	trial	that	aims	to	determine	the	effectiveness	of	CBR	for	schizophrenia.	Piloting	of	the	trial	methods	has	allowed	preparation	for	a	high-quality	evaluation.	The	trial	design	and	analysis	have	been	carefully	shaped	to	enable	understanding	of	not	just	whether,	but	how,	CBR	impacts	upon	functioning.	The	next	chapter	will	discuss	the	findings	and	implications	of	the	work	presented	in	this	thesis	as	well	as	its	conclusion.	
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9 DISCUSSION	
	
	
9.1 INTRODUCTION	
	 This	chapter	will	begin	with	a	summary	of	the	thesis	findings	in	relation	to	each	objective	and	the	contribution	of	these	findings	to	the	global	mental	health	and	wider	literature	(Section	9.2.1).	Three	cross-cutting	themes	–	access	to	mental	health	care,	the	personal	recovery	model	and	poverty	-	will	then	be	explored	in	greater	depth	(Section	9.2.2).	The	strengths	and	limitations	of	the	thesis	methodology	will	then	be	discussed	(Section	9.3).	The	following	section	will	cover	recommendations	relating	to	policy,	programmes	and	future	research	directions	(Section	9.4).	This	will	include	reflections	on	how	the	‘Implementation’	stage	of	the	MRC	framework	may	manifest.	The	final	sections	will	discuss	the	potential	impact	of	the	work	contained	in	the	thesis	and	its	overall	conclusion,	as	well	as	a	summary	of	the	RISE	trial	progress	to	date.				
9.2 THESIS	FINDINGS	
	
9.2.1 Findings	and	contributions	to	the	literature	by	objective	
	
9.2.1.1 Objective	one:	The	evidence	for	the	effectiveness	of	community-based	
psychosocial	interventions	for	schizophrenia	in	LMIC	
	 The	systematic	review	presented	in	Chapter	4	identified	11	RCTs	in	five	middle-	income	countries.	Community-based	psychosocial	interventions	may	have	beneficial	impacts	for	people	with	schizophrenia	including	reducing	symptoms,	improving	functioning	and	reducing	hospital	readmissions.	However	the	quality	of	evidence	was	often	low.	The	content	of	included	interventions	varied	considerably	from	single-faceted	psychoeducational	interventions,	to	multi-component	rehabilitation-focused	interventions,	to	case	management-type	interventions	typically	delivered	following	discharge	from	inpatient	care.	A	third	of	the	included	studies	did	not	incorporate	any	community	involvement,	only	two	studies	included	community	awareness-raising,	and	none	explicitly	employed	the	broader	aspects	of	community	mobilisation	that	are	encouraged	in	the	WHO’s	CBR	guidelines	[1].	
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Whilst	interventions	appear	to	be	effective	without	community	mobilisation,	this	type	of	approach	may	be	advantageous	in	low-income	settings	with	fewer	social	welfare	and	health	resources.		 A	previous	systematic	review	of	CBR	for	mental	and	physical	disabilities	was	conducted	in	2012	[2].	The	systematic	review	presented	in	this	thesis	brings	up	to	date	our	knowledge	of	the	evidence	base	for	community-based	psychosocial	interventions	in	LMIC	and	therefore	represents	an	important	contribution	to	the	literature.	Ten	new	records	were	identified	in	addition	to	the	three	RCTs	relating	to	schizophrenia	that	were	included	in	the	Iemmi	review;	seven	of	these	ten	studies	were	published	during	or	post	2012.	Furthermore	the	review	served	to	highlight	pressing	gaps	in	the	research	literature.	In	particular	there	is	a	need	for	high	quality	RCTs	of	community-based	psychosocial	interventions	for	schizophrenia	delivered	by	non-specialists	in	low-income	countries,	which	assess	the	importance	of	a	community	mobilisation	approach	and	integrate	process	and	qualitative	evaluations.				
9.2.1.2 Objective	two:	The	design	of	an	acceptable	and	feasible	CBR	
intervention	for	people	with	schizophrenia	in	Ethiopia	
	 The	intervention	development	work	presented	in	Chapter	5	employed	a	range	of	participatory	methodologies	to	address	this	objective,	structured	using	a	theory	of	change	framework.	This	paper	joins	a	small	group	of	publications	that	describe	the	systematic	development	of	a	mental	health	intervention	for	a	LMIC	setting	[3-5],	and	is	one	of	only	small	handful	that	have	employed	the	theory	of	change	framework	[6].	This	work	was	an	innovative	attempt	to	tailor	CBR’s	capacity	to	promote	inclusion	and	improve	access	to	essential	services	to	the	needs	of	people	with	schizophrenia.	It	was	found	that	a	CBR	intervention	delivered	by	non-	specialists	was	likely	to	be	acceptable	and	feasible	to	a	range	of	relevant	stakeholders,	including	people	with	schizophrenia,	caregivers,	primary	care	staff	and	community	leaders.	The	final	intervention	involved	home	visits,	community	mobilisation	and	family	support	groups	over	a	12	month	period.	Novel	features	of	the	RISE	intervention	include	the	fact	that	it	is	designed	to	be	delivered	in	the	context	of	minimal	or	absent	specialist	mental	health	supervision;	and	the	
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inclusion	of	a	substantial	community	mobilisation	component.	The	RISE	intervention	was	designed	to	be	delivered	by	a	new	cadre	of	community-health	workers,	as	utilising	existing	health	extension	workers	or	primary	care	staff	was	deemed	to	be	unfeasible.		 The	RISE	materials	presented	in	Chapter	6	guide	intervention	delivery	in	a	more	structured	way	than	previous	psychosocial	interventions	for	schizophrenia,	such	as	in	the	COPSI	trial	[3].	The	RISE	manual	also	includes	detailed	steps	to	conduct	community	mobilisation	tasks,	including	resource	mapping;	establishing	relationships	with	community	leaders;	conducting	awareness-raising	events;	mobilising	financial,	practical	or	emotional	support	from	individual	community	members;	and	facilitating	income-generating	opportunities.	The	RISE	materials,	which	will	be	made	freely	available,	are	therefore	of	unique	value	to	the	field	of	global	mental	health	implementation,	in	particular	to	interventions	involving	non-	specialist	workers.		
9.2.1.3 Objective	three:	Pilot	of	the	CBR	intervention	for	people	with	
schizophrenia	to	determine	its	acceptability	and	feasibility	in	practice	
	 As	presented	in	Chapter	7,	qualitative,	quantitative	and	process	data,	again	structured	around	a	theory	of	change	framework,	allowed	an	in-depth	analysis	of	the	CBR	pilot	from	a	range	of	perspectives.	This	pilot	demonstrated	that	overall	the	RISE	CBR	intervention	could	have	a	positive	impact	on	the	lives	of	people	with	schizophrenia	through	maximising	family	and	community	support,	facilitating	access	to	mental	health	services	and	anti-psychotic	medication,	facilitating	income-	generating	activities	and	increasing	hope	and	self-esteem.	The	hypothesised	causal	pathways	to	functioning	were	adjusted	on	the	basis	of	the	pilot	findings,	namely	by	the	introduction	of	improved	family	stability	and	care,	increased	hope,	and	involvement	in	decision-making	about	care	as	intermediate	outcomes.	There	were	some	concerns	as	to	whether	any	gains	in	functioning	would	endure	after	CBR	had	terminated.	Several	assumptions	were	confirmed	as	reasonable,	including	the	competence	of	CBR	workers	and	the	acceptability	of	CBR	from	the	perspective	of	CBR	workers,	community	leaders	and	health	centre	staff.	Community	mobilisation	was	confirmed	as	an	important	component	of	CBR,	but	there	was	little	firm	evidence	that	community	support	would	be	sustainable.	Concerns	around	acceptability	from	the	perspective	of	people	with	schizophrenia	were	felt	to	be	
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resolvable	with	supplementary	training	for	CBR	workers	and	increased	flexibility	of	intervention	delivery.	However	some	contextual	issues,	such	as	poverty	and	inaccessible	anti-psychotic	medication,	may	be	beyond	the	capacity	of	CBR	to	influence.	These	issues	require	further	monitoring	in	the	RISE	trial,	along	with	other	assumptions	that	require	assessment	at	a	larger	scale.		 The	RISE	pilot	represents	a	significant	contribution	to	the	global	mental	health	literature.	A	particular	achievement	is	the	demonstration	that	a	community-based	intervention	for	people	with	schizophrenia	can	be	acceptable	and	feasible,	and	possibly	produce	a	positive	impact,	when	delivered	by	non-specialists	with	almost	no	input	from	mental	health	professionals.	Most	previous	relevant	studies	were	set	in	middle-income	countries	and	featured	clinical	reviews	by	psychiatrists,	including	the	COPSI	trial	in	India	[7].	The	concomitant	threats	of	substantial	mental	illness	burden	and	the	dearth	of	mental	health	specialists	experienced	by	low-income	countries	render	the	RISE	pilot	findings	of	particular	importance.		 A	further	contribution	of	this	pilot	study	relates	to	the	comprehensive	application	of	the	theory	of	change	approach.	A	recent	systematic	review	of	the	application	of	theory	of	change	in	developing	and	evaluating	public	health	interventions	noted	several	shortcomings	in	the	identified	studies.	In	general	there	was	little	detail,	and	often	no	diagrammatic	representation,	of	the	theory	of	change,	making	it	difficult	for	the	reader	to	judge	the	validity	of	the	expected	pathways	[8].	Furthermore	only	two	of	the	62	included	studies	explicitly	identified	and	tested	assumptions,	despite	this	being	a	core	part	of	the	theory	of	change	[8].	The	RISE	pilot	study	may	be	used	as	a	detailed	blueprint	to	guide	the	use	of	theory	of	change	for	the	development	and	evaluation	of	complex	mental	health	interventions.	For	researchers	or	policy	makers	in	other	settings,	this	study	may	also	provide	useful	insights	into	the	challenges	and	opportunities	for	delivery	of	similar	interventions,	as	well	as	helping	to	determine	how	to	replicate	this	intervention	[9].		
9.2.1.4 Objective	four:	The	protocol	for	a	cluster	randomised	controlled	trial	
to	evaluate	the	CBR	intervention	
	 As	described	in	Chapter	8,	the	RISE	trial	is	a	carefully	designed	and	rigorous	evaluation	of	CBR	for	schizophrenia	with	several	measures	in	place	to	minimise	potential	bias.	As	such	the	trial	will	be	an	important	contribution	to	an	evidence	
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base	currently	characterised	by	the	poor	quality	of	many	studies	(see	Chapter	4).	Furthermore	the	trial	will	join	a	small	group	of	RCTs	across	all	mental	disorders	and	interventions	that	is	set	in	a	low-income	country	[10-13].	The	RISE	trial	will	therefore	represent	a	key	addition	to	the	field,	especially	given	the	urgent	need	for	the	implementation	of	evidence-based	mental	health	interventions	in	these	settings.	To	our	knowledge	this	will	also	be	the	first	RCT	of	comprehensive	CBR	for	schizophrenia,	including	a	community	mobilisation	element,	in	any	setting.		 In	the	recent	systematic	review	there	were	no	examples	of	theory	of	change	being	used	to	inform	the	design	of	RCTs	[8].	The	RISE	trial	design	therefore	represents	an	innovative	use	of	theory	of	change.	Bonnell	et	al	noted	that	whilst	hypothesised	causal	pathways	are	frequently	described,	there	is	often	no	attempt	to	test	the	pathways	[14].	In	this	study,	a	theory	of	change	approach	was	used	to	design	the	evaluation,	in	particular	to	select	and	modify	outcome	measures	to	determine	whether	the	intervention	functions	as	expected.	The	statistical	analysis	was	then	designed	to	assess	the	validity	of	the	hypothesised	causal	pathways.	Qualitative	analysis	will	be	used	to	enrich	and	challenge	quantitative	findings.			
9.2.2 Cross-cutting	findings	
	
9.2.2.1 Access	to	mental	health	care	and	anti-psychotic	medication	
	 Access	to	mental	healthcare,	which	is	understood	as	both	access	to	a	competent	mental	health	provider	and	anti-psychotic	medication,	was	a	pertinent	issue	to	each	of	the	objectives	addressed	in	this	thesis.	In	the	systematic	review,	usual	care	differed	considerably	between	included	studies	but	in	all	cases	it	incorporated	at	least	access	to	anti-psychotic	medication.	It	is	therefore	implicit	that	community-	based	interventions	such	as	CBR	are	usually	designed	to	supplement	a	basic	mental	health	service,	which	is	assumed	to	be	present.	It	follows	that	‘Anti-	psychotic	medication	is	accessible’	was	identified	as	an	assumption	in	the	theory	of	change	developed	in	the	intervention	development	phase.	Moreover,	‘Improving	access	to	mental	health	care’	was	designated	as	a	core	CBR	module,	reflecting	the	fact	that	this	is	an	area	of	need	for	many	people	with	schizophrenia	in	rural	Ethiopia	[15].	Additionally,	‘Improved	access	to	mental	health	care’	was	included	as	an	intermediate	outcome	on	the	causal	pathway	to	improved	functioning.	The	
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potential	role	of	CBR	in	improving	access	in	each	of	the	five	dimensions	(availability,	geographical	accessibility,	affordability,	adequacy	and	acceptability)	can	be	grasped	by	considering	the	ACCESS	framework	developed	by	Obrist	et	al	(see	Figure	9.1)	[16].		
Figure	9.1	The	ACCESS	framework	(from	Obrist	et	al	2007)	
	
	 According	to	the	ACCESS	framework,	in	the	context	of	livelihood	insecurity	the	degree	of	health	service	access	obtained	depends	on	two	factors:	1)	the	health	care	services,	policies,	institutions,	organisations	and	processes	in	place	and	2)	the	livelihood	assets,	comprising	human,	social,	natural,	physical	and	financial	capital,	that	potential	service	users	can	mobilise	[16].	CBR	can	be	conceptualised	as	a	means	of	galvanising	livelihood	assets	in	order	to	increase	access.	In	the	pilot	study	the	actual	ability	of	CBR	to	mobilise	these	livelihood	assets,	and	therefore	increase	access	to	mental	health	care,	was	assessed.	Despite	the	recent	integration	of	mental	health	in	primary	care	in	Sodo,	CBR	workers	encountered	several	difficulties	in	improving	access	to	mental	health	care	and	medication;	this	was	a	key	acceptability	and	feasibility	issue	that	also	threatened	to	‘block’	the	causal	pathway	to	improved	functioning.	I	had	initially	hypothesised	that	having	a	low	level	of	facility-based	care	would	make	it	easier	to	demonstrate	the	effectiveness	of	an	adjuvant	intervention	such	as	CBR	(see	Chapter	4,	Section	4.4.1).	The	pilot	findings	allow	a	more	nuanced	conclusion,	namely	that	a	minimum	level	of	facility-	based	care	seems	to	be	required	in	order	for	CBR	to	function.	It	is	also	possible	that	
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most	of	the	effect	of	CBR	is	mediated	through	increased	access	and	adherence	to	medication;	methods	to	test	this	possibility	were	described	in	Chapter	8	(Section	8.3.2).	Table	9.1	presents	the	pre-existing	barriers	associated	with	each	dimension	of	access,	and	the	ability	of	CBR	to	address	these	barriers.	Recommendations	arising	from	the	body	of	work	in	this	thesis	are	also	listed	in	Table	9.1.	These	recommendations	are	presented	as	the	contextual	changes	needed	in	addition	to	CBR,	in	relation	to	health	services,	policies	and	processes,	to	successfully	address	these	barriers.	Some	of	these	issues	changed,	often	for	the	better,	during	the	trial;	these	early	findings	will	be	discussed	below	(see	Section	9.5).	
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Table	9.1	Dimensions	of	access,	barriers	and	role	of	CBR	in	mobilising	livelihood	assets	
	
Dimension	of	
access	
Degree	of	access	
and	barriers	
Potential	for	CBR	to	
mobilise	 livelihood	
assets	
Recommendations	for	
contextual	changes	
needed	to	improve	access	
(health	services,	policies	
and	processes)	
Geographic	
accessibility	
Moderate	
Barriers:	Main	issue	is	accessing	hospital	(e.g.	for	depot	injection).	Health	centre	generally	accessible	
Moderate	
Social	capital:	encouraging	family	members	to	help	to	transport	people	with	schizophrenia	to	health	facility	
Consolidate	integration	of	mental	health	in	primary	care.	Expand	remit	of	primary	care	to	cover	depot	injections	
Availability	 Moderate	
Barriers:	Erratic	supply	of	anti-	psychotic	medication	in	health	centres	
Poor	 Improved	systems	for	the	supply	and	financing	of	anti-	psychotic	medication	
Affordability	 Poor	
Barriers:	User	fees	for	medication;	poor	access	to	medication	fee	waiver;	no	health	insurance	
Moderate	
Human	capital:	Advocating	for	medication	fee	waiver	
Human/	financial	
capital:	facilitating	income	generation	
Social	capital:	asking	extended	family	members	to	pay	for	medication	
Universal	free	medication	for	schizophrenia	or	health	insurance	scheme	
Acceptability	 Poor	
Barriers:	side	effects	often	intolerable.	Some	issues	with	taking	medication	alongside	holy	water.	
Moderate	
Human	capital:	give	knowledge	to	go	back	to	health	centre	to	manage	side	effects	or	review	dose.	
Human	capital:	give	psychoeducation	to	encourage	to	take	medication	alongside	holy	water.	
Greater	choice	of	medication	with	better	side	effect	profile.	
	 Incorporate	training	on	treatment	preferences/	shared	decision	making	into	mhGAP	training.	
Adequacy	 Good	 Moderate	
Human	capital:	improve	communication	between	primary	care	staff	and	people	with	schizophrenia	
Inclusion	of	holistic	approach	in	training.	Supervision	of	prescribing	practices.	
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On	the	whole	there	was	good	geographical	access	to	the	health	centres	in	the	pilot,	though	problems	occasionally	arose	when	participants	were	required	to	travel	to	the	hospital	in	the	neighbouring	district	to	receive	a	depot	injection.	In	some	cases	CBR	workers	successfully	encouraged	extended	family	members	to	accompany	the	individual	on	the	journey	(mobilisation	of	social	capital).	These	findings	suggest	that	aside	from	emergencies	and	the	most	remotely	located	households	it	is	not	usually	necessary	to	provide	a	service	through	which	medications	are	brought	to	the	home.	However,	treatment	options	for	the	most	severely	ill	or	complex	cases,	for	example	depot	injections,	should	be	available	in	primary	care	to	avoid	travel	to	specialist	centres.		 The	pilot	study	showed	that	the	availability	of	a	mental	health	workforce	in	primary	care	did	not	always	equate	to	anti-psychotic	medication	being	available.	The	distinction	between	personnel	and	products	has	not	always	been	made	clear	in	previous	local	studies	of	accessibility	to	mental	healthcare	[15].	Erratic	provision	of	anti-psychotic	medication	arose	due	to	failings	in	the	supply	and	financing	systems.	Though	the	precise	cause	of	these	issues	was	usually	opaque,	it	is	possible	that	they	were	due	to	teething	problems	experienced	by	a	new	service.	Aside	from	checking	availability	in	advance	to	prevent	a	wasted	journey	by	participants,	CBR	workers	had	little	capacity	to	address	this	issue	in	the	pilot.	More	robust	supply	and	financing	systems	and	are	needed,	led	by	the	Ministry	of	Health	and	supported	by	regional	and	district	health	administrations,	to	ensure	a	continuous	supply	of	psychotropic	medication	is	provided	to	primary	care.		 The	affordability	of	medication	was	a	significant	issue	for	several	pilot	participants.	CBR	workers	supported	income	generation	(mobilisation	of	financial	
capital),	but	it	was	not	always	clear	if	this	translated	into	greater	ability	to	pay	for	medication.	There	was	no	success	in	accessing	the	medication	fee	waiver	in	the	pilot.	It	is	therefore	apparent	that	without	some	form	of	universal	subsidy,	anti-	psychotic	medication	will	remain	inaccessible	to	many	Ethiopians.	It	is	unlikely	that	anti-psychotic	medication	will	be	subsidised	either	in	the	scale	up	of	the	PRIME	programme	which	has	begun	across	the	Gurage	Zone,	or	in	the	national	scale	up	of	mental	health	in	primary	care.	A	national	health	insurance	scheme	is	however	planned	for	Ethiopia.	
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There	were	significant	issues	with	the	acceptability	of	anti-psychotic	medication	in	the	pilot	study.	Low	rates	of	anti-psychotic	medication	adherence	are	not	unique	to	this	study	or	even	this	setting	[17].	In	an	US	RCT	comparing	different	anti-	psychotic	medications	(including	both	first	and	second	generation	drugs),	74%	of	the	1,432	participants	had	discontinued	their	medication	by	18	months	[18].	A	cross-sectional	study	in	Southern	Ethiopia	found	that,	even	amongst	inpatients	in	a	psychiatric	unit,	only	19.6%	of	people	with	schizophrenia	were	completely	adherent	to	their	anti-psychotic	medication	[19].	Aside	from	the	issues	of	availability	and	affordability,	the	most	common	reasons	for	non-adherence	are	ineffectiveness	and	intolerable	side	effects	[17,	18,	20],	which	were	also	important	issues	amongst	the	pilot	participants.	Read	et	al	described	how	in	Ghana	non-	adherence	arose	from	the	mismatch	between	the	disabling	effects	of	anti-psychotic	medication	and	the	notion	of	“health	as	strength”	[21].	There	are	arguably	similar	processes	at	play	in	Ethiopia.	Moreover,	sedating	side	effects	of	medication	tangibly	impeded	functioning,	the	very	thing	CBR	professed	to	help.		 In	contrast	to	the	near	universal	experience	of	sedating	side	effects,	causal	attributions	played	a	minor	role	in	determining	the	acceptability	of	medication	in	the	pilot.	Irrespective	of	their	explanatory	model,	participants	were	generally	willing	to	try	anti-psychotic	medication.	This	may	demonstrate	the	pluralism	of	illness	beliefs	that	exists	in	Ethiopia	[22,	23],	and	possibly	the	level	of	desperation	reached	by	people	with	schizophrenia	and	their	families.	However	one	participant	stopped	her	medication	when	at	the	holy	water	site,	implying	that	receiving	the	treatments	together	would	render	both	ineffective.	In	another	case	the	fact	that	medication	was	not	only	ineffectual	but	brought	more	problems	was	seen	as	evidence	that	the	illness	had	a	spiritual	cause,	and	contributed	to	the	participant	stopping	medication.		 There	was	little	specific	information	on	the	adequacy	of	care	received	at	the	health	centre,	though	one	CBR	worker	felt	that	primary	care	staff	did	not	take	account	of	the	broader	social	needs	of	people	with	schizophrenia.	CBR	workers	may	have	a	role	in	improving	communication	between	primary	care	staff	and	people	with	mental	illness	to	ensure	their	wider	needs	are	taken	into	account.	This	kind	of	holistic	approach	should	also	be	addressed	in	the	training	of	primary	care	staff	in	mental	health,	though	the	time	capacity	of	such	staff	to	truly	address	
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broader	issues	also	needs	to	be	considered.	It	is	also	possible	that	improved	prescribing	practices	by	primary	care	workers	could	reduce	the	prevalence	of	intolerable	side	effects.		
9.2.2.2 Poverty	and	livelihoods	
	 The	issue	of	poverty	was	the	second	cross-cutting	theme	across	all	objectives.	There	is	good	understanding	that	poverty	is	both	a	principal	cause	and	consequence	of	disability	related	to	mental	illness	[24,	25].	The	importance	of	incorporating	poverty	alleviation	in	mental	health	interventions	in	LMIC	has	therefore	been	repeatedly	highlighted	[24,	26-28],	yet	none	of	the	community-	based	interventions	identified	in	the	systematic	review	involved	explicit	attempts	to	alleviate	poverty.	During	the	intervention	development,	support	returning	to	work	was	seen	as	a	crucial	component	of	CBR,	and	the	lynchpin	for	improved	functioning	and	economic	status.	Microfinance	schemes	are	incorporated	into	some	CBR	programmes	[1]	and	are	also	used	in	the	BasicNeeds	mental	health	and	development	model	[29].	Such	an	approach	could	arguably	have	been	incorporated	into	the	RISE	CBR	intervention.	An	RCT	using	a	general	population	sample	in	South	Africa	found	that	the	provision	of	small	loans	was	associated	with	increased	stress	[30],	whilst	other	studies	from	sub-Saharan	Africa	have	concluded	that	microfinance	can	exacerbate	poverty	[28].		In	the	intervention	development	phase	it	was	felt	these	negative	effects	could	be	even	more	prominent	amongst	persons	with	schizophrenia,	hence	a	microfinance	component	was	avoided.	Furthermore,	such	a	scheme	may	have	jeopardised	the	sustainability	and	scalability	of	CBR	as	it	may	require	an	on	going	supply	of	financial	capital	that	could	substantially	increase	the	running	costs	of	the	intervention.		 ‘Getting	back	to	work’	was	however	included	as	an	optional	CBR	module,	and	increased	income	was	identified	as	an	intermediate	outcome	on	the	causal	pathway	to	improved	functioning	(as	well	as	an	effect	of	improved	functioning).	The	pilot	study	suggested	that	a	failure	to	effectively	grapple	with	poverty,	particularly	in	a	setting	where	medication	costs	are	out	of	pocket,	may	be	unacceptable	to	participants	and	therefore	doom	any	intervention	to	failure.	In	the	pilot	CBR	workers	had	some	success	at	facilitating	income-generating	activities,	without	providing	microfinance.	This	was	achieved	by	setting	up	opportunities	for	daily	labouring,	or	simply	encouraging	home	production	of	alcohol	or	handicrafts.	
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There	were	also	some	instances	where	CBR	workers	tapped	into	family	and	community	networks	to	improve	access	to	food.	However,	the	question	of	whether	CBR	can	truly	address	poverty,	or	just	circumvent	it	by	making	medication	more	affordable,	was	not	fully	resolved	and	requires	further	investigation	in	the	trial.	The	impact	of	CBR	on	economic	status	will	be	assessed	with	qualitative,	quantitative	and	process	data,	as	well	as	through	a	general	assessment	of	whether	CBR	can	meet	the	needs	of	people	with	schizophrenia.	 
9.2.2.3 Recovery-oriented	approach	The	issues	around	using	a	recovery-oriented	approach	was	the	third	cross-cutting	theme	across	all	objectives.	In	the	systematic	review,	some	studies	employed	recovery	principles,	such	as	linking	to	self-help	groups	and	focusing	on	human	rights.	In	the	intervention	development	stage,	it	was	decided	to	focus	the	intervention	around	recovery	principles,	such	as	emphasising	the	participants’	own	goals	and	the	importance	of	hope;	however	these	elements	were	mainly	included	to	ensure	the	acceptability	of	the	intervention.	In	the	pilot	stage	it	emerged	that	not	only	could	CBR	have	a	powerful	impact	on	hope	and	self-esteem	amongst	participants,	but	that	this	was	an	important	part	of	the	causal	pathway	to	improved	functioning.	There	were	some	indications	that	CBR	participants	experienced	other	personal	recovery	processes,	relating	to	connectedness,	identity	and	meaning	in	life	[31].	A	contributory	factor	to	increased	self-esteem	and	hope	may	have	been	the	close	and	trusting	relationships	between	some	participants	and	CBR	workers,	in	which	CBR	workers	saw	participants	as	“any	normal	person”.	Being	considered	a	person	rather	than	just	‘a	patient’	is	thought	to	have	an	important	role	in	the	recovery	process	for	many	people	with	mental	illness	[32].	Conversely,	a	‘them	and	us’	attitude	between	service	users	and	mental	health	professionals	has	been	noted	to	impede	recovery	[32];	this	may	have	been	minimised	in	this	study	due	to	CBR	workers	being	non-specialists,	from	the	local	area.		There	were	also	two	important	challenges	relating	to	increased	hope.	First	is	the	possibility	of	raising	unrealistic	hopes	amongst	people	with	mental	illness	and	their	families,	which	is	a	potential	problem	with	the	personal	recovery	approach	in	any	setting	[33].	The	issue	may	have	been	exacerbated	by	the	difficulty,	previously	identified	in	Nepal,	in	training	non-specialists	to	foster	feasible	expectations	for	
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improvement	[34].	In	the	pilot,	the	absence	of	real	changes	in	functioning	was	particularly	disappointing	to	caregivers	of	both	women	with	comorbid	intellectual	disability;	it	is	likely	that	hopes	were	built	too	high	initially.	It	isn’t	known	how	the	women	with	schizophrenia	themselves	perceived	this	issue	as	they	were	assessed	not	to	have	the	cognitive	capacity	to	participate	in	qualitative	interviews.	Second	is	a	broader	issue	around	the	applicability	of	the	recovery	model	in	LMIC.	This	study	showed	that	factors	external	to	the	illness	itself	often	meant	basic	wishes	and	goals	could	not	be	brought	to	fruition.	For	example,	gaining	salaried	work	was	not	possible	due	to	a	lack	of	employment	opportunities	and	medication	doses	were	missed	due	to	an	erratic	supply	at	the	health	centre.	These	findings	demonstrate	that	it	is	difficult	to	be	truly	empowered	in	a	context	that	is	disempowering	in	so	many	ways.	Furthermore,	these	findings	nicely	exemplify	that	the	genesis	of	disability	lies	in	the	combination	of	illness	and	environmental	factors	(see	Chapter	2;	Section	2.3.1).	However	there	are	ways	for	CBR	to	address	these	issues.	For	example,	it	became	clear	that	goals	should	be	realistic	and	relevant	[34],	such	as	aiming	towards	home-based	income	generation	such	as	handicrafts,	rather	than	paid	employment.	The	findings	also	suggest	that	targeted	training	is	needed	on	differing	expectations	for	functioning	of	people	with	co-morbid	schizophrenia	and	intellectual	disability.	White	et	al	propose	that	the	capabilities	approach,	rather	than	the	recovery	approach,	should	be	used	to	guide	global	mental	health	initiatives;	this	model	identifies	the	sources	of	social	inequality	and	structural	violence	that	may	hamper	individuals	from	engaging	in	the	behaviours	that	they	value	[35].	The	qualitative	study	alongside	the	trial	will	explore	experiences	of,	and	barriers	to,	personal	recovery.	The	role	of	spirituality,	which	has	been	raised	as	potentially	having	an	important	influence	on	recovery	[36,	37],	will	be	explored.	It	is	hoped	the	results	of	this	work	will	advance	understanding	of	the	applicability	of	this	model	to	the	LMIC	context.	Further	difficulties	in	the	application	of	the	recovery	model	related	to	anti-psychotic	medication.	In	all	parts	of	the	world	there	is	generally	an	assumption	that	medication	non-adherence	signifies	poor	judgment	by	the	person	with	schizophrenia	and	presents	a	problem	to	be	solved	through	education,	encouragement	or	altering	the	medication	[33].	Furthermore,	as	highlighted	by	Read	[21],	global	mental	health	discourse	tends	to	unquestioningly	drive	towards	increasing	access	and	adherence	to	anti-psychotic	medication	for	people	with	
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	schizophrenia	[38].	There	is	less	recognition	of	the	difficulties	people	with	schizophrenia,	globally,	have	with	long-term	adherence	to	medication.	The	mhGAP	intervention	guide	for	psychosis	does	mention	the	need	to	take	into	account	treatment	preferences	[39],	which	is	a	key	component	of	a	recovery-orientated	model	of	care	[32].	However	there	is	generally	little	emphasis	on	this	issue	in	strategies	for	scaling	up	mental	health	services	in	LMIC.	Although	the	CBR	training	was	explicitly	framed	in	recovery	terms,	CBR	workers	nonetheless	found	it	challenging	to	accept	participants’	choices	not	to	continue	treatment.	A	key	reason	for	this	is	likely	to	be	the	fact	there	was	little	discussion	of	issues	around	capacity	nor	any	nuanced	training	on	how	to	support	informed	decision	making	in	people	with	schizophrenia.	This	was	underpinned	by	a	tendency	in	the	RISE	training	manual	to	frame	adhering	to	medication	as	the	only	logical	option	(the	pre-specified,	if	optional,	goal	was:	“Person	with	schizophrenia	is	willing	to	take	medication”).	It	is	arguable	that	CBR	training	was	guilty	of	an	“abuse”,	rather	than	a	“use”,	of	the	recovery	model,	namely	through	promoting	the	incorrect	notion	that	“services	can	make	people	recover	through	effective	treatment”[40].	Moreover,	and	despite	the	friendly	relations	between	many	CBR	workers	and	participants,	it	is	likely	that	CBR	workers	adopted	the	same	paternalistic	approach	to	giving	health	advice	that	is	pervasive	in	Ethiopian	clinical	settings.	With	further	training	and	experience,	it	is	hoped	that	in	the	trial	CBR	workers	will	develop	an	important	role	in	helping	people	with	schizophrenia	to	negotiate	the	treatment	choices	available	to	them,	as	well	as	identifying	problems	with	side	effects	early	in	order	for	changes	to	be	made	to	dosage	or	medication.	However	the	underlying	issue	is	the	manifest	lack	of	choices	available	to	people	with	schizophrenia	in	this	setting.	For	many	people	the	only	‘choices’	are	which	of	two	first	generation	anti-psychotic	medications	to	take	(chlorpromazine	or	haloperidol),	and	at	what	dose.	This	issue	is	beyond	the	scope	of	CBR	to	address.	Two	important	implications	from	this	study	are	therefore	the	need	to	shift	towards	respecting	patient	choice	within	both	primary	care	and	interventions	such	as	CBR,	but	perhaps	more	importantly	to	ensure	more	real	choices	are	available	and	can	be	enacted.	There	are	three	key	reasons	why	the	personal	recovery	model	may	not	be	appropriate	for	rural	Ethiopia.	First	is	the	fact	that	people	may	have	a	preference	for	a	paternalistic	mode	of	care,	as	this	is	the	normative	model	in	Ethiopia	for	both	physical	and	mental	health	[41].	To	make	the	assumption	that	an	approach	
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	increasingly	favoured	in	the	West	is	suitable	in	other	contexts	is	arguably	an	example	of	the	imposition	of	Western	values	and	treatment	models	(see	Section	9.3.11).	There	has	been	little	culture	of	self-determination	amongst	people	with	mental	illness	in	Ethiopia;	for	example	there	is	no	self-advocacy	movement,	such	has	been	seen	in	other	sub-Saharan	African	countries	[42].	Second,	the	recovery	model	requires	that	opportunities	and	resources	actually	exist	for	individuals	to	make	choices	about	their	employment,	social	life,	living	arrangements	and	so	on	[43].	As	discussed	above,	options	for	meaningful	life	changes	are	often	highly	limited	in	the	rural	Ethiopian	setting,	due	to	the	high	levels	of	poverty,	poor	infrastructure,	lack	of	supported	housing	and	lack	of	employment	opportunities.	Third,	there	may	be	challenges	in	operationalizing	a	highly	individualized	approach	such	as	recovery,	whilst	using	a	standardized	and	manualized	psychosocial	intervention	[44].	However,	there	are	also	arguments	to	support	the	use	of	the	recovery	model	in	Ethiopia.	First,	there	was	evidence	from	the	pilot	that	a	paternalistic	approach	is	not	always	acceptable,	especially	in	terms	of	medication	advice.	Furthermore,	CBR	delivery	may	entail	a	therapeutic	relationship	that	is	unusual	for	the	Ethiopian	setting;	that	is,	between	older,	sometimes	male,	participants	and	often	younger,	sometimes	female,	CBR	workers.	More	collaborative	goal	setting	is	likely	to	be	more	acceptable	in	such	scenarios.	Second,	whilst	recovery	might	“look	different”	in	low-income	settings	[44],	the	same	principles	may	apply.	The	pilot	showed	that	seemingly	modest	achievements,	such	as	successfully	maintaining	a	vegetable	patch,	could	hold	great	significance	for	participants	in	terms	of	self-esteem,	motivation	and	income.	Mental	health	researchers	and	practitioners	may	need	to	adjust	expectations	about	what	a	meaningful	change	might	look	like.	Third,	the	RISE	CBR	intervention	was	designed	to	be	highly	personalized	to	the	individual’s	own	needs	and	goals	through	repeated	needs	assessments	and	the	joint	selection	of	appropriate	optional	modules.	In	summary,	the	recovery	model	may	be	a	useful	approach	for	low-income	settings,	but	this	requires	further	investigation.	In	the	first	instance	qualitative	methodologies	may	be	most	appropriate	to	explore	the	applicability	of	the	model	to	different	contexts	such	as	Ethiopia.		
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	9.3 STRENGTHS	AND	LIMITATIONS	
9.3.1 Issues	relating	to	theory	of	change	The	theory	of	change	approach	provided	a	unifying	framework	to	progress	through	each	stage	of	the	MRC	framework	for	developing	and	evaluating	complex	interventions	[45].	All	aspects	of	the	MRC	guidance	on	the	process	evaluation	for	complex	interventions	were	considered:	implementation,	context,	and	mechanisms	of	change	[9].	Moreover,	causal	assumptions	and	outcomes	were	also	incorporated	into	the	same	model.	A	strength	of	this	work	is	that	it	has	laid	the	groundwork	to	unpack	the	‘black	box’	of	CBR.	In	the	future	this	will	allow	me	to	understand	which	elements	of	CBR	are	fundamental	to	its	functioning	and	which	are	not,	and	therefore	how	to	best	replicate	observed	effects	in	other	settings	[9].		However,	there	were	some	limitations	relating	to	the	application	and	scope	of	theory	of	change	in	this	thesis.	First,	there	was	limited	ownership	of	the	theory	of	change	by	stakeholders,	in	particular	by	people	with	schizophrenia	and	caregivers.	Whilst	it	has	been	argued	that	full	stakeholder	participation	is	not	always	feasible	or	necessary	for	theory	of	change	[46],	the	lack	of	meaningful	involvement	may	have	had	important	ramifications	for	the	RISE	study.	In	particular	the	final	outcome	of	‘sustained	improved	functioning’	was	determined	a	priori	without	the	input	of	stakeholders.	During	the	pilot	study	it	emerged	that	the	overriding	priorities	for	people	with	schizophrenia	and	their	families	were	income	generation	and	livelihoods.	Whilst	livelihoods	and	functioning	are	inextricably	linked,	it	is	conceivable	that	placing	livelihoods	as	the	final	outcome	would	have	resulted	in	the	design	of	a	different	intervention,	which	would	have	been	better	placed	to	truly	address	the	needs	of	participants.	Second,	unintended	consequences	of	the	intervention	were	not	captured	on	the	theory	of	change	[6],	such	as	non-CBR	participants	potentially	being	deprioritised	for	access	to	scare	medication	(see	RISE	trial	progress	in	Section	9.5).	Third,	the	final	theory	of	change	had	less	clear	causal	pathways	compared	to	earlier	iterations,	presenting	instead	multiple	bidirectional	connections	between	levels	of	intermediate	outcomes.	Whilst	this	may	be	a	valid	representation	of	the	likely	process	of	change,	testing	the	validity	of	the	causal	pathways	may	be	challenging.		
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	9.3.2 Qualitative	methodology		Approaches	to	qualitative	analysis	can	be	broadly	categorised	into	realist	methods	and	constructionist	methods.	Realist	approaches,	such	as	interpretative	phenomenological	analysis,	give	primacy	to	the	reported	experiences	of	participants.	Constructionist	approaches,	such	as	discourse	analysis,	are	interested	in	the	way	events	and	experiences,	and	the	way	they	are	spoken	about,	may	reflect	various	discourses	operating	within	society	[47].	It	has	been	argued	that	thematic	analysis	can	be	used	across	epistemological	approaches.	Thematic	analysis	can	identify	themes	through	an	inductive	(data-driven)	approach	or	through	a	deductive	(theoretical)	approach	[47].	In	the	RISE	pilot	analysis	I	tended	towards	a	realist	approach;	within	this,	overarching	themes	were	identified	a	priori,	whilst	sub-themes	were	drawn	from	the	data.	Taking	a	realist	approach	meant	that,	whilst	not	taking	all	speech	purely	at	face	value,	I	generally	identified	sub-themes	by	examining	the	surface	(semantic)	meanings	of	the	data.	In	contrast,	a	latent	approach	to	identifying	themes	would	have	involved	drawing	out	the	underlying	ideas	or	assumptions	that	underpinned	what	is	actually	articulated	by	participants	[47].	Whilst	I	used	a	realist	approach,	I	did	use	the	data	to	assess	the	salience	of	my	a	priori	themes.	In	Sections	7.4.2-	7.4.4	I	discussed	how	the	theory	of	change,	and	the	assumptions	that	underpin	it,	were	adjusted	using	the	pilot	findings.	There	were	two	main	rationales	for	using	a	more	realist	approach.	First,	the	overarching	aim	of	this	qualitative	analysis	was	to	determine	the	acceptability,	feasibility	and	potential	impact	of	CBR.	This	meant	that	it	was	appropriate	to	retain	focus	on	participants’	experiences	of	receiving	or	delivering	the	intervention,	rather	than	necessarily	looking	beneath	these	accounts	for	underlying	discourse.	Nevertheless	the	findings	were	contextualised	by	considering	the	social	and	economic	setting	in	which	experiences	took	place.	A	further	way	that	context	was	taken	into	account	was	to	discuss	with	the	interviewer	any	non-verbal	cues	in	the	participant	that	may	have	indicated	discomfort	in	discussing	certain	topics.	Second,	the	interviews	were	conducted	by	a	research	assistant,	then	transcribed	and	translated	to	English	prior	to	analysis.	I	did	not	observe	the	pilot	qualitative	interviews	as	it	was	felt	by	the	research	team	that	my	presence,	as	a	Western	researcher,	would	generate	additional	expectations	from	CBR	participants	that	they	would	receive	financial	benefits	from	the	project.	Furthermore,	it	is	possible	
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	that	nuances	in	the	way	participants	expressed	themselves,	and	potentially	revealed	underlying	meanings,	were	lost	in	translation	[48].	Despite	clarifying	with	the	interviewer	any	text	and	cultural	idioms	that	were	initially	unclear,	in	sum	these	issues	meant	I	had	some	‘distance’	from	the	participants	and	the	data.	If	it	had	been	feasible,	a	social	constructionist	analysis	may	have	given	a	richer	understanding	of	how	environmental	or	structural	factors	influence	the	genesis	of	disability	in	rural	Ethiopia,	and	how	these	may	act	as	barriers	to	the	effectiveness	of	CBR.	However	attempting	this	approach	would	have	implied	a	deeper	connection	with	the	participants,	and	the	language	they	used,	than	was	actually	possible.	An	ethnographic	approach,	for	example	by	observing	CBR	participants	in	the	daily	lives,	could	also	have	given	an	additional	dimension	to	the	findings.	However,	as	discussed	above,	it	was	felt	that	my	presence	would	greatly	risk	altering	the	participants’	expectations	of,	and	therefore	participation	in,	CBR.	I	did	however	gain	some	understanding	of	the	typical	home	and	work	environment	of	people	living	in	rural	Ethiopia	through	separate	field	trips	to	non-CBR	participants’	homes.			
9.3.3 Scope	of	pilot	and	readiness	for	the	trial	The	MRC	guidance	highlights	three	key	roles	of	pilot	studies:	(i)	testing	procedures,	(ii)	estimating	recruitment	and	retention	and	(iii)	determining	sample	size	[45].		Traditionally,	pilot	studies	are	designed	so	that	these	three	areas	can	be	assessed	and	the	results	interpreted	prior	to	commencing	the	full	evaluation	or	trial.	The	RISE	pilot	design	differed	from	this	approach	in	that	it	was	a	rolling	pilot.	The	first	nine	months	of	the	pilot	took	place	prior	to	the	trial	commencing,	meaning	many	of	the	early	findings	could	be	used	to	adjust	the	trial	procedures	in	advance	of	the	trial	starting.	However,	the	last	three	months	of	the	pilot	overlapped	with	the	trial.	Whilst	minor	iterative	adjustments	to	the	trial	procedures	were	still	possible,	overall	there	was	no	clear	hiatus	between	the	pilot	and	the	trial.	This	is	arguably	a	major	limitation	of	the	RISE	study,	and	the	implications	of	this	are	discussed	below.	The	RISE	pilot	study	nevertheless	achieved	some,	but	not	all,	of	the	MRC	objectives.		
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	(i)	Testing	procedures	Nearly	all	procedures	for	the	full	trial	were	tested	in	advance.	The	pilot	gathered	rich	data	on	the	acceptability	of	CBR,	and	also	assessed	in	detail	whether	CBR	can	be	delivered	as	intended.	However	feasibility	was	assessed	using	a	smaller	geographical	area	and	workload	than	was	planned	for	the	trial;	the	implications	of	this	shift	in	scale	are	discussed	in	Section	9.3.4.	Most	procedures	to	be	used	during	the	trial	were	assessed	during	the	pilot	including:	data	collection,	data	entry,	CBR	adherence	rates,	and	eligibility	assessment.	The	adjustments	made	on	the	basis	of	this	piloting	are	presented	in	Chapter	8	Section	8.3.1.	The	safety	of	CBR,	from	the	perspective	of	both	participants	and	CBR	workers,	was	also	assessed	using	process	data	and	qualitative	interviews.	The	importance	of	using	a	pilot	to	train	research	staff,	in	particular	to	strengthen	the	skills	needed	to	conduct	the	trial	according	to	GCP	principles,	has	been	highlighted	[49].	The	RISE	pilot	gave	us	the	chance	to	practice	adherence	to	GCP	guidelines	and	make	adjustments	to	procedures	accordingly,	for	example	the	detection	and	initial	reporting	of	serious	adverse	events	was	piloted.	The	RISE	pilot	also	fulfilled	an	important	role	in	increasing	the	CBR	workers’	and	supervisors’	experience	of	delivering	the	intervention	in	preparation	for	the	trial.	Arguably	an	important	omission	is	that	a	control	group	was	not	integral	to	the	RISE	pilot.	It	has	been	proposed	that	use	of	a	control	group	in	pilot	studies	“allows	for	a	more	realistic	examination	of	recruitment,	randomization,	implementation	of	interventions,	blinded	assessment	procedures,	and	retention	in	blinded	interventions.”[49]. The	rationale	for	not	using	a	‘RISE-specific’	control	group	was	that	facility	based	care,	which	represents	usual	care	and	the	control	arm	of	the	trial,	was	piloted	as	part	of	the	PRIME	study	alongside	the	RISE	CBR	pilot.	The	PRIME	team	responded	to	emerging	findings	in	the	delivery	of	facility-based	care,	for	example	by	adjusting	supervision	procedures	for	primary	care	staff.	The	use	of	a	control	group	as	an	integral	part	of	the	RISE	pilot	was	therefore	deemed	unnecessary.	An	independent	statistician	carried	out	the	randomization	of	clusters	in	advance	of	recruitment;	it	would	have	been	impractical	to	‘pilot’	this	process.	Most	other	trial	procedures	could	be	piloted	without	use	of	a	separate	control	group.	(ii)	Estimating	recruitment	and	retention		
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	Rates	of	recruitment,	refusal	and	retention	were	estimated	from	the	pilot	study,	though	once	again	this	was	based	on	small	numbers;	the	alterations	made	on	the	basis	of	the	pilot	are	described	in	Chapter	8	Sections	8.3.1.2	and	Section	8.3.1.3.		(iii)	Determining	sample	size	The	RISE	pilot	was	not	used	to	estimate	effect	sizes	and	variance,	nor	to	adjust	the	sample	size	calculation.	This	was	due	to	the	small	sample	size	and	also	the	fact	that	the	trial	began	before	the	pilot	was	completed.	In	fact	the	MRC	guidance	and	others	suggest	that	pilot	study	results	should	be	used	cautiously	in	the	determination	of	sample	size	as	effects	sizes	are	likely	to	be	smaller	and	show	greater	variability	than	when	the	intervention	is	delivered	at	scale	[45].	The	MRC	guidance	also	proposes	that	pilot	data	can	be	used	for	initial	analysis	to	understand	potential	interactions	[45].	Due	to	the	small	sample	size	only	a	descriptive	analysis	was	conducted	for	the	RISE	pilot;	however	qualitative	data	were	used	to	refine	the	conceptual	framework	for	how	CBR	may	impact	on	functioning.	These	pathways	will	then	be	tested	in	the	trial	analysis	(see	Chapter	8	Section	8.3.2).	On	balance,	the	pilot	work	presented	in	this	thesis	does	demonstrate	readiness	to	progress	to	a	full	trial	of	CBR.	Many	of	the	MRC	objectives	for	a	pilot	were	addressed.	However,	the	fact	that	the	trial	commenced	three	months	prior	to	the	completion	of	the	pilot	created	some	challenges	in	the	development	and	evaluation	process.	This	schedule	meant	that	whilst	findings	evident	in	the	earlier	stages	of	the	pilot	could	be	successfully	translated	into	adjustments	to	the	trial	intervention	or	evaluation	design	(see	Chapter	7),	issues	arising	later	could	not.	For	example,	it	was	only	towards	the	end	of	pilot	that	it	was	possible	to	grasp	the	full	implications	of	frequent	home	visits	for	reduced	acceptability	in	some	participants.	It	was	difficult	to	consider	changing	the	intervention	structure	at	this	stage	as	the	trial	had	already	commenced.	Furthermore	whilst	a	responsive	approach	to	intervention	development	is	encouraged	[9,	14],	there	are	sometimes	practical	challenges	to	implementing	this.	In	this	study,	trial	protocol	amendments	had	to	be	reviewed	by	three	ethics	committees	and	the	data	and	safety	monitoring	board;	this	was	often	a	time-consuming	process	that	occasionally	led	to	delays	in	conducting	the	research.			
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	9.3.4 Differences	between	the	pilot	and	the	trial	There	were	three	areas	of	differences	between	the	pilot	and	the	trial,	relating	to	the	participants,	the	intervention	and	the	setting,	that	were	planned	in	advance	and	did	not	arise	due	to	adjustments	made	on	the	basis	of	the	pilot	findings.	In	the	pilot,	participants	were	recruited	immediately	after	facility-based	care	for	schizophrenia	was	implemented	into	local	health	centres	by	PRIME.	This	meant	that	five	of	the	ten	participants	were	treatment	naïve	at	the	pilot	baseline	and	only	one	was	receiving	treatment	at	the	time	of	recruitment.	In	contrast,	the	trial	was	designed	to	include	participants	who	had	had	access	to	facility-based	care	for	at	least	six	months	prior	to	recruitment.	It	is	therefore	arguable	that	the	pilot	and	trial	participants	may	have	different	needs;	important	conclusions	from	the	pilot,	and	the	way	the	intervention	was	shaped	by	the	pilot	findings,	may	therefore	have	had	less	relevance	to	the	trial	participants.	For	example,	supporting	access	to	facility-based	care	may	have	less	relevance	to	trial	participants	who	are	already	habituated	to	attending	the	local	health	centre.	Trial	participants	may	also	have	better	controlled	illness	after	several	months	of	taking	anti-psychotic	medication.	The	impact	of	the	latter	difference	should	be	minimised	by	having	almost	identical	eligibility	criteria	between	the	pilot	and	trial.	Elements	of	the	supervision	arrangements	also	differed	between	the	pilot	and	trial.	As	part	of	the	pilot	process	data	collection	I	conducted	fortnightly	feedback	meetings	with	CBR	workers	and	supervisors.	As	well	as	providing	valuable	information	on	the	implementation	of	CBR,	these	meetings	acted	as	training	sessions	for	CBR	workers	and	CBR	supervisors	(who	had	no	previous	experience	of	CBR).	I	was	also	present	at	group	supervision	meetings	and	some	individual	supervision	meetings	during	the	pilot.	In	contrast,	during	the	trial	supervision	and	refresher	training	was	entirely	led	by	the	supervisors	and	intervention/trial	coordinator.	My	role	was	to	remotely	help	to	resolve	occasional	emerging	challenges	in	intervention	delivery	that	had	not	arisen	during	the	pilot.	These	differences	were	implemented	deliberately	and	reflect	the	fact	that	the	aim	of	the	pilot	was	to	further	develop	the	intervention,	whereas	the	trial	intervention	was	designed	to	be	scalable.	According	to	MRC	guidance	on	the	process	evaluation	of	complex	interventions,	continuous	quality	improvement	activities	are	suitable	during	piloting	but	it	is	not	usually	appropriate	for	researchers	to	conduct	such	
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	activities	during	effectiveness	studies	[9].	My	changing	role	between	the	pilot	and	trial	was	therefore	appropriate.	However,	as	my	role	during	the	pilot	was	arguably	one	of	implementer	rather	than	simply	evaluator,	the	intervention	may	function	differently	in	the	trial.	CBR	quality	in	the	trial	may	be	reduced,	and	therefore	CBR	may	be	less	effective	than	expected.	On	the	other	hand,	we	would	expect	CBR	worker	competence	to	improve	over	time	with	increased	experience.	CBR	quality	will	be	monitored	with	external	ENACT	assessments	throughout	the	trial.	The	CBR	worker	workload	and	area	of	coverage	are	much	greater	in	the	trial	compared	to	the	pilot.	This	may	mean	that	the	intervention	is	less	feasible	than	it	appeared	to	be	in	the	pilot.	Furthermore	CBR	workers	may	have	provided	more	intensive	support	and/or	conducted	more	community	mobilisation	work	in	the	pilot	than	will	be	possible	in	the	trial.	Three	CBR	workers	did	provide	over	the	expected	22	home	visits	over	12	months.	However,	this	was	only	minimally	more	intensive	(23,	24	and	27	visits	were	provided	in	these	cases),	and	additional	visits	tended	to	be	related	to	encouraging	engagement	in	CBR	rather	than	the	delivery	of	CBR	modules.	On	the	basis	of	the	pilot	findings,	I	also	accounted	for	the	greater	travel	distances	in	the	trial	by	decreasing	the	anticipated	CBR	workload	and	increasing	transport	allowance.	Finally,	some	contextual	changes	were	seen	in	the	trial	compared	to	the	pilot,	in	relation	to	the	availability	of	anti-psychotic	medication.	These	will	be	discussed	below	(see	Section	9.5).		
9.3.5 Classification	of	CBR:	an	intervention	or	an	approach?	Throughout	this	thesis	CBR	has	been	referred	to	as	an	‘intervention’.	Referring	to	CBR	as	an	intervention	aligns	it,	and	allows	it	to	be	readily	compared	to,	other	types	of	psychosocial	interventions	for	schizophrenia.	The	systematic	review	(Chapter	4)	found	that	psychosocial	interventions	for	schizophrenia	in	LMIC	are	diverse	and	comprise	both	multifaceted	interventions,	and	also	single	component	interventions,	such	as	psychoeducation	or	family	intervention.	Furthermore	the	term	intervention	reflects	the	fact	that	I	developed	a	unified	conceptual	framework	(theory	of	change)	for	how	the	various	components	of	CBR	work	synergistically	to	improve	functioning.		
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	The	alternative	view	is	that	it	is	misleading	to	describe	CBR	as	an	intervention.	Instead	CBR	may	be	better	described	as	a	package	of	care,	a	treatment	model	or	simply	an	‘approach’.	These	terms	better	acknowledge	the	fact	that	whilst	aiming	to	achieve	similar	goals,	that	is	the	improved	quality	of	life	and	social	inclusion	of	people	with	disabilities,	CBR	programmes	in	general	can	cover	a	range	of	elements	to	fit	in	with	the	local	context	and	the	needs	of	participants.	Indeed	the	diversity	of	such	programmes	is	arguably	one	of	CBR’s	defining	features.	Moreover,	within	the	RISE	intervention	there	are	a	range	of	components	which	individuals	may	receive,	or	not,	depending	on	their	particular	needs	and	wishes.	These	include	a	choice	of	11	optional	modules	(from	strategies	to	deal	with	anger,	to	support	getting	back	to	work),	targeted	mobilisation	of	financial	or	practical	support	from	community	members	and	participation	in	family	support	groups.	The	great	number	of	potential	permutations	might	make	it	challenging	to	create	a	fidelity	measure	for	the	RISE	CBR	intervention.	On	the	other	hand,	core	components	of	CBR	were	specified	in	the	intervention	design;	these	comprise	the	receipt	of	the	four	core	modules	by	individuals	and	the	local	delivery	of	seven	core	community	mobilisation	tasks,	such	as	community	awareness-raising	events.	Process	data	were	collected	in	the	pilot	and	trial	to	determine	whether	these	core	components	were	carried	out	as	planned.	As	discussed	in	Chapter	8	(Section	8.3.2),	a	sensitivity	analysis	will	be	conducted	on	trial	data	to	elucidate	the	impact	of	receiving	different	components	of	CBR	on	disability,	including	both	core	and	optional	components.	It	is	conceivable	that	a	fidelity	scale	could	be	created	from	this	information,	specifying	the	receipt	of	components	that	are	needed	for	impact	on	disability.		In	summary	CBR	may	be	best	described	as	a	package	of	care,	but	this	‘package’	can	nevertheless	be	evaluated	as	a	unified	intervention	in	a	cluster	randomised	trial.	A	theory	of	change	framework	can	be	used	to	understand	which	parts	of	the	CBR	package	were	implemented	in	practice,	how	these	components	contribute	to	changes	in	functioning,	and	ultimately,	how	the	entire	CBR	package	exerts	its	impact.	
9.3.6 Sustainability	of	CBR	According	to	the	WHO’s	CBR	guidelines,	sustainability	should	be	a	guiding	principle	for	all	CBR	projects	[1].	Attempts	to	formalise	support	from	edir	groups	
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	were	found	to	be	unfeasible	in	the	pilot,	and	the	creation	of	new	formal	structures	to	continue	some	aspects	of	CBR	was	ruled	out	at	the	intervention	development	stage.		However	it	is	possible	that	some	of	the	successes	relating	to	the	community	mobilisation	work	(for	example,	the	financial	support	from	local	benefactors)	may	continue	in	a	self-propelling	fashion	once	CBR	has	finished.	A	limitation	of	the	pilot	and	trial	evaluations	is	that	we	are	unable	to	determine	the	extent	to	which	these	informal	support	mechanisms	will	continue.			
9.3.7 Enduring	impact	of	CBR	Due	to	time	and	resource	constraints	there	is	no	planned	long	term	follow	up	of	pilot	or	trial	participants.	Simply	gathering	stakeholder	opinions	as	to	whether	the	positive	impacts	of	CBR	are	likely	to	endure	is	of	interest	(and	it	is	noteworthy	that	several	pilot	CBR	participants	were	pessimistic).	However	this	approach	does	little	to	inform	us	whether	receiving	12	months	of	CBR	confers	an	enduring	advantage	to	individuals	after	home	visits	have	terminated.			
9.3.8 Issues	relating	to	the	comparator	(facility-based	care)	It	is	arguable	that	a	more	consistent	form	of	facility-based	care	should	have	been	provided	by	the	research	project	for	all	pilot	and	trial	participants,	for	example	by	providing	free	medication.	This	would	have	allowed	a	‘cleaner’	evaluation	of	CBR,	more	akin	to	an	efficacy	trial.	The	results	of	such	a	trial	may	have	been	more	useful	to	policy-makers	on	the	assumption	that	financing	and	scaling	up	of	an	adjuvant	intervention,	such	as	CBR,	is	unlikely	to	occur	without	more	fundamental	service	provision,	such	as	free	anti-psychotic	medication,	already	being	in	place.	Yet	the	RISE	trial	is	able	to	answer	what	are	possibly	more	important	questions:	first,	does	CBR	offer	any	additional	benefit	in	the	context	of	a	real-life	mental	health	care	system	characterised	not	only	by	several	barriers	to	access	but	also	inconsistencies	and	rapid	changes	in	service	provision?	And	second,	by	what	means	can	CBR	successfully	navigate	this	system	to	improve	access	to	mental	health	care?	This	is	a	more	pragmatic	approach	given	that	there	is	no	immediate	prospect	of	free	anti-psychotic	medication	being	made	available	in	Ethiopia.		
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9.3.9 Generalisability		Pilot	and	trial	participants	were	restricted	to	those	with	enduring	or	disabling	illness;	and	those	with	this	level	of	illness	after	six	months	access	to	facility-based	care,	in	the	case	of	trial	participants.	The	rationale	for	this	design	was	that	if	this	intervention	were	scaled	up	in	a	resource-poor	setting	such	as	Ethiopia,	it	is	likely	to	be	rationed	for	a	similar	group. Yet	there	is	an	alternative	argument	that	this	‘difficult	to	treat’	group	may	not	represent	the	population	of	patients	who	would	most	benefit	from	the	intervention,	nor	the	group	to	whom	the	intervention	would	be	delivered	were	it	to	be	scaled	up	in	other	settings.	This	may	limit	the	generalisability	of	the	trial	results.		The	inclusion	of	participants	with	co-morbid	intellectual	disability	was	a	pragmatic	design	decision	that	reflects	the	likely	range	of	conditions	that	would	be	included	at	the	implementation	stage	of	CBR	for	schizophrenia.	This	therefore	improves	the	generalisability	of	the	results.		
	
9.3.10 Scalability	The	RISE	materials	will	be	made	freely	available	via	the	Mental	Health	Innovations	Network	(www.mhinnovation.net).	We	anticipate	that	they	will	be	relevant	for	researchers,	NGOs	and	policy-makers	in	Ethiopia	and	other	LMICs.	If	this	CBR	intervention	is	found	to	be	effective	it	could	be	readily	incorporated	into	the	large	global	network	of	CBR	programmes	for	people	with	disabilities	[1].	The	CBR	intervention	was	developed	in	collaboration	with	CBM,	which	is	an	international	disability	organisation	linked	to	numerous	CBR	projects	around	the	world.	The	RISE	CBR	intervention	design,	training	materials	and	manual	will	be	used	to	guide	or	expand	the	inclusion	of	mental	health	into	existing	CBM-partnered	CBR	projects	in	Ethiopia	and	other	LMICs.	It	is	possible	that	individual	programmes	would	adapt	the	RISE	CBR	intervention	for	their	own	needs.	For	example	a	set	12	month	intervention	may	not	be	appropriate	for	programmatic	settings;	instead	people	with	schizophrenia	may	participate	in	CBR	for	shorter	or	longer	periods	according	to	their	needs.	It	is	conceivable	this	more	flexible	approach	would	be	more	acceptable	and	feasible.		
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	As	part	of	a	forthcoming	endeavour,	the	RISE	project	will	also	be	used	as	a	case	study	in	the	creation	of	a	set	of	CBM	guidelines	for	best	practice	relating	to	CBR	and	mental	health	(personal	communication,	Julian	Eaton).	Whilst	these	represent	exciting	applications	of	the	RISE	CBR	intervention,	the	coverage	of	existing	CBR	programmes	is	generally	low,	and	would	be	unable	to	reach	the	whole	population	of	people	with	schizophrenia	who	require	support	and	who	may	benefit	from	CBR.		Formal	health	systems	represent	another	route	for	scaling	up	community-based	psychosocial	interventions	such	as	CBR.	From	one	perspective,	if	it	is	found	to	be	effective,	the	RISE	CBR	intervention	offers	a	scalable	model	of	community	care	for	settings	with	scarce	mental	health	resources.	The	CBR	workers	and	also	the	main	supervisors	are	non-specialists,	thereby	addressing	the	shortage	of	mental	health	professionals	in	low-income	countries	such	as	Ethiopia.	Although	the	RISE	intervention	featured	psychiatric	nurse	and	psychiatrist	input	when	required,	there	was	no	routine	supervision	by	mental	health	specialists.	Running	costs	can	be	kept	low	as	there	are	few	outgoings	apart	from	staff	salaries:	there	is	no	microfinance	element,	no	medication	provision	and,	whilst	office	space	is	required,	overhead	costs	can	be	kept	at	a	minimum	as	the	intervention	is	delivered	at	participants’	homes.	In	addition,	non-specialists	are	likely	to	require	lower	salaries	compared	to	psychiatric	nurses	or	other	specialists.	The	COPSI	trial	found	that	much	of	intervention	cost	stemmed	from	the	cost	of	supervision	by	psychiatric	social	workers	and	psychiatrists	[7].	Training	can	be	completed	in	a	relatively	short	period	of	five	weeks,	compared	to	the	one-year	training	for	health	extension	workers	in	Ethiopia.	This	means	the	CBR	programme	could	be	rapidly	initiated,	though	on	going	on-the-job	training	is	required	as	demonstrated	in	the	pilot	study.		However,	the	use	of	a	new	cadre	of	workers,	rather	than	existing	health	extension	workers	or	primary	care	staff,	also	renders	the	intervention	difficult	to	implement	on	a	national	level	in	the	short	term.	It	is	highly	unlikely	that	policy	makers	in	LMIC	such	as	Ethiopia	would	prioritise	a	purely	schizophrenia,	or	even	mental	health,	focused	work	force	at	the	community	level.	It	is	also	possible	that	the	RISE	intervention	would	be	seen	as	too	intensive	or	lengthy	for	implementation	at	a	large	scale.	Yet	the	RISE	pilot	and	trial	nevertheless	hold	value	as	proof	of	concept	studies.	LMIC	such	as	Ethiopia	are	typically	at	the	early	stages	of	developing	community-based	mental	health	services.	To	maintain	momentum	in	this	process	
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	it	is	important	to	evaluate	interventions	that	may	not	be	immediately	implemented,	but	which	are	likely	to	be	valuable	at	the	later	stages	of	systems	development.	It	is	recognised	that	increased	resources,	including	greater	numbers	of	personnel,	are	critical	to	achieving	universal	access	to	mental	healthcare.	Studies	such	as	RISE	help	to	determine	the	potential	shape	of	the	future	workforce	and	models	of	care.	A	strength	of	the	RISE	trial	is	the	economic	evaluation	that	is	planned;	the	results	of	this	evaluation	will	help	policy	makers	to	determine	whether	it	is	worth	investing	in	this	additional	human	resource.		
9.3.11 Critiques	of	global	mental	health	In	the	last	decade	the	field	of	global	mental	health	has	emerged,	with	the	primary	agenda	of	scaling	up	services	for	people	with	mental	health	problems,	especially	in	LMIC	[50].	Several	criticisms	of	global	mental	health	have	been	voiced	[51-53].			First,	it	is	proposed	that	‘Western’	diagnoses	of	mental	disorders	should	not	be	exported	to	settings	that	have	traditionally	used	alternative	explanatory	models	and	labels	for	distress	or	disturbed	behavior	[53],	and	that	this	is	a	form	of	‘medical	imperialism’	[51].	This	is	supported	by	the	fact	that	the	validity	of	psychiatric	diagnostic	criteria	are	also	being	questioned	in	the	West	[54].		Second,	core	global	mental	health	initiatives,	such	as	the	WHO’s	mhGAP,	are	regarded	as	suffering	from	an	over	reliance	on	psychotropic	medication,	and	this	too	is	thought	to	represent	an	imposition	of	Western	values	and	solutions.	Again,	the	fact	that	psychotropic	medications	have	limited	effectiveness	and	result	in	adverse	effects	has	been	highlighted	[55].	The	possibility	has	also	been	raised	that	the	aim	or	consequence	of	global	mental	health	efforts	is	to	create	new	markets	for	‘Big	Pharma’	[56].	Third,	it	has	been	argued	that	the	scale	up	of	biomedical	services	will	marginalize	or	eliminate	faith	and	traditional	healing	[57],	a	possibility	that	some	have	argued	is	akin	to	colonial	practices	of	outlawing	traditional	health	systems	[53].	It	is	suggested	that	these	traditional	healing	practices,	along	with	general	community	support,	may	contribute	to	better	outcomes	amongst	people	with	mental	disorders	in	the	‘global	South’	[53].	Fourth,	that	the	social	and	structural	determinants	of	mental	health	are	not	taken	into	account	and	that	global	mental	health	efforts	amount	to	the	‘medicalization	of	everyday	distress’	[57].	Finally,	there	are	the	criticisms	that	the	lived	experiences	of	the	people	experiencing	
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	distress	are	ignored	in	the	field	of	global	mental	health	[53]	and	that	truly	collaborative	partnerships	between	institutions	in	the	North	and	South	are	absent	[56].		These	critiques	raise	important	issues,	and	in	responding	it	should	be	noted	at	the	outset	that	CBR	was	first	initiated	by	the	WHO	following	the	International	Conference	on	Primary	Health	Care	in	1978	and	the	resulting	Declaration	of	Alma-Ata	[1]	.	Whilst	the	concept	and	scope	of	CBR	has	since	evolved	with	the	input	of	people	from	low-income	countries,	and	many	projects	are	now	initiated	from	within	these	settings,	it	is	ultimately	a	model	of	care	with	Western	origins.	However,	the	RISE	project	exemplifies	why,	in	some	cases,	the	criticisms	that	have	been	put	to	global	mental	health	are	questionable	or	unfounded.		First,	I	have	endeavored	to	develop	a	deep	understanding	of	explanatory	models	for	mental	illness	in	Ethiopia,	through	reading	local	qualitative	and	ethnographic	studies	and	through	discussions	with	local	researchers	and	practitioners.	Even	if	such	experiences	are	given	a	different	name	and	explanation,	there	is	no	doubt	that	what	in	the	West	we	know	as	schizophrenia	often	leads	to	immense	suffering	in	those	affected	and	their	families.	Far	from	ignoring	contextual	issues,	I	spent	more	than	two	years	examining	the	impact	of	mental	illness	on	individuals	and	families	in	Sodo	district	in	rural	Ethiopia	and,	more	specifically,	attempting	to	develop	a	locally	acceptable	and	effective	response.	For	example,	whilst	biomedical	accounts	of	mental	illness	were	given	as	part	of	psychoeducation,	CBR	workers	were	also	trained	to	acknowledge	and	understand	other	explanatory	models	that	participants	may	have.	Second,	the	underlying	rationale	for	CBR	is	that	psychotropic	medication	alone	is	insufficient	to	address	the	complex	psychosocial	needs	of	people	with	schizophrenia.	Yet	whilst	CBR	workers	do	not	have	prescribing	privileges	they	certainly	endorse	such	forms	of	treatment.	As	explained	by	Patel,	it	would	be	“unethical	to	withhold	what	biomedicine	has	to	offer,	simply	because	it	was	‘invented’	somewhere	else.”	[58].	CBR	may	have	an	important	role	in	helping	people	with	schizophrenia	to	navigate	choices	around	psychotropic	medication.	An	important	pilot	finding	was	the	need	for	honest	discussion	of	the	risks	and	benefits,	and	for	CBR	workers	to	respect	the	wishes	of	those	who	chose	not	to	use	this	form	of	treatment	(see	Section	9.2.3.3).		
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	Third,	traditional	and	religious	healers	were	directly	consulted	in	the	intervention	development	phase	and	the	CBR	intervention	was	designed	to	encourage	engagement	with	these	practitioners,	for	example	for	them	to	contribute	to	the	moral	or	practical	support	of	participants.	However,	in	the	pilot	there	were	no	examples	of	this	type	of	engagement,	which	may	indicate	that	this	work	is	not	as	acceptable	or	feasible	as	was	hoped.	The	lack	of	engagement	was	partly	due	to	popular	holy	water	sites	being	outside	of	the	district	and	therefore	impractical	for	CBR	workers	to	reach.	Some	types	of	traditional	healers	are	known	to	be	taboo	and	‘hidden’	within	their	communities;	this	means	that	identifying	and	approaching	these	healers	may	have	felt	undesirable	to	CBR	workers	and	participants	(see	Chapter	7	Section	7.4.4).	There	was	little	evidence	that	traditional	practitioners	themselves	were	opposed	to	engaging	in	CBR,	though	this	possibility	cannot	be	discounted.	There	may	be	opportunities	to	assess	this	further	in	the	trial.	CBR	workers	were	successfully	trained	not	to	challenge	the	use	of	holy	water	or	other	treatments	by	their	participants,	as	long	as	they	were	not	associated	with	abusive	practices.	Some	pilot	participants	did	continue	to	use	holy	water	whilst	receiving	CBR.	The	fact	that	some	families	in	rural	Ethiopia	resort	to	physical	restraining	their	relatives	indicates	that	existing	care	systems,	including	traditional	forms	of	care,	are	unable	to	address	all	the	needs	of	people	with	mental	illness.	Attempts	by	CBR	workers	to	engage	participants	in	biomedical	care	are	therefore	justified.		Fourth,	a	central	aim	of	CBR	is	to	address	the	social	and	structural	determinants	of	disability.	Whilst	the	work	contained	in	this	thesis	was	carried	out	largely	within	a	Department	of	Psychiatry,	I	explicitly	used	a	social	model	of	disability	to	frame	the	project	(see	Chapter	2	Section	2.3.1).	The	extensive	intervention	development	work	and	piloting	was	carried	out	with	the	explicit	objective	of	determining	the	local	needs	of	people	with	mental	illness	and	creating	an	intervention	to	address	those	expressed	needs.	Locally	appropriate	responses	were	developed,	for	example	through	mobilizing	informal	community	support.	Finally,	whilst	there	were	challenges	in	successfully	addressing	poverty	and	supporting	livelihoods,	the	work	in	this	thesis	was	not	an	exercise	in	simply	‘importing’	a	Western	model	of	care.	Extensive	efforts	were	made	to	seek	the	views	of	people	with	schizophrenia,	their	caregivers	and	the	wider	community	through	qualitative	interviews	and	participatory	workshops.	The	information	gained	was	central	to	the	intervention	design	and	subsequent	amendments.	This	project	arose	from	a	knowledge	gap	
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	identified	by	colleagues	at	the	Department	of	Psychiatry	at	Addis	Ababa	University,	and	the	entire	project	was	completed	in	partnership	with	this	research	group.	Indeed	it	would	have	been	impossible	to	conduct	the	work	without	their	full	support.	I	learnt	a	huge	amount	through	collaborating	with	investigators	at	this	world-leading	centre	for	psychosis	research.	 In	summary,	CBR	is	not	an	approach	that	is	indigenous	to	Ethiopia.	However	in	this	project	I	made	numerous	efforts	to	ensure	it	was	nevertheless	an	acceptable	and	appropriate	model	of	care,	which	is	designed	to	be	useful	to	those	accessing	it.			
9.4 RECOMMENDATIONS	
9.4.1 Policy	and	programmes	The	2012	Ethiopian	National	Mental	Health	Strategy	[59]	laid	out	plans	to	improve	the	availability	and	accessibility	of	mental	healthcare	and	highlighted	the	importance	of	rehabilitation	services	for	people	with	severe	mental	illness.	Yet	the	realisation	of	these	plans	remains	in	the	early	stages	and	there	is	little	detail	on	the	resources	or	services	that	will	be	provided	to	support	rehabilitation.	The	following	recommendations	are	formulated	on	the	basis	of	the	thesis	findings	to	address	the	current	gaps	in	care.	1. In	LMIC	such	as	Ethiopia,	a	community-based	intervention	such	as	CBR	should	be	provided	as	an	adjuvant	service	in	addition	to	facility-based	care	for	people	with	schizophrenia	who	experience	high	levels	of	disability.	The	community-based	service	should	include	home	visits	as	standard	and	should	involve	the	individual’s	family.	Community-based	care	should	be	linked	to	facility-based	care,	rather	than	existing	as	a	stand-alone	service.	2. Non-specialists,	such	as	CBR	workers,	who	are	recruited	from	the	local	area,	should	deliver	community-based	interventions.	Non-specialist	workers	represent	the	most	feasible	option.	3. The	fundamental	aims	of	the	community-based	service	should	be	to	support	livelihoods,	to	improve	understanding	of	schizophrenia,	to	maximise	family	stability	and	care	for	the	individual,	and	to	facilitate	engagement	with	
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	primary	care.	The	service	should	follow	recovery	principles	and	incorporate	a	shared	decision-making	approach.	4. A	facility-based	service	for	mental	health	should	be	provided	in	primary	care	in	line	with	the	WHO’s	mhGAP	guidelines.	The	workforce	providing	this	service	should	be	adequately	trained	and	supervised.			5. Robust	supply	and	financing	systems	should	be	set	up	to	ensure	there	is	continuous	provision	of	psychotropic	medication	to	primary	care.	Primary	care	treatment	options	should	be	expanded	to	include	depot	injections,	atypical	anti-psychotic	medications	(which	may	have	a	more	acceptable	side	effect	profile)	and	anti-cholinergic	medications	to	help	manage	extra-pyramidal	side	effects.	More	acceptable	medication	may	improve	the	acceptability	of	community-based	services	such	as	CBR,	as	well	as	improving	medication	adherence,	which	could	increase	the	impact.	Home-based	provision	of	medication	should	be	available	for	emergency	situations	and	the	most	remotely	located	households.		6. Anti-psychotic	medication	should	either	be	made	free	for	all	people	with	schizophrenia	or	available	through	a	workable,	transparent	and	accessible	national	health	insurance	scheme.		
9.4.2 Directions	for	future	research	1. A	briefer	or	less	intensive	version	of	the	CBR	intervention	could	be	developed	to	create	a	more	readily	scalable	model.	This	would	require	careful	analysis	of	the	trial	data	to	determine	which	components	of	CBR,	and	in	what	quantity,	are	essential	for	its	effectiveness.	For	example,	if	community	mobilisation	proves	to	have	minimal	contribution	to	the	impact	of	CBR	this	element	could	be	eliminated.	Conversely	if	most	of	the	effect	of	CBR	is	through	one	particular	pathway	(such	as	family	support,	livelihood	support	or	adherence	support),	these	components	could	be	prioritised	for	inclusion.	A	further	RCT	of	the	refined	intervention	would	then	be	needed.	2. More	research	is	needed	to	explore	the	applicability	of	the	recovery	model	in	LMIC	contexts.	The	exploratory	qualitative	work	underway	alongside	the	trial	should	provide	a	foundation	for	this.	Future	research	may	involve	the	
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	adaptation	of	quantitative	measures	of	personal	recovery,	such	as	the	Questionnaire	about	the	Process	of	Recovery	[60].	3. Further	evaluations	are	needed	to	examine	the	enduring	effects	of	CBR.	Ideally	participants	would	be	followed	up	for	at	least	12	months	after	the	intervention	has	terminated.	Three	key	research	questions	could	be	addressed	(i)	For	how	long	and	to	what	extent	does	any	positive	impact	of	functioning	acquired	through	12	months	of	CBR	endure?	(ii)	To	what	extent	does	improved	family	support	and	community	support	endure	following	termination	of	CBR,	and	what	is	their	role	in	sustaining	improved	functioning?	And	(iii)	Do	hypothesised	causal	pathways	function	beyond,	but	not	within,	the	12-month	time	frame?	For	example	public	attitudes	may	be	slow	to	change	and	affect	social	inclusion.	4. Research	is	needed	on	the	effectiveness	of	strategies	to	implement	and	scale	up	those	interventions	that	have	been	shown	to	be	effective	at	the	evaluation	stage	[61],	which	in	the	future	may	include	CBR	for	schizophrenia.	The	theory	of	change	method	could	be	extended	to	support	this	implementation	stage	[6].	5. Research	governance	and	ethics	procedures	should	evolve	to	reflect	the	needs	of	researchers	developing	and	evaluating	complex	interventions.	This	would	address	the	delays	I	faced	when	seeking	repeated	ethical	approvals	for	the	trial,	due	to	minor	adjustments	to	the	protocol	based	on	the	pilot	findings.	Systems	need	to	be	in	place	to	absorb	on	going	iterative	adjustments	to	the	intervention	design	as	the	research	progresses,	whilst	maintaining	high	ethical	standards.		
9.5 RISE	TRIAL	PROGRESS	
In	total	166	participants	were	recruited	across	48	clusters	(sub-districts).	In	the	intervention	arm	(CBR	plus	facility-based	care)	there	are	79	participants	in	24	clusters	and	in	the	control	arm	(facility-based	care)	there	are	87	participants	in	24	clusters	(see	Figure	9.2).	No	participants	with	co-morbid	intellectual	disability	were	recruited.	The	expected	total	sample	size	was	182	participants	in	54	clusters.	The	reason	for	the	lower	than	expected	recruitment	rate	was	primarily	due	to	
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	lower	than	expected	numbers	identified	by	the	PRIME	cohort.	However,	the	high	proportion	that	consented	to	RISE	largely	made	this	up	for	this;	only	three	participants	did	not	consent	to	participate	out	of	those	who	were	eligible.	This	actual	sample	size	will	give	81%	power	to	detect	a	20%	difference	in	WHODAS	between	treatment	arms	at	12	months,	using	the	same	assumptions	listed	in	the	trial	protocol	paper	(Chapter	8)	and	accounting	for	23%	attrition	of	participants	and	loss	of	four	clusters	(i.e.	assuming	128	participants	in	44	clusters	are	available	for	the	analysis).	At	midline	(6	month)	data	collection	151	participants	(91%)	were	retained	in	45	clusters.	Of	the	15	participants	who	were	lost	to	follow	up	eight	were	in	the	intervention	arm	and	seven	were	in	the	control	arm;	11	participants	were	temporarily	absent	from	their	place	of	residence,	one	had	moved	permanently	to	another	district	and	two	had	died.	In	the	first	13	months	of	the	trial	(until	mid	October	2016)	there	have	been	four	serious	adverse	events:	one	death	by	suicide	(in	the	control	arm),	two	deaths	due	to	other	causes	(one	each	in	the	control	arm	and	intervention	arm)	and	one	suicide	attempt	(in	the	control	arm).	During	the	trial,	medication	availability	appears	to	have	improved	with	depot	injections	now	sporadically	available	in	some	health	centres.	In	some	cases	CBR	workers	have	also	negotiated	with	health	centre	staff	for	their	CBR	participant/s	to	receive	one	of	the	few	available	doses.	Whilst	acting	as	an	advocate	is	arguably	in	keeping	with	the	aims	of	CBR,	this	approach	does	not	address	the	systemic	unavailability	of	medication.	Due	to	the	limited	pool	of	medication,	those	not	receiving	CBR	may	actually	have	less	access	to	medication	than	before	CBR	was	operating	locally,	as	CBR	workers	may	ensure	it	is	all	allocated	to	their	participants.	This	is	therefore	a	worrying	development	that	could	ultimately	serve	to	increase	rather	than	decrease	inequalities	in	access	across	the	whole	of	the	local	population	with	schizophrenia.	This	also	further	underlines	the	need	for	universal	measures	for	improving	access	to	medication.		The	medication	fee	waiver	was	obtained	by	CBR	workers	for	18	participants	in	the	trial.	A	further	eight	participants	had	accessed	the	waiver	prior	to	commencing	CBR;	data	are	not	yet	available	on	the	number	of	control	arm	participants	accessing	the	fee	waiver.	Moreover	the	local	health	administration	began	providing	free	anti-psychotic	medication	for	all	service	users	at	one	of	the	eight	health	centres	during	the	trial	period.	This	provision,	which	is	available	for	participants	in	
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	both	arms	of	the	trial	who	are	utilising	that	health	centre,	may	minimise	differences	between	the	trial	arms	in	relation	to	medication	access	and	therefore	functioning.		
Figure	9.2	CONSORT	diagram	for	RISE	trial	
	
 
 
9.6 CONCLUSION	
The	work	presented	in	this	thesis	attempted	to	resolve	a	central	conundrum:	how	best	to	support	some	of	the	world’s	most	vulnerable	people	whilst	utilising	only	minimal	resources?	The	RISE	pilot	demonstrated	that	CBR	delivered	by	non-specialists	might	be	an	acceptable	and	feasible	approach	to	support	people	with	schizophrenia	in	rural	Ethiopia.	Some	CBR	workers	found	it	challenging	to	accept	the	choices	of	people	with	schizophrenia,	and	this	was	a	threat	to	the	acceptability	of	the	intervention.	A	recovery-oriented	model	of	care,	in	particular	greater	emphasis	on	the	involvement	of	people	with	schizophrenia	in	decision-making,	
316	par(cipants	pre-screened	
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1	person	with	schizophrenia	declined	to	
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87	par(cipants	assigned	to	facility-based	care	only		
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	may	tackle	some	of	these	issues.	This	study	also	highlighted	that	the	fundamental	unmet	need	for	accessible	and	affordable	medication	must	also	be	addressed.	Livelihoods	are	the	biggest	priority	for	many	people	with	schizophrenia	and	their	families.	Whilst	there	were	promising	indications	that	CBR	can	impact	on	poverty	it	is	not	yet	known	whether	this	intervention	can	effect	real	and	lasting	change.	The	RISE	trial	will	help	to	determine	whether	CBR	can	impact	on	a	range	of	outcomes	in	people	with	schizophrenia,	including	functioning	and	economic	activity.																
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